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DIRECTOR'S REPORT
The collective decisions of knowledgeable men go sour
more often than we want. We should not be surprised,
however, that blue ribbon solutions like those proposed
several years ago for recombinant DNA research fre-
quently go astray. High-level committees are generally
called into action only when a problem arises that has
no simple response, or maybe no answer at all.
This was the case when in 1973 Herbert Boyer and
Stanley Cohen came upon a method for rearranging
DNA molecules in the test tube to create hybrid
molecules ("recombinant DNA"), which might be de-
rived, say, partly from mouse DNA and partly from
bacterial DNA. Their ability to put these recombined
molecules functionally back into cells had possibly
opened the way to the creation of novel life forms that
might alter the course of evolution. Moreover, the pro-
cedures for making recombinant DNA were simple and
cheap and if uncontrolled were likely to be universally
taken up and exploited throughout the world within a
year or two at most. So it was natural that concern
should develop as to whether we should just plunge
ahead and hope for the best or whether we should try to
block the momentum of recombinant DNA research
until we could be sure that we were not doing ourselves
in.
But whom to turn to was not at all obvious, since
recombinant DNA research was so open-ended that no
one person was clearly qualified to point the way. This
unsettling fact should have warned us that there might
be no logical response to the existence of recombinant
DNA and that we had no recourse but to move ahead.
Our civilization had reached its present highly ad-
vanced state only by facing the unknown, always hop-
ing that we could generate enough ingenuity to get us
out of any jams that might arise.
Instead, the National Academy of Science made what
then looked like a prudent response. It put together a
high-level committee of scientists who worked with
DNA with the hope that they would do more than throw
dice-that somehow their past experiences would
equip them for a logical response. The truth in such
situations, however, is often just the opposite. But no
one likes to advertise that we may have no meaningful
guide for what tomorrow will bring. Psychologically this
is hard to accept, and our sanity almost demands plac-
ing more faith in experts than the facts warrant. So when
we bring authorities together, we have already half
committed ourselves to following their advice. We
know that if we don't, we may have to make the deci-
sion ourselves and shoulder the criticism if the wrong
moves are made.
Of course, if our experts recommend action that looks
as though it will block what we want to do tomorrow,
we may need much persuasion before we even consider
going along. Most smokers, for example, are unlikely to
stop puffing in public no matter who advises the action.
On the other hand, most Americans would accept a ban
on supersonic airliners since we would not notice their
disappearance. Only those who directly want to use the
Concorde would cry "murder" and employ our legal
system to the full to try and block what they would
regard as capricious nonsense. They know that once a
recommendation has been codified into administrative
rules, the subsequent backpedaling needed to nullify
them may be very hard to bring off.
We should thus be very careful not to push for regula-
tions which we cannot logically defend. We do not
know, for example, whether we are entering a warming
or cooling period for the earth. So it would be a bad
mistake to say we should cut down on the burning of oil,
gas, and coal because if too much CO, is released, the
atmospheric temperature will rise to unacceptable
levels (the so-called greenhouse effect). In fact, we may
want warmer weather to reduce our winter fuel needs.
The point here is that if too many variables exist, predic-
tion becomes impossible and we should back away
from decisions that give the impression that we know
more than we do.
In particular we mustn't overreact by assuming the
worst possible outcome and settling into a siege re-
sponse that prevents the possibility of progress if in fact
nothing catastrophic happens. For example, we would
destroy any chances of maintaining our national pros-
perity if all our governmental actions were predicated
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upon the belief that the Russians were about to engage
us in a nuclear war. And almost equal senseless panic
would result if, say, six months of almost no rain led us
to half-starve ourselves because of the fear that we were
about to enter a decade of no rain.
Likewise, we shall only harm ourselves by assuming
that the newly developed recombinant DNA technol-
ogy poses a credible threat to our civilization. The good
that can come out of its use is immense-it can revolu-
tionize our understanding of human chromosomes, give
us a practical way to make vaccines against difficult-
to-grow viruses like hepatitis, and yield unlimited
amounts of now scarce drugs like the antiviral agent
interferon. Nonetheless, there is opposition to its use
based on the conjecture that our blessings might indeed
be mixed and that recombinant DNA procedures might
also generate new disease agents or modify preexisting
organisms so as to badly upset the earth's ecology.
Not even hints exist, however, that any of these dour
events would be plausible outcomes of totally unre-
strained DNA research. Infectious-disease experts tell
us that pathogenicity is not easy to generate, and the
illegitimate interspecies DNA transfers mediated in na-
ture by viruses have probably already tested the ecolog-
ical consequence of any DNA transfer that we can now
do in the laboratory. We should thus not get into a tizzy
because we can't now, or even in the far distant future,
have a way to disprove implausible hypotheses about
how we may meet our doom. Instead we should push
recombinant DNA research and development as fast as
our resources permit, while keeping alert to the highly
improbable event that one or more lab workers will
come down with a disease that we have not seen before.
Unfortunately, we are not now acting with such bold
intelligence. We are badly held back by a morass of
bureaucratic regulations that are seen by most of the
scientists they affect as having no intellectual validity.
Alas, I was one of those who helped bring about these
increasingly despised rules. Some eleven molecular
biologists, of whom I was one, called in the spring of
1974 for a temporary moratorium on experiments in-
volving either tumor virus genomes or the transfer of the
genes coding for dangerous toxins from one group of
bacteria to another. The moratorium was to last almost a
year, until the matter could be discussed by a larger
internationally based expert group that was to meet in
California at the Asilomar Conference Center. In doing
so, we opted for an apparently fair middle position that
could satisfy both those many scientists who wanted to
move swiftly and those who felt that if we were to err it
should be on the side of caution.
This moratorium call, made in half-haste after only a
half-day meeting at MIT, was an act I later came to badly
regret. The experiments we had so casually halted were
soon to strike me as much safer than many categories of
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work with disease-causing agents that the micro-
biologists have been carrying out for decades without
significant harm to themselves, much less to the public
at large.
For example, experiments with tumor virus genes
inserted into E. coli instinctively appear safer than work-
ing with the viruses themselves. Yet there are no firm
regulations governing tumor virus research-the pre-
cautions to be taken being left to the individual inves-
tigator to decide. This seeming indifference to public
health is not that at all. Without knowing the level of
risk, if any, it is impossible to know what precautions, if
any, are necessary. Any rigid rules governing tumor
virus research are bound to appear capricious to many,
and the only practical recommendation is a prudent
respect for commonly accepted microbiological safety
procedures.
Why then did we react so much more cautiously to.
recombinant DNA? A major reason was that the re-
combinant DNA procedures were not yet a necessary
ingredient for our day-to-day research. Until they be-
came so, we did not see the need to appear possibly
indifferent to the public good by unilaterally ignoring
those who said that science was now out of control.
Moreover, Watergate was still with us and the national
mood was very much to come clean with what one was
up to. So we saw no harm and possibly some consid-
erably credit in so attracting public attention. It was
thought best to overestimate rather than underestimate
our concerns. Later, when more experiments had been
done and no one had taken ill because of recombinant
DNA, we could seriously downgrade, if not forget, the
whole matter. Then no one could accuse us of keeping
back even our most paranoid ideas.
Unfortunately, none of us seriously questioned
whether we might be alerting the public unnecessarily
and by doing so give recombinant DNA doomsday
scenarios a credibility they didn't deserve. For the min-
ute the moratorium was announced, we had, in effect,
asked the public to join us in the decision-making pro-
cess. Why would we have actually halted our exper-
iments if we weren't really worried? This point was not
initially perceived, nor to my knowledge did anyone see
the consequences of forming subcommittees to rate
various types of recombinant DNA experiments for their
potential risks. For if, in fact, risks could be quantitated,
they would have to be real and the virtual inevitability of
the public's insisting that more formal rules take over
when the moratorium ended.
The trap was thus almost closed when we assembled
at Asilomar in February 1975. By then there had been so
much talk to the press and TV about the wisdom of our
initial caution, that it was generally thought politically
unacceptable to argue, as I did, that the whole confer-
ence was a mistake and we would do everyone a service
by cutting it short with a brief statement to the effect that
it was logically impossible to regulate conceptual risks.
Already in their opening statements the organizing
committee cautioned us not to appear self-serving and
instead to come up with guidelines that would have the
dual virtue of having teeth yet being imaginative enough
so that we would not have to stop too many scientif-
ically valid experiments. This mood was quickly shared
by most participants, and speaker after speaker rose to
identify his position with that of intelligent caution.
During the next two days there were only a few minor
embarrassing outcries that the logic behind the pro-
posed rules was paper-thin if not nonexistent; virtually
everyone joined together to come up with a set of inter-
nationally applicable rules to govern how everyone
should subsequently work with recombinant DNA. In
doing so the Asilomar congregants placed their collec-
tive reputation behind the statement that the dangers
were real enough to embrace four categories of increas-
ing presumptive risk. Some experiments were left al-
most unregulated while others became saddled with so
many precautions that virtually all laboratories would
be prevented from their execution.
At first, the Asilomar solution pleased almost every
participant except those relatively few who sensed that
they had been stopped without a fair hearing and that
they had been stymied merely because Asilomar would
have been judged a whitewash if no one had been
seriously hurt. Most others left for home happy that their
own experiments might be done without too much has-
sle if the Asilomar recommendations were soon ac-
cepted by their respective governmental authorities.
The general mood was that of relief, and virtually no one
faced up to what his response would have been if the
majority of experiments had been proscribed as too
dangerous for the ordinary lab.
Quickly, however, the uneasy truth began to emerge
that Asilomar had been more of an emotional experi-
ence than a logical response to firm facts. With no
experiments existing that might provide any clues to the
magnitude of the theoretical bad, there was no convinc-
ing way to defend its conclusions either against those
critics, like me, who saw no compelling reasons for any
guidelines at all, or against the doomsday prophets who
wanted all recombinant DNA work to stop. Thus, not
unexpectedly, the guidelines began to unravel the mo-
ment they became open for formal reexamination.
The initial assault came when the first committee set
up by NIH to receive Asilomar met in July 1975 at
Woods Hole. It was chaired by Dave Hogness and
composed largely of eukaryotic molecular biologists,
several of whom by then had already taken up recom-
binant DNA in a big way. With formal rules now hang-
ing over them, they saw Asilomar as less benign than at
first perceived. Even worse, not one of them felt the
slightest apprehension about work with recombinant
DNA. The only anxiety, in fact, came from the jour-
nalistic build-up of Asilomar as one of science's finest
hours. Such farfetched exaggeration could only make
the public far more concerned than the matter war-
ranted. Hoping to defuse the issue, the Hogness Com-
mittee urged a general relaxation of the proposed rules.
In particular they downgraded what they felt were un-
necessarily harsh regulations for working with tumor
viruses and mammalian DNA.
Almost immediately, however, there were counter
arguments to beef up Asilomar from a group of phage
workers that met here in Cold Spring Harbor a month
later. They proclaimed the Woods Hole action a
dangerous example of the failure of self-regulation.
Making a virtue of their own immediate lack of need for
recombinant DNA technologies, they viewed them-
selves as more objectively suited to decide which exper-
iments should be carefully regulated. They were par-
ticularly bothered by unregulated work with tumor vi-
ruses and wanted assurances that they would not need-
lessly be exposed. However, being totally unqualified to
discuss how tumor virus genes inserted into E. coli could
realistically threaten human beings, they focused
mostly on the putative social misuses of recombinant
DNA and in particular on how it might hasten the day
when we could genetically engineer human life.
NIH quickly caved in and expanded its recombinant
DNA Advisory Committee, knowing that they had no
logical way of choosing the Hogness Committee's rec-
ommendations over those proposed by the self-
proclaimed socially conscious phage world. Moreover,
with Senator Kennedy taking a populist cry that recom-
binant DNA was too important to be left in the scientist's
hands, they wanted to be protected by a broader-based
committee that would listen to all scientific viewpoints
including that of the so-called concerned public. Whom
from the public to choose, however, was not that obvi-
ous, and NI H's first course was to be sure that attention
was given to representatives from both the new left,
which for political reasons wanted to use recombinant
DNA as a rallying cry for the downtrodden in order to
get back at MIT, Harvard, and Berkeley, and from the
Calvinistic hard core of the environmental movement,
which believe that only tighter and tighter regulations
could protect us from our baser motives of greed and
ambition.
This ploy badly misfired as those who now found
recombinant DNA regulation intellectually impossible,
and thus absurd, found themselves outnumbered on the
official scene. The balance tilted toward tougher regu-
lations, and the final guidelines that emerged from NIH
in June of 1976 restricted DNA work far more stringently
than those proposed by Asilomar.
Like any compromise between irreconcilable posi-
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tions, the new guidelines satisfied no one. For example,
the environmentalists reacted with lawsuits based on
NIH's presumed failure to prepare adequate environ-
mental impact statements. And the Science for the
People crowd cried that the guidelines could no be
enforced over industry and that the capitalistic impera-
tive for profits would deluge us with newly created
deadly germs. Equally angry were the increasingly large
number of molecular biologists who could not start their
experiments until the certification of the so-called safe
strains that none of them felt were at all needed. While
so waiting, they could only curse themselves for ac-
quiescing so witlessly in the Asilomar charade. Even
worse, they didn't see how they could call off the whole
thing without seeming erratically self-serving. Having
been greatly praised by the press for their wisdom in
calling for Asilomar, virtually none of them was anxious
to say he thought that the whole exercise was a silly
miscalculation.
Instead, most molecular biologists felt the best course
was to argue in public that the Asilomar guidelines were
the correct response and that if we were to follow them
we would have nothing to worry about. This tactic,
however, frequently created more anxiety than it dis-
persed, for it implied that we knew what we were pro-
tecting ourselves against. If that were so, the dangers
which society faced were real and we must worry what
would happen if the NIH guidelines are not strictly
adhered to. Inevitably there was more and more talk
about the need for some form of punitive national legis-
lation, and drafts of proposed laws began to circulate in
Congress in 1977.
Initially the virtual certainty of some form of national
legislation was accepted by most molecular biologists,
who at the first public go-arounds before Congress al-
most without exception said that some form of
guidelines, if not laws, would be a good thing. This way
they hoped not to antagonize those in power and so
hopefully tone down the final harm. Happily, Congress
got tangled up in trying to decide which form of legisla-
tion was needed, in particular whether it should forestall
the passage of even tougher rules by state and local
governments. This gave us hope that if we lobbied hard
enough the absurdity of recombinant DNA regulation
would become clear and the guidelines would gradu-
ally fade away before anyone codified them into real
law.
In fact this has partly happened, though not as fast as
would have occurred if we all quickly said in public
what we were endlessly boring ourselves with in pri-
vate. In any case, the about-face last Spring of the politi-
cally astute Senator Kennedy almost certainly signifies
that recombinant DNA no longer has any political value
and that public hysteria cannot be maintained indefi-
nitely in the absence of a credible villain. To be sure, not
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all senators are yet on our side, and Senator Stevenson
just recently issued a lengthy report arguing for legisla-
tion. Fortunately his colleague on the Science Commit-
tee, Senator Harrison Schmidt, has issued a strong
counter report and the odds now appear to be against
any recombinant DNA legislation going through Con-
gress in the foreseeable future.
Our main concern now is the speed with which NIH
can rid itself of its regulatory role over DNA research.
New committees must reverse the actions of old ones,
and approximately one year ago there commenced a
concentrated push to effect a general lowering of
all guidelines and in particular to open up tumor virus
genomes to recombinant DNA analysis. To do these
latter experiments we then had to go to England or
France where the rules were not nearly as dogmatic as
ours. New ad hoc groups thus were charged by NIH's
Director, Don Fredrickson, to come in with arguments
for less stringent guidelines. In due course they did their
job, and a by-now somewhat emboldened Recombi-
nant Advisory Committee gave its consent last June to
the desired relaxations. This process, however, was far
from painless. The now absurdly lengthy procedural
details which must be followed to give due process to
those who disapprove any downgrading have con-
sumed a disgracefully disproportinate amount of the
NIH directorate's time. However, by late September we
thought we were at last home, with only the remaining
step being approval by HEW Secretary Califano. His
staff, being lawyers, had no way of independently as-
sessing the pros and cons, and we initially hoped that
Secretary Califano, being a busy man, would just sign
the new guidelines and move on to something to which
he might make a real contribution.
Instead we found the Secretary's staff was in no hurry
to sign and had homed in on the future complexion of
the Recombinant Advisory Committee, which would
have the power to still further downgrade the regula-
tions. In particular they strongly objected to the pro-
posal of NIH that the Committee be dominated by lead-
ing scientists who wanted to work with recombinant
DNA. Instead they wanted an ethically balanced com-
mittee that would represent all sides of the matter.
This proposal naturally depressed many of us since it
opened up the prospect of persons without any scien-
tific qualifications deciding what science we should not
do. Naturally we called on everyone we knew in the
White House to alert them to this new folly within HEW.
We were told, however, that we shouldn't worry, as in
fact the Secretary would on December 15th OK the
proposed guideline relaxations, and, moreover, that
only a few of the public members would be real ob-
structionists and we could count on the rest to help us
quietly dismantle the whole hateful artifice. Why the
White House should see it necessary to put any obstruc-
tionists on board at all is beyond me since I doubt the
current administration would lose more than 500 votes
over the entire United States were it to announce that we
can do anything we want with recombinant DNA.
Now I'm afraid we must remain very vigilant, since
the new public members, by being so appointed, natu-
rally presume they have a real job to do. It is not as if they
were directors of the Postal Service and getting $25,000
per year for twiddling their thumbs. Instead they all too
clearly will be wasting their time if they routinely act as
rubber stamps for a scientific community that knows it is
hopeless to teach them the subtleties of molecular biol-
ogy. Their self-respect may thus demand that they try to
show that we scientists don't know everything; and so
we must expect that they will say "no" more often than
we want.
We must not fight back, however, by saying that only
we scientists can judge unquantifiable conceptual risks.
We are no more qualified than the man in the moon to
assess such situations, and we are stewing in this mess
because at Asilomar we said we were. On the contrary,
if there were firm facts showing us that recombinant
DNA research was leading to dangerous new bugs, then
it would be totally proper for the public to help us
decide what we should do next. Since, however, no
data exist to let us decide rationally whether we or the
public should worry at all, no Recombinant Advisory
Committee should exist at all.
This point, not whether there should be public mem-
bers, is the crux of the matter. We are upset by the
thought of too many public members only because they
may take regulation seriously-unlike almost all
molecular biologists, who now painfully realize their
past blunders and can now be counted on to vote them-
selves out of existence. But if too many public members
exist, they might co-opt enough faint-hearted scientists
to delay the dissolution, so that next year at this time, if
not for another decade, we shall still be writing up these
idiotic memoranda of understanding. We must thus call
out as loudly as we can for the ability to do all forms of
recombinant DNA research unfettered by any inher-
ently mindless chains.
To act otherwise is against all the traditions that have
given us modern science and we should not think our-
selves at all courageous to demand the right to go ahead
with new experiments as long as there is no valid reason
to presume we might harm someone. Yet Secretary
Califano is now proposing that we start serious exper-
iments to show we shall not be put in danger from our
newly created bugs. This is effectively an impossible
demand, for some incalculable risks go along with al-
most all major medical or technological steps, no matter
how we proceed. This fact of life cannot be avoided by
the setting aside of large sums of money for "risk as-
sessments" that necessarily have no generalized
applicability. Given the almost infinite variety of poten-
tial recombinant DNA experiments there is no way that
such risk assessments could ever be done on the mas-
sive scale necessary to reassure anyone with a real
brain. At best the limited highly touted examples would
only waste more public monies.
Yet to my amazement Ms. Shirley Williams, the
hitherto thought most competent Minister of Education
and Science of the British government, has recently
stated on TV that they are prepared to spend "tens of
millions of pounds" (at least one-third of the entire
budget of Britain's Medical Research Council) for re-
combinant DNA risk assessment. This extraordinary
statement is a painful reflection of the gaps that exist
between the two cultures, both in England and here in
the United States, and we can only hope she is soon put
in contact with scientists who have their feet on the
ground.
How we are to educate Secretary Califano and his
staff is not clear, since they seem to see the political
imperative to give almost as much weight to outsiders as
they do to the leaders of our profession. Why this should
be so is hard to fathom, since the Secretary could not
have been indifferent to quality advice in his legal days,
and his public views on cigarettes show he can strongly
choose sides.
We thus have no choice as scientists but to make
widely known our lack of confidence in Secretary
Cal ifano's office, and the possibility that its misguided
equalitarianism will deprive the American nation of the
full benefits of the most powerful new research tool
available for biological research.
Highlights of the Year
Homing in on the way tumor viruses make cells
cancerous
Nine years ago when we started tumor virus research we
chose to emphasize the papovaviruses (e.g., SV40 and
polyoma) since they have unusually small chromo-
somes that at most can code for 5-10 genes. Hopefully
only a few, if not one, would code for the key protein(s)
that converts normal cells into cancerous equivalents.
Now we believe only two protein products (big T and
little t) have this role, and both are so-called early pro-
teins that function in the beginning phases of the viral
life cycle. T and t have the same amino terminal se-
quences, an inexplicable result until RNA splicing was
discovered with its momentous implication that the
same DNA segment could code for a multiplicity of
different proteins. The larger of these two proteins, big T
(m.w. - 95,000), was shown last year to bind specifi-
cally to tandemly repeating sequences at the origin of
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DNA replication. This was a pleasing result since for
several years T has been thought to function specifically
in DNA initiation as opposed to elongation. Over this
past year Bob Tjian has gone on to show that highly
purified T has an ATPase activity, an attribute previously
found for several bacterial proteins known to facilitate
DNA initiation. Clearly the next step will be to develop
an in vitro system for DNA synthesis in which T plays an
essential part.
t (m.w. - 17,000) remains much more mysterious as
there is no easy way yet known to prepare it in amounts
large enough for conventional biochemical analysis.
Unlike big T, which exclusively functions in the nu-
cleus, small t resides in the cytoplasm, where work by
Bill Topp suggests that it is responsible for the more
disorganized cytomusculature characteristic of SV40-
transformed cells. Addition of epidermal growth factor
to normal cells mimics most t action, leading to the
hypothesis that t functions to convert quiescent cells
into cells metabolically able to commence DNA syn-
thesis provided that specific initiation factors like T are
present. Further progress is likely to depend upon the
construction of genetically engineered viruses that
overproduce t.
Exploitation of our splicing discovery
Last year's discovery of RNA splicing has been quickly
followed up by the sequencing of the tripartite leader
sequence which precedes all the late adenovirus mes-
sages. We started by making a cDNA transcript of
purified fiber mRNA and inserting this through recom-
binant DNA procedures into an E. coli plasmid, which
later could be highly amplified for sequencing studies.
be Sambrook went to ICRF in London to do the recom-
binant DNA steps, since the guidelines then in effect
here precluded work the English permitted. Subse-
quently Sayeeda Zain and Rich Roberts did the neces-
sary sequencing, using the newest Sanger methodolo-
gies. Comparison of the mRNA sequence with that of
the respective genomic DNA sequences showed that
adeno splicing occurs at the same specific sequences
where splicing occurs for ovalbumin, immunoglobulin,
and hemoglobin mRNAs. The enzymes that do the spl ic-
ing are probably similar, if not identical.
The exact significance of the 120-nucleotide-long
leader remains unknown except for the obvious fact that
it must somehow facilitate mRNA binding to eukaryotic
ribosomes.
Our Symposium marks the 25th anniversary of the
Double Helix
For several years we had thought that the 1978 Sym-
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posium should be on DNA replication. Not only was the
Double Helix found in 1953, but it was at the 18th
Symposium (on Viruses) that it got its first real public
presentation. Moreover, experiments on DNA replica-
tion might at last be converging on the final answer and
in addition were beginning to strongly affect our think-
ing about crossing over. So, early in June we brought
together for our 43rd annual Symposium most of the key
scientists now involved with DNA replication and re-
combination. The formal program was our fullest yet, as
was the total attendance of some 425. Our main lecture
hall holds only 225 seats, so we set up closed-circuit TV
in several outlying spots including a massive tent. Hap-
pily, there were not many complaints from the late
arisers who never saw the live morning show, which
each day started as soon as the lecture room was totally
occupied. By the end of the meeting, sessions were
beginning just after 8 a.m., or less than nine hours after
the completion of the previous evening session.
We started out strongly with an opening talk by Arthur
Kornberg, and the conclusion was delivered with the
crisp elegance of Frank Stahl. Altogether there were
some 153 presentations, both formal and informal, and
we much look forward to the necessarily massive pro-
ceedings, which are scheduled to be ready early in May.
A very pleasant diversion from the necessarily hectic
pace were the gracious dinner parties that our neighbors
held for the speakers. This year we wish to thank in
particular Mr. and Mrs. David Clark, Mr. and Mrs. Nor-
ris W. Darrell, Jr., Mr. and Mrs. Clarence E. Galston, Mr.
and Mrs. Charles S. Gay, Mrs. Carol Lamb, Mr. and Mrs.
James A. McCurdy, Mr. and Mrs. Richard Olney, Mr.
and Mrs. James J. Pirtle, Mr. and Mrs. Franz Schneider,
Mr. and Mrs. Stanley S. Trotman, Jr., Mrs. Ethelbert
Warfield, Mr. and Mrs. Richard J. Weghorn, and Mr. and
Mrs. Theodore Wickersham.
The steadily increasing size of successive Symposia
naturally concerns us, since we cannot view the trend as
temporary. When these meetings began, high-level
biology was practiced at relatively few institutions and
there was almost an avant garde quality to our audience.
Now, however, virtually every important biological
discipline has hundreds of active members and it seems
almost impossible to pick an exciting topic that should
have an audience of less than 300, if not 400. We have
thought of building a lecture hall of, say, twice our
current size; but without simultaneously expanding our
dining, housing, and parking facilities, we would still be
pressed to the wall. Thus common sense tells us not to
plan for another lecture hall, but instead we must just
accept further chaotic Symposium weeks. As long as we
can pick topics in the forefront of biology, we trust the
high quality and integrity of the occasions will compen-
sate for our inadequacies as hotel keepers.
Appointment of Victor McElheny to direct our Banbury
Conferences
Some 18 months ago we began searching for Founda-
tion help to let us start up at our Banbury Conference
Center a major program of small, high-powered meet-
ings aimed at assessing the risks to humans of the ever-
increasing collection of chemicals known to damage
our genetic material. Many such agents initiate cancers,
and how we should realistically respond to their steadily
rising presence in high-technology societies is often not
clear. Happily, we were able to persuade Victor
McElheny, the Technology Correspondent of The New
York Times, to consider directing our efforts, and with
his leadership dangled as bait, the Klingenstein Fund
and the Sloan Foundation each responded last spring
with awards of $100,000 to cover our first two years of
operation.
Vic formally joined us in mid-May, just before we
began our first such Banbury Meeting. Its topic was
"Assessing Chemical Mutagens: The Risk to Humans."
Funding came from the Environmental Protection
Agency, which shared the organization of a program
that brought together for three very intensive days some
25 experts in chemical mutagenesis. The proceedings
were transcribed and, after extensive editing by our
staff, will appear in book form in March 1979 as our first
Banbury Report.
Full-scale operation of Banbury will commence in
April of this coming year, and plans are now well-
advanced for three risk-assessment-related meetings in
the spring and three in the fall.
Planning a new residence for our Banbury guests
From the start of our planning for a meetings facility at
the Robertson estate we have considered 32 partici-
pants as optimal for small, specialized conferences last-
ing two to three days. This number should allow every-
one to meet informally, hopefully over one or more
meals, yet is large enough for a diversity of outlook and
experience. So we renovated the Georgian-style garage
to give us a meeting room to handle this number, pur-
chased 32 super Herman Miller chairs to go around our
specially designed massive conference tables, and took
comfort that the dining facility at Robertson House
could, if slightly pressed, handle only 32.
The number of guests, however, that can live in the
main house is a maximum of 21, and then only with
double occupancy of most bedrooms. This is not always
practical, and we knew initially that almost half our
conference participants would have to be housed
elsewhere, a far from perfect situation when a major aim
is extended informal conversation.
So, with the start-up of our Risk Assessment Program
assured, and Victor McElheny in command, we corn-
menced plans for a small residence that would provide
us with 16 single rooms. Our architects, Moore, Grover
and Harper, were asked to come up with schematics for
a building that would be architecturally harmonious
with the Georgian-style buildings constructed for the
Robertson family. Their stunning proposal, which came
to us in September, is for a square residence of classical
Palladian form, with a central hall around which eight
rooms are located on each of the two floors. Happily,
the Kresge Foundation gave its consent to use the
$150,000 in funds that it granted us last year, toward the
construction costs. We have now started on the working
drawings, with ground-breaking planned at the latest by
late Spring. Our target completion date is March 1980,
in time for that year's spring group of risk-assessment
meetings.
Major changes in our scientific staff
This August, Ray Gesteland, a member of our scientific
staff for 10 years, left us to join the University of Utah as
the Howard Hughes Professor of Biology. Always one of
our key scientists, Ray also served with great distinction
as our Assistant Director for Research. We would not be
where we are today were it not for his unequivocal
devotion both to the Lab and to the Cold Spring Harbor
community in which he, his wife Harriett, and their four
children were such respected and well-liked members.
Ray Gesteland
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Just before their departure more than a hundred of their
friends here joined them for a nostalgic farewell evening
cruise on the Great South Bay. And an inscribed clock of
elegant Tiffany design was presented to them as they
began their journey to Salt Lake City. We wish them all
forms of success in their new lives and trust they will find
new occasions to again grace our surroundings.
Also leaving our staff this fall was Jim McDougall,
who has taken a senior position at the Hutchinson
Cancer Center in Seattle. While here he began in-situ
nucleic acid hybridization methods that finally should
settle the question whether Herpes II virus is a causative
agent for cervical cancer. And Bob Tjian returned to
Berkeley, where he was an undergraduate, to become
an Assistant Professor of Biochemistry. His superb
biochemical training was an invaluable asset to James
Laboratory and his departure creates a gap that will not
be easily filled.
Departing at the completion of their postdoctoral
training were Ray Bigelis to work at Cornell with Jerry
Fink, Denise Galloway to continue work in Seattle with
Jim McDougall, Walter Schaffner to take up a faculty
position at the University of Zurich, Merilyn Sleigh to
return to the CSIRO Genetics Lab in Sidney Australia,
and Mark Zabeau to join the staff at the EMBO lab in
Heidelberg.
Newly appointed to head our Mammalian Cell Ge-
netics group is Michael Wigler, who moved here early
in December from the College of Physicians and Sur-
geons of Columbia University. Joining him early in 1979
as a Staff Investigator will be David Kurtz. Both did their
Ph.D. research at P & S, where they stayed on for post-
doctoral research. In James Lab, Bill Topp has moved up
to become a Senior Staff Investigator, while Ashley
Dunn and Dan Klessig have become Staff Investigators.
Mike Mathews has moved from James to Demerec, to
lead the Protein Synthesis section jointly with Jim Lewis.
And in the Cell Biology group Stephen Blose is now a
Staff Investigator.
Our first appointment in Neurobiology is Birgit
Zipser. Before coming here Birgit was a Research As-
sistant Professor at Downstate Medical School in Brook-
lyn, to which she moved after graduate and postdoctoral
research at the Albert Einstein College of Medicine.
We acquire our first powerful computer
This spring the National Science Foundation awarded
us a major grant of $120,000 to purchase equipment
that will let us quantitatively analyze two-dimensional
protein gels. These gels, first developed several years
ago by Pat O'Farrell when he was a graduate student at
Boulder, have enormous potential for probing cells.
They allow us to look at each of the thousands of pro-
teins that a given cell type possesses. So much informa-
tion, however, is present in each gel that mere visual
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observation is inadequate, and quantitative procedures
for scanning and subsequent computerization are a re-
quisite for their full utilization. Working them out
proved not to be a simple problem, and only recently
did Jim Garrells, then at the Salk Institute, make the
necessary first steps. Now a member of our Cell Biology
section, Jim is further developing these methodologies
with the help of a very high resolution optical scanner
coupled to a PDP 11-60 computer that we have recently
installed in the second floor of our library.
The electrophoretic procedures themselves will be
done in McClintock Laboratory, in space that is being
vacated as we complete the move of our shops and
photo services to their new quarters in the renovated
greenhouses. We shall start the necessary construction
early in 1979 and plan to have the new biochemical
labs ready late in the spring. We hope for a routine
operation of this program by fall. Then, with the finan-
cial help of the National Science Foundation, we will
make this unique facility available also to our neighbors
in the New York area.
Starting up a year-round yeast group in Davenport Lab
We now have a very active year-round research group
in Davenport Lab focusing on Yeast Genetics. Not only
are yeasts extraordinarily interesting in themselves, but
the recent discovery that they can be transformed opens
up the possibility that they will become a powerful
cloning vehicle for eukaryotic genes. Most fortunately
we were able to attract Jim Hicks and Jeff Strathern, both
former students of Ira Herskowitz, to give us our initial
momentum. They were soon joined by Jim Broach, who
learned to work on yeast genetics in Bob Mortimer's
Berkeley lab before coming to work with Ray Geste-
.44/447"
Jim Carrells works at new computer
land, and by Amar Klar, who first worked with yeast as a
doctoral student of Harlyn Halvorsen and then mastered
yeast genetics with Seymour Fogel in Berkeley. There is
space for this group to grow to six or maybe seven
members and its bright future seems already assured.
Our only problem is how to help it survive the nine
summer weeks when it must coexist with our genet-
ically oriented summer courses.
The Robertson Research Fund remains uniquely
important
The existence of a sizable endowment specifically re-
stricted to research is an asset possessed by few inde-
pendent research institutions. Each year our Robertson
research funds let us respond quickly to opportunities
for the possibility of carrying out an incisive experiment
or attracting highly talented scientists. Most impor-
tantly, they routinely let me give guarantees of salary or
equipment support where a key grant or fellowship
stipend fails to materialize. For example, we assured Jim
Garrells that we would back up his request to the Na-
tional Science Foundation for the scanner and computer
needed for his 2-D protein gel program. Happily, NSF
came through with almost all the monies he requested,
and then we used the Robertson monies to acquire an
even more powerful computer than we had originally
planned for-in this case most fortunate, since even our
new computer seems likely to run at full capacity within
a year.
This year we also used Robertson funds to add two
most badly needed scintillation counters (in Demerec
Lab), for the stipends of summer research students, for
the salaries of key junior staff, and to help start up the
new yeast group in Davenport Lab.
The greenhouse renovation nears completion
Long a prominent feature standing between the library
and McClintock Laboratory have been the shingled
potting sheds to which were attached five separate
greenhouses. Built in 1912, they ceased being effective
greenhouses in the 1950s and for many years seemed
ripe for the wrecker's ball. Indeed, three years ago we
started plans to put a new cell biology lab on their site.
Last winter, however, we reversed our course and asked
our architects, Moore, Grover and Harper, to draw up
plans for a total renovation project which would keep
the general outlines of the preexisting structures, yet
provide us with a sparkling new facility. In it we pro-
posed to put our receiving space, stockrooms, our me-
chanical and electronic shops, equipment mainte-
nance, the safety office, photography and other artistic
services, as well as offices and a seminar room for many
of the scientists who work in Demerec Lab.
We very much liked their plans, and the rebuilding
process began in mid-May, with completion targeted for
late December. Renovation of old structures, however,
is seldom straightforward, and not unexpectedly, we
have fallen behind schedule and anticipate final com-
pletion by late February. Already we can see that we
have a visual triumph, which provides a still further case
where the adaptive reutilization of an out-of-date build-
Renovated greenhouse provides new facilities
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ing successfully allows an institution to maintain a firm
connection with its past heritage.
We must also note that this spring we finished an
almost total reconstruction of Cole Cottage. It was built
in 1932 as an unheated summer dwelling and enlarged
slightly with a furnace in 1953. It was justly famous for
its drafts and correspondingly astronomical heating
bills. Now it is a remarkably tight structure, to which a
tiny porch has been added to strengthen its Colonial
Revival-style appearance.
A totally new look was also given this summer to
Olney House by repainting it in colors appropriate to its
elegant 1885 Queen Anne-style construction. Before
painting there was extensive carpentry work to make up
for decades of total neglect, and a chimney was rebuilt
that otherwise might have soon toppled over in a fierce
gale.
A most impressive number of book sales
This year we published four major books as well as the
Abstracts for our eight summer meetings. The first book
to appear was a most comprehensive volume on the
Replication of Mammalian Parvoviruses, edited by
David Ward and Peter Tattersall. Then our latest Sym-
posium appeared, a 1250-page, two-book set on
Chromatin. It was embarrassingly late, owing to the
combined effects of our unbelievably hard winter, the
unexpected resignations of several editors, and the loss
by a messenger of the last folios of edited page proofs.
Fortunately it is one of our more impressive Symposium
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volumes and we trust it will obtain virtually encyclo-
pedic employment. Finally, in December, both our vol-
umes on the Differentiation of Normal and Neoplastic
Hematopoietic Cells and on The Operon appeared. In
these books we have much to be proud of, and we
remain most fortunate that so many outstanding scien-
tists have written well in our behalf.
Our total sales this year will come to more than
16,000 volumes and abstracts, 3000 more than the
1977 sales of 13,000. So far we have already sold over
4500 copies of Origins of Human Cancer, which came
out just as 1977 ended. Its sales are continuing to be
strong, confirming our belief that it contains the best
overview now available of the incidence and causation
of human cancer.
The working conditions of our publications shop are
very cramped and Ms. Nancy Ford and her editorial
staff-comprised of Annette Zaninovic, Roberta Salant,
Chris Nolan, Mary-Teresa Halpin, and Barbara
Cowley-Durst-cleserve much credit for their continued
high level of performance in The face of seemingly
never-ending telephonic interruptions. We have tried to
improve their state by a total remodeling job on their
two tiny rooms, but the only real long-term answer will
be the acquisition of more working space.
Over 1900 attendees at our summer meetings
Seven major meetings were held this summer in addi-
tion to the Symposium. We started with a small gather-
Cole Cottage, restored
ing devoted to "Phorbol Esters," still very mysterious
compounds that promote the growth of newly created
cancer cells. It was followed by a much larger meeting
on "Cytoskeleton and Cytomusculature," which
brought together many leading cell biologists who work
on microfilaments, 100A filaments, and microtubules.
Then we hosted a truly gigantic "RNA Tumor Virus
Meeting" whose afternoons were crowded with poster
sessions to keep the formal talks to a manageable level.
In late July our by now longstanding "SV40, Polyoma,
and Adenovirus Meeting" was attended by almost 300
participants. Then, in August, came our long-traditional
"Phage Meeting," somewhat smaller than normal be-
cause of overlaps with this year's Symposium. Follow-
ing it was a very concentrated "tRNA Meeting," which
will form the basis of a new volume in our Molecular
Biology monograph series. Concluding the summer was
our sixth annual "Conference on Cell Proliferation,"
most ably organized by Gordon Sato and Russell Ross
and centered on hormones and cell culture. It was dedi-
cated to the memory of Gordon Tompkins and uniquely
marked by two concerts, one of chamber music, the
other of jazz, of which Gordon was a saxophone master.
That so many massive meetings could occur so
smoothly owes much to our ever versatile Meetings
Office staffed by Gladys Kist, Winifred Modzeleski, and
Barbara Eggers.
Continued expansion of our Neurobiology efforts
Two new Neurobiology courses were added this past
summer. The first, on "Basic Neuroanatomical Meth-
ods," was taught with enthusiastic vigor by Matt and
Jenny LaVail. The large number of excellent applicants
reflected the fact that this material is not yet available to
graduate students, even in most advanced universities.
Equally successful was our lecture course in "Devel-
opmental Neurobiology," taught at the Banbury Con-
ference Center by Dale Purvis and Paul Patterson. All
the students lived in Robertson House and totally en-
joyed the ambiance.
Banbury was also the site of a far-ranging workshop
on "Artificial Intelligence" organized by Dave Zipser of
our staff and David Marr of MIT. It was supported by the
Cognitive Sciences Program of the Sloan Foundation
and brought together a number of leading experimental
neurobiologists with their computer-oriented equiva-
lents. Virtually all the participants left satisfied, and we
plan a related workshop this coming summer.
As our summer program continues to grow, the prob-
lems involved in organizing it have correspondingly
increased, particularly in view of our virtually chronic
difficulty in obtaining even limited Federal support to
help cover the very substantial costs. So, most vital to
this past summer's success was help from the Sloan and
Eppley Foundations, and from the Marie H. Robertson
Fund for Neurobiology. In particular, these private
monies allowed us to run advanced workshops on the
"Synapse" in July and September, and on "Visual Per-
ception" in August. All these workshops strongly com-
plemented our more formal courses and we are plan-
ning two more this coming summer, one on the
"Neurophysiology of Pain Receptors" and the other on
the "Use of Computers in Processing Neurophysiologi-
cal Signals."
Given the superb equipment for neurobiology which
we now possess, a serious year-round research program
could be quickly started if we were to obtain the neces-
sary financial support. A first move in this direction was
the appointment this fall of Birgit Zipser as a Staff Inves-
tigator, with her support coming from the National Sci-
ence Foundation and the National Institutes of Health.
Her research focus is the neurobiology of the leech, an
interest which commenced when she took our leech
course in the summer of 1975.
By now we feel most proud of our contributions to
neurobiology, noting the impressive number of our
former students who now hold teaching positions in
major university centers. Hopefully the long-term future
of our program will be assured by the finding of new
endowment monies both to support our courses and to
allow us finally to make long-term salary commitments
to scientists whom we would like to do year-round
research here.
A very high-level course on "Cellular Immunology"
The significance of the immune response in the control
of cancer is still very unresolved, and current attempts to
generate clinical responses suffer strongly from deep
ignorance concerning the basic interactions between
lymphocytes which lead to immune responses. We
therefore decided to use our NCI funds committed to-
ward the teaching of tumor immunobiology for the
holding of an intellectually demanding two-week lec-
ture course that emphasized the major conceptual prob-
lem in cellular immunology. We were very lucky to
have Harvey Cantor and William Paul as the organizers,
and the leading immunologists they brought to lecture
here provided a unique opportunity for the students to
see how our best immunologists try to stay one step
ahead of their data. All in all it went very well and it will
be repeated in 1979 in basically the same form.
Transfer of the last remaining Carnegie lands to the
Laboratory
When, in 1963, the Carnegie Institution of Washington
closed down its Department of Genetics and conveyed
its buildings to the Cold Spring Harbor Laboratory, it
retained ownership of two separate land parcels that
had been acquired as a buffer to help preserve the
relative solitude of science along Bungtown Road. One
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piece of some 10 acres, lying along Route 25A and
extending up Moore's Hill Road to Stewart's Lane, had
been acquired in 1924 with the help of Mrs. E. H.
Harriman from the Estate of Townsend Jones, to whom it
had been deeded by his uncle, John D. Jones, the
Founder of this Laboratory. The second parcel, lying
south of Olney House, with a border along Bungtown
Road and running well up to land owned by the Smoot
Family, was acquired in 1953 from the legendarily errat-
ic Rosalie Jones, daughter of Oliver Livingston and Mary
Elizabeth Jones, and long known for her possession of a
goat herd.
With the gradual development of most of the vacant
land around us, the value of this land as a buffer is even
greater than when it was purchased, and for several
years we have been attempting to have its title trans-
ferred to us. Last year a sense of urgency developed
when we realized that the most desirable site for a badly
needed new animal facility was across Bungtown Road
from Demerec Lab, partly on Carnegie-retained land.
Happily, Jim Ebert's assumption of the Carnegie presi-
dency in July helped bring a speedy agreement whereby
all the remaining Carnegie land would come to us for a
purchase price of $200,000, to be payable over five
years without interest. It then became a matter for the
lawyers, and with the invaluable help of our neighbor,
Jim Eisenman, the final papers changed hands just be-
fore the New Year arrived.
Downscaling our "super mouse house" plans
The very limited quarters 1- 1000 sq. ft.) we have for
holding small rodents in our "mouse house" means that
we have no choice but to build more such space if we
are to stay in the forefront of modern molecular and
cellular biology as it relates to cancer research. Upon
his arrival here three years ago, Jim McDougall com-
menced plans for a new 11,000 sq. ft. building that
would give us the most advanced air handling, ten large
rooms expressly designed for animals, and many well -
equipped auxiliary research rooms. The then-estimated
cost of this facility was some two million dollars, and we
applied to the National Cancer Institute for 11/2 million
dollars-the maximum allowed under their 75:25
matching provisions. For a site we decided on land that
we hoped soon to acquire from the Carnegie Institution.
We had been forewarned that we might have to wait
some two or three years before our proposal, if ap-
proved, might be funded. But, in fact, we were awarded
a construction grant in August 1977, which meant that
ground could be broken by the spring of 1979. In our
excitement we then expanded our plans to include
laboratories for advanced mouse embryology in what
otherwise would have been vacant basement areas,
thereby bringing the total estimated cost to just over
three million dollars!
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Early this year progress ground to a halt as our
negotiations with the Carnegie Institution stalled, we
hoped temporarily. At the same time Jim McDougall,
the proposed principal user of these facilities, made the
decision to move his research to the Hutchinson Cancer
Center.
We thus began to reexamine what form of animal
facility we should build when we did acquire the Car-
negie land. In particular, we began to worry that Federal
monies for cancer research were reaching a plateau,
and that once our "super mouse house" was built it
might become increasingly difficult to find the operating
funds for it. After we knew for certain that we would
soon have the Carnegie land, we scaled back our design
to a building of some 4500 gross sq. ft., with a projected
total cost of $750,000. Schematic architectural plans for
this more-economical building are in preparation and
by the spring of 1980 we should have at last broken
ground for a building to meet our animal needs for at
least the next decade or two.
LIBA holds its first Dorcas Cummings
Memorial Lecture
Beginning in 1924, community support for us has been
channeled through a marvelous organization, the Long
Island Biological Association (LIBA), which exists solely
for seeing that we prosper. Over the past three years they
have been carrying on a special appeal for funds to
cover the cost of our newly rebuilt Williams House.
Happily this drive, for a total of $225,000, came to a
successful conclusion early this year when the final
$15,000 was conveyed to the Laboratory. We remain
uniquely indebted to Mr. Edward Pulling, Chairman of
LIBA, for overseeing this most appreciated fund drive.
For many years one of the Association's most devoted
members was Dorcas Cummings who, with her hus-
band Robert and family, lived close above us on Ridge
Road. Upon her most untimely death two years ago,
many of her friends gave special gifts to LIBA to create
the Dorcas Cummings Memorial Fund, which now to-
tals some $12,000 in assets. The income from the fund
will henceforth be used to support an annual spring
lecture, the Dorcas Cummings Lectureship. The first of
these lectures was given on Sunday, May 14, by Profes-
sor John S. Kopper of the Department of Anthropology
of C. W. Post College. Entitled "Human Evolution and
Geomagnetism," it related climatic changes induced by
reversals in the earth's magnetic field to sudden bursts of
human evolution.
The Annual Meeting of LIBA, held on Sunday, De-
cember 10, attracted an unusually large and enthusias-
tic audience. The main speaker was Professor Fernando
Nottebohm, a noted authority on bird song, who does
his research at the Millbrook Field Station of The Rocke-
feller University. His talk, on the organization of the
nerve cells that control singing, amazed all of us, who
had never imagined that canaries could be used for
profound science.
Departing from the LIBA Board of Directors at the
conclusion of the maximum six-year intervals were Mr.
Ralph Maffei and Mr. Gerard Piel. Each has served us
well, and we trust we can continue to count on their
loyal assistance. We also lost the long-invaluable ser-
vices of Joan Olney, who, because of her remarriage to
Robin Tilney, moved to Far Hills. Newly elected to the
LIBA Board were Mr. Joseph C. Dey, Jr., Dr. Alfred
Azzoni, and Mr. Edmund Bartlett.
On Sunday afternoon, November 14, there was a
special meeting of the LIBA Directors in the James Li-
brary, at which Jim Hicks and Jeffrey Strathern of our
staff explained the use of recombinant DNA to study
fundamental problems in yeast genetics. Then everyone
went down to Davenport Lab to observe how, in prac-
tice, such experiments are carried out. The gathering
then moved to Blackford, where they joined other
members of our scientific staff for an informal supper.
All the assembled Directors and spouses found the oc-
casion most worthwile and we shall plan similar occa-
sions for succeeding years.
Regretfully we note the death this December of
Louise Ford, for over 25 years one of our staunchest
supporters. Our deepest condolences to her husband
Nevil, LIBA Chairman from 1957 to 1963.
Extraordinary efforts to survive a very ferocious winter
Jack Richards and his Buildings and Grounds depart-
ment performed far beyond the ordinary call of duty to
prevent the massive ice storm of January 14th from
wounding us severely. Electricity from LILCO was off for
almost three days in subfreezing weather, and without
their nonstop efforts so many pipes would have become
frozen that we might have lost months of research.
Particularly to be singled out are our plumbers, Lane
Smith and Doug Haskett, and our electrician, Owen
Stewart, whose quick collection of several small gas-
fired generators and seemingly miles of temporary lines
kept some hours of electricity in all our key buildings.
This blow was soon followed by two of the largest snow
storms ever to hit Long Island. In all, some 55 inches
came down, and without Hans Trede's and Vincent
Carey's devoted snow-removal efforts we would have
been effectively closed down for most of February.
As we do still more and more maintenance and reno-
vation, Jack Richards' life correspondingly has gotten
that much more hectic. We note with satisfaction that
Jack now has the assistance of Charles Schneider, who
comes to us with some 30 years of experience as a
successful Long Island contractor.
More invaluable help from our Board of Trustees
The inevitable challenges that necessarily accompany
our desire to act as a major research institution demand
responses that frequently are not obvious. I remain thus
most fortunate that I have a powerful Board of Trustees,
whose diversely successful backgrounds provide an
enormous potential for incisive counsel. Harry Eagle
leads this remarkably helpful body in an optimistic no-
nonsense fashion that may have no equal. Now joining
him on our Executive Committee are Edward Pulling,
Clarence Galston, Bayard Clarkson, Robert Cummings,
and Vittorio Defendi.
Our spring meeting, once postponed because of
threats of still another devastating storm, inaugurated
what we hope will be a yearly event-a preceding
dinner at Robertson House where our scientific staff
Blackford Hall during 1978 ice storm
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may have started grammar school. For the most part, 
however, our staff do not have the savings necessary to 
make the required down payments for such houses. So if 
they are to have the opportunity of moving off the 
grounds, they must be provided with specially tailored 
mortgage help. To th^end, our Board of Trustees .has 
given its provisional consent to a program similar to that 
now available at Princeton, which provides low- 
down-payment, long-term (30-year) ,mortgagesHo its 
permanent faculty.
The role of the Director needs reexamination
This year over six million dollars were spent for our 
operating and capital programs, an increase דכver the 
past decade of more than fivefold when corrected for 
inflation. Our day-by-day duties are correspondingly 
that much more complex, and I carinot take so lightly 
those who question me as to whether I regret leaving 
science to become an Administrator. Until about two 
years ago I still easily found the free time to talk or read 
science, and my life was not greatly different from when 
I was full-time at Harvard running a large research 
group. Now, however, I fear I administer more than is 
compatible with a daily infusion of new scientific facts 
into my head. Some form of long-term administrative 
reorganization must thus occur. This necessity only 
partly reflects my boredom with tasks that several years 
ago might have seemed novel. The more important 
consideration is that the Director of this Lab must be 
actively in science to insure that we look ahead, not 
backward, in making new staff appointments, organiz- 
ing new courses or meetings, and choosing topics for 
books which will be widely read.
That this situation is not yet totally out of control owes 
much to the first-class job done by Bill Udry in his 
capacity as Administrative Director. To my relief, he 
and his family have just moved to a nearby house on 
Stewart's Lane and he becomes even more available to 
help me out on short notice. And we now also benefit 
gladly from the appointment of Pat Hickey to direct our 
Personnel efforts, including staff benefits, and to oversee 
our hotel I ike aspects.
Equally important, at this year's beginning Joe Sam- 
brook agreed to take on the role of Assistant Director. 
Together we can swiftly solve many problems, but given 
his major role of running James Lab, he is doing more 
|p:an we can rightfully ask for the Ipng term.
Extensive delegation of many more duties to our sci- 
entific staff thus appears to be a prerequisite for our 
long-term health. Up till .now, I have been reluctant to 
move this way, feeling that our scientists needed all the 
time they could get for their research. This still remains 
true for our younger staff, but now it seems inescapable 
that our senior members become more equal partners in 
our universitylike operations.
informally talked and dined with the scientists on our 
Board. It was a most enjoyable occasion, illustrating 
well the great advantages of having a strong scientific 
contingent ;on our Board itself.
Departing from the Board as of our Annual Meeting 
on October 25 were Mr. William Grant, Dr. Julian 
Davies, Dr. Howard Hiatt, Mrs. Joan Olney Tilney, and 
Mr. Walter Page. All have been invaluably helpful and 
we shall much miss them. In particular I must single out 
our neighbor, Walter Page, for the crucial help he gave 
in the setting up of the Robertson Research and Mainte- 
nance Funds. The question was bound to arisie whether 
we, as a then relatively small institution, could respon- 
sibly handle the proposed endowment monies. Walter's 
coming back to our Board in 1972 left no doubt as to our| 
intelligent probity.
Following the Annual Meeting was a dinner held at 
Robertson House to honor our retiring members and to 
let them know how much we want them to remain our 
active friends.
Guarantee of senior scientists' positions through 
"Rolling Five" appointments
Like most private research institutions with limited en- 
dowments, we face the problem of how to guarantee 
long-term salary security to our key senior staff. We 
can't expect them to have the peace of mind necessary 
for real creativity if they fear they might soon have to 
leave if fhe&^urrent grants are not renewed. At the same 
time it is far from clear how long we should continue 
salary support for scientists who cease doing the high- 
quality science for which they were appointed.
To try and satisfy these conflicting imperatives, our 
Board of Trustees at their May meeting approved the 
creation of the rank of Senior Scientist, whose spiders 
would have a continuoqsfe||]ling commitment of five 
more years of salary support. It is our intention to ap- 
point to this rank only individuals who have demon- 
strated exceptional scientific promise; once so ap- 
pointed we would hope that they spend a large fraction 
of their scientific careers here.
Appointed to this rank as of July 1 were Guenter 
Albrecht-Buehler, Michael Botchan, Ahmad Bukhari, 
Richard Roberts, and David Zipser.
Adoption of a mortgage program to help the senior staff 
live in our community
Most of our scientists, when they arriveH ve in one of 
our apartments or smalbhouses along Bungtown Road. 
Virtually none of these units, however, is large enough 
for their needs when, as their families grow, they ac- 
cumulate more and more possessions. The natural 
course for our senior staff is to move into ah already 
existing house or build a new one within the boundaries 
of our local school district, where their children already
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We should not be air-JO to try for the best
When I tirst took over, I assumed that we would grow to
a proper size and then stop, satisfied that we had made
it. Now, after 11 years of steadily increasing budgets, I
realize first -class institutions don't operate that way. It is
not that we want growth per se-for necessarily that
much more money must be raised, and this coming year
we already shall be spending some $20,000 per day.
More to the point is that it is impossible to have an
outstanding staff which does not generate new ideas or
set about to till vacuums that should not exist. When-
ever we see a way to solve a classic problem we should
get on with it, even if we may have to totally reinstru-
ment ourselves. We naturally have to weigh carefully
our chant-es for success, since once financially overex-
tended, climbing back to safety is not always straight-
forward. The best defense against such mistakes, of
course, is the possession of the highest quality scientific
staff, and we must always work hard to remain competi-
tive with the very' best research institutions and univer-
sities. Here we have no more powerful tool than a firm
reputation for pushing first-class ideas with the greatest
possible vigor.
To do this we shall need the continued help of all the
wonderful friends who in the past have helped us raise
so well the unrestricted monies that give us the real
leverage for the unusual. As long as they remain behind
us, and I believe they will, our inherent future remains
indeed bright.
January 6, 1979 1. D. Watson
I must now note our great sorrow at the death on Febru-
ary 15, 1979 of Lucy Lettingwell Pulling.
Her interest in our Lab dates back over fifty years. I ter
father, Russell G. Leffingwel I, a leader in the New York
banking community, helped found LIBA in 1924 and
was one of its original directors. In 1928 Lucy married
Edward Pulling, then a master at Groton. This union was
to last happily over fifty years. In 1931 they founded the
Millbrook School, which, under their devoted, wise
direction, became a leading private preparatory school.
Upon her husband's retirement as headmaster in 1965,
they came back to Oyster Bay to settle in the wonderful
rambling farmhouse on Yellowcote Road in which her
parents had lived.
Quickly Lucy became one of our more important
supporters, and, in particular, I want to acknowledge
the warm friendship which she extended to Liz and me
when we came down from Harvard to begin our mar-
riage. She gave to her home and to all who were privi-
leged to know her a sense of gentle compassion, sensi-
ble loyalty, and open-minded intelligence. Our lives
can never be the same without her, and we shall long
remember how firmly she stood with us.
Lucy Pulling and Nina Calston at Airslie, lune 1978
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YEAR-ROUND RESEARCH
MOLECULAR BIOLOGY OF TUMOR VIRUS
J. SAMBROOK, B. Ahrens, M. Botchan, J. Dorso, A. Dunn, R. Frisque, L. Garbarini, Y. Gluzman, A. Graessman,
M. Graessman, R. Greene, T. Grodzicker, S.-L. Hu, R. Kelch, D. Klessig, D. Lane, M. Lazarus, M. Mathews, R.
McGuirk, R. McKay, R. Pashley, C. Paul, A. Robbins, W. Schaffner, M. Sleigh, D. Solnick, N. Stow, J. Stringer, R.
Tjian, W. Topp, S. Weirich, I. Wendel, J. Wiggins, S. Young, W. Keller
ADENO AND ADENO-SV40 HYBRID VIRUSES
Genetics
In general, we are interested in the way in which the
genomes of DNA tumor viruses are organized and
expressed both during the lytic cycle and in the inte-
grated state. During the last year work has progressed
on several problems. Previously we have reported the
characterization of host-range mutants of the non-
defective Ad2-SV40 hybrid virus Ad2+ ND1. Unlike
Ad2, which grows poorly in monkey cells, Ad2+ N D1
grows equally efficiently in human and monkey cells.
This extended host range is presumably due to the
expression of the integrated SV40 sequences that map
between 0.28 and 0.11 fractional units on the SV40
map. The seven host-range mutants that grow well in
human cells comprise one complementation group,
grow poorly and are defective in the synthesis of late
proteins (especially fiber) in monkey cells, and, like
Ad2, are complemented for growth in monkey cells by
SV40. Thus, they behave as if they have lost the en-
hancement or "helper" function provided by SV40.
Ad2+ND1 expresses a 30,000-m.w. protein that is
coded for in part by SV40 sequences. Whereas four of
the host-range mutants synthesize a 30K protein in
infected human cells and are probably missense mu-
tants, three of the host-range mutants (71, 140, and
162) synthesize no 30K protein but direct the synthesis
of 10K, 19K, and 19K fragments, respectively.
We reported last year that these mutants carried
ochre and amber mutations. Thus, in in-vitro transla-
tion systems, mRNA isolated from mutant-infected
cells yielded the 30K wild-type protein as well as the
mutant polypeptide fragment in the presence of yeast
suppressor tRNAs (Gesteland et al., Proc. Natl. Acad.
Sci. 74: 4567 [1977]). This year, in collaboration with
Adolf Graessmann, who was visiting from the Institut
fur Molekularbiologie and Biochemie, Berlin, we as-
sayed the in-vivo activity of yeast suppressor tRNAs in
mammalian (monkey) cells. We found that microin-
jection of the appropriate yeast tyrosine suppressor
tRNA into mutant-infected monkey cells increased the
yield of viral fiber protein and total virus production.
We are now interested in seeing whether yeast sup-
pressor tRNA genes can be properly expressed in these
cells.
We reported last year that Ad2+ND1 grows in mon-
key cells because it expresses the 3' region of the
inserted SV40 sequences. At that time, we had isolated
revertants of the nonsense mutants that had regained
the ability to grow on monkey cells and had altered
genomes. These mutants either carried duplications of
the distal end of the SV40 insertion fused to the Ad2
fiber gene or had deletions of the proximal end of the
SV40 sequences. Probably they arose by a process of
unequal crossing-over. This is important to what fol-
lows. Several years ago Dan Klessig had isolated mu-
tants of Ad2 and Ad5 that had gained the ability to
grow on monkey cells without acquiring SV40 se-
quences. In collaboration with him, we have been
using marker-rescue and DNA transfection techniques
to map the sites of the mutations in these viruses. Our
first results placed the location of the mutations be-
tween 0.62 and 0.70 on the adenovirus genome, a
region that includes sequences of the genes for both
the early and the late 100K protein. More recent map-
ping, using smaller DNA fragments for marker rescue,
has narrowed the limits of the lesion in one mutant so
First row: S. Zain; P. Reichel and B. Hoffman; second row: T. Gingeras; H. Khatoon; R. Tjian;
third row: D. Zipser; W. Schaffner; fourth row: G. Wong; A. Bukhari; Y. Gluzman
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that we are fairly confident it is located in the early
adenoviral gene that codes for the 72K binding pro-
tein.
Because the Ad5 host-range mutant was isolated
without mutagenic treatment and because revertants
of Ad2 +ND1 appeared to arise by a process of aber-
rant recombination, we set out to see whether host-
range mutants of Ad2 or Ad5 could be obtained that
had altered genomes and might have arisen by re-
combination. Such mutants would be recognized by
differences in the restriction patterns of their DNAs.
Human cells were infected at moderately high mul-
tipl icites with Ad5 or Ad2 for several cycles and then
plated on monkey cells to isolate mutants. Several
nondefective mutants that now grew well were ob-
tained. Analysis with restriction enzymes showed that
they had, indeed, rearranged genomes. However, the
majority of the alterations were not found in the region
that codes for the binding protein, but at the right end
of the genome in and around the fiber gene, whose
expression is severely reduced in monkey cells. We
are presently analyzing these mutants in detail to see
how the control of gene expression has been altered.
A new Ad5-SV40 hybrid virus
A new Ad5-SV40 hybrid (Ad5++D1) has been cloned
from a stock of Ad5 that, many years ago, had been
"adapted" by Hartley et al., (Proc. Soc. Exp. Biol. Med.
92:667 [1956]1 to replicate in rhesus monkey kidney
cells. The hybrid is defective and requires helper Ad5
for productive infection of simian cells. Infection of
monkey cells with the hybrid virus at low multiplicity
gives rise to infectious SV40 virions.
The structure of the genomes in an Ad5 ++D1 hybrid
population has been determined by analysis with re-
striction enzymes, hybridization, and electron mi-
croscopy. They comprise a family of hybrids that differ
from each other by one copy of SV40. The structure of
the largest Ad5++D1 hybrid genome is shown in Fig-
ure 1.
This molecule is divided into two identical halves,
which are joined together as inverted repeats. Each
half of the hybrid DNA molecule contains 2.7 SV40
genomes, organized as a tandem head-to-tail repeat
and joined to 10% of the Ad5 genome located be-
tween map positions 0 and 10. We are presently de-
Ad5
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5540
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termining the DNA sequence of the junctions between
the adenoviral and SV40 sequences and at the reflec-
tion point in the center of the molecule.
9
Transcription and splicing
Within the past 18 months a great deal of evidence has
accumulated that suggests that the transcription of
eukaryotic genes is fundamentally different from that
observed in prokaryotic systems. The unprecedented
observation that many mature viral mRNAs are com-
posed of sequences (leaders) derived from noncon-
tiguous regions of the genome was first demonstrated
with the Ad2 system by groups working independently
at Cold Spring Harbor and MIT. More recently, analy-
sis of eukaryotic genes in several other systems has
revealed the presence of intervening sequences that
are not represented in mature RNAs. In the case of
Ad2, mRNAs transcribed from the viral r strand con-
tain a common leader derived from three noncontigu-
ous regions of the genome around map positions 16.6,
19.6, and 26.6. Until recently it was believed that
functional late Ad2 mRNAs contained only these three
leader segments. However, it is now clear that some
late mRNAs contain additional leaders, which are
thought to be intermediates in processing pathways
that lead to mature mRNAs.
Within the past 12 months we have made a detailed
study of the mRNA
polypeptide-fiber, the most distal of all the late
genes. Frequently, fiber mRNAs containing the tripar-
tite leader also carry the y leader encoded 2000 nu-
cleotides upstream from the fiber gene (Dunn et al.,
Cell 15:511 [1978]; Chow and Broker, Cell 15:497
[1978]). Our analysis of fiber mRNA has been
carried out, in part, usi ng the nondefectiveadeno-SV40
hybrid virus Ad2+ND1 dp2. A convenient feature of
this hybrid is the presence of an insertion of SV40 DNA
immediately distal to the start of the fiber gene. During
the course of productive infection with Ad2+ND1
dp2, a viral mRNA is synthesized whose 5' end in-
cludes the 5' fiber mRNA sequences and whose 3' end
contains SV40 sequences. Biochemical and electron
microscopic heteroduplex analyses reveal that two
forms of this hybrid mRNA exist in the cytoplasm of
cells at late times in infection. Both forms contain the
conventional tripartite leader present on late Ad2
SV40 Ad5
83
Figure 1
Structure of the largest defective Ad5-SV40 hybrid.
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mRNAs but they differ in that the y leader component,
consisting of 180 nucleotides of Ad2 sequences, is
either present or absent. This relative difference in size
has allowed us to separate and isolate the two forms of
hybrid mRNA by electrophoresis through denaturing
agarose gels. By introducing highly purified prepara-
tions of both forms of the hybrid mRNA into a cell-free
translation system, we established that the presence or
absence of the y leader sequence has little or no influ-
ence on the ability of the messenger to direct the
synthesis of the hybrid protein. It seems unlikely,
therefore, that the 4th leader sequence itself plays a
direct role in the messenger translation process. We
considered the alternative possibility that the ribo-
some is the site for a final splicing event in the matura-
tion of the hybrid mRNA. Specifically, we wondered
whether the 4th leader sequence of the hybrid mRNA
is removed during the translation process. Highly
purified 32P-labeled 4th-leader-containing RNA was
incubated in both the reticulocyte lysate and wheat-
germ protein-synthesizing systems under conditions
that yielded efficient synthesis of the hybrid protein.
The RNA recovered from these reactions and assayed
in methyl mercuric hydroxide-agarose gels appeared
unaltered in electrophoretic mobility.
As an extension of this work, we have fractionated
preparations of adenovirus "late" mRNA by elec-
trophoresis through agarose gels containing methyl
mercuric hydroxide and examined the coding capac-
translation. The results
have allowed us to make accurate size estimates of the
RNAs coding for each "late" polypeptide and thereby
confirm or justify the assignments arrived at by other
means. This information is complemented by data
arrived at by hybridization-selection and hybrid-
arrested translation techniques, in experiments carried
out with Bryan Roberts at Brandeis and Bruce Paterson
at NIH, to build up a detailed picture of the arrange-
ment of the translated sequences on the viral genome.
The combination of methods has been particularly
useful in resolving .the species within families of
mRNAs that share common 3' termini (about five such
families exist in the major "late" transcription block).
For example, in one block we have substantiated the
placement of the sequence coding for polypeptide pVl
as an adduct on the 5' side of the sequence coding for
hexon, and in another we have clarified the order as
(5' to 3') penton, pVll, and core-protein V. Having set
the methods on a firm footing, we are now turning to
the problems posed by the "early" mRNAs, where
more extravagant sequence translocations (splices)
and lesser mRNA availability combine to redouble the
difficulties.
How adenoviral mRNAs are fashioned is unknown.
It is generally accepted that posttranscriptional pro-
cessing of short-lived precursor RNAs is involved, but
the mechanism by which leaders become covalently
linked to each other and to the sequences coding for
mRNAs is undiscovered. Presumably, enzymes exist
that recognize specific sequences within the precursor
molecule and cause the removal of intervening se-
quences by endoribonucleolytic cleavage followed by
RNA ligation. To determine whether common features
exist between leader segments and corresponding in-
tervening sequences, we have prepared recombinant
plasmids carrying reverse transcripts of the purified
fiber mRNA of Ad2. In collaboration with Rich
Roberts, Sayeeda Zain, and Walter Keller the com-
plete DNA sequence of the leader region has been
determined and, where possible, the junction be-
tween conserved and intervening sequences has been
defined by reference to the DNA sequence of the Ad2
genome. Although the presence of short, repeated
sequences of the splice junctions make it impossible to
locate the splice point unambiguously, the borders
between conserved and intervening sequences can be
arranged in a configuration that reveals several striking
features (Fig. 2). First, the dinucleotides GT and AG are
found at the respective 5' and 3' ends of each interven-
ing sequence. Second, the nucleotides within the
leaders immediately adjacent to intervening regions
are considerably similar. The prototype sequence de-
rived from our analysis of the junctions between con-
served and intervening regions of adenoviral mRNAs
(Fig. 2) is closely related to that obtained previously for
several other eukaryotic RNAs. In seven mRNAs of the
chicken ovalbumin gene, in the early and late SV40
mRNAs, in the small and large introns of mouse and
rabbit /3-globin, and in the small and large introns of
IgG, the terminal di nucleotides at the 5' and 3' ends of
the intervening sequences are GT and AG, respec-
tively. Furthermore, in all of these cases, as in Ad2,
only limited divergence of the nucleotides adjacent to
the invariant nucleotides is observed. From these data
it seems likely that the common nucleotides at the 5'
and 3' ends of the intervening sequences serve as
recognition signals for excision-ligation enzymes. It is
possible that specific folding of the primary transcript
could arrange the prototype sequences in a configura-
tion conducive to action of these enzymes.
Adeno-SV40 hybrid proteins
A protein related to SV40 T antigen has been isolated
from cells infected with the adeno-SV40 hybrid virus,
Ad2+D2, and shown to bind to DNA (see last year's
report). We discovered that the 107,000-dalton D2
hybrid protein binds sequentially to three tandem rec-
ognition sequences located within a stretch of 120
nucleotides which encompasses the origin of SV40
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Figure 2
Comparison of DNA sequences of adenoviral leader-intervening sequence junctions. A map of the Ad2 genome (not
to scale) showing the four leader sequences of fiber mRNA and their map coordinates. Numbers in parentheses
indicate specific leader-intervening sequence junctions. The leader sequence presented is of the RNA strand (5,-->39
where T has been substituted for U. DNA sequence of the intervening region follows the same polarity (5'-)3').
Vertical dashed lines indicate junction of conserved and intervening sequences. Boxes indicate short direct repeated
sequences at the splice junctions. This feature does not allow precise definition of junction points between leader
and intervening sequences. Letters in parentheses (regions [2] and [3]) indicate predicted nucleotides. The line
beneath the sequence ATG (AUG) (line 8) indicates the translation initiation codon within the main body of fiber
mRNA.
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DNA replication. Recently, we carried out similar
binding studies with T antigen isolated from a different
adeno-SV40 hybrid, Ad2+D1, which encodes an "au-
thentic" large-T- and small-T-antigen protein. Not
surprisingly, the 96,000-dalton D1 T antigen binds to
the origin of SV40 replication in precisely the same
manner as the D2 hybrid protein. To investigate fur-
ther the interaction between these viral DNA-binding
proteins and regulatory sequences at the origin of
replication, we have utilized the reagent dimethyl sul-
fate to methylate adenine and guanine bases which
are not shielded by the binding protein. By sequencing
the methylated DNA, we were able to identify specific
purine residues which are in close contact with the D2
hybrid protein in the DNA-protein complex (Fig. 3).
Our findings indicate that the D2 hybrid protein con-
tacts the DNA exclusively in the major groove of the
double helix and that each of the three binding sites
encompasses approximately 20-25 nucleotides, with
a space of about 20 bases between each site.
Moreover, the binding protein appears to make highly
symmetrical contacts with the DNA. This feature of the
interaction between DNA and protein is most dramat-
ic within binding-site II, where the sequence of nu-
cleotides can assume a conformation consisting of a
perfect 27-nucleotide hairpin-loop structure (Fig. 4).
In addition to obtaining a detailed picture of the way in
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which the D2 hybrid protein embraces the sequences
at the origin of SV40 DNA replication, we have also
discovered that this binding protein interacts in an
analogous fashion with the origin sequences of two
closely related papovaviruses, the murine polyoma
and the human BK viruses.
A logical extension of our efforts to understand the
mechanism of action of SV40 T antigen is to determine
whether the product of A gene is able to catalyze
certain enzymatic reactions that might play a role in
DNA replication or cellular transformation. Our most
recent studies reveal that the D2 hybrid protein is
associated with both an ATPase and a protein kinase
activity. Both of these activities copurify with the
T-antigen-related protein during several rigorous
chromatographic steps. By improving the purification
procedure, we were able to resolve two chromato-
graphic forms of the D2 hybrid protein. Form-I protein
contains only an ATPase activity, whereas form II is
able to catalyze the hydrolysis of ATP as well as trans-
fer the y-phosphate of ATP to either the D2 hybrid
protein itself or to exogenously added phosphopro-
teins such as phosvitin. During glycerol gradient
sedimentation in the presence of SV40 DNA, both
forms bind DNA, but the ATPase activity appears to
cosediment with SV40 DNA more efficiently than the
associated protein kinase activity. Antibody directed
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Figure 3
Purine bases in the T-antigen binding site specifically protected from methylation by dimethyl sulfate. Restriction
endonuclease cleavage fragments of SV40 DNA were generated by digestion with Hinfl and EcoRll. Hinfl fragment A
and EcoRll fragment G were labeled at the 5' ends with [y-31PIATP by T4 polynucleotide kinase and subsequently
cleaved with Mbol and Hint!, respectively. The end-labeled fragments containing the T-antigen binding sites were
punned by agarose gel electropnoresis and subjected to methylation by dimethyl sulfate in the absence (-) and
presence (+) of the D2 hybrid protein. The methylation reaction was performed in 200 pi of buffer containing 1 p.g
end-labeled DNA, 10-20 tag purified D2 hybrid protein, 0.1 mcacodylate (pH 7.1), 0.1 mm EDTA, and 10 µg /ml of BSA.
After methylation of the purine bases, the DNA fragments were sequenced as described by Maxam and Gilbert (1977).
Guanine and adenine residues in the early strand of SV40, which were methylated by dimethyl sulfate, are displayed in
the four lanes at the left; purines from the late strand of SV40 are shown in the four lanes at the right. The
position in the sequencing gel of specific guanine residues that were shielded from methylation or undermethylated
(_ -_) the position of adenine residues that were overmethylated as a result of the interaction between the D2 hybrid
protein and the T-antigen binding sites on the DNA. The cleavage products for each guanine and adenine reaction are
shown in two separate gel loadings so that the pattern of bands near the upper part of the gel are displayed more
clearly.
against SV400 T antigen can specifically inhibit the
ATPase and protein kinase activities, whereas preim-
mune sera have no effect. These findings suggest that
one and possibly two enzymatic activities are intrinsic
to the SV40 gene-A protein. At present, we do not
know what structural differences distinguish these two
forms of the D2 hybrid protein, nor can we be certain
that the associated enzymatic activities are, in fact,
catalyzed by the SV40-encoded gene-A protein.
However, in the year ahead some of these issues
should be resolved, and we may have a better under-
standing of how T antigen functions both in the lytic
cycle of the virus and in transformed cells.
Properties of transformed cells
Over the last two years our interests have centered on
elucidating the role of the two, early gene products of
SV40 (small T, m.w. 17K, and large T, m.w. 96K) in the
maintenance of the transformed state. Our approach
has been to isolate and characterize cell lines trans-
formed following infection with mutant virus strains
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Figure 4
Points of contact between the D2 hybrid protein and SV40 DNA. The parallel solid lines represent the sequence of
nucleotides in SV40 DNA which encompasses the origin of DNA replication and the three tandem T-antigen binding
sites. (.) Purine residues that are in close contact with DBP; (+) the location of specific adenine residues that are
enhanced for methylation to dimethyl sulfate in the presence of the D2 hybrid protein. (I) Strong binding site; (11)
medium binding site; (Ill) weak binding site. The top diagram illustrates the arrangement of contacts made between
the D2 hybrid protein and the SV40 DNA in a conventional duplex conformation. The bottom diagram depicts the
pattern of contacts made between DBP and DNA represented in an alternate configuration containing a hairpin loop
formed by a perfect 27-nucleotide palindrome centered around the Bgl cleavage site. The nucleotides CGC and GCC
shown at the loops of the hairpin structure indicate the location within binding site II that fails to contact the binding
protein.
defective in one or the other of the two "early" pro-
teins. Conditionally lethal Its) mutants of SV40 were
isolated several years ago by Peter Tegtmeyer (I. Virol.
10:591 [1972]) and others. The tsA mutants are defec-
tive in an early function, failing to induce viral DNA
synthesis at restrictive temperatures, and, as shown by
Alwine et al. (Cell 6:529 [1975]), produce a thermally
labile large-T protein. Deletion mutants of SV40 that
have lost DNA sequences within the region trans-
cribed early were isolated in 1976 by the Berg group
(Shenk et al. I. Virol. 18:664 [1976]), and several more
mutants of this class (dI54/59) have been isolated in
our lab. Last year we showed that these dl54/59 SV40
mutants in many cases produced a small-T protein
with an altered electrophoretic mobility, and that the
decrease in protein size corresponded closely to that
predicted from the approximate number of DNA base
pairs deleted. We have isolated a large number of rat
embryo fibroblast (REF) cell lines transformed both by
wild-type (wt) SV40 and by the d154/59 (small-T-
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defective) and LsA (conditionally large-T-defective)
SV40 mutants. These lines have been characterized
extensively during this past year. We have been as-
sisted in these studies by collaboration with Dan Rifkin
and Ruth Crowe at NYU on plasminogen activation of
the lines and with Chungming Chang at NIH on
characterizing the virus-specified proteins present in
these lines.
The specific properties of the REF transformants we
have chosen to study carefully are those described by
Pollack and coworkers (Pollack et al., Proc. Natl.
Acad. Sci. 71:4792 [1974]) at Cold Spring Harbor in
1974: namely, the ability to produce clonal lines, the
ability to proliferate in culture medium supplemented
with only low levels of fetal calf serum, the ability to
grow without anchorage, the ability to activate plas-
minogen to plasmin, and the loss of cytoplasmic
actin-containing fibers. Pollack found that, as a rule,
only two classes of SV40 REF transformants existed.
Their properties are listed in Table 1. In our previous
Table 1
Two classes of SV40-transformed REF
Minimal Maximal
Properties clone on plastic
grow in low serum
Apparent phenotype T+t-
clone on plastic
grow in low serum
clone in methocel or agar
activate plasminogen
lose actin cables
tumorigenicity in nude mice
T+t*
work we had shown that the d154/59 transformants
cloned with high efficiency on plastic cell-culture
dishes and grew well in low-serum medium. On the
other hand, these transformants failed to grow when
suspended in methocel.
More recently we have found that the majority of
d154/59 SV40 REF transformants fail to activate plas-
minogen to plasmin. Although many of the d154/59
viruses do induce loss of actin cables, we have iden-
tified several viruses of this class that we feel are
particularly "tight" for the small-T defect. A large
number of lines were isolated following infection with
these "tight" mutants (e.g., SV40), and 90% of these
lines retained actin cables. Thus, we feel that actin-
cable loss and plasminogen activation, like growth in
methocel medium, require the presence of small-T
activity.
The classification of mutants as "tight" or "leaky"
for small-T function is not totally ad hoc. We had
previously shown that, by some criteria, several of the
dl54/59 mutants (e.g., d1890 and dI2001) transform
with efficiencies intermediate between those obtained
with wild-type SV40 and the residue of the mutants.
Furthermore, when relative viral burst sizes on CV1
and SV40-transformed (presumably small-T comple-
menting) CV1 cells were compared, many dl54/59
mutants gave the same ratio of bursts as did wild-type
SV40, whereas others were ten-fold reduced in the
CV1 line. Because the small-T protein is by all ac-
counts not required for viral proliferation or plaque
formation on CV1 cells, there was no selection either
for or against small-T activity at the time of isolation of
these mutants. It is quite reasonable that both "tight"
and "leaky" mutants should exist. This is to be con-
trasted with the situation with the similar polyoma
virus mutants in which only tight mutants (which
showed a host range) were isolated.
To complete our analysis, we have characterized
the tsA SV40 REF transformants. Earlier work by Mary
Osborn and Klaus Weber (I. Virol. 15: 636 [1975]) had
shown that similar transformants were temperature-
sensitive for the ability to clone and to grow in low
serum, a result we have verified with our lines. In
addition, we find that these lines show only a minor
temperature sensitivity of plasminogen activation. We
feel that in all probability this is due to some propor-
tion (20-80%) of the cells in the several lines tested
totally shutting down viral transcription at the restric-
tive temperature, an effect that would lead to loss of
both viral proteins, and that the decreased activation
reflects the loss of small-T activity.
To evaluate the role of large T in the loss of actin
cables, we turned, through a collaboration with Adolf
and Monika Graessmann who spent six months at
Cold Spring Harbor on sabbatical leaves, to microin-
jection of SV40 species into single cells in culture. We
chose this approach rather than using the tsA trans-
formants both because of the partial shut down of viral
transcription alluded to above and because the mor-
phology of most cells is itself temperature-sensitive.
We found that microinjection of wild-type SV40 DNA
into either the cytoplasm or the nucleus produced a
disappearance within 24 hours of actin cables (as
assayed by immunofluorescence) in approximately
90% of the cells injected. Microinjection of a
restriction-endonuclease-generated DNA fragment
encoding only small T (Hpal+11B) produced a similar
loss, whereas microinjection of dl884 SV40 DNA
(presumably encoding only large T) or a purified SV40
large-T-antigen-related proten (the D2 protein) failed
to affect the actin network in any way, although the
bright nuclear fluorescence characteristic of large T
was obtained. We think that these experiments show
that the loss of actin cables depends only on small-T
activity.
Thus, we now feel that those properties characteris-
tic of the minimal transformants (Table 1) depend only
on large-T activity and those properties unique to the
fully transformed cells (Table 1) depend only on
small-T activity (Table 2). In this analysis we would
characterize the minimal transformants as phenotypi-
cally T+t- and the full transformants as T+t+. The logi-
cal explanation for this difference would be the pres-
ence or absence of small-T protein.
Now that we have identified those properties of
transformed rat-embroyo cells that depend on each of
27
Table 2
Dependence of the properties of transformed REF cells on large T and small T
Property Depends on
Clone on plastic
Grow in low serum
Clone in methocel or agar
Activate plasminogen
Lose actin cables
large T
large T
large and small T
small T
small T
Independent of
small T
small T
large T
large T
the two proteins, we are searching, both in vitro and in
vivo, for other factors (hormones, phorbol esters, etc.)
that act similarly in this system as a step towards
elucidating the mechanism of viral transformation.
It is interesting to note that those properties that
correlate well with cellular tumorigenicity of SV40
REF transformants are just those that depend only on
the small-T protein, and thus we would expect that
small T would play an important role in viral
tumorigenicity. This is apparently the case. In parallel
studies we have undertaken to assess the tumorigenic-
ity of the small-T-defective viruses. Normally, SV40 is
tumorigenic if injected subcutaneously into 6-12 -
hour -old hamsters. Using an inbred line of Syrian
hamsters (LHC), we find that wild-type SV40 produces
tumors in greater than 90% of the animals within 8
months, with an average latency of 4-5 months. At
the time of writing this (11 months) the leaky D154/59
mutants have produced tumors in 10-20% of the
animals injected, with an average latency of 10
months, the tumors have yet to appear from the tight
mutants. Although these tumors are just now being
established into culture to analyze their pattern of
growth in vitro and have not yet been examined his-
tologically, it is already clear that the small-T protein
plays an important role in viral tumorigenicity.
We still have not been able to evaluate fully the role
of SV40 large T in viral tumorigenicity. At present we
still lack that class of transformants that we would
characterize as T-t+, and we are currently undertaking
to isolate such cell lines.
The organization of integrated SV40 DNA sequences
It has been established that the large T (or 96K) early
gene product of SV40 is involved in the maintenancc
of the phenotype of cells transformed by this virus (see
above). On the other hand, the roles of large-T and
small-T proteins in the early events, or the "initiation"
steps, of the transformation process are unclear. One
particular early event that has been a focus of our work
is the recombination that occurs between SV40 and
chromosomal DNA. Previous work from our group
has shown that the cell contains a large number of
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chromosomal DNA sites for the attachment of the viral
DNA; and furthermore that the viral DNA does not
contain a unique DNA site that mediates this attach-
ment. In this past year we have learned that the SV40
viral DNA frequently can be inserted in the chromo-
some as a partial or complete tandem repeat of the
viral DNA sequences. A simple assay for a tandem
insert that we employ is the detection of unit-length
viral DNA fragments after hydrolysis of total cellular
DNA with restriction enzymes which clear viral DNA
once. In general, transformed cell lines that contain
multiple copies of viral DNA usually have at least one
insert that appears to be a tandem array. For example,
evidence for tandem insertions of viral DNA was ob-
tained in nine cell lines independently transformed by
a sea urchin histone DNA-SV40 DNA chimeric virus.
Although our data are incomplete, we suspect that
even in cell lines transformed by restriction fragments
of SV40, complex tandem arrays of viral DNA are
inserted into the chromosome. Our current hypothesis
is that these integrated structures arise by a recombi-
nation event between an oligomeric replicating SV40
molecule and chromosomal DNA. A requirement for
limited viral synthesis prior to integration would be
consistent with the need for an active gene-A product
in the initiation of transformation steps for both mini-
mal and fully transformed lines. A simple origin for
these tandem insertions of SV40 DNA, namely, a re-
combination between a nonintegrated viral molecule
and a chromosomal copy, seems to be ruled out by the
following experiment. We have previously charac-
terized revertant cell lines that still maintain an inte-
grated copy of viral DNA (Steinberg et al. Cell 13 :19
[1978]). These lines can be superinfected with SV40
and subsequent retransformants picked from cultures
grown under appropriate selective conditions. New
tandem arrays of viral DNA could be detected in 8 of
15 such retransformants studied. However, in no case
was the parental or primary insertion of the revertant
cell line perturbed. This experiment shows that tan-
dem insertions arise early in the transformation pro-
cess and are independent of preexisting chromosomal
copies.
With the relaxation of the NIH guidelines for re-
combinant DNA research, we are looking forward to
Figure 5
Heterotriplex DNA consisting of (1) a A Charon 4A DNA strand, (2) a strand of A Charon 4A DNA into which the cellular DNA
EcoRl restriction fragment that contains integrated SV40 DNA has been inserted, and (3) a strand of SV40 DNA linearized by
cleavage with EcoRl.
applying recombinant DNA methods to analyze the
molecular details of the junctions between viral DNA
and chromosomal DNA in transformed cells. We have
recently cloned in the lambda phage Charon 4A, from
the cell line 14B, an endoRl restriction fragment that
contains the entire viral insert of this cell line along
with flanking chromosomal sequences from both the
5' and 3' ends of this integrated DNA. Figure 5 shows a
picture of a heterotriplex molecule constructed by
annealing the phage strands of Charon 4A with the
recombinant viral DNA and RI linear molecules of
SV40. This figure shows that the SV40 sequences in
the chromosomal DNA sequences are very asymmet-
rically placed with respect to the RI restriction sites.
We have begun DNA-sequence analysis of the SV40
junction from the side of the insert that contains very
little cell DNA. Our preliminary results show that there
are 72 nucleotides of cell DNA extending from this
EcoRl site and that these sequences simply merge into
SV40 sequences without any interspersion or muta-
tion of viral sequence at the joint.
We have been particularly interested in this cell line
because of the excision products of the integrated
DNA that are detected after fusion of 14B cells with
permissive simian cells. In contrast to other lines
which yield discrete SV40 molecules upon cell fusion,
the replicating "rescued" forms detected in hetero-
karyons of 14B cells and simian cells are very hetero-
geneous. We have also cloned these excision products
in the lambda WES phage and have begun an analysis
of their structures. It appears that these circular forms
are created by an illegitimate recombination between
SV40 DNA and cell DNA in some cases and cell DNA
from one side of the insertion with cell DNA from the
other side of the insertion in other cases.
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Amino-terminal sequence of adenovirus proteins
We have used the citrate synthase treatment devised
by Palmiter (/. Biol. Chem. 252:2060 [1977]) to
synthesize, in vitro, adenovirus proteins with un-
blocked amino terminals that can thus be sequenced
by Edman degradations. The sequencing has been
done by Carl Anderson at the Brookhaven National
Laboratory, using an automated sequencer. Without
the citrate synthase treatment, about 90-95% of the
material synthesized in vitro has a blocked amino
terminus, making sequencing impractical. We have
been able to synthesize the major late Ad2 proteins in
sufficient amounts to permit sequencing using [355]
methionine and 'H- labeled lysine, leucine,
isoleucine, proline, serine, alanine, phenylalanine,
arginine, glutamic acid, and aspartic acid. Since
nearly the entire amino acid sequence of hexon is
known (H. Jornvall et al., pers. comm.), we first used
hexon to check the functioning of our techniques. By
labeling with methionine and proline, we found that
the initial methionine was at least 80% removed, that
other methionines occurred at residues 6, 7, and 13,
and that proline occurred at residues 4 and 8, exactly
as expected. We next tried fiber, since Sayeeda Zain
and her colleagues here at Cold Spring Harbor have
sequenced the DNA in the region where the 5' end of
fiber mRNA maps and have predicted the amino-
terminal sequence of fiber. In contrast to hexon, the
initial methionine of fiber is not cleaved. So far, we
have found the sequence of fiber to be: Met Lys-
Ala-Pro-Glu-Phe-Pro-Tyr Pro Tyr, exactly as
predicted from the DNA sequence. We consider iden-
tification of 10 of the first 17 residues sufficient to
establish the exact map position of fiber on the se-
quence of that region of Ad2 DNA. Nevertheless we
are currently analyzing samples of fiber labeled with
arginine, serine, aspartic acid, and tyrosine to estab-
lish the general validity of this method. Also, we have
begun to analyze minor core component (V) by the
same method.
Comparison of terminal protein with Ad2-coded
proteins
The protein covalently bound to the 5' termini of Ad2
DNA has been prepared by disrupting density-
gradient-purified, [35S]methionine- labeled virus by
heating in SDS and by separating the DNA-protein
complex from the virion proteins by chromatography
on SDS-sepharose columns. The complex was di-
gested with pancreatic DNase and the 55,000-m.w.
terminal protein isolated. Two-dimensional analysis
of tryptic peptides was used to compare the terminal
protein with the early region 1A 38-50K protein and
late protein IVa2, also [355] methionine -labeled. These
two proteins were chosen for comparison because
they are virus-encoded proteins that have molecular
weights similar to the terminal protein. The compari-
son with 38-50K was of particular interest because
this protein is encoded by the transforming region of
Ad2. However, both comparisons were negative.
Terminal protein shares few, if any, peptides with
either 38-50K or IVa2. We are currently comparing
terminal protein with the recently reported 55K pro-
tein whose gene maps between 4.6 and 11.1 map
units; i.e., within the region required for stable trans-
formation but not within the minimal region of the
genome required to produce cell lines with some
characteristics of transformed cells.
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Table 1
Map coordinates on Ad2 DNA of genes for Ad2 proteins.
Region Strand Coordinates Proteins
Early Proteins
1A R 1.3-4.5 38-50K
1.3-2.6/3.3-4.5
1.3-1.7/3.3-4.5
1B 4.6-11.1 55K2
4.6-6.1/9.8-11.1 15K
9.8-11.1 IX
2 75.2-75.1/68 6-68.4/66.7- 61.8 72K
72.0-71.9/68.6-68.4/66.7-61.8
86.6-86.1/68.6-68.4/66.7-61.8
3 76.6-77.6/78.6-84.7 15.5K °
76.6-77.6/78.6-82.7 14K
76.6-77.6/78.6-81.3 13K
76.6-77.6/78.6-79.1/81.3-86.1
76.6-77.6/78.6-79.1/81.3-84.7
76.6-77.6/78.6-79.1/81.3-82.7
76.6-77.6/78.6-79.1/82.7-86.1
76.6- 77.6/78.6- 79.1 82 7-84.7
76.6-77.6/78.6-79.1/84.7-86.1
4 99.3-99.2/96.8-91.3 23K
99.3-99.2/96.1-91.3 21K
99.3 -99.2/96.8-94.3/92.4-91.3 19K
99.3-99.2/95.5-94.3/92.5-91.3 17K
99.3-99.2/94.8-94.3/92.4-91.3 14K
99.3-94.3/92.4-91.3 13K
11K
Late Proteins
9.8-11.1 IX
L 11.2-14.9 IVa2
R 29.1-49.5 Ills
1111, V)
pVll
R 49.5-62.2 pVI
41.9-62.2
68.0-78.6 100K
38K
pVIII
86.2-91.5 IV
Data from L. Chow, T. Broker, and I. Lewis (unpubl.).
Proteins from Lewis et al. (Cell 7:141 119761); Harter and Lewis (J. Virol. 26:736 (19781).
afirst described by D.J. Spector, M. McGrogan, and H.I. Raskas, personal commun.
°Exactly which mRNA species
within each region encodes which protein has not yet been determined.
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Analysis of heterogeneity of early Ad2 mRNA's
In collaboration with Louise Chow and Tom Broker,
we have been mapping the position of Ad2 early
mRNAs on the viral DNA by using R-loop analysis
(Chow et al., Cell 1 1 :819 [1977]). Since the discovery
that early Ad2 mRNA is "spliced" (Kitchingham et al.,
Proc. Natl. Acad. Sci. 74: 4392 [1977]), we have
reinvestigated the structures of early Ad2 mRNAs by
annealing them with Ad2 single-stranded DNA and
then characterizing the heteroduplexes in the electron
microscope. The picture that has emerged is much
more complicated than our earlier investigation indi-
cated. As can be seen from the summary given in Table
1, as many as nine species of mRNA are complemen-
tary to one early region. Whether each of these
mRNAs codes for a different protein or whether some
species are precursors or aberrant forms is not yet
known. We are currently using methyl mercuric
hydroxide-agarose gel electrophoresis to separate the
various species of mRNA complementary to a given
early region so that an exact correlation can be made
between a given mRNA species and the protein en-
coded by that species. Preliminary results indicate that
21K is encoded by the smallest of the six region-4
mRNAs.
An intriguing observation that arose from this study
is that the 72K mRNA has a different structure at early
and late times. Before the onset of viral DNA synthesis,
and at later times if cycloheximide is used to block the
onset of the late phase, the short 5' leader sequence of
the 72K mRNA is encoded at map position 75. At late
times, even if cytosine arabinoside is used to block
DNA replication, the 5' leader sequence is encoded at
position 72. These results indicate that some differ-
ence in transcription or processing factors exists be-
tween early and late times in Ad2 infection, and that
these factors are synthesized after viral infection, such
as a virus-encoded early protein.
Additional early proteins
Our original studies (Lewis et al., Cell 7:141 [1976]) of
early Ad2 mRNA detected only a 15,000-m.w. early
protein encoded in the region 4.6-11.1 map units.
Subsequently, Persson et al. (Virology 90: 67[1978])
demonstrated that component IX (9.8-11.1 map
units) was synthesized early as well as late, and D.
Spector, M. McGrogan, and H. Raskas (pers. comm.)
reported that a 55,000-m.w. protein was also en-
coded by RNA complementary to this region if the
RNA was prepared 16-20 hours after infection from
cells in which viral DNA replication had been blocked
by cytosine arabinoside. We have confirmed their
observation and, in addition, observed a 17,000-
m.w. protein encoded in this region. Neither the
17,000-m.w. nor 55,000-m.w. protein is synthesized
if RNA is prepared at 6 hours postinfection from cells
in which early protein synthesis has been blocked by
cycloheximide. However, we find that the 22S mRNA
mapping in the interval 4.6-11.1 map units, which
Spector et al. have shown to code for 55K, is seen by
electron microscopy in the 6-hour cycloheximide
RNA preparation in amounts equivalent to those seen
in the 16-hour cytosine arabinoside RNA preparation.
We do not yet understand why the 6-hour 22S mRNA
does not appear to be translated into 55K. Perhaps
there is a difference in structure between the 6-hour
and 16-hour 22S mRNAs that is too small to detect in
the electron microscope. Conceivably, such a differ-
ence could require the action of an Ad2 early protein.
Characterization of mutants of Ad2 and Ad5 which
multiply efficiently in simian cells
Human adenoviruses multiply a thousandfold less ef-
ficiently in simian cells than in permissive human
cells. This block to multiplication can be overcome by
coinfection of the simian cell with SV40. Five host-
range mutants of human adenovirus have been iso-
lated which no longer require the presence of SV40 for
their growth in simian cells. Four are of Ad2 origin
(H2hr400-H2hr403) and were selected by passage in
simian cells after nitrous acid mutagenesis. The fifth
(H5hr404) is a naturally occurring variant of Ad5.
These mutants form plaques and multiply with similar
efficiency in both simian and human cells. These
growth properties are similar to those found for wild
-
type Ad2 or Ad5 in simian cells when the block is
overcome by coinfection with SV40.
The block in wild-type infections prevents efficient
expression of many of the late viral genes. These mu-
tations allow full expression of the late genes. With the
best characterized mutant, H2hr400, the mutation
appears to act in trans, enhancing expression of the
Ad5 fiber gene when simian cells are coinfected with
H2hr400 and Ad5.
These mutants appear to be point mutations, as no
deletions, substitutions, or rearrangements can be de-
tected by restriction-endonuclease digestion or
heteroduplex and hybridization analyses. These re-
sults exclude the possibility that SV40 sequences,
which in certain Ad2-SV40 hybrid viruses (e.g.,
Ad2+N D1) allow adenovirus to multiply efficiently in
simian cells, are present in H2hr400.
In collaboration with Terri Grodzicker, the muta-
tions have been physically mapped using a modified
marker-rescue technique. Because transfection of sim-
ian cells is very inefficient, we have had to use the
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permissive human 293 cell line. These cells were co-
transfected with intact wild-type adenovirus DNA and
purified restriction-endonuclease-generated frag-
ments of the mutant genome by means of the Ca++ ppt
method (Graham and van der Eb, Virology 52: 456
[1973]) followed by glycerol treatment to further en-
hance transfection (Frost and Williams, Virology
91:39 [1978]). The resulting lysate was then passaged
twice on simian cells (CV1) to enrich for recombinants
between the wild-type genome and the restriction
fragment carrying the host-range mutation. After the
second passage, the virus yield was titrated on CV1
monolayers to determine which fragment contained
the mutation. In these experiments the serotype of the
wild-type virus genome differed from that of the mu-
tant from which the fragments were generated so we
would be able to take advantage of the difference in
restriction-endonuclease patterns between the
serotypes. Restriction-endonuclease analysis of the
genomes of the resulting interserotypic recombinants
provided a convenient check on the identity of the
fragment containing the mutation.
The BamHl A (coordinates 59-100), EcoRl B
(58.5-70.7), and Kpnl E (62-72.5) fragments of
H2hr400-H2hr403 recombined with Ad5 or Ad2 to
yield recombinants with extended host ranges. This
places the mutation between coordinates 62 and 70.7.
This region contains most,. if not all, of the early 72K
gene and the 5'-half of the late 100K gene. The
BamHl -EcoRl double-digest-fragment B (59-76) and
Xma I D (56-68) of H5hr404 rescued Ad2. Thus, this
mutation must lie in the region defined between
coordinates 59 and 68. This region contains the 72K
gene, although the presence of the extreme 5' end of
the 100K gene cannot be excluded. Finally, the 100K
gene was excluded by mapping the H2hr400 mutation
within the main body of the 72K gene (coordinates
61.5-66) by rescue with fragment Ball K (62.9-65.6).
Since the 72K gene is already fully expressed in
simian cells infected by wild-type adenovirus, the mu-
tation must be affecting the activity rather than the
synthesis of 72K protein. This protein binds single-
stranded DNA and is involved in viral DNA replica-
tion. However, since viral DNA replication occurs
normally in wild-type-infected simian cells, the muta-
tion must be affecting yet another function of this
protein. Since the mutants fully express their late
genes, in contrast to their parents, the mutated gene
product must be involved in the control of expression
of these genes. Perhaps the wild-type 72K can interact
correctly only with the human cellular component(s)
to turn on the expression of the late genes, whereas the
mutant 72K can interact properly with both human
and simian cellular components.
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Structure analysis of mRNAs from adenovirus-
infected simian cells
The inability of adenovirus to multiply efficiently in
simian cells results from poor expression of its late
genes. Previous experiments, which utilized cell-free
translation and Cat analysis (Klessig and Anderson, J.
Virol. 16:1650 [1975]), suggested that the block to full
expression of these genes may reside at the level of
RNA processing. These experiments indicated that al-
though the synthesis of Ad2 fiber protein was de-
creased 200-1000-fold in abortively (Ad2) vs pro-
ductively (Ad2 + SV40) infected simian cells, the level
of the corresponding mRNA (cytoplasmic RNA com-
plementary to EcoRl E, the restriction fragment encod-
ing fiber) was reduced only 7-20-fold. Although a
nonlinear relationship between concentration of
mRNA and amount of synthesis of the corresponding
protein could explain the above results, the alternative
possibility that the fiber mRNA was defective was
considered first.
Since the cap structure (7mG5'ppp5'N-) at the 5'
terminus of eukaryotic mRNAs is required for efficient
translation of these RNAs (for review, see Shatkin, Cell
9:656 [1976]), the fiber mRNA from infected simian
cells was analyzed for the presence of this structure.
Fiber mRNA from productively infected cells contains
the cap, as does 100K mRNA isolated from both abor-
tive and productive infections. The latter was used as a
positive control since its synthesis and translation is
normal in both types of infections. Fiber mRNA from
abortively infected cells also appears to be capped.
However, as most of of the late mRNAs contain a
common cap (Gelinas and Roberts, Cell 11:533
[1977]; Klessig, Cell 12:9 [1977]) as part of a long,
common, 5' terminal leader, the possibility that the
cap found in fiber mRNA preparations originates from
other contaminating late mRNAs has not been rigor-
ously excluded.
The presence on late Ad2 mRNAs isolated from
human cells of this unusual tripartite leader, which is
encoded distant from the main body of the late genes
(Berget et al., Proc. Natl. Acad. Sci. 74:3171 [1977];
Chow et al., Cell 12:1 [1977]; Klessig, Cell 12:9
[1977]), suggested that the formation of such a struc-
ture is a complex process which might be defective in
abortively infected simian cells. Two approaches are
being used to test this. First, the size and number of
cytoplasmic RNAs from each region of the genome are
being accurately determined by fractionation of the
RNA on methyl mercury-agarose gels, transferring the
fractionated RNA to diazotized paper (Alwine et al.,
Proc. Natl. Acad. Sci. 74:5350 [1977]), followed by
hybridization with radioactively labeled restriction
fragments to detect complementary RNAs. This has
confirmed our earlier findings that there is a consider-
able difference in amount of viral RNA from produc-
tively vs abortively infected cells for each region of the
genome. The size and number of species of viral
mRNAs from each region, however, appear to be the
same regardless of whether the RNA is isolated from
infected human cells or productively or abortively
infected simian cells.
The second approach (in collaboration with Louise
Chow and Tom Broker) involves electron microscopic
analysis of the fine structure of viral RNAs from simian
cells. The majority of the late RNAs that are encoded
between coordinates 27 and 92 and contain the
tripartite leader have similar patterns of splicing in
abortively (vs productively) infected simian cells.
These splicing patterns mirror those seen in permissive
human cells. In marked contrast, fiber mRNA aber-
rantly is spliced in the abortive infection. In addition to
the tripartite leader (encoded between 16-27) and the
main body of the gene (encoded between 86-92), a
large fraction of the fiber RNAs made in Ad2-infected
simian cells contain a large heterogeneous segment of
RNA encoded between coordinates 68 and 78. Pre-
sumably, abnormal splicing results in failure to re-
move this region during fiber mRNA processing.
This observation, taken together with the location of
the host-range mutations within the 72K gene, sug-
gests that the 72K protein may be involved in viral
RNA processing. This is the first evidence in any sys-
tem that a virus may contribute to the presumed host
splicing apparatus. Having preliminarily defined an
abnormal splicing system and mutations that will
overcome this abnormality, we are now in a position
to dissect what is likely to be a very complex enzymat-
ic process.
The lysis gene of the MS2 group of phages appears to
overlap two other genes
Ribosome binding experiments performed with Joan
Steitz from Yale revealed that the main binding site for
mammalian ribosomes on MS2 RNA centered on the
AUG which exists in the +1 reading frame 15 codons
before the coat-gene termination signal. Examination
of the nucleotide sequence determined by Fiers et al.
(Nature 260:500 [19761) shows that a polypeptide
which initiates at this position should contain 75
amino acids. Our previous mammalian cell-free
protein-synthesis experiments (Atkins, et al., J. Biol.
Chem. 250:5688 [19751) showed that a major MS2-
di rected product was a polypeptide of approximately
this size. Recently, in experiments performed with the
held of Carl Anderson, the positions of the proline and
methionine residues in this polypeptide have been
determined. The results show that this polypeptide is
encoded in the +1 reading frame at the end of the coat
gene.
Ten years ago P. Model identified a lysis-defective
UGA mutant of the closely related phage f2 (unpubl.,
but see Horiuchi (RNA Phages, Cold Spring Harbor
Laboratory [1975]). The polypeptide encoded in the
+1 frame is not seen on addition of RNA from this
mutant to the mammalian translation system in the
absence of UGA suppressor. It is seen when UGA
suppressor tRNA from S. pombe (courtesy of J. Koh I i) is
present in the translation system. Similar results were
obtained in an E. coli translation system, although the
relative amounts of the relevant polypeptide were
substantially lower. These results suggest that the +1
frame gene may be the lysis gene, and sequencing of
the suppressed protein derived from the lysis mutant is
required to test this hypothesis, as the nucleotide-
sequencing studies of Steitz severely delimit the pos-
sibilities for the mutant site.
Effect of tRNA balance on gene expression
The major products of in vitro translation of phage
MS2 RNA are the coat protein and synthetase, which is
a component of viral replicase. However, in an E. coli
cell-free translation system, about 5% of the ribo-
somes that initiate translation at the beginning of the
synthetase gene yield a product that is about 3000
daltons larger than the main synthetase protein (Atkins
and Gesteland, Mol. Gen. Genet. 139:19 [1975]).
Heterogeneity of the template RNA is not the explana-
tion for the larger form of the synthetase, as it is not
produced in a mammalian translation system that
yields the main synthetase. It follows from the
nucleotide-sequencing studies of Fiers and colleagues
(Nature 260:500 [1976]) and from in vitro translation
studies with nonsense suppressors that the larger form
of the synthetase cannot be derived from in-phase
reading past a leaky termination codon. Utilizing
purified E. coli tRNAs provided by B. Reid and S.
Ribeiro, it was shown that the proportion of the larger
form of the synthetase is increased by adding Thr
ACU/ACC tRNA and decreased by Pro minor tRNA.
The nucleotide sequence suggests that a fraction of the
ribosomes shift into the -1 reading frame at a proline
codon near the end of the synthetase gene and con-
tinues in that frame to generate the larger form of the
synthetase. Similarly, Ser AGU/AGC tRNA enhanced
synthesis of a protein from the coat gene which is
larger than the "0"-frame product, and Ala GC A tRNA
decreases this misreading. These pairs of tRNAs have
also been seen to affect the synthesis of other polypep-
tides. Thus, the relative amounts of different tRNAs
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influence the type of proteins synthesized. The com-
petition between these tRNAs cannot be explained by
conventional decoding rules.
Identification and mapping of the transcriptional and
translational products of the yeast plasmid 2p. circle
Investigation of the structure and function of 2p circle
has been pursued because of its value as a cloning
vehicle for eukaryotic DNA and because it is one of
the few eukaryotic plasmids. It is a 6000-base-pair
circular species and contains an inverted repeat se-
quence of 600 base pairs separated by unique DNA.
RNA from S. cerevisiae was fractionated on methyl
mercury-agarose gels, and the pattern transferred in-
tact to diazotized paper, which covalently binds nu-
cleic acid, following the procedure developed by Al-
wine et al. Proc. Natl. Acad. Sci. 74:5350 [1977]). The
immobilized RNA was then probed with labeled 2A
circular DNA and hybridization detected by au-
toradiography. Using this method, we identified two
major and approximately ten minor poly(A)-
containing RNA species that arise from in-vivo trans-
cription of the 2/..t circular DNA.
The two major species, which are 1325 and 1275
bases in length, are transcribed from the two unique
halves of the plasmid and extend into the inverted
repeat sequences that separate the unique regions.
The map position of the minor transcripts, which range
in length from 2600 bases to 350 bases, indicate that,
except for a small region of the genome in which no
transcription is observed, both strands of the entire
2g-circle genome are transcribed. We also found that
RNA transcribed from 2A circular DNA is used to
program the synthesis of specific proteins in yeast: (1)
yeast RNA complementary to 2p, circle can be trans-
lated in vitro to produce specific polypeptides of sub-
stantial size, and (2) some of the 2A-circle transcripts
are found on polysomes. Finally, the pattern of tran-
scription of 2p, circle suggests the possibility that
mRNA species are derived by cleavage of larger tran-
scripts and, in addition, that the intramolecular re-
combination of 21z circle that occurs in yeast functions
as a genetic switch to allow separate expression of two
sets of genes on the 2A-circle genome.
Suppressors
In collaboration with Terri Grodzicker and Adolf
Graessmann we are asking whether isolated suppres-
sor tRNA of yeast can rescue the growth of nonsense
mutants of the adeno-SV40 hybrid ND1. Mutant-
infected monkey cells are injected with either Su-
tRNA or tRNA from various suppressor lines and the
virus yield is measured. This will tell us whether the
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suppression event that we know works in vitro gives an
active 30K product in vivo that is capable of providing
rescue. Preliminary results suggest that the yeast
tyrosine ochre suppressing tRNA will rescue growth of
the H71 mutant. We then plan to see if a yeast suppres-
sor gene can function in a mammalian cell.
We have been supplying suppressor tRNA to vari-
ous laboratories interested in investigating the termi-
nation signals at the ends of specific genes. These
experiments have led to the conclusion that in at least
two cases it is possible that read-through of a normal
terminator is a mechanism used to generate longer
polypeptides which are precursors for essential func-
tions. Lennart Philipson working in David Balitmore's
lab at the Massachusetts Institute of Technology
(Philipson et al., Cell 13:89 [19781) showed that the
gag protein precursor (78K) is the predominant prod-
uct of cell-free synthesis and a gag-pol precursor of
180,000 molecular weight is only a minor product.
Furthermore, addition of yeast amber suppressing
tRNA to this reaction mixture greatly enhances the
amount of gag-pol precursor. The implication is that
the gag gene is terminated by an amber codon and that
partial reading of this terminator results in synthesis of
a gag-pol precursor that is further processed to give the
polymerase protein.
In parallel experiments (in collaboration with J.M.
Bishop's lab, University of California) with the avian
tumor viruses, the same situation does not hold. Here,
amber suppression results in a partial elongation of the
equivalent gag protein, but there is no change in the
amount of the polymerase precursor. The conclusion
is that amber is the terminator of the gag gene, but that
there is a second in-phase terminator that prevents
further reading into the message.
It seems unlikely that these two similar viruses
would use completely different mechanisms for syn-
thesis of the polymerase precursor and thus a dilemma
exists. Of course, these experiments say nothing di-
rectly about how the polymerase is made in vivo.
Rather, they only tell us what the structure of the
genome is and what might be possible. Therefore,
although it is possible that the murine leukemia virus
(MuLV) polymerase is made by a low-level reading of
the amber terminator at the end of the gag gene, there
are still a number of other possibilities. Our exper-
iments with the adenovirus mutants (Gesteland et al.,
Proc. Natl. Acad. Sci. 74:4567 [1977]) and Capecchi's
experiments with HGPRT nonsense mutants (Capec-
chi et al., Cell 12:371 [1977]) suggest that mammalian
cells do not have an appreciable leakage rate through
amber terminators. Therefore, perhaps the read-
through seen in vitro is purely a fortuitous result and
the low level of gag-pol precursor normally seen both
irrvivo and in vitro in the absence of suppresion is due
to spliced mRNA or perhaps even modification of a
small fraction of the mRNA such that the terminator is
nonfunctional. In the case of the avian virus, the same
argument could say that the large precursor comes
from a small fraction of spliced or modified message.
Another possibility is that MuLV does use the amber
read-through mechanism to make the polymerase
precursor and it is the context surrounding this amber
terminator that makes it genuinely leaky. And that in
the avian case, another translation mechanism such as
frame-shifting allows 'production of the large precur-
sor. These various possibilities are accessible to exper-
imentation using in-vitro protein synthesis, messenger
structure analysis, and DNA sequencing, and such
experiments are underway in various laboratories.
In collaboration with Hugh Pelham (Nature 272:
469 [19781) an amber read-through mechanism has
been implicated in the production of tobacco mosaic
virus (TMV) proteins. Here, larger precursor protein is
produced in increased amounts when amber sup-
pressing tRNA is added to a cell-free system pro-
grammed with TMV RNA. Again, the validity of this
explanation for in-vivo synthesis is as yet unclear.
These results coupled, with the results described
above on frame-shift by E. coli ribosomes, suggest that
perhaps modulation of translation may, in fact, be a
valuable way for cells to increase the availability of
information and to control the levels of protein prod-
ucts without necessarily synthesizing new messages.
In collaboration with Ken Cremer and Bill Summers
of Yale, nonsense mutants of herpesvirus thymidine
kinase have been identified.
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MAMMALIAN CELL GENETICS
J. McDOUGALL, C. Casserly, C. Copp le, D. Galloway, C. Mutt, E. Paul, M. Slevchuk, C. Stewart, M. Szadowski,
D. Whitfield
During the past year we have continued with studies
on herpesvirus-transformed cells and on the persis-
tence of berpesvirus nucleic acid sequences in human
tissues. The collaboration of Dr. Cecelia Fenoglio at
the Columbia University College of Physicians and
Surgeons has been invaluable.
This work, which was supported by the National
Institutes of Health Cancer Research Center grant, will
continue at our new location-the Hutchinson Cancer
Research Center, Seattle, Washington.
Herpesvirus-2 (HSV2) transformation
We have studied and characterized extensively the
properties of cloned cell lines derived from a UV-
inactivated HSV2-transformed Syrian hamster cell
line. The cloned lines, which came from an extremely
heterogeneous cell population, have defined
cytogenetic markers, are different in their oncogenic-
ity in newborn hamsters, and have been shown to
contain herpesvirus messenger RNA in a portion of the
cells, as detected by in situ molecular hybridization.
We have carried out reassociation kinetics analyses of
a number of these clones, using as probes restriction-
endonucleasederived fragments of HSV2 DNA (D.
Galloway, C. Copple, and J. McDougall, in prep.).
Restriction cleavage of the herpesvirus DNA results in
the generation of fragments whose molarities are
nonuniform. Molar fragments result from restriction
cleavage within the unique sequences; half-molar
fragments represent the termini of the DNA; and
quarter-molar fragments arise from the junctions of the
long and short components in the four configurations.
Isolation of a complete set of restriction fragments
from a single enzyme digest is difficult.
After HSV2 DNA (100 /kg) was digested with an
endonuclease, the cleavage products were fraction-
ated through 0.4% agarose, made visible to UV light
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with ethidium bromide, removed from the gel by
electroelution, extracted with phenol and chloroform,
and ethanol-precipitated. The fragments were resus-
pended in buffer and 0.5 /kg of the fragments were
nick-translated with [32P]deoxytri phosphates to
specific activities around 5 x 10' cpm/p.g. Eight frag-
ments from 4 different restriction-enzyme digests were
used, which, although they did not provide complete
coverage of the genome, had the advantages that they
could be isolated cleanly and represented 80% of the
unique sequences as well as the repetitive DNA of the
short component.
The extent to which the radioactive probe annealed
alone, or in the presence of transformed cell DNA, or
in the presence of one, five, or ten copies of HSV2
DNA was measured in a reaction containing 1.8
mg/ml cellular DNA and 4.8 x 10-4 p.g/m1 of fragment
in 1 m NaCI. The amount of hybrid was measured by
hydroxyapatite chromatography, and the fraction of
single-stranded DNA and the number of copies of the
viral sequences present in the transformed cell DNA
were calculated. A summary of our results diagram-
ming the viral sequences found in 333-8-9 and in the
cloned transformed cell lines is given in Figure 1.
Our results and the published and unpublished ob-
servations of Niza Frenkel and her coworkers support
the following conclusions about the presence of viral
DNA sequences in hamster cells transformed by
UV-inactivated HSV2:
1. All of the lines examined contained HSV2 DNA.
2. Only a subset of the total viral sequences was
retained. Some lines contained an extensive set of
sequences, whereas other lines retained only a
minimal amount.
3. The sequences that were retained were present in
relatively few copies per cell.
4. Viral sequences in the cloned cells have segregated
-,11111MINNI
333-8-9
C
Ca
C to
Oa t
Tu 35
YTut
Figure 1
Viral DNA sequences in hamster cells transformed by UV-inactivated HSV2. These resultsare taken from data obtained by
renaturation kinetics studies using as probes various restriction-enzyme fragments of HSV2 DNA. The black boxes indicate
that the transformed cell DNA contains sequences homologous to those of the HSV2 fragment; the white boxes also indicate
homologous sequences in the transformed cell DNA, but these may be explained by homologyto a subset of the sequences;
the dotted lines indicate that no data are available; the thatched boxes represent anomalous results that needto be retested.
from the original parental line, 333-8-9, and con-
tinue to segregate upon subcloning and by passage
in animals.
5. There is no correlation between the content of viral
sequences and the extent of tumorigenicity.
Persistence of herpesvirus nucleic acid in human
tissues
One of the techniques used previously to demonstrate
the presence of herpesvirus DNA in the neurons of
sensory ganglia was the hybridization in situ of
radioactive virus-specific complementary RNA to
sections of ganglia. The state of the virus when latent in
the neurons is unknown and could be in any form,
from viral DNA (integrated or as free molecules) to
incomplete virions. To establish whether any trans-
cription of the latent herpesvirus genome could be
detected in neurons, we hybridized 3H-labeled HSV2
DNA to frozen sections of human sensory ganglia
obtained at autopsy. The preliminary results from
these studies show that virus-specific RNA can be
detected in some neurons. The background level of
grains over supporting cells is very low, thereby pro-
viding a high degree of confidence in the application
of this method for the detection of viral RNA in other
situations where persistence of the viral genome may
not have been previously established.
Using the same viral DNA probe we have examined
a series of human cervical biopsies taken for
pathological diagnosis. The results from these
cytological hybridizations indicate that HSV2 RNA
can be detected in areas of cells undergoing premalig-
nant changes, autoradiographic grains being as-
sociated most frequently with neoplastic cells but also
associated in some sections with macrophages and
lymphoid cells in the areas of abnormality. The nick-
translated HSV2 DNA probe does not hybridize to
normal cells or to human DNA bound to nitrocellulose
filters under conditions that detect 5 x 10-5 gg of
contaminating human DNA in the probe. Hybridiza-
tion of other viral DNA probes to cervical sections has
proven negative. The results from this series of cervical
biopsies are shown in Table 1; the negative results are
from sections that did not contain any area of abnor-
mality that could be related by pathological examina-
tion to malignant or Oremalignant changes.
The results from the in situ cytological hybridiza-
tions described here are at least indicative of a sig-
nificant presence of HSV2 RNA in cervical tumor tis-
sue. Infection of the human genital area with HSV2 is
common and it is a recognized venereal disease; con-
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Table 1
Cervical biopsies (42 cases)
Diagnosis
In-situ hybridization with
3H-labeled HSV2 DNA
HSV2 RNA
positive
HSV2 RNA
negative
CIN I-Ill 10 4
Squamous metaplasia 2 2
Negative diagnosis 1 23
Total 13 29
sequently, it is possible that we have detected viral
RNA synthesized in virus replication. As HSV2 can
persist in ganglia, there could be reactivation of latent
virus, with consequent replication in the area of
neoplastic tissues when all cells are permissive, and
we have no evidence to suggest that these patients
were undergoing acute infection at the time of biopsy
or that infectious virus was present in the tissues. In-
situ hybridizations using restriction-endonuclease-
derived fragments of HSV2 DNA should identify the
regions of the viral genome from which the observed
RNA species are transcribed.
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MOLECULAR GENETICS
D. ZIPSER, E. Cheng, D. Kwoh, T. Kwoh
The main projects we worked on during the year were:
(1) the mechanism of aberrant protein degradation in
Escherichia coli; (2) the interaction of Mu repressor
with DNA; (3) the expression of cloned yeast genes in
E. coli minicells; and (4) nuclear injection of DNA into
Xenopus oocytes.
Mechanism of aberrant protein degradation in E. coil
We have completed the purification to homogeneity
of protease Ill from E. coli, and have shown it to be a
metal-requiring enzyme that can use Zn", Mn", or
Co" for activity. Protease HI greatly favors as sub-
strates small proteins of less than 7000 molecular
weight. The cleavage specificity was determined by
using theg chain of insulin as a substrate. Protease Ill
cleaves it rapidly at tyrosine-leucine (16-17) and
slowly at phenylalanine-tyrosine (25-26). Mutations
have been isolated in the structural gene for protease
III and they are being mapped. The phenotype of these
mutants is being investigated. We are also studying the
residual protease activity of protease-III- mutations,
which appears to be due to a new protease with quite
different properties from protease III. We are purifying
and characterizing this new enzyme.
Interaction of Mu repressor with DNA
Using the plasmid pMB9, we have cloned a region of
Mu DNA that codes for the Mu repressor and have
been able to identify the Mu repressor protein in 355 -
labeled minicells. This year we have developed
techniques for studying the binding of this Mu repres-
sor to DNA. The binding studies showed that Mu
repressor binds to all DNA at salt concentrations of
< 0.1 M, but in the range of 0.2 to 0.3 m sodium
chloride, it binds specifically to Mu DNA and not to X
or other heteroimmune phage DNAs. By means of
DNA binding assays we have been able to map the
position of the Mu operator, which was shown to be
on the 1000-base-pair fragment of DNA that carries
the repressor. Since operators generally overlap or
follow promoters, it is likely that the early Mu promo-
ter is also on this fragment. This means we have clones
that carry the Mu repressor, the Mu repressor promo-
ter, a Mu operator, and the promoter for Mu early
functions, all within 1000 base pairs of cloned DNA.
Expression of cloned yeast genes in E. coli minicells
We have studied in E. coli minicel Is the expression of a
large number of plasmids carrying cloned yeast DNA.
Those plasmids have been chosen whose inserted
DNA is complementary to a major yeast mRNA.
Among about 50 such plasmids, five produced very
prominent protein bands in labeled minicells. This
means they have promoters and protein initiation sites
that are recognized by E. coli at a high level of effi-
ciency. Several other yeast-DNA-carrying plasmids
express proteins at lower or trace levels, and the rest
showed no detectable expression. We are continuing
this analysis and hope to characterize the features of
yeast DNA that allow high-level expression in E. coli.
Nuclear injection of DNA into Xenopus oocytes
We have been able to set up a nuclear injection system
for Xenopus oocytes analogous to that developed by
John Gurdon of the Medical Research Council, Cam-
bridge. The system functions about as well as the one
in England. We have gotten expression of SV40 DNA
injected into oocytes. Two proteins, VP1 and the 17K
fragment of T antigen, are made in sufficient quantities
to be seen easily on one-dimensional acrylamide gels
using only one-tenth of an egg per gel slot. The rate of
successful injections ranges from 20% to 50%. This is
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a combination of the successful rate of hitting the
nucleus, which is from 50% to 80%, and the sub-
sequent chance of survival of the oocytes as healthy
cells. We are now injecting a variety of eukaryotic
cloned DNAs into oocyte nuclei to see whether they
are expressed.
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INSERTION ELEMENTS AND PLASMIDS
A.I. BUKHARI, L. Ambrosio, G. Chaconas, F. de Bruijn, M. Du Bow, D. Evans, H. Khatoon and N. Sarvetnik
In a series of papers during the past 3 years, we prop-
osed that integration of bacteriophage Mu DNA is
intimately linked with its replication and that the pro-
cess of Mu integration might be a prototype for the
integrative recombination of transposable elements.
Initial arguments, based on the structure of Mu DNA,
underlined the parallel behavior of Mu DNA and that
of the known prokaryotic transposable elements
(Bukhari, Ann. Rev. Genet. 10: 389 [1976]). A
characteristic feature of transposable elements is that
they generate duplications of 5 or 9 base pairs of host
DNA at the site of insertion. (For example, IS I causes
duplication of 9 base pairs and Tn3 and Tn5 cause
5-base-pair duplications.) The nucleotide-sequencing
results of R. Kahmann and D. Kamp indicate that Mu
also conforms to this rule and causes the duplication of
5 base pairs. Thus, the idea that Mu DNA insertion
may be a general model for transposition continues to
gain acceptance. However, before this idea can be
extended to its logical limit, a clear picture of the
molecular mechanism of Mu integration is required.
The process of Mu integration remains a puzzle. It
has not been possible to define the steps involved in
transposition of Mu DNA from one site to another,
because replication of Mu DNA and its insertion at a
new site appear to happen simultaneously and Mu
DNA intermediates involved in replication or integra-
tion have eluded detection.
The Mu paradox
The suggestion that transposition of Mu DNA follows
its replication has raised some intriguing questions.
The evidence so far is consistent with the hypothesis
that prophage Mu DNA replicates in situ and that the
products of this reaction are transposed to other loca-
tions. We know, however, that the prophage Mu DNA
(if the prophage carries an X mutation) can be excised
at a low frequency from the host DNA. A model for Mu
transposition must resolve this apparent paradox. That
is, although a mechanism for Mu excision exists, exci-
sion does not appear to be included in the normal
course of events during the Mu growth cycle. We have
shown that excision is a Mu-specific function and that
it requires the product of the A gene of Mu. We have
constructed strains containing the Mu X prophage with
an amber (am) mutation in theA or B gene of Mu. Mu X
Aam mutants can be excised only in Su' cells,
whereas Mu X Bam mutants can be excised in both Su-
and Su+ cells. (Some excision can be seen with Mu
Barn mutants even without the superimposed X muta-
tions.)
The A + B hypothesis
The Mu X mutants are defective prophages which
generally carry insertions in the B gene of Mu. Both the
A-and B-gene products are thought to be required for
Mu replication and integration. The realization that
elimination of the B-gene function allows Mu excision
has led us to propose the following hypothesis. Rec-
ognition of the ends of the Mu prophage by the A-gene
product can lead to different consequences, depend-
ing on the presence or absence of the B-gene function.
The A-gene product recognizes the ends of the
prophage and initiates the process that would culmi-
nate in the replication and transposition of Mu DNA if
the B gene were functional. If the B gene is nonfunc-
tional, the action of the A gene at the ends of Mu may
leave the prophage in a state susceptible to excision.
Thus, in this model the excision of Mu DNA is an
abortive transposition event. We are now testing this
hypothesis.
Excision products
Hajra Khatoon's studies on excision of Mu DNA from
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the IacZ gene, involving extensive fine genetic map-
ping and DNA-DNA hybridization, have revealed
some interesting aspects of the excision process of Mu
DNA. Imprecise excision is 10 to 100 times more
frequent than precise excision. About 80% of the de-
tectable imprecise excision events result in minor
changes in the host sequences at the site of Mu inser-
tion. These changes may be further corrected to give
rise to wild-type sequences. The rest of the imprecise
excisions leave deletions of various sizes. Most of
these deletions end at the point of Mu insertion and
extend either to the right or to the left of the prophage
site. Figure 1 shows the mapping of the excision prod-
ucts of two Mu X prophages located in the Z gene of
the lac operon. In some cases, deletions remove only a
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part of the Mu DNA or no detectable part of the Mu
DNA at all. In these cases, the /acY gene presumably
has come under the control of a Mu promoter.
Nature of insertions in Mu X mutants
We have characterized the insertions in about 50 in-
dependent Mu X mutants. These insertions are located
at a few specific sites within a 1000-base-pair segment
of Mu DNA defining the B gene. All of the insertions
have been identified by DNA-DNA hybridization as
151,155, or 152. These results show that transposition of
the IS elements in E. coli occurs in the following order:
151 > 155 > 152.
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Figure 1
Map of the lacZ gene showing some deletions generated by excision of Mu X mutants. The X mutants originated from two Mu
cts62 insertions located close to each other in the Z gene. Insertion 8354 carries the c end (left) of Mu proximal to the lacP0
region, whereas insertion 8306 has the opposite orientation. The numbers above the Z-gene line represent nonsense
mutations and the numbers below the line show deletions used for mapping. The vertical lines arbitrarily define segments of
the Z gene. The horizontal lines show deletions generated by Mu excision. The lines confined within the smallest segment may
or may not be deletions (8306, nos. 11, 13, and 14). Only some of the excision products (Z-Y. revertants) mapped are shown.
Extensive mapping of such excision products has resulted in the accumulation of a very large number of internal deletions
spanning the Z gene.
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In vitro and in vivo manipulations of Mu DNA
We have cloned the ends of Mu prophages (Mu lo-
cated in the lacl gene or the lacZ gene) in small plas-
mids such as pBR322. These plasmids are being used
as substrates for examining the proteins that bind to the
Mu ends, for analyzing the cutting of Mu ends during
packaging of Mu DNA, and for sequencing several
different sites of Mu insertion. Several other plasmids
containing internal deletions of Mu have been man-
ufactured to study the process of Mu transposition and
replication. For example, from a pSC101 plasmid
containing a Mu insertion (obtained from M. Casada-
ban of Stanford University), we have removed the
middle fragment of Mu by digestion with the en-
donuclease Pst I. The enzyme Pst I makes two cuts in
Mu DNA; the left cut is within the A gene of Mu and
the right cut is just to the left of the G segment. This
plasmid containing the in-vitro-deleted prophage is a
hyperproducer of Mu repressor and presumably con-
tains the regulatory region controlling the synthesis of
the A gene. The lac operon of E. coli and several
drug- resistance markers are being cloned or recom-
bined into the Mu DNA on this plasmid.
In their report Dietmar Kamp and Regine Kahmann
describe the studies, involving nucleotide-sequencing
and structural analyses, on the small plasmids con-
structed by them. One of these plasmids, pTM2, con-
taining 1000 base pairs from the left end of Mu joined
to 850 base pairs from the right end, is unable to
coexist with a wild-type Mu prophage. This plasmid
has been found to be compatible only with the X
mutants (or B- mutants) and apparently induces the
excision of the X mutants. Interaction of this plasmid
with the X mutants is being examined further.
Prophage Mu induction
We have examined the effect of the induction of
prophage Mu located in the lacl gene on the expres-
sion of the IacZ gene. The synthesis of p-galactosidase
is not affected after induction when Mu is located in
the lac/ gene in either orientation. Thus, there is no
readthrough from Mu into the nearby genes. In strains
of the type lac1::Mu cts 0÷Z±Y±/lacl 0±Z+Y± (in which
there are two lac operators and one functional repres-
sor gene) the rate of synthesis of p-galactosidase is not
affected after induction. This further shows that, after
induction, sequences adjacent to Mu DNA are neither
dramatically amplified nor dramatically destroyed.
On the other hand, we know that transfer of F' pro lac
episomes containing Mu is depressed beginning about
15 minutes after induction. Thus, there must be some
local effect on the Mu-host junction that does not
interfere with the functioning of the genes adjacent to
the prophage. These studies are now being extended
by directly examining the changes in the structure
of small plasmids containing Mu DNA after induc-
tion.
Mu proteins
To study the temporal sequence of synthesis of Mu
proteins (in particular the A and B proteins of Mu), we
have pulse-labeled proteins with [14C]leucine at dif-
ferent times during the Mu growth cycle. Mu does not
shut off host-protein synthesis. Furthermore, there are
minor variations in the synthesis of host proteins dur-
ing Mu growth (in particular after heat induction of a
prophage). Unlike some other bacteriophages, Mu
does not grow in UV-irradiated cells. Thus, a system in
which host-protein synthesis can be specifically
eliminated without affecting Mu-protein synthesis is
not available, and it is very difficult to define clearly
Mu proteins that are made in small amounts. By run-
ning one-dimensional and two-dimensional poly-
acrylamide gels, we have identified several Mu pro-
teins that are made at different times. Morphogenetic
proteins can be clearly seen about 20 minutes after the
commencement of the productive cycle, spanning
about 75 minutes. The A and B proteins are made
immediately upon induction, but in small amounts,
which makes their characterization difficult. Im-
munological methods are being used to characterize
the early proteins of Mu further.
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ELECTRON MICROSCOPY
T.R. BROKER, L.T. CHOW, J.A. Engler, B.A. Kilpatrick, J.M. Scott, M. Hallaran
The Electron Microscopy Section has two major re-
search commitments: (a) the characterization of RNA
splicing patterns and the pathways of adenoviruses
and (b) the analysis of the genome organization of
bacteriophage Mu, including RNA transcription pat-
terns, the control and function of DNA G-segment
inversion, Mu translocation during replication, and
the structures and biological properties of bacterial
insertion sequences transposed into Mu. Additional
investigations have been made of the replication of
adenovirus DNA and of the transcription of 2-,am
circular DNA plasmids from yeast. For many of these
studies, we have enjoyed extensive collaborative in-
teraction with colleagues from most of the other re-
search units at the Laboratory, and some of the re-
search and conclusions will be described in other
sections of this Annual Report.
Adenovirus RNA splicing: Introduction
The phenomenon of "RNA splicing" was discovered
at Cold Spring Harbor Laboratory in early 1977 as a
result of a large set of interrelated experiments on
adenovirus transcripts (Broker et al., Cold Spring Har-
bor Symp. Quant. Biol. 43:531 [1978]). Briefly, the
nucleotide sequences present in mature adenovirus
serotype 2 (Ad2) mRNAs are derived from two or more
noncontiguous segments of the genome and these
become covalently joined by a series of posttranscrip-
tional RNA deletions that occur in long, nuclear pre-
cursor transcripts.
Our objectives in the past year have been (1) to
extend and complete the identification and mapping
of all mRNA species produced by Ad2; (2) to quanti-
tate the relative abundances of all early RNA species
present under various infection conditions; (3) to
begin determining the pathways by which transcripts
are spliced; (4) to compare the structures and sequ-
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ences of transcripts from different adenovirus
serotypes, hybrid viruses, and mutants; and (5) to infer
from the RNA splicing patterns some of the biological
consequences of this complex form of gene expres-
sion. In the course of the electron microscopic
analyses, apparent processing intermediates have
been identified that should be suitable substrates in the
search for splicing enzymes. The structures of the
transcripts identified by electron microscopy can be
correlated with the Ad2 DNA sequences being deter-
mined in R.J. Roberts's and B.S. Zains's laboratories
and elsewhere, with the cDNAs to messages prepared
by A. Dunn, W. Keller, and J. Sambrook, and with the
proteins characterized by J.B. Lewis and M.B.
Mathews and their collaborators.
Methodology
Adenovirus-specific RNA samples were prepared
under a great variety of conditions. Human KB or HeLa
cells were grown either in suspension culture or in
monolayers on plates, an important distinction which
will be discussed later. Cytoplasmic RNA samples
were isolated at early, intermediate, and late times
after infection. In some experiments, cycloheximide
(CH), an inhibitor of protein synthesis, or cytosine
arabinoside (araC), an inhibitor of DNA replication,
was utilized. Numerous adenovirus serotypes,
Ad2±SV40 hybrids, and other host-range mutants
have been examined.
RNAs were hybridized to denatured adenovirus
DNA near the melting temperature of the DNA in 80%
formamide, conditions that favor RNA:DNA associa-
tion over DNA:DNA reassociation. The RNA:DNA
heteroduplexes were prepared for electron micros-
copy by spreading in cytochrome c films in the pres-
ence of 40-45% formamide, which allows single-
stranded DNA segments to remain extended and
traceable. RNA:DNA duplexes can be recognized by
their thick appearance relative to single-stranded
segments. Splice junctions and the segments of
polynucleotide deleted in the composite RNAs are
identified by deletion loops constrained in the DNA.
Each DNA loop corresponds to one splice in position
and length (Fig. 1). Analysis of the RNA structures
involved photography and measurement of several
thousand samples. Quantitation of the relative abun-
dances of RNAs as a function of time after infection
and in the presence of drugs was performed by visual
inspection in the electron microscope.
Late adenovirus RNAs
All late Ad2 mRNAs, except perhaps that for peptide IX
a
(map coordinates 9.8- 11.1), are composite
molecules with sequences derived from at least two to
seven or more separate portions of the genome. A
common tripartite leader sequence totaling about 200
nucleotides is complementary to map coordinates
16.5-16.6, 19.5-19.7 and 26.5-26.8 (Chow et al.,
Cell 12: 1 [1977]; Klessig, Cell 12: 9 [19771) and
becomes coupled to the 5' end of about 13 different
RNAs synthesized from the rightward-transcribed (R)
strand (Fig. 2). These 5' ends map at coordinates 29.1,
30.5, 33.9, 37.0, 38.8, 42.8, 45.1, 49.5, 51.2, 66.1,
68.0, 74.0, and 86.3. The transcripts constitute five
major families. mRNAs of any one group share 3'
proximal sequences and have common 3' ends at
39.0, 49.5, 61.5, 78.3, or 91.3, but they differ substan-
C "
,.
Figure 1
Electron micrographs of Ad2 late RNA:single-stranded DNA heteroduplexes demonstrating multicomponent 5' leader
sequences. (a) Illa (peripentonal hexon-associated) mRNA; (b) V (minor core) mRNA; (c) IV (fiber) mRNA with the extra y
leader derived from early-region 3. Large arrowheads and small arrowheads indicate 5' and 3' ends, respectively.
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Figure 2
A simplified RNA transcription and splicing map of Ad2, determined by electron microscopy of cytoplasmic RNA:DNA
heteroduplexes. The scale indicates map coordinates in percentages of the 35,000-base-pair genome. Early RNAs are depicted
with thin arrows and late RNAs with thick arrows. The arrows indicate the direction of transcription. Gaps in arrows
designate splice deletions in mRNAs. Only the major species from early-regions 2, 3, and 4 are shown, and processing
intermediates for the late RNAs have been omitted. The proteins translated from various RNAs are designated K (1000 daltons
molecular weight) or by Roman numerals to indicate relative mobility during SOS gel electrophoresis. Late proteins are
underlined. Protein assignments are based largely on the work of I. Lewis and M. Mathews and their collaborators.
tially in length at their 5' ends and, therefore, in the
coordinate at which the leader sequences are at-
tached. Less frequently 3' ends are also seen near
coordinates 42, 46, and 74. The longer mRNAs in a
family are physically polycistronic. Processing of the
primary R-strand transcripts is a complex process that
must involve subtle controls to ensure their proper
distribution into all the mRNAs.
A late transcript synthesized from the L strand con-
sists of a single-component leader from 16.1-15.7
joined to the main body of the IVa2 message, located
from 15.1-11.1. The proximity of its 5' end at 16.1 to
the 5' end of the major R-strand leader component at
16.5 indicates that late transcription diverges leftward
and rightward from a pair of promoters in the interval
16.1-16.5. Other late RNAs are encoded in the inter-
vals 4.6-11.1 (R strand), 76.6 -86.1 (R strand), and
72.1-61.5 (L strand) and represent the continued or
modified expression of early RNAs.
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Early adenovirus RNAs
During the first 8 hours of infection, transcription is
largely limited to five "early" regions of the Ad2
chromosome; regions 1A, 1B, and 3 are transcribed
from the R strand and regions 2 and 4 from the L strand.
Working with Jim Lewis, we have extended previous
studies done in other labs and have shown that early
RNA from each region consists of a set of composite
RNAs with up to four conserved segments spliced
together by the deletions of intervening sequences
(Fig. 2). Members within each set differ from one
another in their splicing patterns and in the lengths and
positions of the conserved segments. The derivation of
alternative mRNAs from similar precursor transcripts
highlights one of the complexities of RNA splicing.
Early-region 1, necessary and sufficient for adeno-
viral transformation of cells, is divided into two por-
tions, located between coordinates 1.3-4.5 (1A) and
4.6-11.1 (1B). Region 1A has at least three forms of
transcript with the same 5' and 3' ends, but internal
deletions of various lengths. This splicing pattern is
analogous to that found by others in the early trans-
cripts of the DNA tumor viruses, SV40, and polyoma.
The relative abundance of the longest internal deletion
increases at intermediate times after infection, a tran-
sition suppressed by cycloheximide. N. Harter and
J. Lewis (/. Virol. 26: 736 [1978]) have identified a set
of related proteins encoded by RNAs from this region.
J. Maat and H. van Ormondt of the University of
Leiden, The Netherlands, have sequenced the DNA in
this portion of the closely related Ad5 serotype and
shown that two, long, open translation frames are
separated by termination codons. The internal splice
deletions in the early RNA apparently bypass these
termination codons to join the open frames and permit
the synthesis of larger proteins than would otherwise
be possible. Early-region 1B specifies two transcripts;
one is continuous, the other spliced. The presence of
araC results in a relative increase of the unspl iced form
at the expense of the deleted species.
The transcripts from early-region 2 (75 -61; L
strand), which encode the single-stranded DNA-
binding protein (DBP), consist of either three or four
segments. The latter class has a very small internal
splice in the main body of the message and was de-
tected by a new type of heteroduplex structure. Sur-
prisingly, the splicing pattern of this message changes
with time after infection. At early times the short 5'
leader segment of the message is encoded at map
coordinate 75. At late times the short 5' leader is
derived from either coordinate 72 (major form) or
coordinate 86 (minor variant) (Fig. 3). In the presence
of cycloheximide, this changeover does not occur.
The alternative 5' leaders probably indicate the utili-
zation of different promoters at early and late times,
with activation of the late promoters dependent upon
protein synthesis.
Early-region 3 (76.6-86.1; Rstrand)givesrisetomul-
tiple transcripts, which have four different splicing
patterns represented in families of transcripts with
three different 3' ends. The relative abundance of each
species within region 3 is largely unaffected by time or
by the presence or absence of araC or CH. Harter and
Lewis observe three protein products from this region.
At late times this region can be transcribed under the
direction of the major late promoter at 16.5. Region 3,
like region 2, exhibits a splicing change at late times;
the transcripts can have the common late tripartite
leader coupled to the 5' ends of a set of composite
mRNAs similar to that seen at early times.
Early-region 4 (99.3-91.3; L strand) has six or more
different species with the same 5' and 3' ends but
variable internal splicing. This is reflected in the pro-
teins synthesized during cell-free translation of this
RNA; Harter and Lewis find five different proteins,
some of which share common tryptic peptides. In
agreement with the work of several others, transcrip-
tion of region-4 RNA is increased dramatically when
CH is present during the infection, and the relative
abundances of the species with respect to one another
Figure 3
Electron micrographs of Ad2 single-stranded DNA-binding-protein mRNA:DNA heteroduplexes. (a) Early form; (b) major late
form; (c) minor late form. Large arrowheads depict 5' ends and small arrowheads point to 3' ends.
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are also modified. Again, the species with fewer or
shorter splice deletions predominate in the presence
of CH.
Other adenovirus serotypes
Several class-C (1, 5, 6) and class-B (3, 7) adenovirus
serotypes have been examined, in collaboration with
R. Gelinas, for splicing of their late mRNAs. These
studies were performed by hybridizing late polysomal
adenoviral mRNAs with single-stranded adenoviral
DNA and several of its restriction fragments and exam-
ining the heteroduplexes by electron microscopy.
Each serotype studied exhibits splicing of tripartite
leaders to the 5' end of many mRNAs transcribed from
the R strand. In the newly studied class-C adenovi-
ruses, the tripartite leaders are homologous to those of
Ad2 (another class-C virus). The tripartite leaders of
Ad3 and Ad7 mRNAs are homologous to one another,
but their nucleotide sequences have diverged sub-
stantially from those of class-C viruses and do not
cross-anneal with Ad2 DNA. Nevertheless, class-B
leader sequences map at essentially the same respec-
tive positions found for Ad2 leaders, and these are
joined to ten or more different R-strand messages, with
5' ends at the same coordinates as determined with
Ad2. The spliced structures of Ad3 and Ad7 mRNAs
for early-region 1 B, IVa2, and DNA-binding proteins
are also very similar to those of Ad2. Apparent Ad3
and Ad7 RNA-processing intermediates with addi-
tional 5' leader sequences were observed. The inter-
mediates are analogous to those found in other ade-
novirus serotypes, as discussed below. These
similarities in RNA structure emphasize a strong con-
servation of processing signals, despite the general
divergence in nucleotide sequences between serotype
classes, and make comparative sequence analysis of
particular importance in the search for features neces-
sary for splicing. The divergence in leader sequences
of class-B and class-C mRNAs may explain, in part, the
apparent species barrier to recombination between
serotype classes if leader sequences must be matched
to the remote message sequences for RNA splicing to
occur.
Ad2+SV40 hybrids and processing intermediates
Cytoplasmic RNAs isolated from HeLa cells at different
times after infection with Ad2 or with the adenovi rus-
SV40 hybrids Ad2+ ND1 and its mutant H71 have
been examined in collaboration with T. Grodzicker, J.
Sambrook, and J. Lewis. When cytoplasmic RNAs are
recovered from infected cells grown in monolayers on
plates, presumptive processing intermediates for the
tripartite leader segment on all the late R-strand
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mRNAs were found as predominant species shortly
after the onset of late transcription. The most common
form, present in up to 80% of the cytoplasmic RNAs,
has an extra segment located between the second and
third leaders in the interval 22.0-23.2; others extend
continuously from coordinate 22 through the third
leader segment, and still others retain variously sized
extra sequences between coordinates 24.0 and 26.8.
The frequency of observation of the extra sequences
decreases gradually as infection progresses, but a
substantial number may persist even at 36 hours. For
as yet unexplained reasons, splicing is much slower in
cells grown on plates than in those grown in suspen-
sion cultures.
The joining of the tripartite leader sequence to the
main bodies of several of the mRNAs, notably those for
fiber (86.3-91.3) and for the Illa protein (30.5-39.0),
are also multistep reactions. The Illa mRNA seems to
be derived by a two-step deletion from a longer
member of the same family, extending from
29.1-39.0. In the firsideletion, the internal segment
29.6-30.5 is eliminated. Then the internal segment
29.1-29.6 is deleted, and the tripartite leader is
thereby transferred to the 5' end of the Illa message.
Interestingly, the segment 29.1-29.6 corresponds to
most or all of the sequences in virus-associated RNA
(VA) RNA,, previously characterized by M. Mathews,
U. Pettersson, and their colleagues.
One, two, or three leader segments derived from
coordinates 77 (x), 79 (y), and 85 (z) can be found
situated between the tripartite leader and the main
body of the message in some of the fiber transcripts
(Fig. 1c). These segments correspond to the three
components of one of the early-region-3 transcripts.
This coincidence indicates that early splicing signals
may continue to be recognized at late times during the
processing of the one late gene (fiber) that is separated
from its leader region by early-region 3. Eventually,
most of these x, y, and z segments become deleted,
which occurs in several orders and combinations.
Dunn and collaborators (Cell 15: 511 [1978]) have
studied they leader in fiber-region transcripts from the
hybrid virus Ad2+ ND1 dp2 and have shown that it
does not affect the efficiency or the product of transla-
tion.
The joining of the leaders to many other late mRNAs
also appears to proceed by multistep deletions of in-
tervening sequences. In addition to the common
tripartite leader, one or more leader sequences can be
found preceding the main body of the mRNAs. In each
case, the extra leader consists of short sequences de-
rived from the 5' end of an upstream gene. We pro-
pose that these segments serve as carriers to transport
the common leader to downstream coding sequences
in polycistronic precursor transcripts, i.e., that the
coupling of the leader regions to distal messages oc-
curs by multiple small deletions that pass the leaders
down the polynucleotide chain to preferred splice
targets. These preliminary observations are now being
examined in more detail.
Our overall view is that RNA splicing can occur in
different patterns within a single region; that deletions
need not occur in a single complete step, but rather
take place by a series of partial deletions; thatthe order
in which deletions occur can be variable with respect
to both time and relative upstream-downstream loca-
tion; and that multiple pathways can be followed in
the conversion of precursor to product. The adenovi-
ruses are superb systems with which to analyze RNA
processing and will likely be ideal probes of normal
cellular processes.
Adenovirus DNA replication
L. Kaplan, R. Kleinman, and M. Horwitz of Albert Eins-
tein College of Medicine have developed an in-vitro
replication system for adenoviral DNA. DNA that has
initiated replication in vivo can continue synthesis
after extraction (Proc. Natl. Acad. Sci. 74:4425[19771).
The system is dependent upon added deoxynu-
cleoside triphosphates and ATP. We have used elec-
tron microscopy to analyze the replication complexes
present at the time of extraction and after synthesis in
vitro. In agreement with the results of Lechner and
Kelly (Cell 12: 1007[19771), who studied replication
intermediates directly after extraction from infected
cells, we observed a variety of structures consistent
with the following replication model: (a) double-
stranded DNA undergoes initiation at either end, with
the displacement of the homologous parental chain as
a single-stranded branch (type-1 structures); (b) up to
four or five initiations can occur at the same end before
the first replication fork reaches the distal end; (c)
when replication does reach the distal end, the
single-stranded branch is released as a free strand; (d)
these displaced strands can then undergo initiation at
their 3' ends, and they become converted to partially
double-stranded structures (type-2 structures); (e) as
with double-stranded templates, type-2 replication in-
termediates can undergo several successive reinitia-
tions so that they may have several single-stranded
branches as well as a single-stranded end. Rarely,
replication can initiate from opposite ends of the same
duplex template.
Replication proceeds for up to 2 hours in vitro with
the utilization and formation of the same structures
observed in vivo. However, no evidence for initiation
of replication in vitro has been achieved. The main
intent of future studies is to characterize the defects of
temperature-sensitive adenovirus mutants by compar-
ing biochemica and electron microscopic analyses
and by attempting in-vitro complementation of defec-
tive functions.
Bacteriophage Mu DNA structure
The DNA from the temperate bacteriophage Mu of E.
coli is a linear duplex about 38 kilobase pairs (kb) in
length. A 3-kb segment of its DNA, designated G, can
be present in either orientation relative to its
neighboring segments to the left (a, 30.7 kb) and to the
right (0, 1.7 kb). Inversion of the G segment is
catalyzed by the product of the Mu gene, gin. Phage
Mu DNA integrates at random into the bacterial
chromosome during lysogenization and repeatedly
transposes to new sites during DNA replication,
whether after prophage induction or during lytic in-
fection. The attachment sites on the phage DNA are
the ends of its genome. During maturation, integrated
Mu DNA is encapsidated into phage heads, starting
just beyond the left end within the flanking bacterial
DNA, and packaging is from the left toward the right
end of the genome (Bukhari and Taylor, Proc. Natl.
Acad. Sci. 92:4399 [19751). Because the head can
accommodate slightly more DNA than constitutes the
Mu genome, rather long segments (1-3 kb) of bacte-
rial DNA flanking the right ends are packaged. Fol-
lowing denaturation and reannealing of mature Mu
DNA, these heterogeneous bacterial sequences form
single-stranded "split ends" adjacent to the g region.
In last year's Annual Report we described a variety
of experiments on the structure and function of the
invertible G segment. This year our effort has been
directed toward understanding the Mu translocation
process as well as the early and late transcription
patterns.
Translocation of a mini-Mu phage
The construction of a mini-Mu-containing plasmid
pTM2 is described by D. Kamp and R. Kahmann
elsewhere in this Report. Briefly, it contains only the
end segments of the Mu prophage present in E. coli
strain DK445 (Chow, Kahmann, and Kamp, I. Mol.
Biol. 113:591 [1977]). The 1000 base pairs of DNA
from the left end of Mu are joined to a portion of the
bacterial insertion element IS2 and then to the 850
base pairs of /3 DNA from the right end of the Mu
genome. This mini-Mu DNA and a small amount of
lacZ-gene DNA flanking the original DK445 lysogen
are carried in the vector pBR322. To test the ability of
the mini-Mu DNA to replicate, to translocate, and to
be packaged, helper functions were provided by
superinfecting the plasmid-containing E. coli with Mu
vir phage. Progeny phage resulted, and their DNAs
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Figure 4
Electron micrograph of a heteroduplex between phage Mu DNA and encapsidated mini-Mu DNA. The c-end (left) 1000 bases
and the 850 bases at the right end of the /3 region are present in both chromosomes and establish duplex pairing. Mini-Mu
contains most of bacterial insertion element 152 and contributes a very long split end (SE) of bacterial DNA. Wild-type Mu
forms a large substitution loop between the paired left and right ends and contributes a short split end of bacterial DNA.
were examined by electron microscopy. Following
denaturation and renaturation of the DNAs to form
heteroduplexes, two types of phage were identified in
the lysate. One was the helper phage Mu vir. The other
was mini-Mu in association with heterogeneous
bacterial DNA; therefore, mini-Mu replicated, trans-
located, and was packaged. The left (c) end of
mini-Mu DNA was always found at one end of the
packaged DNA, which was as expected since encap-
sidation starts from the left end. Because the mini-Mu
sequences are only 2800 base pairs long and the Mu
head can accommodate about 38,000 base pairs of
DNA, the heterogeneous bacterial sequences adjoin-
ing the /3 (right) end were very long and formed
dramatic split ends in heteroduplexes (Fig. 4). Addi-
tional copies of mini-Mu were often found embedded
within the heterogeneous bacterial DNA. These
mini-Mu genomes could be of either the same or the
opposite orientation as the first copy. As a result, the
DNA single strands often exhibited a snap-back du-
plex equal in length to the mini-Mu (2800 base pairs).
In some examples of packaged DNA, mini-Mu was
found near Mu vir helper DNA sequences arranged in
either the same or opposite orientation. Work is in
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progress to follow the translocation of wild-type Mu
after infection or induction.
Electron microscope mapping of Mu-specific RNA
transcripts
Electron microscopy was used to map the RNA iso-
lated at various times after heat induction of Mu cts62
lysogens. The RNA was annealed to self-renatured Mu
vir or Mu cts62 DNA to form R loops. The split ends of
bacterial sequences and the G-segment inversion
loop, when present, served to orient the molecules.
Tetracycline was employed to retard intracellular
degradation of the RNA and to block protein synthesis,
as well as the early-late switch in transcription. When
tetracycline was added to Mu lysogens at a late time
(35 min after heat induction) and RNA was extracted
10 minutes later, the samples formed R loops of vari-
ous sizes along nearly the entire Mu DNA molecule
and revealed the presence of early plus late RNA.
When tetracycline was added 5 minutes before in-
duction, however, the RNA present was complemen-
tary to genome coordinates from 3% to 21% of the left
(or c) end, which defined the region transcribed at
early times. RNA synthesized from a cloned segment
of Mu DNA (Zipser et al., Gene 2:263 [1978]) derived
from the immunity (repressor region mapped in the
leftmost 3% of the genome, often resulting in a forked
structure with one double- and one single-stranded
arm.
The middle segments of Mu DNA defined by two
EcoRl and two Barn restriction-enzyme cuts were
cloned using the bacterial plasmid pBR322 as a vec-
tor. Three isolates were chosen for further study: a
10.5-kb segment defined by the leftmost EcoRl and
leftmost Barn cleavage sites, a 12.5-kb segment de-
fined by the leftmost EcoRl and rightmost Barn cleav-
age sites, and a 6-kb segment defined by the rightmost
Barn and the rightmost EcoRl cleavage site. In collab-
oration with M. Howe and coworkers at the University
of Wisconsin, marker-rescue experiments were per-
formed which showed that the leftmost and rightmost
Barn cleavage sites cut, within the Mu E and F genes,
respectively.
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DNA-PROTEIN INTERACTIONS
D. KAMP, R. KAHMANN
For the last year we have focused our work on two
site-specific recombination phenomena: the integra-
tion of bacteriophage Mu DNA and the inversion of
the G segment of Mu DNA. Both are prominent
examples of how, through the specific interaction of
proteins with DNA, rearrangements of DNA occur
which can alter the genetic content.
Integrative recombination of Mu
We have determined the nucleotide sequence of the
Mu attachment sites. Cloned end fragments of Mu
phage DNA were analyzed with restriction enzymes
and subsequently sequenced using the Maxam-
Gilbert method. Sequences obtained for three clones
from the left end have shown a precise juncture point
between DNA common in all three clones and DNA
that is different for every end and is presumed to be
bacterial DNA. For the right end we have found an
analagous situation. This substantiates a concept that
has emerged during the last years, namely, that phage
Mu DNA is linked at both ends to heterogeneous host
DNA. The precise juncture points suggest an integra-
tion mechanism whereby a phage-encoded protein
recognizes a specific nucleotide sequence at or near
these junctures, commonly referred to as attachment
sites. The attachment sites of the left or immunity end
(attL) and the right or variable end (attR) are not identi-
cal. They do show similarities, however, that could
represent contact points of proteins that interact with
the attachment sites. For instance, the first two nucle-
otides at attL and attR are the same. A closer inspection
reveals that, in fact, the first 30 base pairs in attL are
almost completely present in attR, but they are ar-
ranged differently. The first 14 base pairs of attL are
found 79 base pairs away from the juncture in attR,
whereas nucleotides 15 to 31 in attL seem to corre-
spond to the first 20 nucleotides in attR (Fig. 1). The
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biological significance of this sequence arrangement
remains to be seen. In addition to attachment sites in
mature phage DNA, we have sequenced the attach-
ment sites of a Mu prophage, Mu 445, which is in-
serted in the lacZ gene of E. coli. From the known
amino acid sequence of the /3- galactosidase (the
product of the lacZ gene) and the sequence of the Mu
attachment sites as determined for mature phage
DNA, we were able to reconstruct the sequence of the
Mu 445 insertion site. We found that the Mu 445
insertion is associated with the direct repeat of a se-
quence of 5 bases of lacZ DNA, one copy appearing
at each junction. Duplication of host sequences at the
insertion site seems to constitute a general feature of
recombination systems associated with transposable
elements. Integrative recombination is therefore re-
lated to the insertion mechanism of transposable ele-
ments.
To study the relevance of the host DNA duplication
and other features of the sequence for the mechanism
of Mu integration, a biological assay is required. We
have designed a system whereby we can test frag-
ments containing the attachment sites of Mu for their
capability to act as substrates for transposition. End
fragments of the Mu 445 prophage were joined to-
gether and inserted into the plasmid pBR322 in such a
way that the original insertion site of Mu 445 was
recreated. This plasmid, pTM2, is lacking 95% of the
Mu 445 prophage DNA. We have shown that the
remaining Mu sequences, which we refer to as TnM1
and which consist of 1000 base pairs of the left end
and 1600 base pairs of the right end of Mu 445, are
transposed from pTM2 to the host DNA when a Mu
helper phage provides the integration functions of Mu.
The helper phage not only transposes the TnM1 se-
quences, but also will package them together with
host DNA into phage particles. Since the pTM2 plas-
mid is much too small to be packaged into a full-size
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Figure 1
Structural features of the Mu attachment sites. To illus-
trate the similarities of the two Mu attachment-site re-
gions a single-stand sequence is presented in a stem-
loop structure. attL indicates sequences from the left end
and attR indicates sequences from the right end of the
Mu genome. Numbers indicate distances from the ends
of the genome (in base pairs).
phage particle, transposition from the plasmid to the
host genome is a prerequisite for packaging of the
TnM1 sequences. The presence of the TnM1 sequence
in the DNA of mature phage particles has been dem-
onstrated by restriction-enzyme analysis and, in col-
laboration with L.T. Chow, by electron microscopy.
As a first application of this assay, we have replaced
the Mu attR fragment in pTM2 with different attR frag-
ments obtained from mature phage DNA such that the
TnM1 sequence is restored but the bacterial DNA is
different in each case. With three of these new plas-
mids we have shown transposition of the TnM1 se-
quence. We consider that the possibility that a dupli-
cation of 5 base pairs of host DNA is retained by
chance in all three recombinant plasmids is extremely
remote and thus conclude that the homology provided
by the duplication is not essential for translocation.
Preliminary experiments indicate that excision of
the TnM1 sequence can occur when the plasmid is
grown in the presence of the expressed A gene of Mu
provided by a Mu X mutant or a X-Mu hybrid. When
the plasmid DNA is isolated from such a strain, its
DNA is heterogeneous in size, a fraction of the
molecules being smaller than the original pTM2
plasmid. In collaboration with A.I. Bukhari, we are
determining whether precise excision occurs in the
presence of the host duplication and, if so, whether the
duplication is actually needed for excision.
Inversion of the G segment of Mu DNA
In continuing our studies on the invertible G segment
of Mu we have characterized the recbmbination
mechanism that promotes G inversion. G inversion
does not seem to be related in any way to the integra-
tive recombination of Mu. Functions that are required
for Mu integration are not required for G inversion,
and vice versa. All functions essential for G inversion
are expressed by the recombinant plasmid pGM1,
which contains the entire G segment plus 1200 base
pairs of the Mu alpha segment and 850 by of the Mu
beta segment. The only function implicated in G in-
version thus far, the gin function of Mu, has now been
mapped precisely within the 850 base pairs of the beta
region right next to the G segment. The mapping was
achieved by complementation analysis with various
X-Mu hybrid phages and derivatives of plasmid pGM1
constructed in vitro. In collaboration with D. Kwoh
and D. Zipser, these plasmids have also been used to
identify the gin protein in an Escherichia coli minicel I
system. We have not been able to demonstrate trans-
position of the G segment to bacteriophage X. All
available evidence seems to indicate that the G seg-
ment, unlike the Mu phage itself, does not represent a
transposable element, but rather that recombination
promoted by the gin protein resembles recombination
protmoted by the int protein of bacteriophage X. Site-
specific "transposition" of the G segment can be ob-
served, however, in the sense that one Mu G segment
can exchange with another Mu G segment at high
frequency through recombination promoted by the
gin protein. We have investigated the possibility that
the presence of an invertible segment in P1 DNA that
is homologous to the G segment of Mu and that fur-
thermore represents the only homology between P1
and Mu could be due to such a site-specific transposi-
tion event. In spite of the fact that a Mu G segment can
be inverted by a P1 gin function, a Mu G segment
cannot be replaced by a P1 G segment by means of
recombination promoted by either the P1 or Mu gin
protein. This suggests that the two systems are not the
same. The target sites for the Mu and P1 gin proteins
may not be entirely identical, yet they may be similar
enough to allow the complementation of a Mu gin-
mutant by P1. It is also possible that the gin protein is
not involved directly in the recognition of the target
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Figure 2
The Pen phenotype: Inhibition of Mu 445-5 G(+) by Mu
445-5 G(-) phage particles. Concentrated lysates (about
109 phage particles/mi) of Mu 445-5 G(+), Mu 445-5 G(-),
and a 1:1 mixture of both phages were spotted on a lawn
of a Mu-sensitive indicator strain.
sites but is instead part of the enzymatic machinery for
G inversion. A second gene product would then be
required which is responsible for the site specificity
and could be different in P1 and Mu.
As a prerequisite for a rigorous search for additional
functions that control G inversion and also for func-
tions that are controlled by G inversion, we have
isolated insertions of the transposable element Tn5
(encoding kanamycin resistance) in the G area of the
plasmid pGM1. These insertion mutants are being
characterized physically by electron microscopic
methods and restriction-enzyme analysis in collab-
oration with K. McElwain and T. Broker. Of 30 mu-
tants that have been mapped thus far, 20 have Tn5
insertions at different locations in the G segment; for
every potential gene in the G segment, at least one
insertion mutant should be available for further
characterization.
One new mutant phenotype of Mu that bears upon
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the phenomenon of G inversion has been uncovered
accidentally. These mutants, called Pen- (penetra-
tion), are unable to inject their DNA into the cell when
the same cell is infected by a G(-) phage particle. 1 he
Mu Pen- mutants appear to be the result of point
mutations, they are gin and mom-, and they can be
rescued from the plasmid pGM1, indicating that the
mutations map in or near the G segment. The Pen-
phenotype was originally observed with Mu 445-5
G(+) (Fig. 2), which is Gin- and Mom-. Pseudorever-
tants to Pen+ which ' retain their Gin- and Mom-
phenotype have been isolated from Mu 445-5.
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NUCLEIC ACID CHEMISTRY
R.J. ROBERTS, J. Bonventre, J. Brooks, P. Bullock, R.E. Gel inas, T.R. Gingeras, M. Kelly, M. Moschitta, P.A.
Myers, D. Sciaky, M. Wallace, G. Wong, S. Zain
Ad2 sequences
Following our discovery last year of the phenomenon
of mRNA splicing in the late Ad2 mRNAs (and in the
late mRNAs from other adenovirus serotypes), it has
become apparent that transcription of the Ad2
genome at both early and late times is extremely com-
plicated. Studies of Ad2 mRNAs by electron micros-
copy (L.T. Chow and T.R. Broker) suggest that more
than 50 splicing events are required for the production
of the complement of mature mRNAs and have indi-
cated that multiple pathways may be present. To un-
derstand the molecular events inherent in the splicing
process will require the determination of the sequ-
ences involved and the characterization of the en-
zyme(s) responsible. Our initial attempts to isolate an
enzyme activity able to perform splicing in vitro have
been unsuccessful and further efforts have been post-
poned until an appropriate substrate is available.
However, progress has been made in characterizing
the sequences involved in the splicing process.
Two kinds of sequence information are required for
this purpose, one being the sequences present within
individual mRNAs and the other being the genome
sequences from which they are transcribed. Con-
sequently, two major projects are underway at the
present time, one of which, the determination of the
complete sequence of the Ad2 genome, has occupied
much of our attention. In view of the size of the
genome, 35,000 nucleotide pairs, it was essential that
a rapid method be used, and so we have set up the new
chain-termination sequencing technique which uses
2', 3' dideoxynucleotides developed by Dr. F. Sanger
(MRC Laboratory, Cambridge). The template is pre-
pared by exonuclease-Ill digestion of either intact Ad2
DNA or isolated restriction fragments and the primers
are prepared from subfragments of the genome. Sequ-
ences are determined using all possible template-
primer combinations and no fine-structure mapping is
being undertaken. The assembly of the complete
sequences of the subfragments, followed by the as-
sembly of the complete sequence of the genome, re-
lies heavily upon computer-assisted methods as de-
scribed below.
One major technical improvement of the dideoxy
method has been made and involves the more efficient
use of primers. By treating a primer with exonuclease
III prior to its hybridization to template, it is possible to
use much less primer than usual, as the hybridization
now proceeds without the competitive effect of the
complementary strand of the primer. In addition,
sequences from within the primer are obtained, so that
the net result is more sequence from less primer. Also,
by using all four [a-32P]deoxyribonucleoside triphos-
phates, one sequencing reaction can now be ac-
complished using as little as 0.05 pmole of template
and primer.
The determination of sequences present in Ad2
mRNAs has been undertaken and this also uses the
dideoxy method. In this case, mRNA, rather than
DNA, is used as the template and reverse transcriptase
is the source of the DNA polymerase. Although this
approach has certain inherent limitations due to the
presence of multiple mRNA species and the require-
ment for appropriate primers, it has been used suc-
cessfully to study the junction between the main body
of fiber mRNA and either the third or fourth leader
segments. The results obtained have been useful in
conjunction with sequences obtained from a cloned
copy of a reverse transcript of fiber mRNA, prepared
by). Sambrook, A. Dunn, and W. Keller. The complete
sequence of the leader region present in this plasmid
has been determined and, by comparison with
genomic sequences, the exact lengths of the four
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leader segments are rlow known. We are currently
completing the analysis of the genomic sequences
from which these leaders are transcribed so that we
can assess the role of primary sequence and putative
secondary structure in the excision of the intervening
sequences.
Following our success in studying fiber mRNA di-
rectly, we have been interested in looking at some of
the early mRNAs, and experiments are in progress to
define the sequences present in early mRNAs from the
extreme ends of the genome-where much of the
genomic sequence is now known. In addition, the
early mRNA transcribed from EcoRl fragment D is
being studied because it too is transcribed from a
region of the genome that has been almost completely
sequenced. Furthermore, within the limits allowed by
electron microscopy, there is some possibility that the
splicing events associated with the formation of this
mRNA may be related to the existence of the fourth
leader component of fiber mRNA.
Computer-assisted methods
In the surge of sequence information arising from our
ongoing research, it has become impractical to rely
upon manual methods of storage and analysis. Con-
sequently, we have been exploring computer-assisted
methods to aid in these tasks. Two main projects have
been undertaken, one which is related to the analysis
of restriction-enzyme sites and a second which is es-
sential to the determination of the complete Ad2 se-
quence.
A major problem in the analysis of DNA sequences
lies in the recognition of patterns, which may be of
biological significance. Although the computer is ide-
ally suited for the rapid identification of specific pat-
terns provided by the operator, it is presently impossi-
ble for the computer to identify patterns de novo. Our
intuitive human ability to do so is still an essential
ingredient in successful computer programming.
Within a DNA sequence, restriction-enzyme cleav-
age sites provide patterns whose positions are re-
flected by the length of the fragments produced upon
cleavage. We have written a program, in collaboration
with J. Milazzo from the Stony Brook Computing
Center, that can be provided with the approximate
lengths of the fragments resulting from restriction-
enzyme cleavage of a DNA of known sequence and
can then predict the recognition sequence of the re-
striction enzyme. This program has proved useful in
the analysis of several new restriction enzymes, in-
cluding Bbvl and SfaNl. At present, it is especially
useful for enzymes recognizing tetra- or pentanuc-
leotide sequences, as such enzymes usually have
many sites within the available substrates of known
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sequence. It will be of considerably greater value
when much larger, fully sequenced substrates, such as
Ad2, are available.
The second use of the computer that we have ex-
plored lies in the assembly of DNA sequences from the
raw data obtained by performing arbitrary template-
primer reactions. Such data contain sequences from
within the segment of the Ad2 genome from which the
primer was prepared. We have written, again in col-
laboration with J. Milazzo, a program that can assem-
ble these isolated sequences into a complete se-
quence. In essence, a file is maintained of all stretches
of primary sequence and a search made for regions of
direct homology (i.e., exact sequence match) or of
complementarity. Where these occur, the primary se-
quences are merged to produce a new, longer .se-
quence that contains all elements of the two primary
sequences. By repeating this process for all available
data, the complete sequence is produced for the DNA
fragment from which the primers were generated. In
this way it is possible to avoid the preparation of
fine-structure restriction-enzyme maps, and indeed a
comparison of predicted and observed cleavage pat-
terns can serve as an additional check on sequence
accuracy.
Restriction endonucleases
The collection of restriction enzymes continues to
expand, and of the more than 150 such enzymes now
known, over 65 different specificities exist. Although
screening of new strains has been limited, one new
enzyme, Bbvl, has been characterized in Bacillus bre-
vis and its recognition sequence deduced (GC(A/
T)GC). A second enzyme, FnuAll, which is an iso-
schizomer of Mbol, has been isolated from Fusobac-
terium nucleatum A.
Recognition sequences have been determined for a
number of restriction endonucleases, including Mstl
(TCCGCA) from a Microcoleus strain, Kpnl
(GGTAC-,C) from Klebsiella pneumoniae, Pvul
(CGATCG) from Proteus vulgaris, and Sfa NI (GATGC)
from Streptococcus faecalis.
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CELL BIOLOGY
G. ALBRECHT-BUEHLER, S. Blose, K. Burridge, A. Bushnell, A. Ca lasso, J.Farrar, J. Feramisco, J. Garrels, W.
Gordon, L. Jordon, E.B. Lane, T. Lukralle, M. Schwartz
The main research topic of the Cell Biology group is
the motility of animal cells. There are fundamental
biological reasons for the choice of this focus, as
pointed out in previous Annual Reports. By and large,
motility seems to be a matter of the cytoplasm. There-
fore, the efforts of the group focus not only on the
phenomenology of cell movement and cell migration,
but also on the organization of the cytoplasm, and
there particularly on the organizations of fibrous struc-
tures, such as microfilaments, microtubules, and in-
termediate filaments. This includes the study of rela-
tionships between them as well as to the plasma
membrane.
There are two major approaches to the organization
of the cytoplasm. One is a more biochemically
oriented study of the structural proteins, their interac-
tions, and their expression in various cell types and
states. The other is a more micromorphologically
oriented study of the spatial distributions of these pro-
teins and of the changes concomitant with movement
and changes of cell states. The Cell Biology group
attempts to cover both approaches in selected topics,
such as the phenomenology of cell movement, the
cytoplasmic organizations of actin, tropomyosin,
a-actinin, and 10-nm filaments and their role in de-
termining cell morphology and movement, and the
study of the overall protein composition of the cyto-
plasm. Our progress in various aspects of these topics
is reported further below.
As of next year, the entire group will be housed in
the McClintock building. Remodelling of the building
is underway. We are grateful for Dr. Watson's support
in this matter, as well as for financial support from the
Robertson Research Fund for the construction.
There were several changes in our staff. Lan Bo
Chen left us to join the staff at the Sidney Farber Cancer
Center in Boston. We regret his leaving, because his
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lively and imaginative approach to Cell Biology was a
great source of inspiration for us. In July 1978 Stephen
H. Blose joined us as a junior staff member. He has
discovered an intriguing ring of 100-A filaments sur-
rounding the nucleus of guinea-pig vascular endothe-
lial cells. This system seems quite promising in
elucidating the role of these intermediate filaments in
cell motility becaUse the ring-shaped array can be
observed in live cells by polarization light micros-
copy. James Garrels joined us in September 1978. He
recently received his Ph.D. from the University of
California, San Diego, and will work on a computer
analysis of two-dimensional gels. His work will con-
siderably strengthen our efforts to study differences in
protein composition between normal and transformed
cells. Jim Feramisco, likewise a postdoctoral fellow,
who joined us in October, will concentrate on the
biochemistry of a-actinin and associated proteins. At
the same time, Birgit Lane arrived from England. Her
main interest is the study by electron microscopy of
100-A filaments in cultured cells.
The guidance behavior of 3T3 cells
Animal cells respond to anisotropies on the substrate
by orienting or even migrating along them. Various
explanations for this phenomenon, called "contact
guidance" by Paul Weiss, have been suggested in the
past, and its importance for malignant invasion, im-
mune response, and embryonic development has
been emphasized.
The guiding substrate we used was designed to be
reproducible, to be easy to vary experimentally, and to
be compatable with high-resolution light microscopy
and the previously described technique of phagokinet-
ic tracks. We used glass coverslips which were cov-
ered with a 290-A-thick homogeneous layer of evapo-
Figure 1
(a) 3T3 cell migrating along a guiding line with the nucleus centered above it. (b) Phagokinetic track of a 3T3 cell (upper right
corner) migrating within a network of guiding lines. Arrows point to some of the recordings of a "probing" action of the cell at
intersections between guiding lines. Note that the cell can migrate across a gold square as shown in the beginning of the track
(bottom). (c) Phase micrograph of a live 3T3 cell at the intersection between guiding lines. The arrow indicates the direction of
approach. Arrowheads point in the directions into which the cell probing has already extended (upper arrow) or is extending.
(d) Phagokinetic track formed by a migrating group of Ptkl cells during 4 days. (e) Scanning electron micrograph of a migrating
group of PtK1 cells.
rated gold. Using a fine diamond tip, thin lines were
scratched into the gold layer to expose the underlying
glass surface without, however, scratching it. The
guidance behavior of cells on such substrates was
recorded by their phagokinetic tracks. Therefore, as
required by the technique, an additional thin layer of
denatured bovine serum albumin, followed by a layer
of supracolloidal gold particles, was placed on top of
the guiding substrate.
In typical tracks produced by 3T3 cells on the guid-
ing substrates, it was obvious that the cells followed
the guiding scratches for some distance (average 280
p,m) but were able to leave them by turning at certain
angles. Similar behavior could be observed on
platinum layers. Live-cell observations showed that
cells following scratches generally extended to both
sides into the gold area while keeping the nucleus
approximately centered over the scratch. Their
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method of locomotion involved the usual formation of
a leading edge and a retracting tail as is seen on normal
substrates (Fig. la).
Measuring the angles at which cells moved into or
out of the guiding lines yielded essentially identical
angular distributions. Therefore, both distributions
were combined into one. This angular distribution of
directional change shows a peak between 40° and 60°
and decreases gradually towards 180°.
In another type of experiment there were two sets of
parallel scratches crossing each other at a prefixed
angle. A cell following a guiding line and approaching
the intersection between two lines had the options of
continuing straight ahead, of turning at the prefixed
angle w, of turning at the complementary angle
180 ° -w, of migrating backwards, or of leaving the
guiding lines by moving into one of the diamond-
shaped gold areas. Counting in nine independent ex-
periments the percentage of cells which turned at the
present angle w or at its complement 180°- w in a total
of 2208 encounters of cells with an intersection again
yielded a curve where one can discern a preference for
angles between 30° and 60°.
Live-cell observations showed the intriguing action
of cells at intersections whereby they extend into the
various possible directions before following one of
them (Fig. 1c). Such "exploring" activity can also be
seen recorded in the phagokinetic tracks as short
thorns extending into various preformed directions at
intersections (see arrows in Fig. 1 b).
Group locomotion of PtK1 cells
In the animal embryo, single cells can migrate (e.g.,
primary mesenchyme cells) but also whole sheets of
cells can deform and move (e.g., gastrulation, folding
of the neurocrest). Single cells can also migrate in
tissue culture. Whole sheets of human epidermal cells
on top of a feeder layer were recently shown to deform
and fold into swirls (Green and Thomas, Science
200:1385 [1978]).
One may wonder whether there is an intermediary
form of cell locomotion between the two extremes of
single-cell migration and collective deformation of
entire cell sheets. The following study shows that an
intermediary form does exist in the form of small
groups of PtK1 cells (rat-kangaroo kidney cells isolated
by Walen and Brown, Nature 194:406 [1962]), which
are able to migrate in unison across glass substrates.
During 4 days of observation, single PtK1 cells mi-
grated very little, although they were alive, as shown
by the particle-free rings around them. There were also
large groups of cells (Fig. 1a) that hardly displaced
themselves, whereas the group shown in Figure 1 d left
a wide and approximately 700 -µm -long particle-free
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track on the gold-particle-coated substrate indicating
its collective migration. Figure 1e shows one migrating
group in scanning electron microscopy. Its
phagokinetic track extends further to the right-hand
side of the frame.
By observing living cells, we found various ways by
which migrating groups propagated themselves. As
one would expect, only cells at the periphery of the
groups were able to extend the ruffling lamellipodia,
which appear necessary for single-cell locomotion in
fibroblasts and epithelial cells. The centrally located
cells in a group, which could not extend lamellipodia,
nevertheless changed their outlines continuously dur-
ing the migration of the group.
Yet, a quite different type of group migration could
be observed as well. In other live-cell sequences, the
largest extending lamellae were consistently at the
rear end of the group and small, frequently retracting
lamellae were located at the front edge of the group.
Consistent with an earlier report by Brecher (Exp.
Cell Res. 96:303 [1975]), we found an abundance of
100-A filaments in electron micrographs of both
fast-migrating and nonmigrating groups of PtK1 cells.
Besides this conspicuous cytoskeletal feature of PtK1
cells, there was often a striking parallel orientation of
actin-containing microfi lament bundles across cell
border lines.
The orientation of centrioles in migrating 3T3 cells
On the one hand, and as a consequence of their
ninefold rotational symmetry, centrioles divide their
circumference into portions of.360°/9 = 40°. On the
other hand, it seems that migrating 3T3 cells change
direction preferentially at angles of 40° ± 20°, as was
pointed out above. Of course, the simultaneous ap-
pearance of this angle in seemingly so unrelated sub-
jects as centriole structure and angular spectrum of
directional changes may be fortuitous. Yet, one may
tentatively take seriously what might be a coincidence
and test one of its immediate consequences: If an
angle related to the structure of centrioles is, indeed,
expressed in the movement of 3T3 cells, it seems
logical to suspect that the centrioles themselves main-
tain a certain well-defined orientation with respect to
the direction of movement and the plane of the sub-
strate.
We selected and serially sectioned 20 cells that had
formed phagokinetic tracks more than 200 Am in
length without undergoing cell division, as judged by
the fact that their tracks did not branch.
For each cell, we collected the micrographs that
showed centrioles and oriented them relative to the
light micrographs that showed the cells' tracks and a
phase-contrast image of the cells. We consistently
found the centrioles in levels above the substrate
where the cells did not contain any microfilament
bundles, indicating that the centrioles float above the
ventral network of microfilament bundles.
With the exception of two cells, we consistently
found the centrioles sectioned either approximately
perpendicular or parallel to the substrate.
This finding of a peculiar orientation of centrioles
relative to the substrate supports the previous sugges-
tion that the preferential angle of directional change of
40° ± 20° may be related to the 40° angle resulting
from the ninefold rotational symmetry of centrioles.
The angle of 40° occurs in the plane perpendicular to
the centriole axis. If the centriole axis is oriented per-
pendicular to the substrate, as reported, then this angle
could conceivably become expressed in the plane of
the substrate.
Polygonal networks and intermediate filaments in
nonmuscle cells
In the studies of the organization and function(s) of the
microfilament system of cultured nonmuscle cells, we
used a cell line derived from a fibroma of a gerbil.
These cells were chosen for two reasons: they have
numerous uniformly thin stress fibers, and, at a well-
defined time during spreading, form transient poly-
gonal networks of microfilaments (Fig. 2).
Figure 2
Electron micrograph of a polygonal network near the
ventral side of a gerbil fibroma cell.
In the studies of the stress fibers, we have used
antisera against chicken gizzard actin, myosin, and
filamin and bovine skeletal muscle a-actinin to
localize these proteins by means of immunofluores-
cence. From work by others, it was known that
myosin, tropomyosin, and a-actin in are distributed in
stress fibers in periodically arranged units. These re-
sults led to the suggestion by numerous authors that
stress fibers have a sarcomerelike arrangement of
contractile proteins. One key piece of information
needed to support this suggestion was the relationship
between the myosin and a-actinin units; a sarcomeric
arrangement requires an alternate spacing. Another
important question was whether actin is periodically
arranged as in myofibrils. Both pieces of information
have been provided by our immunofluorescent and
electron microscopic studies. Myosin and a-actinin
units are spaced alternately along stress fibers, with
a-actinin localized in Z-line-like dense bodies and
with myosin in spaces between them. An actin peri-
odicity can be detected along some stress fibers in at
least some cells by immunofluorescence (Gordon,
Exp. Cell Res. 1 17:253 [1978]).
In immunofluorescent studies of respreading rat
embryo cells, Lazarides (1. Cell Biol. 68:202 [1976])
discovered an actin-based polygonal network of fi-
bers. He localized actin, a-actinin, and tropomyosin
In this network and proposed that the network serves
as a structural intermediate during stress-fiber forma-
tion. The polygonal networks that form in gerbil fi-
broma cells are similar to those seen in rat cells. We
used immunofluorescence to demonstrate the distri-
bution not only of actin and a-actinin in these net-
works, but also myosin and filamin. In addition, the
ultrastructure of the networks was examined by elec-
tron microscopy. They are constructed of foci, con-
densed meshworks of microfilaments attached to the
inner surface of the plasma membrane, and intercon-
necting microfilament bundles indistinguishable from
stress fibers (Gordon and Bushnell, Exp. Cell Res.
[1979, in press]).
In recent studies we have reinvestigated both the
stress fibers and polygonal networks of the gerbil fi-
broma cells by means of a double immunofluorescent
labeling technique. Employing this technique we have
been able to demonstrate that in both stress fibers and
polygonal networks the units of myosin and
tropomyosin occur in exactly the same locations. We
have also been able to provide direct evidence for the
complementarity of the distribution of these myosin-
tropomyosin regions with the a-actinin-containing
regions.
In the course of studies on the microfilament system
of cultured nonmuscle cells, we discovered a unique
autoimmune antiserum reactive with the major pro-
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tein (56,000 m.w.) and possibly a minor protein
(30,000 m.w.) of the intermediate (10-nm) filaments of
most cultured cell types, muscle and nonmuscle. The
immunofluorescent results, ultrastructural views of the
filaments and the immunochemical characterization
of the autoimmune antiserum have been published
(Gordon, Bushnell, and Burridge, Cell 13:249 [1978]).
In collaboration with Dr. Ian Buckley (John Curtis
School of Medicine, Canberra, Australia), we have
investigated another aspect of the intermediate fila-
ments in a variety of nonmuscle cells. Buckley and
Raju (I. Cell Biol. 78:644 119781) reported that inter-
mediate filaments of glycerol permeabi I ized cells after
mild trypsin treatment (5 µg/ml for 1 hr at 20°C) can
bind heavy meromyosin (HMM), forming the well-
known arrowhead pattern characteristic of actin fila-
ments. This led these authors to conclude that inter-
mediate filaments in primary cultures of chicken em-
bryonic connective-tissue cells have an actin core.
Together, we reinvestigated this finding employing a
wide variety of nonmuscle cultured cell types viewed
in glutaraldehyde-tannic acid-fixed, HMM-labeled,
critical-point-dried whole mounts. Apparently, it is a
general phenomenon that mildly trypsinized inter-
mediate filaments of nonmuscle cells can bind HMM
(Buckley and Raju J. Cell Biol. 78:644 [1978]).
10-nm Filaments in vascular endothelial cells
In previous work we discovered that vascular en-
dothelial cells cultured from guinea-pig thoracic aorta
and portal vein contain a ring of 10-nm filaments that
encircles the nucleus (Fig. 3). Currently, we have ob-
served that intracellular organelles-mitochondria,
lipid vacuoles, lysosomes, and phagosomes--are
closely associated with the ring and the attending
10-nm filaments. When the ring is induced to undergo
cap formation by colcemid, these organelles become
dispersed throughout the cell. Reversal of this experi-
ment by washing out colcemid causes the ring to
re-form with the reassociation of organelles, These
observations have led us to the hypothesis that the
10-nm-filament ring in endothelial cells operates to
organize and/or transport intracellular organelles.
Utilizing time-lapse video-tape microscopy on living
endothelial cells, we are in the process of determining
whether 10-nm filaments are involved in the orderly
movement of organelles.
We have also studied the fate of the 10-nm-filament
ring during mitosis. By indirect immunofluorescence
utilizing antibodies against gizzard 10-nm-filament
protein or the 10-nm-filament autoimmune antisera
(Gordon, Bushnell, and Burridge, Cell 13:249 [19781),
endothelial cells at various stages of mitosis were
stained. During late metaphase, the ring is largely
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distorted, though still a closed structure. In anaphase,
the major axis of the ring enters the daughter cells
preceding the chromosomes. In late telophase,
cytokinesis cleaves into crescents the 10-nm filaments
at the site of the contractile ring. Inhibition of
cytokinesis by treatment with cytochalasin B causes
the daughter nuclei to remain surrounded by the par-
ent 10-nm-filament ring. At no point during mitosis
does the array of 10-nm filaments disassemble into
molecular components. This is in contrast to the other
major cytoplasmic structures that disassemble. We are
presently investigating the intriguing possibility that
during mitosis the 10-nm filaments carry topological
information about the distribution of organelles and
structural proteins into daughter cells.
Computerized two-dimensional gel analysis of
proteins
A two-dimensional gel scanning facility has been set
up on the second floor of the Carnegie library. The
equipment includes a PDP 11/60 computer, an 88M
byte disk drive, an Optronics film scanner, and an
interactive IV display system. the computer will pro-
cess the data from each gel scan to detect and quanti-
tate the spots that represent proteins. The TV system
will be used to display the data and to match patterns
from separate scans. The position of each detected
protein will be expressed in terms of a standardized
coordinate system and the list of protein coordinates
and intensities will be stored on the disk for future
reference. Because the data will be standardized, it
will then be possible to compare the types and
amounts of the proteins that occur in any or all of the
samples that have been analyzed previously.
A special laboratory facility for two-dimensional gel
electrophoresis is being constructed in the McClintock
building. This facility will make possible the routine
production of large numbers of two-dimensional gels,
which will be required for many of the experiments
that are planned. A number of labor-saving features
have been incorporated into the design, as well as
features to assure a high degree of reproducibility.
When the electrophoresis and gel-scanning
facilities are in operation, we plan to begin studies on
the basic mechanisms of cellular differentiation. We
will first examine briefly a large number of different
cell types and animal tissues to determine how much
heterogeneity of gene expression does exist and to find
some of the basic tissue-specific patterns of gene ex-
pression. This survey will establish a data base that will
be frequently referenced and expanded in future ex-
periments. We plan then to concentrate our studies
primarily on the molecular mechanisms of muscle
differentiation, using cloned cell lines that can be
Figure 3
Phase (a) and polarized light (b) micrographs of the same living endothelial cell, demonstrating the perinuclear ring of 10-nm
filaments surrounded by lipid vacuoles, lysosomes, and mitochondria. (Bars = 25 pm) (c) An electron micrograph of the ring,
F, shows association of a lysosome, Ly, and a phagosome, Ph, with the 10-nm filaments. N, nucleus. (Bar = 1 pm.)
induced to undergo myogenic differentiation in cell
culture.
The association of a-actinin with the plasma
membrane
A major unresolved question in the movement of cells
is how the presumed force-generating elements, such
as the actin and myosin, are linked to cell membranes
or membrane components. During this last year we
have concentrated on how actin filaments may be
linked to the plasma membranes of motile cells, such
as fibroblasts and lymphocytes. A possible candidate
which may link actin filaments to membrane compo-
nents is the protein a-actinin. Originally, this protein
was considered to be specific to muscle and to func-
tion in the attachment of actin filaments to muscle Z
lines. The discovery of this protein in nonmuscle cells
suggested that it might have a similar function in at-
taching actin to membranes. Suggestive indirect evi-
dence supporting this possibility has come from im-
munofluorescent antibody studies. Since ultimately
the mode of actin attachment will have to be resolved
biochemically, we have asked the question whether
a-actin i n is present in pure preparations of the plasma
membrane and, if so, can it mediate the attachment of
actin filaments. a-Actinin is a difficult protein to assay
as it has no known enzymatic function. As a result, we
have identified a-actinin by means of the technique
we developed two years ago for detecting antigens
directly in gels by their binding of specific antibodies.
When purified plasma membranes are analyzed on
gels, a band at 100,000 daltons is revealed that reacts
with specific anti-a-actinin antibodies. We have ob-
tained this result by means of two different procedures
to purify plasma membranes from HeLa cells, lym-
phocytes, and cultured fibroblasts. Because the
a-actinin could be present in these preparations for the
trivial reason that it is attached to the actin which is
bound to membrane components via some other
molecules, we have tried various extraction proce-
dures to find out how the ce-actinin is associated with
the membranes. Whereas myosin associated with
these membranes can easily be extracted in the pres-
ence of ATP and high ionic strength, much of the
a-actinin is difficult to extract and can only be re-
moved from these membranes when conditions are
used to depolymerize and dissociate the actin. This
fraction of the a-actinin that is tightly associated with
the plasma membrane may still be present as a conse-
quence of its interaction with actin, but the necessity
to depolymerize the actin in order to remove the
a-actinin from these membranes is also consistent
with the a-actinin mediating the actin attachment.
Further work will be needed to distinguish between
these two alternatives. One possibility is to do recon-
stitution experiments with membranes depleted in
both actin and a-actinin and to determine whether
either protein can interact directly with specific
membrane proteins in the absence of the other com-
ponent.
In studies of membranes, the red blood cell has
provided a popular, albeit specialized, model system.
Since actin has been found peripherally associated
with the red-blood-cell membrane, we decided it
would be interesting to look here also for the presence
of a-actinin. We were unable, however, to detect a gel
band reactive with our anti-a-actinin antisera in gels of
red-blood-cell membranes. Since our antiserum has
quite a broad specificity, it seems unlikely that the
red-blood-cell membrane contains any a-actinin; but
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given the unusual properties of red blood cells, it
could still be that a related molecule is present though
sufficiently different not to cross-react with our anti-
body.
Whether or not a-actinin does mediate the attach-
ment of actin to membranes, it is clearly an interesting
protein both in muscle and nonmuscle cells. Yet, it is a
protein about which surprisingly little is known when
compared with many of the other proteins of the con-
tractile complex. We have, therefore, undertaken a
biochemical study of this protein in order to compare
muscle and nonmuscle forms and also to "dissect" the
regions of the protein responsible for its different func-
tions. Just as a decade ago the myosin molecule was
dissected into a "head" region which carried the
catalytic and actin-binding sites and a "tail" region
whose properties were responsible for its association
into filaments, so we hope to dissect the a-actinin
molecule into various functional regions. In this study,
it will be particularly interesting to identify major dif-
ferences between the muscle and nonmuscle proteins,
possibly indicating different potential interactions or
functions.
Changes in glycoproteins during muscle
development
The cell surface is a critical region in muscle-cell
differentiation. Some of the stages of muscle-cell de-
velopment can be studied conveniently in tissue cul-
ture using either primary cultures or myoblast cell
lines. We have been analyzing the glycoproteins of a
clonal rat myoblast line that is a derivative of Yaffe's L8
line. The glycoproteins of the prefused and the post-
fused myotubes have been compared with each other
and with those from a nonfusing clone by direct
lectin-binding analysis to SDS gels of whole cells. We
have used several lectins with different carbohy-
drate-binding specificities. Some glycoprotein
changes are very prominent, but comparison with the
nonfusing clone has enabled us to show that some of
the changes do not relate to myoblast fusion itself but
correlate more with actively growing cultures or cul-
tures that have become quiescent. However, some
bands are specifically lost as myoblast fusion occurs,
whereas others appear. The bands that appear may
represent glycoproteins involved in the fusion event or
they may represent specialized glycoproteins of the
differentiated myotube. Certainly, the mature muscle
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does have specialized membranes and membrane
functions not present in myoblasts, such as the sarco-
plasmic reticulum and the transverse tubular system. It
will be interesting to identify any of the specific
glycoproteins that we detect on gels with proteins
whose functions in the mature muscle are known.
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POSTGRADUATE
TRAINING PROGRAMS
SUMMER 1978
Since its inception, the postgraduate program at Cold Spring Harbor
Laboratory has been aimed at meeting the rather special need for
training in interdisciplinary subjects that are either so new or so
specialized that they are not adequately treated by universities. Our
intention is to provide intensive training in the most recent devel-
opments and techniques in each of the subjects so that, upon comple-
tion, the students will be able to enter directly into research in the
particular area. To ensure this up-to-date coverage of current research
work, we bring together a workshop staff from many laboratories
around the world and supplement this staff with a series of seminar
speakers.
THE TRANSFORMED CELL, June 11-July 1
INSTRUCTORS
Rifkin, Daniel, Ph.D., New York University Medical Center, New York
Ozer, Harvey, M.D., Hunter College, City University of New York, New
York
ASSISTANT
Crowe, Ruth, B.A., New York University Medical Center, New York
In vitro transformation of mammalian cells by oncogenic viruses or by
environmental agents has served in the last decade as a central model
for the earliest steps of the process of oncogenesis. This new course
presented an integrated series of laboratory exercises, informal dis-
cussions, and guest lectures designed to provide each student with a
chance to carry out and to critically review the many different assays
that detect differences between normal and transformed cells. Wher-
ever possible, these assays also were made to serve as starting points
for examinations of the molecular events underlying them and of their
relationship to in vivo processes such as initiation, promotion, an-
giogenesis, invasion, and metastasis. Exercises included SV40-virion
and DNA transformation of murine precrisis fibroblasts and cell lines,
immunofluorescent localization of viral antigens, preparation of chick
embryo myoblasts and fibroblasts, transformation by is and wt RSV,
fibrinolysis, gel electrophoresis and localization of LETS by antibody-
and lectin-staining on gels, immunofluorescent localization of cyto-
skeletal proteins and of LETS, and explanation of tumors from the nude
mouse. Additional experiments dealt with the approaches of cell
genetics including selection of drug resistant mutants, isolation of cell
hybrids, and karyotype analysis.
Special thanks for their contributions of time and material to these exercises go to Bill Topp, Keith Burridge,
Seung-II Shin, Richard Hynes, and Robert Pollack.
PARTICIPANTS
AMtmann, Eberhard, B.A., Deutsches Krebsforschungszentrum, Heidelberg, Germany
Babson, John R., B.S., Oregon State University, Corvallis
Canary, Patricia K., M.S., Albert Einstein College of Medicine, Bronx, New York
Coutino, Rocio, B.S., Instituto Politecnico Nacional, Mexico City, Mexico
Dittmar, Kurt, Ph.D., Max-Planck-Institut, Berlin, Germany
Frantz, Christopher N., M.D., Sidney Farber Institute, Boston, Massachusetts
Gebhardt, Rolf, B.S., University of Tubingen, Germany
Hill, David J., B.S., Tufts University, Medford, Massachusetts
Iyzo, Paola, B.S., University of Naples, Italy
Klarlund, Jes K., B.S., Fibiger Laboratory, Copenhagen, Denmark
Lis, Martin, Ph.D., Clinical Research Institute of Montreal, Canada
Mizunaga, Takemitsu, Ph.D , Waksman Institute, Rutgers University, New Brunswick, New Jersey
Montarras, Didier, M.S., Institut Pasteur, Paris, France
Mullins, Deborra E., B.S., University of Florida, Gainesville
Nadakavukaren, Karen K., B.S., University of Oregon, Eugene
Reyes, Gregory R., B.A., Johns Hopkins University, Baltimore, Maryland
SEMINARS
Reich, E., Rockefeller University. General properties of malignancy.
Vogt, P., University of Southern California Medical School. Transformation by RNA viruses.
Tegtmeyer, P., State University of New York, Stony Brook. Transformation by DNA viruses.
McCulloch, E., Ontario Cancer Institute. Hematopoietic cells in culture.
Green, H., Massachusetts Institute of Technology. Epithelial cells in culture.
Barrett, C., National Institute of Environmental Health Sciences. Chemical carcinogenesis.
Rifkin, D., New York University Medical Center. Proteases and transformation.
Gospodarowicz, D., Medical Center, University of California, San Francisco. Hormones and growth factors in culture.
Hochstadt, J., New York University Medical Center. Transport changes and transformation.
Pollack, R., Columbia University. Cytoskeleton changes with transformation.
Hynes, R., Massachusetts Institute of Technology. Surface changes and transformation.
Martin, B., National Institutes of Health. Regulation of DNA synthesis in transformed cells.
Nicholson, G., University of California, Irvine. Metastasis.
Seung-II, S., Albert Einstein College of Medicine. Tumor growth in the nude mouse.
Ozer, H., Hunter College, City University of New York. Transformation and somatic cell hybrids.
Basilico, C., New York University Medical Center. Conditional viral transformants.
CENTRAL NERVOUS SYSTEM OF THE LEECH, June 11-July 1
INSTRUCTORS
Nicholls, John, Ph.D., M.D., Stanford University Medical School, California
Muller, Ken, Ph.D., Carnegie Institution, Baltimore, Maryland
Wallace, Bruce, Ph.D., Stanford University Medical School, California
The aim of this workshop was to provide students with an intensive lab and seminar course that would
enable them to pursue independent work on the leech. To this end, we hoped to provide the students with
techniques for recording from leech cells, now considered straightforward and relatively easy, which took
much time and effort to be refined. With this knowledge, they might avoid many of the trivial technical
difficulties that bedevil anyone starting on the nervous system of the leech or other animals.
The initial work was devoted mainly to recognizing the individual cells, learning how to record from them
with intracellular and extracellular electrodes, getting familiar with the equipment, and performing dissec-
tions. The students then progressed to more difficult experiments, such as recording synaptic potentials
while changing the fluid bathing the preparation or injecting individual cells with marker substances in
order to study their geometry.
The final phase of the course consisted of devising and performing original experiments, some of which
proved to be of sufficient interest to be pursued in greater detail. For example, the nervous systems of
various hitherto unexplored leeches were studied. In addition the properties of a new fluorescent dye,
Lucifer yellow, were tested by intracellular injection into identified cells. A systematic study was made for
the first time of the branching patterns of homologous neurons throughout the length of an animal.
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PARTICIPANTS
Blackshaw, Susanna E., Ph.D., University College London, England
Blair, Seth S., B.S., University of California, Berkeley
Feder, Ned, M.D., National Institutes of Health, Bethesda, Maryland
Feinberg, Andrew P., M.D., University of California, San Diego
Fuchs, Paul A., B.A., Stanford University, California
Payton, Brian W., Ph.D., Memorial University of Newfoundland, Canada
Reiser, Georg, Ph.D., Max-Planck-Institut, Munich, Germany
Stewart, Walter W., BA., National Institues of Health, Bethesda, Maryland
Timpe, Leslie C., B.A., Harvard Medical School, Boston, Massachusetts
Tomosky-Sykes, Al isen J., M.A., Columbia University, New York, New York
SEMINARS
Sawyer, R., University of California, Berkekey. Biology of leeches.
Development of leeches.
Nicholls,j.G., Stanford University Medical School. Introduction.
Sensory and motor cells.
Afterpotentials.
Synaptic mechanisms and tissue culture..
Killing single cells.
Muller, K., Carnegie Institution. Sensory cell abnormalities.
Structure of synapses.
5 cell regeneration.
Wallace, B., Stanford University Medical School. Heart cell synapses.
Regeneration.
Stent, G., University of California, Berkeley. Swimming.
Photoreceptors.
Heartbeat.
Kristan, W., University of California, San Diego. Swimming.
Zipser, B., State University of New York Downstate Medical Center. Neurons regulating sexual behavior.
Cohen, L., Marine Biology Laboratories, Woods Hole. Dyes for recording membranepotential.
Salzberg, B., University of Pennsylvania. Dyes for recording membrane potential.
TECHNIQUES FOR STUDYING THE VERTEBRATE CENTRAL NERVOUS SYSTEM, June 11-July 1
INSTRUCTORS
Kirkwood, Peter, Ph.D., Institute of Neurology, London, England
Shatz, Carla, Ph.D., Stanford University Medical School, California
Stryker, Michael, Ph.D., University of California, San Francisco
ASSISTANT
Mates, Sharon, B.A., University of Washington Medical School, Seattle
One aim of the course was to provide students with the basic technical competence necessary for
conducting independent experimental work. Another was to provide an introduction to the functional
organization of several different areas in the vertebrate central nervous system. The course consisted of four
different laboratory exercises. In all labs students learned the appropriate surgical techniques, the prepara-
tion of microelectrodes, and simple histological procedures for reconstructing electrode tracks. In one lab
the reflex activity of motoneurons in the cat's spinal cord was studied using both intracellular and
extracellular recording techniques. Two other labs focused on the visual system. In one, extracellular
recordings were made from the cat's visual cortex, and the response properties of neurons to visual stimuli
were examined. In the other, stereotaxic techniques were used to place electrodes within deeper structures
(lateral geniculate nucleus) for recordings and microinjections. In this laboratory, the connections between
the lateral geniculate nucleus and the visual cortex were studied. The retrograde transport of horseradish
peroxidase injected into the visual cortex, and the anterograde transport of 3H-proline injected into the
lateral geniculate nucleus were used to identify these connections. In the fourth lab, the regions of the rat's
cortex receiving somatosensory input from the whiskers were studied. Extracellular recordingswere used
together with the recently developed 2-deoxyglucose histochemical method for measuring local glucose
utilization in neural tissue. The structure of this cortical region seen in cell-body stained sectionswas compared
with findings from these physiological techniques.
69
PARTICIPANTS
Bach, Michael, M.S., Albert-Ludwigs Universitat, Freiburg, Germany
Bowling, Doug B., Ph.D., Stanford University, California
Brecha, Nicholas, Ph.D., State University of New York, Stony Brook
Haber, Suzanne N., Ph.D., Stanford University, California
Kohlerman, Nicholas J., B.A., Johns Hopkins University, Baltimore, Maryland
Martin, John H., M.A., Columbia University, New York
Nixon, Bruce, B.S., McMaster University, Hamilton, Ontario
Sudarsky, Lewis R., M.D., Childrens Hospital, Boston, Massachusetts
SEMINARS
Burke, R.E., National Institutes of Health. Anatomy and physiology of monosynaptic action in spinal motoneurons of
the cat.
Wiese!, T.N., Harvard Medical School. The visual system: Adult organization, development, and the effects of
deprivation.
Moore, G.P., University of Southern California, Los Angeles. Theory and use of cross-correlation technique in the
mammalian nervous system.
Kiang, N.Y.S., Massachusetts Eye and Ear Infirmary. The mammalian auditory system.
Bizzi, E., Massachusetts Institute of Technology. The role of proprioceptive afferents in motor control.
Karten, H.J., State University of New York Medical School, Stony Brook. Displaced ganglion cells and the accessory
optic system.
MOLECULAR CYTOGENETICS, June 11-July 1
INSTRUCTORS
Pardue, Mary Lou, Ph.D., Massachusetts Institute of Technology, Cambridge
Gall, Joseph, Ph.D., Yale University, New Haven, Connecticut
ASSISTANT
Erba, Harry, Yale University, New Haven, Connecticut
The molecular cytogenetics course emphasized the integration of classical and molecular techniques for
analysis of chromosome structure and function. A number of visiting scientists joined with the class for
discussion of current problems in the field and for experiments utilizing chromosome banding, the isolation
of chromatin subunits, in situ hybridization, visualization of transcription by electron microscopy,
restriction-enzyme digestion of DNA, nucleic acid sequencing, heteroduplex mapping, and use of Xenopus
oocytes for studies on transcription and translation of exogenous DNA. As always, we benefited from the
many contributions of Barbara McClintock.
Students came from Chile, Denmark, Germany, Israel, Mexico, and various parts of the United States.
Their wide range of previous research experience added a variety of expertise to the group.
PARTICIPANTS
Arancibia, Marco A., M.S., University of Chile, Santiago
Calzone, Frank J., B.A., University of Rochester, New York
Dale, Roderic M.K., Ph.D., Yale University, New Haven, Connecticut
Flores-Lopez, Margarita, B.S., Instituto Politecnico Nacional, Mexico City, Mexico
Grummt, Ingrid, Ph.D., Max-Planck-Institut, Munich, Germany
Leer, Johan, Ph.D., University of Aarhus, Denmark
Mertz, Janet E., Ph.D., University of Wisconsin, Madison
Sears, Barabara B., B.S., Duke University, Durham, North Carolina
Shilo, Ben, B.S., Sidney Farber Institute, Boston, Massachusetts
Strausbaugh, Linda, Ph.D., Johns Hopkins University, Baltimore, Maryland
SEMINARS
Latt, S., Harvard Medical School. Recent studies on chromosome fluoresence and sister chromatid exchange forma-
tion.
Lindsley, D.L., University of California, San Diego, Genetic control of spermatogenseis.
Davis, R., Stanford Medical School. Genes, transposons, and transformation of yeast.
Gall, J., Yale University. Gene amplification in tetrahymena.
McClintock, B., Carnegie Institution of Washington. How to make junk out of the genome.
Hamkalo, B., University of California, Irvine. Studies on the structure of metaphase chromosomes.
Bonner, J.J., University of California Medical School. Induction of puffing in isolated polytene nuclei from Drosophila.
Pardue, M.L., Massachusetts Institute of Technology. The heat shock response: A model system for the study of transcription in
Drosophila.
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Varshaysky, A., Massachusetts Institute of Technology. Compact SV40 viral minichromosomes: Non-random arrangement of
nucleosomes.
Mertz, J., University of Wisconsin. The use of Xenopus oocytes to study transcription of exogenous DNA.
STRUCTURE AND FUNCTION OF THE SYNAPSE, June 11-July 1
INSTRUCTORS
Rahamimoff, Rami, M,D., Hebrew University Medical School, Jerusalem, Israel
Frank, Eric, Ph.D., Harvard Medical School, Boston, Massachusetts
Sanes, Joshua, Ph.D., University of California Medical School, San Francisco
Hudspeth, Albert James, M.D., California Institute of Technology, Pasadena
DEMONSTRATORS
Yaari, Yoel, Ph.D., Hebrew University Medical School, Jerusalem, Israel
Lev-tov, Aharon, M.Sc., Hebrew University Medical School, Jerusalem, Israel
This course was designed for graduate students and research workers interested in the structure and function
of synapses. It consisted of lectures; reading of papers; group discussions; presentation of selected topics by
participants; seminars by instructors, faculty, and participants; and demonstrations. After the course ended,
eight participants who were uninitiated in electrophysiological techniques stayed on for several days to learn the
usage of basic methods. Four additional participants stayed for four weeks learning in detail specific methods
and starting their own research projects.
PARTICIPANTS
Augustine, George, J., B.S., University of Maryland, College Park
Ballivet, Marc, Ph.D., University of Geneva, Switzerland
Barish, Michael E., Ph.D., Stanford University, California
Green, Steven H., B.S., California Institute of Technology, Pasadena
Halegoua, Simon, B.S., State University of New York, Stony Brook
Jackson, Patrick C., B.S., McMaster University, Ontario, Canada
Jahnsen, Henrik, M.D., Institute of Neurophysiology, Copenhagen, Denmark
Kass, Leonard, M.S., Eye Research Institute, Boston, Massachusetts
Marchais, Dominique, B.S., Ecole Norma le Superieure, Paris, France
Marshak, David W., B.A., University of California, Los Angeles
Mich ler, Angelika, Ph.D., Max-Planck-Institut, Gottingen, Germany
Morrison-Graham, Kathleen, B.S., University of California, Los Angeles
North, Paula E., B.A., Vanderbilt University, Nashville, Tennessee
Pawson, Peter A., B.S., McGill University, Montreal, Canada
Pearse, Roger, B.A., McLean Hospital, Belmont, Massachusetts
Pickett, Jackson B.E., M.D., University of California, San Francisco
Rothman, Steven M., M.D., Washington University, St. Louis, Missouri
Sherman, Thomas G., B.S., University of Texas, Dallas
Stein, Cathy, B.A., University of Maryland, Baltimore
Zurn, Anne D., Ph. D., University of Geneva, Switzerland
SEMINARS
Hudspeth, A.J., California Institute of Technology. Neurocytology.
Structure of the synapse.
Structure of the neuromuscular junction.
Sensory transduction in hair cells.
Recycling of synaptic vesicles.
Frank, E., Harvard Medical School. Passive electrical properties of nerve and muscle.
Phenomenology of the action potential.
Cable properties and the propagation of action potential.
Excitatory synaptic transmission.
The ionic basis of the EPSP.
Inhibitory synaptic transmission.
Quantal transmission in the central nervous system.
Ionic selectivity and Eyring rate theory.
Development of synapses in tissue culture.
Rahamimoff, R., Hebrew University Medical School. Ionic basis of membrane potential-forces.
Fluxes through resting nerve membrane.
Resting potential.
Ionic basis of the action potential-currents.
Ionic basis of the action potential-conductances.
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Hodgkin-Huxley model.
Quantal release of transmitter.
Regulation of transmitter release by intracellular calcium.
Frequency modulation of transmitter release.
Leakage of transmitter.
Oscillations in transmitted release.
Raviola, E., Harvard Medical School. Structure of the retina.
Workshop on freeze fracture.
Thomas, R., Bristol University. The electrogenic sodium pump and ion-sensitive microelectrodes.
The regulation of intracellular H* ion concentration.
Sanes, J., University of California Medical School, San Francisco._ Localization and structure of the acetylcholine receptor.
Localization and structure of acetylcholinesterase.
Development of the neuromuscular junction. I. Embryonic development.
Development of the neuromuscular junction. II. Denervation and reinnervation.
Development of the neuromuscular junction. 111. Regulation and mechanisms.
Yaari, Y., Hebrew University Medical School. Electrical synapses.
Presynaptic inhibition in CNS.
Goodenough, D., Harvard Medical School. Gap junctions.
Introduction to X-ray diffraction and the structure of the gap junction.
Erulkar, S.D., University of Pennsylvania School of Medicine. Neurotoxins.
Principles of synaptic pharmacology and false transmitters.
Chemical and electrical transmission in the spinal cord.
Albrecht-Buehler, G., Cold Spring Harbor Laboratory. Geometry and cell movements.
Grinvald, A., Yale Medical School. Voltage-sensitive fluorescent probes.
Yoshikami, D., Harvard Medical School. Microph.ysiology of the postsynaptic membrane.
Postsynaptic potentiation interaction between quanta and the size of the quantum.
Transmission at automatic ganglia.
Slow synaptic potential.
Wallace, B., Stanford Medical School. Octopamine synapses.
Leech demonstration.
Stevens, C., Yale Medical School. Properties of the postsynaptic channel.
The voltage dependence of the postsynaptic channel.
Fluctuation analysis.
Applications of fluctuation analysis.
Ion permeation through channels.
Nicholls, J., Stanford Medical School. Leech demonstration.
Long-term changes, single cell killing, regeneration in the nervous system of the leech.
Meuller, K., Carnegie Institution of Washington. Leech demonstration.
Morphology and function of leech ganglia.
Fambrough, D., Carnegie Institution of Washington. Biochemistry of the acetylcholine receptor.
Synthesis and degradation of the acetylcholine receptor.
Purves, D., Washington University, St. Louis. Cell death and synapse elimination.
Nerve growth factor and the effects of axotomy.
Sprouting of axon terminals.
Specificity of neural connections.
Patterson, P., Harvard Medical School. Migration of neural crest cells.
Influence of the environment on nerve cell differentiation.
ADVANCED BACTERIAL GENETICS, July 4-July 24
INSTRUCTORS
Botstein, David, Ph.D., Massachusetts Institute of Technology, Cambridge
Roth, John, Ph.D., University of Utah, Salt Lake City
Davis, Ronald, Ph.D., Stanford University, California
ASSISTANTS
Johnston, Mark, B.A., University of Utah, Salt Lake City
Rose, Mark, B.A., Massachusetts Institute of Technology, Cambridge
Stinchcomb, Dan T., B.A., Stanford University, California
Starting with a random pool of A phages carrying cloned inserts of Salmonella DNA, students identified by
plaque hybridization phages carrying the naturally occurring IS10 sequence and a Tn/O element present in
the strain. From the same pool, students selected phages carrying portions of the histidine and tryptophan
operon. Phages were characterized by restriction analysis, complementation tests, and electron microscopy.
Inserts from phages were recloned in a plasmid vehicle.
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Students also carried out a variety of genetic experiments involving use of the Tn10 insertion element in
Salmonella typhimurium. These included isolation of insertional auxotrophs and fermentation mutants,
selecting Tn10 insertions near particular genes and using Tn10 to direct insertion of a Ers'Tn10 lack episome
into the chromosome.
PARTICIPANTS
Armaleo, Daniele, M.S., Duke University, Durham, North Carolina
Bates, Marjorie A., B.S., University of California, Los Angeles
Cole, Patricia E., Ph.D., Columbia University, New York
Conklin, Mark A., M.S., National Institutes of Health, Bethesda, Maryland
Donnelly, Robert J., B.S., Johns Hopkins University, Baltimore, Maryland
Eccleshall, T. Ross, Ph.D., Albert Einstein College of Medicine, Bronx, New York
Esposito, Rochelle E., Ph.D., University of Chicago, Illinois
Farrell, Roberta L., M.S., University of Illinois, Urbana
Kwan, Sau-Ping, Ph.D., Albert Einstein College of Medicine, Bronx, New York
Lai, Elaine Y., Ph.D., Brandeis University, Waltham, Massachusetts
Lawther, Robert P., Ph.D., University of California, Irvine
Matteo, Martha R., Ph.D., Union Carbide Corp., Tarrytown, New York
McKenney, Keith H., B.S., National Institutes of Health, Bethesda, Maryland
Monahan, Thomas R., M.S., Schering Corp., Bloomfield, New Jersey
Neufeld, Berney R., Ph.D., Loma Linda University, California
Rice, Douglas A., B.A., University of Chicago, Illinois
Williamson, Patrick L., Ph.D., Amherst College, Massachusetts
SEMINARS
Abelson, J., University of California, San Diego. T4 tRNAs.
Beckwith, J., Harvard Medical School. Genetic engineering in vivo.
Kaiser, D., Stanford University. Chemotaxis in myxobacteria.
Federoff, N., Carnegie Institution of Washington. Analysis of Xenopus 55RNA genes in E. coli.
Ptashne, M., Harvard University. Regulation of A repressor.
Low, B., Yale Medical School. Potpourri of bacterial genetics.
Parkinson, S., University of Utah. Genetics of chemotaxis in E. coli.
Roberts, R., Cold Spring Harbor Laboratory. DNA sequencing (or Der Meistersanger).
Friedman, D., University of Michigan. Nus and bolts of A regulation.
Gilbert, W., Harvard University. Penninsulin.
Franklin, N., Stanford University. Regulation by anti-termination.
ONCOGENIC VIRUSES, July 4-July 24
INSTRUCTORS
Sharp, Phillip A., Ph.D., Massachusetts Institute of Technology, Cambridge
Spear, Patricia, Ph.D., University of Chicago, Illinois
ASSISTANT
Camacho, Ann, Ph.D., University of Chicago, Illinois
Four animal virus groups were discussed during the course and used in laboratory experiments:
papovaviruses, adenoviruses, herpesviruses, and retroviruses. Both the biology and molecular biology of the
viruses were covered by various speakers in a format that allowed the lecturers to provide background
information so that their current work could be understood by students without previous training in the field.
Several members of the permanent staff of Cold Spring Harbor Laboratory gave research seminars and
demonstrations of specific techniques. The afternoons and part of the evenings were occupied with
laboratory work. Topics covered included counting and plating of mammalian cells in culture; transforma-
tion of 3T3 cells by Harvey sarcoma virus; SV40 virus and SV40 DNA; transfection of cells with herpes
simplex viral DNA; transformation of thymidine-kinase-negative mouse cells to thymidine-kinase-positive
cells with herpes simplex DNA; plaque titering of SV40; adenovirus 2 and herpes simplex virus; extraction
of adenovirus 2 virions and SV40 and herpesvirus DNAs from infected cells; restriction endonuclease
cleavage and gel electrophoresis analysis of viral genomes; nick translation of viral DNA; Southern blotting
of cellular and viral DNA; XC assay of Moloney leukemia virus and preparation of an in vitro protein-
synthesizing system using rabbit reticulocyte lysate digested with micrococcal nuclease. Brief demonstra-
tions of injection of mammalian cells by microneedles and electron microscope techniques for visualization
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of DNA were given. In addition to these activities, some students worked on the development of other
procedures used in molecular virology.
PARTICIPANTS
Bowman, Benjamin F., M.S., Max-Plank-Institut, Munich, Germany
De La Vega, Humberto, B.S., Instituto Politecnico Nacional, Mexico City, Mexico
Dworkin, Mark B., Ph.D., Carnegie Institution of Washington, Baltimore, Maryland
Fiser, Ilja, Ph.D., University of Washington, Seattle
Freese, K.U., M.D., Institute of Virology, Freiburg, Germany
Gourlie, Brian B., Ph.D., Wesleyan University, Middletown, Connecticut
Hamelin, Richard, Ph.D., Hopital Saint-Louis, Paris, France
Horowitz, Mia, Ph.D., Weizmann Institute of Science, Rehvot, Israel
Montenarh, Mathias, Ph.D., Universitat Ulm, Germany
Neumann, Jeffrey R., Ph.D., Massachusetts Institute of Technology, Cambridge
Ohtsubo, Hisako, Ph.D., State University of New York, Stony Brook
Subramani, Suresh, M.S., University of California, Berkeley
Taketo, Makoto, Ph.D., Rockefeller University, New York, New York
Wrede, Paul, Ph.D., Massachusetts Institute of Technology, Cambridge
SEMINARS
Todaro, G., National Institutes of Health. Study of viruses in in vitro cell culture.
Hynes, R., Massachusetts Institute of Technology. Alterations of cells during transformation.
Benjamin, T., Harvard Medical School. Papovirus genetics and cell transformation.
Weissman, S., Yale University. SV40 genes and transcription.
Nathans, D., Johns Hopkins University. Mutants of SV40 constructed in vitro.
Williams, J., Carnegie Mellon University. Adenovirus genetics.
Sharp, P., Massachusetts Institute of Technology. Adenovirus transcription.
Roberts, B., Brandeis University. In vitro translation and gene mapping.
Roizman, B., University of Chicago. Herpes simplex virus-DNA replication and gene regulation.
Spear, P., University of Chicago. Herpes simplex virus-induced alterations of cellular membranes.
Ana camacho-herpes simplex virus-transformation.
Miller, G., Yale University. Epstein-Barr virus An overview.
Berg, P., Stanford University. SV40 DNA as a cloning vector.
Shenk, T., University of Connecticut. Isolation of adenovirus type 5 deletion mutants and analysis of the SV40 origin of
DNA replication.
Baltimore, D., Massachusetts Institute of Technology. Molecular biology of retrovirus.
Rowe, W., National Institutes of Health. Murine leukosis virus.
Temin, H., University of Wisconsin. Avian retroviruses and protovirus hypothesis.
Robinson, H. H., Worcester Foundation. Chicken genes which code for virus.
Gilbert, W., Harvard University. Structure of immunoglobin genes of mouse.
BASIC NEUROANATOMICAL METHODS, July 4-July 24
INSTRUCTORS
LaVail, Matthew M., Ph.D., University of California, San Francisco
LaVail, Jennifer H., Ph.D., University of California, San Francisco
ASSISTANTS
Ward, Patricia Ann, B.A., University of California, San Francisco
Sugino, Ilene, M.A., University of California, San Francisco
This course is designed for graduate students and research workers interested in learning basic neuroanatom-
ical techniques. The course is primarily a series of laboratory exercises by the participants, with lectures and
demonstrations by the instructors and visiting faculty.
The classical neuroanatomical methods that were covered in this laboratory course include: perfusion
fixation; embedding in various media; cell staining methods that highlight neuronal and glial cell nucleic
acids; silver salt impregnation methods in the intact nervous system and in selectively interrupted nerve fiber
bundles; brightfield, darkfield, and fluorescence light microscopy; electron microscopy; and data gathering
with camera lucida and photomicrography.
Among new methods covered were the following: various histochemical, radiochemical, and im-
munocytochemical techniques that demonstrate the structure and location of specific neurons or synaptic
terminals based on their characteristic neurotransmitters or state of electrical activity; tracing axonal
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pathways using the anterograde axoplasmic transport of radioactively labeled protein; determining the
sources of neuronal pathways using the retrograde axonal transport of suitable markers; and computer-
assisted techniques for the quantitative analysis of cellular features of the nervous system.
PARTICIPANTS
Fable, W. Manfred, B.S., Max-Planck-Institut, Tubingen, Germany
Herschel, Michael B., M.D., Mailman Research Center, McLean Hospital, Belmont, Massachusetts
Innis, Robert B., B.S., Johns Hopkins School of Medicine, Baltimore, Maryland
Kelly, Amy S., Ph.D., Stanford Medical School, California
Marchand, Claudine, Ph.D., State University of New York, Stony Brook
Pinto, Lawrence, H., Ph.D., Purdue University, Lafayette, Indiana
Schein, Stanley jay, Ph.D., Massachusetts Institute of Technology, Cambridge
Wu, Chun-Fang, Ph.D., California Institute of Technology, Pasadena
SEMINARS
Ralston, H.J., Ill, University of California, San Francisco. Axonal degeneration methods.
Moore, R.Y., University of California, San Diego. Fluorescence techniques and aminergic systems.
Hendrickson, A., University of Washington. Light and electron microscope autoradiographic methods.
Pfenninger, K0 Columbia University College of Physicians and Surgeons. Intramembranous structure of neural
cells-Freeze tracture methods.
Pickel, V., Cornell University Medical College. lmmunocytochemical methods.
Hubel, D., Harvard Medical School. The 2-deoxyglucose method and transneuronal autoradiography.
Woolsey, T.A., Washington University School of Medicine. Computer-assisted methods.
NEURAL DEVELOPMENT, July 4-July 19
INSTRUCTORS
Purves, Dale, M.D., Washington University Medical School, St. Louis, Missouri
Patterson, Paul H. , Ph.D., Harvard Medical School, Boston, Massachusetts
The aim of this intensive two-week course was to expose a group of approximately twenty students to the
classical literature of neural development, with special emphasis on recent advances and controversies in
this rapidly growing field. The selection of students was based primarily on recommendations and potential
rather than background; thus this year's group of 21 students was composed of five postdoctoral fellows and
sixteen graduate students, from the United States and Europe, involved in widely differing research pro-
grams. The common denominator was an interest in pursuing research related to neural development.
The format of the course was to have invited lecturers present a detailed review of particular fields in a
three-hour morning session. The speaker then chose several important papers, generally ones not discussed
in the morning, for the students to read during the course of the afternoon. In the late afternoon the speaker
(and instructors) met with groups of six to seven students to discuss the reading and prepare one of.the
students in each group to present the papers at an evening meeting of the whole class. The evening then
consisted of several students' presentations of aspects of the field not covered by the invited lecturer, as well
as a general discussion of the issues raised during the day. Most evenings ended with one or two student
research seminars in which an individual's work was described for discussion, with criticism by fellow
students and instructors. In general, we attempted to have such presentations on an evening when the guest
lecturer had a special interest in the student's field. An occasional variant of this format was to end the
evening with a research seminar by an additional invited speaker whose material was deemed of interest,
but not broad enough to devote an entire day to.
PARTICIPANTS
Anderson, Hilary, I., Ph.D., University of Oxford, England
Betz, Heinrich, M.D., Institut Pasteur, Paris, France
Caldwell, John H., Ph.D., University of Colorado, Denver
Feldman, Daniel H., B.A., University of California, San Francisco
Green, Steven H., B.S., California Institute of Technology, Pasadena
Hayes, Nancy L., B.A., University of North Carolina, Chapel Hill
Henke, Sigrid, M.D., Max-Planck-Institut, Tubingen, Germany
Holland, Robert L., B.A., University of Oxford, England
Hume, Richard I., Stanford University, California
Kato, Ann C., Ph.D., University of Geneva, Switzerland
Katz, David M., B.A., State University of New York, Stony Brook
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Leber, Steven M., B.S., Albert Einstein College of Medicine, Bronx, New York
Lee, Matt T., B.S., University of California, San Diego
Lichtman, Jeff W., B.A., Washington University, St. Louis, Missouri
Lidov, Hart G.W., B.A., Johns Hopkins University, Baltimore, Maryland
Meiri, Hamutal, B.S., Hebrew University, Jerusalem, Israel
Pilgrim, Alison, J., B.A., University of Oxford, England
Shotwell, Sandra L., B.A., California Institute of Technology, Pasadena
Strong, Judith A., B.A., Yale Medical School, New Haven, Connecticut
Wallenfels, Barbara, Ph.D., Max-Planck-Institut, Tubingen, Germany
Wendon, Linda M.B., B.A., University College London, England
SEMINARS
Cowan, M.W., Washington University School of Medicine, St. Louis. Overview of neural development.
Primary induction and cell proliferation.
Migration and selective aggregation.
Cytodifferentiation and cell death.
LeDouarin, N., Centre National de la Recherche Scientifique. Migration and differentiation of neural crest derivatives.
Patterson, P.H., Harvard Medical School. Control of transmitter biosynthesis in the autonomic nervous system.
Nerve growth factor.
Cell surface interactions as a basis for neuronal recognition.
Purves, D., Washington University School of Medicine, St. Louis. Nerve growth factor: Biological effects.
The elimination of synapses in postnatal development.
Sprouting and retrograde axotomy effects: Maintenance of synaptic connections in maturity.
The formation of specific connections in the peripheral autonomic nervous system.
Nottenbohm, F., Rockefeller University. Hormonal influences in neural development.
Spitzer, N.W., University of California, San Diego. Development of electrical-chemical excitability in nerve and muscle.
Fambruogh, D., Carnegie Institution. The role and regulation of postsynaptic receptors in synaptogenesis.
Dennis, M.J., University of California, San Francisco. The electrophysiology of synaptic development.
The elimination of inappropriate synapses: Possible role in specific connectivity.
Landmesser, L., Yale University. The role of axon guidance in the formation of specific neural connection.
Bentley, D., University of California, Berkeley. Neural development in invertebrates.
Macagno, E., Columbia University. A mechanism for the formation of synaptic projections in the arthropod visual
system.
Hunt, R.K., Johns Hopkins Medical School. The formation of specific retino-tectal connections.
Black, I., Cornell Medical School. The development of sympathetic and parasympathetic ganglia.
Hubei, D.H., Harvard Medical School. Effects of deprivation on the development of the visual system of cats and
monkeys.
Rakic, P., Yale University Medical Schbol. Genetic and epigenetic determinants of brain development.
THE MOLECULAR BIOLOGY AND GENETICS OF YEAST, July 31-August 20
INSTRUCTORS
Fink, Gerald R., Ph.D., Cornell University, Ithaca, New York
Sherman, Fred, Ph.D., University of Rochester, New York
ASSISTANTS
Baim, Steve, B.S., University of Rochester, New York
This program emphasized the major laboratory techniques used in the genetic analysis of yeast:tetrad
analysis, mitotic recombination, and fine-structure mapping. The isolation and characterization of both
chromosomal and cytoplasmic mutants were undertaken. Biochemical studies were performed with
chromosomal and mitochondrial mutants.. Analysis of eukaryotic gene structure used digestion with restric-
tion endonucleases and gel electrophoresis. Several aspects of the yeast transformation system were also
investigated.
PARTICIPANTS
Barney, Michael C., M.S., Medical College of Wisconsin, Milwaukee
Bastia, Deepak, Ph.D., University of Alabama, Birmingham
Brake, Anthony J., M.A., University of California, Los Angeles
Carlson, Marian B., Ph.D., Stanford Medical Center, California
Colby, Diane S., Ph.D., University of California, San Francisco
Duncan, Craig H., Ph.D., Yale University, New Haven, Connecticut
Gallwitz, Dieter F.G., M.D., Universitat Marburg, Germany
Guthrie, Christine, Ph.D., University of California, San Francisco
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Hammond, Charlotte I., B.S., University of Connecticut, Farmington
Jaehning, Judith A., Ph.D., University of California, Berkeley
Kjellin-Straby, Kerstin, Ph.D., University of Umea, Sweden
Mery-Drugeon, Elena, Ph.D., Institut Pasteur, Paris, France
Savage, Margaret A., B.S., Cornell University Medical College, New York, New York
Scott, John F., B.S., Stanford University, California
Truffaut, Nicole, Ph.D., Institut Pasteur, Paris, France
Wernau, William C., Ph.D., Pfizer, Inc., Groton, Connecticut
SEMINARS
Byers, B., University of Washington, Seattle. Cytology of the yeast life cycle.
Petes, T.D., University of Chicago. Structure and replication of yeast DNA.
Genetic analysis of repeating ribosomal DNA genes.
Hicks, J., Cold Spring Harbor Laboratory. Regulation of mating types in yeast.
Warner, J., Albert Einstein College of Medicine. Regulation of ribosomal proteins and RNA.
McLaughlin, C.S., University of California, Irvine. Protein and RNA synthesis in yeast.
Macromolecular synthesis through the cell cycle.
Tzagoloff, A., Columbia University Medical School. The mitochondrial genome.
Mortimer, R.K., University of California, Berkeley. Genetic mapping in yeast.
Gene conversion and post meiotic segregation.
Lawrence, C., University of Rochester. Radiation mutagenesis and repair in yeast.
Esposito, M.S., University of Chicago. Genetic control of recombination and sporulation.
Fink, G.R., Cornell University. Transformation of yeast with hybrid DNA.
Regulation of HIS4 in yeast.
Sherman, F., University of Rochester. Regulation of the iso-cytochromes c.
Nonsense suppression in yeast.
Abelsen, J., University of California, San Diegeo. Transcription and processing of intervening sequences in yeast tRNA
genes.
Guthrie, C., University of California, San Francisco. Genetic and biochemical analysis of yeast suppressor tRNAs.
ELECTROPHYSIOLOGICAL METHODS FOR CELLULAR NEUROBIOLOGY, August 1-August 21
INSTRUCTORS
Kehoe, JacSue, Ph.D., Ecole Normale Superieure, Paris, France
Chiarandini, Dante, M.D., New York University, New York
Stefani, Enrique, M.D., Instituto Politecnico Nacional, Mexico City, Mexico
GUEST LECTURER
Kado, Ray, Ph.D., Centre National de la Recherche Scientifique, Gif-sur-Yvette, France
In this neurobiology course the neuromuscular junction of the frog and the central ganglia of the mollusc Aplysia
were used as experimental preparations for training students in basic electrophysiological methods for cellular
neurobiology. Examination of certain characteristics of the resting potential, action potential, and synaptic
potentials of these two preparations served as a framework for introducing the following techniques: microdis-
section, fabrication of single and mu ltibarrelled capillary microelectrodes, intracellular and extracellular
application of ions and drugs (ionophoresis and pressure injection), and intracellular staining for light and
electron microscopy.
The first three days of the course were devoted to lectures and exercises on electronics for cellular
neurobiologists given by Ray Kado. The last few days of the course were devoted to individual experimental
projects chosen by the students. These projects permitted them to try techniques not taught in the course and to
use biological preparations that they intended to study upon returning to their own laboratories.
PARTICIPANTS
Chillemi, Santi, Ph.D., Laboratorio di Cibernetica, Naples, Italy
Davis, Norman T., Ph.D., University of Connecticut, Storrs
Drager, Ursula C., M.D., Harvard Medical School, Boston, Massachusetts
Kass, Leonard, M.S., Eye Research Institute, Boston, Massachusetts
Nathanson, Neil M., Ph.D., University of California, San Francisco
Nanjundiah, Vidyanand, Ph.D., Indian Institute of Science, Bangalore
Nowycky, Martha C., Ph.D., Yale University, New Haven, Connecticut
Skinner, Kathleen J., B.A., University of California, Davis
Stein, Cathy, B.A., University of Maryland, Baltimore
Walz, Wolfgang W., M.S., Universitat Konstanz, Germany
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SEMINARS
Rang, H.P., St. George's Hospital, London. Basic electronics for neurobiologists. I.
Basic electronics for neurobiologists. II.
Basic electronics for neurobiologists. III.
IMMUNOGENETICS AND TUMOR IMMUNOLOGY, August 1 - August 14
INSTRUCTORS
Cantor, Harvey, M.D., Harvard Medical School, Boston, Massachusetts
Paul, William E., M.D., National Institutes of Health, Bethesda, Maryland
ASSISTANTS
Bojanowski, Jo, B.S., Harvard University, Cambridge, Massachusetts
The course was intended for graduate students and research workers who are interested in studying the
lymphocyte population of the mouse as material for analysis of the molecular biology of cell differentiation
in higher organisms. Some of the general areas that were considered included (1) studies of lymphocyte
development and the molecular basis of lymphocyte differentiation, (2) genetic and biochemical analysis of
recognition structures expressed by different sets of lymphocytes, (3) the special requirements for activation
of lymphocytes by antigen, (4) the role of interactions between different sets of lymphocytes in regulating the
immune response to viruses and other antigens, (5) current information bearing on the molecular basis of
viral leukemogenesis, and (6) the relationship of the immune system to leukemia resistance.
PARTICIPANTS
Bear, Susan E., B.A., Tufts University, Medford, Massachusetts
Bleicher, Paul A., B.S., University of Rochester, New York
Bondada, Subbarao, Ph.D., National Institutes of Health, Bethesda, Maryland
Brodeur, Peter H., B.S., Tufts University, Medford, Massachusetts
Collins, Elizabeth T., B.S., University of Virginia, Charlottesville
Conlon, Paul J., M.S., University of Colorado, Denver
Conzelmann, Andreas, M.D., Swiss Institute for Cancer Research, Lausanne
Corley, Ronald B., Ph.D., Duke University, Durham, North Carolina
Fey, George H., Ph.D., Swiss Institute for Cancer Research, Lausanne
Fink, Pamela, B.S., Massachusetts Institute of Technology, Cambridge
Freeman, Gordon J., B.A., Harvard Medical School, Boston, Massachusetts
Geiger, Benjamin, Ph.D., University of California, San Diego
Gerassi, Esther E., Weizmann Institute, Rehovot, Israel
Greenstein, Julia, B.A., University of Rochester, New York
Guimezanes, Annick, Ph.D., INSERM, Paris, France
Harris, Nancy, Yale University, New Haven, Connecticut
Kraig, Ellen B., B.S., Brandeis University, Waltham, Massachusetts
Longacre, Shirley S., Ph.D., University of Geneva, Switzerland
Mely, Bernard, Ph.D., University of Paris, France
Marion, Tony, M.S., University of Alabama, Birmingham
Miozzari, Giuseppe F., Ph.D., Basel Institute for Immunology, Switzerland
Nakajima, Pamela, Tuffs University, Medford, Massachusetts
Pretell, Judith 0., Ph.D., Yale University, New Haven, Connecticut
Siekevitz, Miriam L., B.A., Massachusetts Institute of Technology, Cambridge
Singer, Dinah S., Ph.D., National Institutes of Health, Bethesda, Maryland
SEMINARS
Boyse, E., Sloan-Kettering Cancer Center. General introduction to immunogenetics.
Weissman, I., Stanford University Medical School. Development of T lymphocytes.
Cantor, H., Harvard Medical School. Genetic markers and functions of T lymphocytes.
Gershon, R., Yale University Medical School. Suppressor function of T lymphocytes.
Shreffler, D., Washington University, St. Louis. Genetics and organization of the MHC. I.
Genetics and organization of the MHC. II.
Paul, W., National Institutes of Health. Specific lr genes.
Shevach, E., National Institutes of Health. Genetic regulation of macrophageir cell interaction.
Marrack, P., University of Rochester. Genetic regulation of T cell/B cell interaction.
Hood, L., California Institute of Technology. Chemistry of MHC gene products.
Kapp, J., Washington University, St. Louis. Genetic aspects of specific helper and suppressor factors.
Zinkernagel, R., Scripps Clinic and Research Foundation. Thymus processing of T lymphocytes.
Virus/T cell interaction.
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Janeway, C., Yale University Medical School. Genetic aspects of alloreactivity.
Warner, N., University of New Mexico Medical School. Genetic aspects of B cell development.
Mage, R., National Institutes of Health. Ig classes, allotypes and idiotypes.
Eichmann, K., Heidelberg Institute of Immunology. Idiotypes as markers for T and B cell receptors.
Leder, P., National Institutes of Health. Molecular genetics of lg.
Generation of diversity.
Gefter, M., Massachusetts Institute of Technology. Genetics of Ig synthesis; hybridomas.
Lerner, R., Scripps Clinic and Research Foundation. Genetics of immunopathologic states.
Rowe, W., National Institutes of Health. Genetics of viral oncogenesis.
BIOLOGICAL INFORMATION PROCESSING WORKSHOP, August 1-August 14
ORGANIZERS
Marr, David, Ph.D., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge
Zipser, David, Ph.D., Cold Spring Harbor Laboratory, New York
During the summer of 1978, the Sloan Foundation's program in cognitive sciences funded a Workshop here
at Cold Spring Harbor on the topic of Biological Information Processing (BIP). BIP is concerned with
analyzing the abilities of the nervous system in terms of information processing concepts. In order to do this
the phenomena of interest must be characterized by biologically appropriate algorithms. "Algorithm" is
used in a quite general sense of any computational procedure sufficiently precise to allow computer
simulation. "Biologically appropriate" means that the algorithm has a plausible neurophysiological im-
plementation. BIP is concerned with the relevant phenomena at several levels. Furthest from physiology is a
characterization of the essential computational nature of a cognitive phenomena. Once this is available,
attention can be focused on discovering the appropriate algorithms.
Because brains -are so unlike computers, biologically appropriate algorithms are generally different from
those developed for machines. Because of the physical complexity of brains, and their origin from random
evolutionary processes, it is not usually possible to make explicit statements about neurophysiology or
neuroanatomy on the basis of this kind of analysis alone. Rather, BIP can supply the neurosciences with a
series of plausible algorithms, whose neuronal implementation would suffice to explain the observed
behavioral phenomena. It then becomes an experimental and theoretical question for neurobiology to
decide whether, in fact, the nervous system implements the algorithms proposed and if so, how? The
important point here is that algorithms for complex, cognitive behavior are in general not directly discerni-
ble from physiological experiment alone; their discovery involves considerable analysis of the nature of the
cognitive processes themselves.
The Workshop brought together about thirty people, from widely differing disciplines, chosen because
their work is related to the biological information processing approach. Talks ranged in subject matter over a
wide area. Although we had a talk on computer speech understanding and several on theories about how
the brain as a whole might function, the main thrust of the Workshop was in the area of early cognition. This
concept refers roughly to what is going on in that part of the nervous system between the transduction of
external signals to internal form and their first reportable appearance as recognizable phenomena. The
perception of shape, motion, depth, and textures are all good examples of the topics discussed in the realm
of early cognition.
One of the purposes of the Workshop was to bring into contact a diverse group of people so that they
could become familiar with each other and discuss their work. In general, the Workshop was characterized
by a productive interchange of ideas among people whose fields are often disjointed but which have
common themes. While this was exhilarating for all who attended, a situation was created in which many
interesting issues could not be discussed fully or examined in detail. The Workshop was limited in its ability
to develop any form of synthesis. Its main strength was in its educational value. In the future we plan to have
workshops which are somewhat smaller and focus on more limited topics with the hope of encouraging
more creative output.
PRESENTATIONS
White, J.G., Medical Research Council, Cambridge, England: Structural and functional aspects of the nematode
nervous system.
Knight, T., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge: Hardware.
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Stent, G.S., University of California, Berkeley: Neural circuits for rhythm generation.
Wehrhahn, C., Max-Planck-Institut fur Biologische Kybernetik, Ribingen, Germany: Signal processing in the fly's eye.
Von der Malsburg, D.C., Max-Planck-Institut far Biophysikalische Chemie, Gottingen, Germany: Ontogenesis of
retinotopic mappings as a paradigm case of organization in the brain.
Zipser, D., Cold Spring Harbor Laboratory, New York: Biological constraints.
Selfridge, 0., Bolt Beranck & Newman, Inc., Cambridge, Massachusetts: Problems in tracking and trailing.
Hoffmann, S., School of Medicine, State University of New York at Buffalo, Amherst, New York: Computer simulation
of specific, natural, neural networks.
Brady, M., University of Essex, Colchester, England: I. My experiences in building a program to read fortran coding
sheets. II. Local Computation of structural descriptions.
Selfridge, P., University of Rochester, New York: Ongoing research in computer vision at the University of Rochester.
Kender, J., Carnegie-Mellon University, Pittsburg, Pennsylvania: Texture gradients and inverse perspective.
Feldman, J., University of Rochester, New York: Towards symbolic models of neural nets.
Julesz, B., Bell Telephone Laboratories, Inc., Murray Hill, New Jersey: From a conjecture to a theory of texture
perception.
Ullman, S., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge: Interpretation of visual
motion.
Stevens, K., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge: Analysis and representation
of visual surface motion.
Nishihara, I-LK., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge: Representation
of the spatial organization of three-dimensional shapes for visual recognition.
Newell, A., Carnegie-Mellon University, Pittsburgh, Pennsylvania: Production system architectures for human cogni-
tion.
Minsky, M., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge: A brain theory.
Wilson, H., University of Chicago, Illinois: Spatiotemporal information processing in the human visual system.
Braddick, 0., Experimental Psychology Laboratory, Cambridge, England: Low-level constraints on visual form and
motion perception.
Marr, D., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge: Human stereo vision.
Barlow, H.B., Physiological Laboratory, Cambridge, England: Psychophysics of visual judgements on noisy figures.
Richards, W., Massachusetts Institute of Technology, Cambridge: Why rods and cones?
Riesbeck, C.K., Yale University, New Haven, Connecticut: Cognitive science in the Yale Al project: Theory and
practice.
Kanade, T., Carnegie -Mellon University, Pittsburgh, Pennsylvania: Theory of origami world and its application.
Marr, D., Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge: Closing remarks.
THE CENTRAL NERVOUS SYSTEM WORKSHOP, August 1-August 31
ORGANIZER
Shatz, Carla J., Ph.D., Stanford University School of Medicine, California
This workshop brought together eight scientists with a strong interest in developmental neurobiology.
Questions raised concerned the extent to which genetic programs, tissue interactions, and environmental
influences control various aspects of development in animals.
Experiments were carried out in the two classical systems used for studying developmental questions, the
frog spinal cord and the vertebrate visual system. M. Hollyday and V. Stirling examined the development of
connections made in the spinal cord by afferent projections of dorsal root ganglion cells during metamor-
phosis. They discovered characteristic differences in the projection of lumbar and thoracic sensory fibers. M.
Constantine-Paton and M. Law studied to what extent connectivities in the visual system of frogs are
changed through embryonic microsurgery when either a third eye is implanted or the frogs are blinded. B.
Harris and C. Shatz used the workshop to develop the visual system of the axolotl as a neurobiological
preparation. The projection to visual nuclei was compared in normal and eyeless mutants. Interestingly in
the eyeless mutant, the optic tectum was found to respond strongly to tactile stimulation. In other projects,
D. Katz studied the sensory projections of cardiovascular afferents in the pigeon and E. Frank and M.
Kennedy explored new anatomical methods to trace functional pathways.
The workshop led to a great deal of collaborative investigation. The participants acquainted each other
with their different techniques. For example, the efficiency of horseradish peroxidase (HRP) and cobalt chloride
nerve filling was compared and several varients of HRP histochemistry were explored. In addition, some
workshop participants taught others electrophysiological techniques.
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PARTICIPANTS
Development of sensory afferent projections in the frog spinal cord.
Hollyday, Margaret, Ph.D., University of Chicago, Illinois
Stirling, Victoria, Ph.D., National Institute for Medical Research, London, England
Anatomical methods for tracing functional pathways in the brain.
Frank, Eric, Ph.D., Harvard Medical School, Boston, Massachusetts
Kennedy, Mary, Ph.D., Yale University School of Medicine, New Haven, Connecticut
The effect of altered retinal input to the optic tectum of frogs.
Constantine-Paton, Martha, Ph.D., Princeton University, New Jersey
Law, Margaret, B.S., Princeton University, New Jersey
Anatomical and Physiological Studies of cardiovascular afferents in the pigeon.
Katz, David, B.S., State University of New York, Stony Brook
Investigations of the midbrain (tectum) in normal and eyeless mutant axolotls.
Harris, William A., Ph.D., Harvard Medical School, Boston, Massachusetts
Shatz, Carla J., Ph.D., Stanford University School of Medicine, California
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COLD SPRING
HARBOR SYMPOSIUM
ON QUANTITATIVE
BIOLOGY
DNA: REPLICATION AND RECOMBINATION
Twenty-five years have now passed since I flew back from England
to the Symposium on Viruses to talk about the double helix that
Francis Crick and I had just found in Cambridge. We were very
elated since almost certainly we knew in principle how DNA, that
is, the gene, functioned as a template for its self-replication. If so,
the long-elusive goal of the theoretical geneticist had been
achieved, and with a marvelous simplicity that did not require years
of training in high-powered chemistry or physics to understand. Yet
on no occasion during those early June days do I remember any
serious discussion of where enzymes would come in. But this was
not surprising since the world of genetics and first-class enzymology
were then more apart than connected and the thought that anyone
might soon make functional DNA in a test tube was too far-out for
serious minds.
We could not have been more wrong. Already by June 1956
Arthur Kornberg was reporting incorporation of radioactive
thymidine into DNA and within several more years the first DNA
polymerase had been characterized. The working out, however, of
all the steps in DNA replication has proved far more complex than
first imagined. Throughout this never-very-easy endeavor genet-
icists have learned that they could no longer think deeply about the
gene without knowing more about enzymes than they ever wanted.
Correspondingly, those biochemists who have wished for success
with DNA needed to be conversant with the world of phages or risk
producing data that would have no lasting significance. The net
result, happily, has been a marvelous outpouring of new ways to
look at the classical problems of gene replication and recombina-
tion. By now virtually no one has doubts that definitive statements
on the enzymological level will soon be in hand.
This year thus seemed propitious for intellectual as well as senti-
mental reasons to hold our Symposium on DNA replication and
recombination. Arranging it proved a major task and Toni Broker
and Ahmad Bukhari did their job very well. Credit should also go to
Arthur Kornberg, Bob Lehman, Charles Richardson, John Cairns,
David Dressler, Bruce Alberts, Jun -Ichi Tomizawa, Frank Stahl, and
Charles Radding for their thoughts as to possible speakers. They
suggested more people than even a much overcrowded week could
handle. So we knew we would make errors of omission that hope-
fully might be partially rectified by impromptu talks during the
various sessions. The resulting almost maddeningly full Symposium week was of such high intellectual
quality that virtually everyone listened to most of the record number of 155 presentations that were given.
The total attendance was 428, also a record.
A meeting of this size is possible only with much outside financial support and we wish to acknowledge
the help of the National Institutes of Health, the National Science Foundation, and the United States Energy
Research and Development Administration, which provided the key funds needed to bring visitors from
abroad and to cover our speakers' expenses while at Cold Spring Harbor.
J.D. Watson
Welcoming Remarks: J. D. WATSON, Cold Spring Harbor Laboratory
Opening Comments: A. KORNBERG, Stanford University, California
Session 1: General Recombination 1-Models from Genetics
Chairperson: M. MESELSON, Harvard University, Cambridge, Massachusetts
R. HOLUDAY, Medical Research Council, London, England: Relationship between the correction of mis-
matched bases, gene conversion, and mutability.
S. FOGEL,* R. MORTIMER,t K. LUSNAK,* and F. TAVARES,t *Department of Genetics and +Division of Medical
Physics, University of California, Berkeley: Meiotic gene conversion-A signal of the basic recombina-
tion event in yeast.
J.-L. ROSSIGNOL, N. PAQUETTE, and A. NICOLAS, Laboratoire de Genetique, University Paris-Sud, Orsay,
France: Aberrant 4:4, disparity in the direction of conversion and frequencies of conversion in AscobolUs
immersus.
A. HINNEN,* J. B. Hicks:, and G. R. FINK,* *Department of Botany, Genetics, and Development, Cornell
University, Ithaca, New York; +Cold Spring Harbor Laboratory, New York: Genetic transformation in
yeast.
R. P. ANDERSON and J. R. ROTH, Department of Biology, University of Utah, Salt Lake City: Legitimate and
illegitimate recombination between sister chromosomes in Salmonella typhimurium.
Session 2: Unwinding
Chairperson: B. ALBERTS, University of California, San Francisco
H. M. SOBELL, Departments of Chemistry and Radiation Biology and Biophysics, University of Rochester
School of Medicine and Dentistry, New York: How DNA unwinds.
A. MCPHERSON,* F. JuRNAK,* A. WANG,t F. KOLPAR,± A. RICH,t and I. MOLINEUX,t *Department of Biological
Chemistry, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey; +Department of
Biology, Massachusetts Institute of Technology, Cambridge; ,Imperial Cancer Research Fund, Mill Hill
Laboratories, London, England: The gene-V product of fd bacteriophage-Structure of a DNA-unwinding
protein and its complexes with DNA.
J. C. WANG, Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Mas-
sachusetts: Superhelical DNA, gyrase, and topoisomerase.
M. GELLERT, K. MIZUUCHI, M. H. O'DEA, H. OHMORI, and J. TOMIZAWA, NIAMDD, National Institutes of
Health, Bethesda, Maryland: Studies on the mechanism of DNA gyrase.
N. R. COZZARELLI,* P. 0. BROWN,* N. P. HIGGINS,* K. N. KREUZER,* A. MORRISON,* C. L. PEEBLES,* and A.
SUGINO, *+ *University of Chicago, Illinois; +National Institute of Environmental Health Sciences, Re-
search Triangle Park, North Carolina: Structure, activities, and function of Escherichia coil DNA gyrate.
M. ABDEL-MONEM, B. KUHN, and H. HOFFMANN-BERLING, Abteilung fur Molekulare Biologie, Max-Planck-
Institut fur Medizinische Forschung, Heidelberg, Germany: DNA helicases.
J. J. CHAMPOUX, L. S. YOUNG, and M. D. BEEN, Department of Microbiology and Immunology, School of
Medicine, University of Washington, Seattle: Studies on the specificity and regulation of the DNA-
untwisting enzyme.
M. DUGUET, G. YARRANTON, and M. GEFTER, Department of Biology, Massachusetts Institute of Technology,
Cambridge: Studies on the rep protein of Escherichia coli.
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Session 3: Specialized Recombination I-The X and Mu Paradigms
Chairperson: A. CAMPBELL, Stanford University, California
A. LANDS, R. HOESS, K. BIDWELL, and W. Ross, Division of Biology and Medicine, Brown University,
Providence, Rhode Island: Site-specific recombination in bacteriophage S-Structural features of recom-
bining sites.
Y. KIKUCHI and H. A. NASH, NIMH, National Institutes of Health, Bethesda, Maryland: Characterization of
the proteins and DNA required for integrative recombination of phage A.
L. ENouis-r, A. KIKUCHI, and R. WEISBERG, NICHHD, National Institutes of Health, Bethesda, Maryland:
Differences between prophage insertion and excision.
L. HEFFERNAN, M. BENEDIK, and A. CAMPBELL, Department of Biological Sciences, Stanford University,
California: Regulation of genes encoding insertion and excision functions of bacteriophage A.
J. A. SHAPIRO and L. A. MACHATTIE, Department of Microbiology, University of Chicago, Illinois: Integration
and excision events involving bacteriophage A and Tn9.
A. I. BUKHARI,* M. S. Du Bow,* H. KHATOON,* L. AMBROSIO,* F. DEBRUIJN,* and 5E. LJUNGQUIST, *Cold Spring
Harbor Laboratory, New York; tKarolinska Institute, Stockholm, Sweden: Integration of bacteriophage
Mu DNA.
D. KAMP, L. T. CHOW, T. R. BROKER, D. KWOH, D. ZIPSER, and R. KAHMANN, Cold Spring Harbor Laboratory,
New York: Site-specific recombination in phage Mu.
M. FAELEN,* A. RtsiBois,t and A. TOUSSAINT,* *Departement de Biologie Molkulaire, Faculte des Sciences;
kaboratoire de Microscopic Electronique, Faculte de Medecine, Universite Libre de Bruxelles, Belgium:
Mini-Mu-Mu mutants with large internal deletions.
P. VAN DE PUTTE and M. GIPHART-GASSLER, Department of Biochemistry, State University of Leiden, The
Netherlands: Characteristics of a plasmid containing the early region of bacteriophage Mu.
Session 4: Specialized Recombination II-IS Elements and Transposons
Chairperson: W. SZYBALSKI, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison
H. A. CHADWELL, H.-J. FRITZ, P. HABERMANN , R. KLAER, S. KUHN, and P. STARLINGER, Institut fur Genetik der
Universitat zu Ko In, Germany: Studies with IS DNA.
W. ARBER, Departmentof Microbiology, Biozentrum, University of Basel, Switzerland: The bacteriophage P1
plasmid can serve as a trap for transposing host insertion elements.
H. SAEDLER, D. GHOSAL, and J. GROSS, Institut fur Biologie III, Universitat Freiburg, Germany: Multiplication
and rearrangements of DNA sequences from both DNA strands of IS2 generate a turn-on signal for gene
expression.
G. WEINSTOCK and D. BOTSTEIN, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Genetic and physical studies of Tn1 (ampR) using bacteriophage P22.
P. K. TOMICH, F. AN, and D. CLEWELL, Department of Oral Biology, University of Michigan, Ann Arbor:
Evidence for an erythromycin-resistance transposon (Tn917) in Streptococcus faecalis- Enhancement of
transposition during induction of erythromycin resistance.
M. CHANDLER, L. SILVER, D. LANE, and L. CARO, Department of Molecular Biology, University of Geneva,
Switzerland: Properties of an autonomous r determinant from R100.1.
D. Ross,* J. SWAN,' D. STEELE,' and N. KLECKNER,' *Department of Biology, Massachusetts Institute of
Technology, Cambridge; tDepartment of Biochemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts: recA-Independent recombination events promoted by Tn10.
S. N. COHEN, J. CHOU, and M. CASADABAN, Department of Genetics and Medicine, Stanford University
School of Medicine, California: Studies for the mechanism and specificity of Tn elements in bacteria.
M. P. CALOS,* L. JOHNSRUD,* and J. H. MILLER,' *The Biological Laboratories, Harvard University, Cam-
bridge, Massachusetts; ',Department of Molecular Biology, University of Geneva, Switzerland: DNA
sequences at insertion sites of IS1 and Tn9 in Escherichia coli.
N. D. F. GRINDLEY, Department of Molecular Biophysics and Biochemistry, Yale University, New Haven,
Connecticut: Sequence analysis at 151 insertion sites-Models for 151 integration.
E. OHisuBo, H. OHTSUBO, and H. OHMORI, Department of Microbiology, State University of New York,
Stony Brook: Nucleotide sequence analysis of a transposable element, Tn3 (TnA), and of an insertion
element, IS1.
84
Session 5: Replication 1- Priming and Okazaki Fragments
Chairperson: J. CAIRNS, Imperial Cancer Research Fund, London, England
T. OKAZAKI, Y. KUROSAWA, T. OGAWA, T. SEKI, K. SHINOZAKI, S. HIROSE, A. FUIIYAMA, Y. KOHARA, Y. MACHIDA,
F. TAMANOI, and T. HozuMi, Institute of Molecular Biology, Faculty of Science, Nagoya University, Japan:
Structure and metabolism of RNA primer in discontinuous replication of prokaryotic DNA.
K. R. THOMAS, P. M. RAMOS, and B. M. OLiVERA, Department of Biology, University of Utah, Salt Lake City:
Studies on the origin and structure of Okazaki pieces.
R. WERNER, D. W. SIEGMANN, A. T. DIAZ, and H. JERING, Department of Biochemistry, School of Medicine,
University of Miami, Florida: Characterization of 5' ends of nascent DNA chains.
I. R. LEHMAN and B.-K. TYE, Department of Biochemistry, Stanford University, California: Excision-repair of
uracil in DNA-Its role in the generation of Okazaki fragments.
D. T. DENHARDT, C. HOURS, J. KOWALSKI, M. MATTHES, C. MIYAMOTO, and N. MIYAMOTO, Department of
Biochemistry, McGill University, Montreal, Quebec, Canada: Some investigations into the nature of the
5' ends of cellular DNA molecules.
M. GOULIAN, B. Y. TSENG, R. H. GRAFSTROM, and D. G. REVIE, Department of Medicine, University of
California, San Diego: Studies on DNA replication in animal cells.
B. BOGENHAGEN, A. M. GiLLUM, P. A. MARTENS, and D. A. CLAYTON, Department of Pathology, Stanford
University School of Medicine, California: Replication of mouse mitochondrial DNA-RNA priming and
asynchronous synthesis of strands.
P. REICHARD, Department of Biochemistry, Medical Nobel Institute, Karolinska Institute, Stockholm, Sweden:
Priming of Okazaki pieces during polyoma DNA replication in isolated nuclei.
Session 6: Replication II-Small Phages and Plasmids as Replication Models
Chairperson: D. HELINSKI, University of California, San Diego
R. R. MEYER, J. SHLOMAI, J. KOBORI, D. L. BATES, L. ROWEN, R. MCMACKEN, K. UEDA, and A. KORNBERG,
Department of Biochemistry, Stanford University School of Medicine, California: Enzymatic conversion
of single-stranded OX174 and G4 circles to duplex forms-Discontinuous replication.
S. EISENBERG, J. SCOTT, and A. KORNBERG, Department of Biochemistry, Stanford University School of
Medicine, California: Enzymatic replication of OX174 duplex circles (RF)-Continuous replication.
S. WICKNER, NCI, National Institutes of Health, Bethesda, Maryland: DNA replication proteins of Escherichia
coli.
C. YASUMOTO, J. IKEDA, E. BENZ, R. VICUNA, K. MARIANS, and J. HURWITZ, Department of Developmental
Biology, Albert Einstein College of Medicine, Bronx, New York: studies on in vitro synthesis of DNA.
G. N. GODSON, Radiobiology Laboratories, Yale Medical School, New Haven, Connecticut: G4 DNA
replication in vivo.
J. Sims, K. KOTHS, and D. DRESSLER, The Biological Laboratories, Harvard University, Cambridge, Mas-
sachusetts: Single-stranded phage DNA replication-Positive- and negative-strand DNA synthesis.
D. S. RAY, S. V. SUGGS, T.-C. CHEN, J. KAGUNI, L. LAVERNE, and J. M. CLEARY, Molecular Biology Institute and
Department of Biology, University of California, Los Angeles: Initiation and termination of rounds of
replication in single-stranded phage DNA replication in vivo.
K. HORIUCHI, J. V. RAVETCH, and N. D. ZINDER, Rockefeller University, New York, New York: DNA
replication of bacteriophage fl in vivo.
H. SCHALLER,* R. SOMMER,* E. A. AUERSWALD,* E. BECK,* R. HERRMANN,* K. NEUGEBAUER,* T. MEYER,t and
K. GEIDER,t *Mikrobiologie der Universitat Heidelberg; *Max-Planck-Institut fur Medizinische
Forschung, Heidelberg, Germany: The origin of DNA replication of bacteriophage fd.
J. TOMIZAWA, T. ITOH, and H. OHMORI, NIAMDD, National Institutes of Health, Bethesda, Maryland:
Initiation of replication of plasmid ColEl DNA.
Session 7: General Recombination-II-Enzymological Considerations
Chairperson: C. RADDING, Yale University School of Medicine, New Haven, Connecticut
G. MOSIG, A. LUDER, G. GARCIA, R. DANNENBERG, and S. BOCK, Department of Molecular Biology, Vanderbilt
University, Nashville, Tennessee: In vivo interactions of genes and proteins in DNA replication and
recombination of phage T4.
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K. B. BURCK and R. C. MILLER, JR., Department of Microbiology, University of British Columbia, Vancouver,
Canada: Marker rescue and partial replication of UV-irradiated T7- bacteriophage DNA.
E. WALDSTEIN, J. K. SETLOW, and L. SANTASIER, Biology Department, Brookhaven National Laboratory, Upton,
New York: A special type of UV-stimulated recombination of Haemophilus influenzae.
R. PORTER and B. Low, Yale Medical School, New Haven, Connecticut: Transduction vs. "conjuduction"-
Evidence for multiple roles for Exo V in recombination in Escherichia co/i.
D. CHATTORAI, J. CRASEMANN, N. DOWER, D. FAULDS, P. FAULDS, R. MALONE, F. STAHL, and M. STAHL, Institute
of Molecular Biology, University of Oregon, Eugene: Asymmetries in Chi activity.
P. HOWARD-FLANDERS, E. CAssuro, and P. Ross, Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut: Covalent circular rhX DNA is cut in extracts of induced Escherichia
coli endA (Xver) when suitably damaged homologous DNA molecules are present.
J. ROSAMOND, B. ENDLICH, and S. LINN, Department of Biochemistry, University of California, Berkeley:
Trans location by the EcoB and recBC enzymes of Escherichia coli.
Session 8: Replication III-Replication Origins
Chairperson: C. RICHARDSON, Harvard Medical School, Boston, Massachusetts
K. BACKMAN, M. BETLACH, H. W. BOYER, and S. YANOFSKY, Department of Biochemistry and Biophysics,
University of California, San Francisco: Genetic and physical studies on the replication of ColEl.
J. H. CROSA, L. K. LUTTROPP, and S. FALKOW, Department of Microbiology, University of Washington, Seattle:
Molecular cloning of replication and incompatibility regions from the R plasmid R6K.
D. HELINSKI, D. FIGURSKI, M. INUZUKA, M. KAHN, and R. KOLTER, Department of Biology, University of
California, San Diego: Replication properties of low-molecular-weight derivatives of plasmids.
G. ATTARDI, S. CREWS, I. NISHIGUCHI, D. OIALA, and J. POSAKONY, Division of Biology, California Institute of
Technology, Pasadena: Sequence of the region of He La-cell mitochondrial DNA surrounding the origin
of replication.
K. KOIKE and M. KOBAYASHI, Cancer Institute (JFCR), Tokyo, Japan: Cloning and characterization of the
replication origin from rat mitochondrial DNA.
M.E. FURTH,* J.L. YATES,t and W.F. DOVE,* *McArdle Laboratory and +Enzyme Institute, University of
Wisconsin, Madison: Positive and negative control of bacteriophage X DNA replication.
K. DENNISTON-THOMPSON, D. D. MOORE, K. E. KRUGER, B. G. WILLIAMS, M. E. FURTH, and F. R. BLATTNER,
Department of Genetics, University of Wisconsin, Madison: Structure and function of the origin of
replication of bacteriophage X.
G. HOBOM, M. LUSKY, R. GROSSCHEDL, and G. SCHERER, Institut fur Biologie III der Universitat Freiburg,
Germany: Dissection of the origin of replication of bacteriophage X.
K. V. MEYENBURG, F. G. HANSEN, and E. ROSE, University Institute of Microbiology, Copenhagen, Denmark:
Origin of replication, oriC, of the Escherichia coli chromosome on specialized transducing phages Aasn.
Y. HIROTA,* S. YASUDA,* A. NISHIMURA,* Y. TAKEDA,* M. YAMADA,* K. SUGIMOTO,t H. SUGISAKI,t A.
OKA,t and M. TAKANAMI,t *National Institute of Genetics, Mishima; Institute for Chemical Research,
Kyoto University, Uji, Japan: Structural and functional properties of Escherichia coil DNA replication
origin.
Session 9: Replication IV-Eukaryotic Systems I
Chairperson: P. REICHARD, Karolinska Institute, Stockholm, Sweden
D.R.W. EDWARDS, J.B. TAYLOR, W.F. WAKELING, and I.R. JOHNSTON, Department of Biochemistry, University
College London, England: Studies on the prereplicative phase of the cell cycle in Saccharomyces
cerevisiae.
L.M.S. CHANG, K. LURIE, and P. PLEVANI, Department of Biochemistry, Uniformed Services University of
Health Sciences, Bethesda, Maryland: A stimulatory factor of yeast DNA polymerase.
R.M. BENBOW, C.B. BREAUX, M.R. KRAUSS, E.M. NELSON, N.S. WANG, and S.H. WHITE, Department ofBiology,
Johns Hopkins University, Baltimore, Maryland: Eukaryotic DNA replication: A multi-enzyme system
from Xenopus laevis eggs.
G.P. TOCCHINI- VALENTINI, M.I. BALDI, G. CARRARA, D. GANDINI-ATTARDI, and E. MATTOCCIA, Laboratory of Cell
Biology, Consiglia Nazionale delle Recherche, Rome, Italy: Cell-free systems constructed from Xenopus
laevis oocytes: Formation of complex DNA and insertion of superhelical turns.
86
P.A. FISHER, T.S.-F. WANG, and D. KoRN, Department of Pathology, Stanford University, California: Structural
and enzymological characterization of human DNA polymerases a and (3.
F. COBIANCHI,* G. MASTROMEI,t S. RIVA,* S. SPADARI,* G. PEPRAti-Nov,* and A. FALASCI II* *Laboratorio di
Genetica Biochimica ed Evoluzionistica, C.N.R., Pavia; *Istituto di Genetica, University di Pavia, Italy: A
DNA-dependent ATPase from human cells.
W.A. HASELTINE, Sidney Farber Cancer Institute; Department of Pathology, Harvard Medical School; De-
partment of Microbiology, Harvard School of Public Health, Boston, Massachusetts: In vitro studies of the
mechanism of synthesis of DNA complementary to the genome of RNA tumor viruses.
D. BALTIMORE, E. GILBOA, and E. ROTHENBERG, Department of Biology and Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge: Infective murine leukemia virus DNA made in vitro is
mainly linear, entirely double-stranded molecules.
H.E. VARMUS, P.R. SHANK, S. HUGHES, H.-J. KUNG, D.H. SPECTOR, J.C. COHEN, G.M. RiNGoto, S. HEASLEY, and
J.M. BISHOP, Department of Microbiology, University of California, San Francisco: Synthesis and integra-
tion of the proviruses of RNA tumor viruses.
D. STEFFEN, P. ANDERSON, M. GOLDFARB, and R.A. WEINBERG, Department of Biology and Center for Cancer
Research, Massachusetts Institute of Technology, Cambridge: Integration of sarcoma and leukemia virus
genomes into the chromosomes of mouse and rat cells.
Session 10: Replication V-Prokaryotic Systems
Chairperson: I.R. LEHMAN, Stanford University, California
C.C. RICHARDSON, M.J. ENGLER, R. KOLODNER, J.E. LECLERC, D. RICHARDSON, L.J. ROMANO, and F. TAMANOI,
Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts: Replication of
bacteriophage T7 DNA by purified proteins.
E. LANKA,* E. SCHERZINGER,* G. HILLENBRAND,* and W. STAUDENBAUER,t *Max-Planck-Institut fur Molekulare
Genetik, Berlin, Germany; *Max-Planck-Institut ftir Biochemie, Martinsried, Germany: T7 DNA primase:
A multifunctional enzyme involved in DNA replication.
C.C. Liu, R.L. BURKE, U. HIBNER, J. BARRY, and B. ALBERTS, Department of Biochemistry and Biophysics,
University of California, San Francisco: Probing DNA replication mechanisms with the T4 bacteriophage
in vitro system.
J. ITO and N.E. HARDING, Department of Cellular Biology, Scripps Clinic and Research Foundation, La Jolla,
California: Bacillus phage DNA-terminal proteins and their role in DNA replication.
C. LARK and K.G. LARK, Department of Biology, University of Utah, Salt Lake City: Regulation of the stability
of the DNA replication complex.
H. SCHUSTER, E. LANKA, M. MIKOLAJCZYK, B. GESCHKE, and M. SCHLICHT, Max-Planck-Institut fur Molekulare
Genetik, Berlin, Germany: Association of the prophage P1 ban protein with the DNA B protein of
Escherichia coli.
H. YOSHIKAWA,* K. YAMAGUCHI,t H. TOYODA,* M. SEIKI,* and N. OGASAWARA,* *Cancer Research Institute,
Kanazawa, Japan; 5NIAMDD, National Institutes of Health, Bethesda, Maryland: Structure and function
of DNA-protein complex containing replication origin markers of Bacillus subtilis.
L.A. LOEB, Department of Pathology, University of Washington School of Medicine, Seattle: On the fidelity
of DNA replication.
M. ENGLER, R.C. PLESS, and M.J. BESSMAN, Department of Biology and McCollum-Pratt Institute, Johns
Hopkins University, Baltimore, Maryland: Factors influencing the fidelity of DNA synthesis.
Session 11: Replication VI-Eukaryotic Systems 11
Chairperson: D. BALTIMORE, Massachusetts Institute of Technology, Cambridge
R. TJIAN, Cold Spring Harbor Laboratory, New York: Protein-DNA interactions at the origin of simian virus
40 (SV40) replication.
D. SHORTLE and D. NATHANS, Department of Microbiology, Johns Hopkins University School of Medicine,
Baltimore, Maryland: SV40 mutants with base substitutions around the origin of viral DNA replication.
Y. TSUBOTA, M.A. WAQAR, J.F. BURKE, B.I. MILAVETZ, M.J. EVANS, D. KowAtsto, and J.A. HUBERMAN, Roswell
Park Memorial Institute, Buffalo, New York: Association of enzymes with replicating and nonreplicating
SV40 chromosomes.
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M.L. DEPAMPHILIS,* S. ANDERSON,* H. EDENBERG,' T. HERMAN,* B. KARAS,* G. KAUFMANN,' H. KROKAN,* E.
SHELTON,* R. Su,* D. TAPPER,* and P. WASSARMAN,* *Department of Biological Chemistry, Harvard
Medical School, Boston, Massachusetts; *Department of Biochemistry, Indiana University Medical
School, Indianapolis; *Department of Biochemistry, Weizmann Institute of Science, Rehovot, Israel:
Replication and structure of SV40 chromosomes.
M. BOTCHAN, W. TOPE', and J. SAMBROOK, Cold Spring Harbor Laboratory, New York: Studies on SV40
excision from chromosomes.
M.-C. YAO and J.G. GALL, Department of Biology, Yale University, New Haven, Connecticut: Amplification
of rDNA in the protozoan, Tetrahymena.
R. T. SCHIMKE, R. S. KAUFMAN, and J. NUNBERG, Department of Biological Sciences, Stanford University
School of Medicine, California: Selective amplification of the dihydrofolate reductase genes in
methotrexate-resistant cultured cells.
C. WEISSMAN, H. WEBER, W. MULLER, and F. MEYER, InStitUL fur Molekularbiologie I, Universitat Zurich,
Switzerland: Site-directed mutagenesis in the 0-globin DNA insert of plasmid Pf3G.
Session 12: Replication Vll- Eukaryotic Systems III
Chairperson: D. NATHANS, Johns Hopkins School of Medicine, Baltimore, Maryland
T.J. KELLY, JR. and R. LECHNER, Johns Hopkins University School of Medicine, Baltimore, Maryland: The
structure of replicating adenovirus DNA molecules.
B.W. STILLMAN and A.J.D. BELLETT, Department of Microbiology, John Curtin School of Medical Research,
Australian National University, Canberra: Replication of DNA in adenovirus type 5 (Ad5)-infected cells.
M. GREEN, M. ARENS, and T. YAMASHITA, Institute for Molecular Virology, St. Louis University, Missouri:
Adenovirus-2 (Ad2) DNA replication in vitro-A model for mammalian cell DNA replication.
M.S. HoRw;Tz and L.M. KAPLAN, Albert Einstein College of Medicine, Bronx, New York: Adenovirus DNA
synthesis in soluble extracts of cells infected with Ad5 or H5ts125-Characterization of proteins associ-
ated with replicating DNA.
K.I. BERNS and W.W. HAUSWIRTH, Department of Immunology and Medical Microbiology, University of
Florida, Gainesville: Adeno-associated-virus (AAV) DNA replication.
C. ASTELL,* M. SMITH,* M. CHOW,' and D. WARD," *Department of Biochemistry, University of British
Columbia, Vancouver; *Departments of Human Genetics and Molecular Biophysics and Biochemistry,
Yale University, New Haven, Connecticut: Nucleotide sequences near the origins of DNA replication for
the parvoviruses minute virus of mice (MVM), H-1, H-3, Kilham rat virus (KRV), and Lulli.
M. ESTEBAN, C. CABRERA, M. SOLOSKI, and J.A. HOLOWCZAK, CMDNJ, Rutgers Medical School, Piscataway,
New Jersey: Replication of vaccinia DNA.
B. FRANCKE, Tumor Virology Laboratory, Salk Institute, San Diego, California: Cell-free DNA synthesis
systems derived from herpes simplex virus type 1 (HSV1)-infected BHK cells.
B. ROIZMAN, R.J. JACOB, L.S. MORSE, M.M. KNIPE, and W.T. RUYECHAN, Viral Oncology Laboratories,
University of Chicago, Illinois: On the mechanism generating the inversions of the covalently linked L
and S components in HSV DNA.
N.M. WILLKIE, A. DAVISON, P. CHARTRAND, V. PRESTON, and N. STOW, Institute of Virology, Glasgow,
Scotland: Recombination in HSV.
Session 13: General Recombination Ill-Structural Considerations
Chairperson: N. ZINDER, Rockefeller University, New York, New York
R.C. WARNER, R.A. FISHEL, and F.C. WHEELER, Department of Molecular Biology and Biochemistry, University
of California, Irvine: The figure-eight as an intermediate in recombination in small DNA phages-
Characteristics of double-stranded branch migration.
H. POTTER and D. DRESSLER, The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Genetic recombination: In vivo and in vitro studies.
C.M. RADDING, R. CUNNINGHAM, C. DASGUPTA, and T. SHIBATA, School of Medicine, Yale University, New
Haven, Connecticut: The role of superhelical DNA in general genetic recombination.
M. Fox, C. DUDNEY, and E. SODERGREN, Department of Biology, Massachusetts Institute of Technology,
Cambridge: Heteroduplex regions in unduplicated bacteriophage X recombinants.
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H. IKEDA and I. KOBAYASHI, Institute of Medical Science, University of Tokyo, Japan: recA-Mediated
recombination of phage A: Structure of recombinant and intermediate DNA molecules and their packag-
ing in vitro.
K. SHIMADA, K. UMENE, T. NAKAMURA, and Y. TAKAGI, Department of Biochemistry, Kyushu University, School
of Medicine, Fukuoka, Japan: Recombination in hybrid ColE1 DNAs as analyzed by A- phage- mediated
transduction.
G.S. ROEDER and P.D. SADOWSKI, Department of Medical Genetics, University of Toronto, Canada: Pathways
of bacteriophage T7 in vitro genetic recombination.
H. ARAKI and H. OGAWA, Department of Pathology, Faculty of Science, Osaka University, Toyonaka, Japan:
Genetic recombination of T7 phage in vitro.
Session 14: Repair and recA Function
Chairperson: E. WITKIN, Douglass College, Rutgers University, New Brunswick, New Jersey
K. MCENTEE, Department of Biochemistry, Stanford University School of Medicine, California: Regulation of
recA gene expression in vivo.
J.W. ROBERTS, C.W. ROBERTS, and N.L. CRAIG, Department of Biochemistry, Cornell University, Ithaca, New
York: The Escherichia coli recA gene product inactivates phage A repressor.
A.J. CLARK, A. GERO, L.J. MARGOSSIAN, L.W. REAM, A. TEMPLIN, and M.R. VOLKERT, Department of Molecular
Biology, University of California, Berkeley: Genetic studies of the regulation and function of recA.
L. GROSSMAN,* S. RIAZUDDIN,* G. CHEN,* K. LINDEN,' and W. HASELTINE,t *Department of Biochemistry, Johns
Hopkins University; tSidney Farber Cancer Research Institute, Harvard School of Medicine, Boston, Mas-
sachusetts: Nucleotide excision-repair of damaged DNA.
M. Ois Hi, C.L. SMITH, and B. FRIEFELD, Public Health Research Institute of the City of New York, Inc., New
York: The molecular events and molecules which lead to induction of prophage and SOS functions.
M. RADMAN,* G. VILLANI,* S. BOITUE,* B. GLICKMAN,T and S. SPADARI,t *Department de Biologie Moleculaire,
University Libre de Bruxelles, Belgium; tLaboratory for Molecular Genetics, University of Leiden, The
Netherlands; +Laboratorio de Genetica Biochimica ed Evoluzionistica, Universita di Pavia, Italy:
Molecular mechanisms and genetic control of replicational fidelity-Involvement in spontaneous and
induced mutagenesis.
M. RYKOWSKI,* P. PUKKILA,* M. RADMAN,T R. WAGNER,* and M. MESELSON,* *The Biological Laboratories,
Harvard University, Cambridge, Massachusetts; tDepartment de Biologie Moleculaire, University Libre
de Bruxelles, Belgium: Undermethylation and strand selection in DNA mismatch repair.
Summary: F. Stahl, University of Oregon, Eugene
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SUMMER MEETINGS
PHORBOL ESTERS, May 11-May 14
arranged by
I. Bernard Weinstein, Columbia University College of Physicians
and Surgeons
Walter Troll, Institute of Environmental Medicine, New York Uni-
versity Medical Center
68 participants
Opening Address: J.D. WATSON, Cold Spring Harbor Laboratory
Introduction: W. TROLL, New York University, New York, New York,
I.B. WEINSTEIN, Columbia University, New York, New
York
Session 1: Studies on Two-stage Mouse Skin Carcinogenesis
Chairpersons: R. BOUTWELL, McArdle Laboratory, University of
Wisconsin, Madison, Wisconsin
B.L. VAN DUUREN, New York University, Medical
Center, New York, New York
R. ALBERT, F. BURNS, M. PEREIRA, and B. ALTSHULER, Institute of
Environmental Medicine, New York University Medical Center,
New York: Pathways and kinetics of BaP and phorbol ester
tumorigenesis in the mouse skin.
B.L. VAN DUUREN, Institute of Environmental Medicine, New York
University Medical Center, New York: Mouse skin bioassays on
analogs and stereoisomers of the tumor promoter phorbol myris-
tate acetate (PMA) and on a series of cocarcinogenic agents.
R.K. BOUTWELL, McArdle Laboratory for Cancer Research, University
of Wisconsin, Madison: The biochemical mechanism of skin
tumor promotion.
A.K. VERMA and R.K. BOUTWELL, McArdle Laboratory for Cancer
Research, University of Wisconsin, Madison: An organ culture of
mouse skin-A simple in vitro model for studying the molecular
mechanism of skin tumor promotion.
S. YUSPA, U. LICHTI, H. HENNINGS, M. POIRIER, and P. STEINERT, NCI,
National Institutes of Health, Bethesda, Maryland: Tumor-pro-
moter-induced alterations of epidermal maturation in cell culture.
U. LICHTI, S. YUSPA, and HENNINGS, NCI, National Institutes of Health, Bethesda, Maryland: Dissociation of
tumor-promoter-stimulated ornithine decarboxylase activity and thymidine incorporation in primary
mouse epidermal cell cultures.
Session 2: Cell Culture Effects-Growth and Transformation
Chairpersons: E. REICH, Rockefeller University, New York, New York
P. SHUBIK, Eppley Institute for Cancer Research, Omaha, Nebraska
S. MONDAL, J.R. LILLEHAUG, C. BOREIKO, D.W. BRANKOW, and C. HEIDELBERGER, University Of Southern
California Cancer Center, Los Angeles: The effects of tumor-promoting phorbol esters on the morphology,
growth, and 2-deoxy-u-glucose uptake of C3H/10T1/2 cells in culture.
A.R. KENNEDY, H. NAGASAWA, and J.B. LITTLE, Harvard School of Public Health, Boston, Massachusetts: Effect
of 12- O- tetradecanoyl -phorbol -13- acetate (TPA) and protease inhibitors on X-ray-induced oncogenic
transformation and sister chromatid exchanges.
V.E. STEELE, A.C. MARCHOK, and P. NETTESHEIM, Biology Division, Oak Ridge National Laboratory, Tennessee:
Growth promotion and tumor promotion by TPA in cultured respiratory epithelium.
V. KINZEL and R. Suss, Institute of Experimental Pathology, DKFZ, Heidelberg, Germany: Some early effects
of phorbol esters in cell cultures.
D.L. BERRY, T.L. SUTTON, A. VIAJE, S.M. FISCHER, and T.J. SLAGA, Biology Division, Oak Ridge National
Laboratory, Tennessee: Uptake and metabolic conversion of TPA by newborn and adult epidermal cells
in culture.
R.D. ESTENSEN, D. SEEHAUSEN, C. COLE, and B. DRAZICH, Department of Laboratory Medicine and Pathology,
University of Minneapolis, Minnesota: Binding of [3H]PMA to human peripheral blood lymphocytes.
A. KINSELLA, S. MOUSSET, C. SZPIRER, and M. RADMAN, Departement de Biologie Moleculaire, University Libre
de Bruxelles, Rhode-St.-Genese, Belgium: The irreversible step in tumor promotion may be due to
aberrant mitotic segregation.
Session 3: Membrane Effects and Prostaglandins
Chairpersons: A. SIVAK, Arthur D. Little, Inc., Cambridge, Massachusetts
T. SUGIMURA, National Cancer Center, Research Institute, Tokyo, Japan
A. SIVAK and M. CHAREST, Arthur D. Little, Inc., Cambridge, Massachusetts: The plasma membrane as
primary transducer of phorbol ester action in 3T3 mouse embryo fibroblasts.
P.B. FISHER, D. SCHACHTER, and I.B. WEINSTEIN, Institute of Cancer Research and Division of Environmental
Sciences, Columbia University College of Physicians and Surgeons, New York, New York: Tumor
promoters alter membrane lipid fluidity of mammalian cells.
S. BELMAN, W. TROLL, and S.J. GARTE, Institute of Environmental Medicine, New York University Medical
Center, New York: Biological and biochemical antagonism between PMA and butyric acid in mouse
epidermis-Correlation with their in vitro effects.
L.S. LEE and I.B. WEINSTEIN, Institute of Cancer Research, and Division of Environmental Sciences, Columbia
University College of Physicians and Surgeons, New York, New York: Interaction of phorbol esters with
receptors of epidermal growth factor in normal and transformed cells.
K. OHUCHI and L. LEVINE, Department of Biochemistry, Brandeis University, Waltham, Massachusetts:
Deacylation of cellular lipids and prostaglandin production in canine kidney cells by tumor-promoting
phorbol esters.
R.A. MUFSON,* P. KULKARNI,t J.D. LASKIN,* and I.B. WEINSTEIN,* *Cancer Center, Institute of Cancer Re-
search; .*Departments of Pharmacology and Opthalmology, Columbia University College of Physicians
and Surgeons, New York, New York: Phorbol-ester-induced aggregation of rabbit platelets occurs
independently of synthesis of cyclooxygenase products.
K. BRUNE,* H. ZUR HAUSEN,t and E. HECKER,t *Biozentrum der Universitat Basel, Switzerland; *Institut fur
Virologie, Zentrum fur Hygiene, Universitat Freiburg, Germany; *Institut fur Biochemie, Deutsches
Krebsforschungszentrum, Heidelberg, Germany: Tumor promoters of the diterpene ester type stimulate
prostaglandin release and induce persisting genomes of oncogenic viruses.
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Session 4: Phenotypic Effects and Mimicry of Transformation
Chairpersons: G.C. MUELLER, McArdle Laboratory, University of Wisconsin, Madison
L. DIAMOND, The Wistar Institute, Philadelphia, Pennsylvania
T.G. O'BRIEN and L. DIAMOND, The Wistar Institute, Philadelphia, Pennsylvania: The relationship between
ornithine decarboxylase activity and DNA sythesis in cell cultures treated with tumor-promoting phorbol
diesters.
R.H. GOLDFARB and J.P. QUIGLEY, Downstate Medical Center, State University of New York, Brooklyn:
Production of plasminogen activator by chick embryo fibroblasts-Synergistic effect of Rous virus
transformation and treatment with the tumor promotor PMA.
M.H. WIGLER, Cancer Center, Institute of Cancer Research, Columbia University College of Physicians and
Surgeons, New York, New York: Enhancement of transformation-specific traits of Rous-sarcoma-virus-
infected chick embryo fibroblasts by tumor-promoting phorbol esters.
P.M. BLUMBERG, P.E. DRIEDGER, and K.B. DELCLOS, Department of Pharmacology, Harvard Medical School,
Boston, Massachusetts: The chick embryo fibroblast as an in vitro system for studying the activity of the
phorbol esters.
N.H. COLBURN, K. NELSON, and B. FORMER, NCI, National Institutes of Health, Bethesda, Maryland: Induction
of anchorage-independent growth in epidermal cells by phorbol esters and its inhibition by tumor
promotion inhibitors.
L. KOPELOVICH and N. BIAS, Sloan-Kettering Institute for Cancer Research, New York, New York: TPA-treated
human skin fibroblasts from individuals genetically predisposed to cancer growth without anchorage.
C.E. WENNER and L.D. TOMEI, Roswell Park Memorial Institute, Buffalo, New York: The relationship of early
membrane effects of TPA and PGF,a to cell-cycle kinetics-An approach through G, mapping.
Session 5: Effects on Differentiation
Chairperson: H. HOLTZER, University of Pennsylvania, Philadelphia
N.E. FUSENIG, German Cancer Research Center, Institute of Biochemistry, Heidelberg, Germany: Effects of
the phorbol ester TPA on proliferation and differentiation of primary and permanent mouse epidermal
cell cultures.
H. HOLTZER, M. PACIFICI, C. WEST, and R. COHEN, Department of Anatomy, School of Medicine, University of
Pennsylvania, Philadelphia: Reversible and irreversible effects of PMA on cell differentiation.
T. SUGIMURA,* T. KAWACHI,* N. NAKAYASU,* N. MATSUKURA,* and S. TAKAYAMA,' *National Cancer Center
Research Institute; +Cancer Institute, Tokyo, Japan: Enhancement of differentiation of mouse leukemia
cells by TPA and promotion of stomach carcinogenesis of rats by orally given croton oil.
H. YAMASAKI, E. FIBACH, R.A. RIFKIND, P.A. MARKS, and I.B. WEINSTEIN, Cancer Center, Institute of Cancer
Research, Columbia University College of Physicians and Surgeons, New York, New York: Inhibition of
Friend erythroleukemia cell differentiation by tumor promoters and the isolation and characterization of
TPA-resistant clones.
C.N. FRANTZ,* C.D. STILES,' H.N. ANTONIADES,t and C.D. SCHER,* *Departments of Pediatric Oncology and
+Cell Biology, Sidney Farber Cancer Institute, Harvard Medical School; +Center for Blood Research,
Harvard School of Public Health, Boston, Massachusetts: TPA induces DNA synthesis in density-inhibited
Balb/c-3T3 cells in the presence of a variety of growth factors.
G.C. MUELLER, T.W. KENSLER, P.W. WERTZ, and C.H. KwONG, McArdle Laboratory for Cancer Research,
University of Wisconsin, Madison: Retinoic acid inhibition of phorbol-ester-mediated comitogenesis,
phospholipid metabolism, and capping in bovine lymphocytes.
Summation and Future Prospects: W. TROLL and I.B. WEINSTEIN
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THE CYTOSKELETAL AND CONTRACTILE NETWORKS OF NONMUSCLE CELLS
May 17 -May 21
arranged by
Robert D. Goldman, Mellon Institute, Carnegie-Mellon University
Joanna B. Olmsted, University of Rochester
188 participants
Session 1: Mitosis
Chairperson: L. I. REBHUN, University of Virginia, Charlottesville
M. W. BERNS, S. BRENNER, J. B. RATTNER, and S. M. RICHARDSON, Department of Developmental and Cell Biology,
University of California, Irvine: Laser microbeam studies on the mitotic apparatus.
S. P. PETERSON and M. W. BERNS, Department of Developmental and Cell Biology, University of California,
Irvine: Nucleic acid function in spindle formation in dividing PTK2 cells shown by laser induced psoralen
photoreaction.
A. FORER* and W. T. JACKSON,T *Biology Department, York University, Toronto, Canada; tBiology Department,
Dartmouth College, Hanover, New Hampshire: Distribution of actin filaments in Haemanthus endosperm
spindles.
K. FUJIWARA,* M. E. PORTER,' and T. D. POLLARD,* *Department of Anatomy, Harvard Medical School, Boston,
Massachusetts; tDepartment of Biology, University of Pennsylvania, Philadelphia: Comparative localization
of myosin, a-actinin and tubulin in tissue-culture cells by double fluorescent antibody staining.
W. Z. CANDE, Department of Botany, University of California, Berkeley: Studies of chromosome movement in
lysed mitotic cells-Nucleotide dependence.
D. P. KIEHART, Department of Biology, University of Pennsylvania, Philadelphia, and the Marine Biological
Laboratory, Woods Hole, Massachusetts: Microinjection studies on spindle assembly and chromosome
movement in vivo.
T. KELLER and L. I. REBHUN, Department of Biology, University of Virginia, Charlottesville: Studies of isolated
spindles and spindle tubulin from sea urchin eggs.
L. GRIFFITH and T. POLLARD, Department of Anatomy, Harvard Medical School, Boston, Massachusetts: Vis-
cometric evidence for actin filament-microtubule interaction mediated by microtubule-associated proteins.
M. J. WELSH, J. DEDMAN, S. COX, B. R. BRINKLEY and A. R. MEANS, Department of Cell Biology, Baylor College of
Medicine, Houston, Texas: Calcium-dependent regulator protein-A dynamic component of the mitotic
apparatus.
J. M. MARCUM, J. R. DEDMAN, B. R. BRINKLEY, and A. R. MEANS, Department of Cell Biology, Baylor College of
Medicine, Houston, Texas: Regulation of microtubule assembly-disassembly by calcium-dependent reg-
ulator protein.
Session 2: Microtubules I
Chairperson: J. B. OLMSTED, University of Rochester, New York
M. OSBORN and K. WEBER, Max-Planck-Institut fiir Biophysische Chemie, Gottingen, Germany: Immunofluores-
cence microscopy of microtubules and other fibrous structures in cells in tissue culture.
B. B. ASCH, D. MEDINA, and B. R. BRINKLEY, Department of Cell Biology, Baylor College of Medicine, Houston,
Texas: Surface and cytoskeletal features of normal, preneoplastic, and neoplastic mouse mammary epithelial
cells in vitro.
R. W. TUCKER,* K. FUJIWARA,T C. D. STILES,* C. D. SCHER,* and A. B. PARDEE,* *Sidney Farber Cancer Institute;
'Harvard Medical School, Boston, Massachusetts: Relationship of centriole cycle to DNA synthesis cycle in
BALB/c-3T3 cells.
M. DE BRABANDER,* J. DE MEYT M. JONIAU,t and G. GEUENS,* *Janssen Pharmaceutical Research Laboratories,
Beerse, Belgium; tMedical Foundation Queen Elisabeth, V.U.B. Brussels, Belgium; ,Catholic University of
Leuven, Kortrijk, Belgium: The distribution of immunoreactive tubulin in cultured cells at the light- and
electron-microscopic level studied with the unlabeled antibody enzyme method.
B. S. ECKERT, Department of Anatomical Sciences, School of Medicine, State University of New York, Buffalo:
Immunocytochemistry of tubulin and actin in glutaraldehyde-fixed cells by light and electron microscopy.
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B. A. PALEvirz, Biology Department, State University of New York, Stony Brook: Microtubules, the plas-
malemma and the control of cellulose orientation in plant cells.
D. L. KIRK and G. I. VIAMONTES Department of Biology, Washington University, St. Louis, Missouri: Cell shape
changes as the basis for inversion in Volvox embryos.
G. I. VIAMONTES and D. L. KIRK, Department of Biology, Washington University, St. Louis, Missouri: Cytological
features underlying cell shape changes in inverting Volvos embryos.
W. D. COHEN and I. NEMHAUSER, Department of Biological Sciences, Hunter College of City University of New
York, New York: Phylogenetic distribution of the marginal band system.
P. SATIR, Department of Anatomy, Albert Einstein College of Medicine, Bronx, New York: Dynein arm structure
and ciliary motion.
L. BABISS,* R. B. LUFTIG,* J. A. WEATHERBEE,* R. R. WEIHING,* U. RAY;, and B. FIELDS:, *Worcester Foundation for
Experimental Biology, Shrewsbury, Massachusetts; +Harvard Medical School, Boston, Massachusetts:
Reovirus serotypes I and III differ in their in vitro association with microtubules.
E. MANDELKOW and E. MANDELKOW, Max-Planck-Institut for Medical Research, Heidelberg, Germany: Image
reconstruction of tubulin hoops.
E. MANDELKOW and E. MANDELKOW, Max-Planck-Institut for Medical Research, Heidelberg, Germany: Aggre-
gates formed by junctions between microtubule walls.
Session 3: Microtubules 11
Chairperson: L. WILSON, University of California, Santa Barbara
R. C. WEISENBERG, Department of Biology, Temple University, Philadelphia, Pennsylvania: Kinetic problems
of microtubule and microfilament assembly.
K. A. JOHNSON and G. B. BORISY, Laboratory of Molecular Biology, University of Wisconsin, Madison: The
thermodynamics of microtubule self-assembly in vitro.
R. V. ZACKROFF and R. C. WEISENBERG, Department of Biology, Temple University, Philadelphia, Pennsylva-
nia: Assembly and stability of microtubules in glucose-o-phosphate.
K. W. FARRELL, A. MORSE, and L. WILSON, Department of Biological Sciences, University of California, Santa
Barbara: Characterization of outer doublet tubulin reassembly in vitro.
A. H. LOCKWOOD, The Cancer Research Center and Department of Anatomy, Laboratories for Cell Biology,
University of North Carolina Medical School, Chapel Hill: A protein essential for microtubule
assembly-Biochemical and immunological characterization.
M. E. STEARNS and D. L. BROWN, Department of Biology, University of Ottawa, Canada: Assembly of
cytoplasmic tubulin of Polytomella on isolated basal body rootlet MTOCs.
K. HINDS* and D. SOIFER,± *Cornell University Medical College, New York, New York; tlnstitute for Basic
Research, Staten Island, New York: Absence of microtubule-associated proteins from hybrid microtubules
assembled from chick brain and human fibroblast protein.
L. I. REBHUN, Department of Biology, University of Virginia, Charlottesville: Sulfhydryls and the assembly of
microtubules.
L. A. Amos, Medical Research Council Laboratory of Molecular Biology, Cambridge, England: Arrangements
of microtubule-associated proteins.
W. S. ADAIR and U. W. GOODENOUGH, Department of Biology, Harvard University, Cambridge, Mas-
sachusetts: Identification of a membrane tubulin in Chlamydomonas.
J. NATH and M. FLAVIN, NHLBI, National Institutes of Health, Bethesda, Maryland: State of tyrosylation of
brain membrane tubulin.
Session 4: Microtubules and 10-nm Filaments
Chairperson: J. ROSENBAUM, Yale University, New Haven, Connecticut
L. VAN DE WATER III and J. B. OLMSTED, Department of Biology, University of Rochester, New York:
Quantitation and characterization of antibody binding to tubulin.
F. SOLOMON, M. MAGENDANTZ, and A. DUERR, Department of Biology and Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge: Analysis of cytoplasmic microtubules in cytoskeleton
preparations of cultured cells.
N. W. SEEDS and R. B. MACCIONI, Department of Biophysics and Genetics, University of Colorado Medical
Center, Denver: Regulation of microtubule formation in nerve cells.
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J. A. WEATHERBEE, R. B. LUFTIG, and R. W. WEIHING, Worcester Foundation for Experimental Biology,
Shrewsbury, Massachusetts: Preparation and fractionation of microtubules from He La cells.
K. HINDS,* B. S. DANES,* and D. SOIFER,t *Cornell University Medical College, New York, New York;
+Institute for Basic Research, Staten Island, New York: Microtubules in Chediak-Higashi syndrome.
P. LEFEBVRE, E. WIEBEN, and J. ROSENBAUM, Department of Biology, Yale University, New Haven, Connec-
ticut: Control of flagellar protein synthesis in Chlamydomonas.
D. P. WEEKS, P. S. Cows, and M. A. GEALT, Institute for Cancer Research, Philadelphia, Pennsylvania:
Differential effects of inhibitors on tubulin induction in Chlamydomonas reinhardi.
G. R. CAMPBELL,* J. H. CHAMLEY-CAMPBELL,* U. GROSCHEL-STEWART,t J. V. SMALL*, and P. ANDERSON,5 *Baker
Medical Research Institute, Melbourne, Australia; +Institut fur Zoologie, Darmstadt, Germany; tlnstitute
of Molecular Biology, Salzburg, Austria; §University of Aarhus, Denmark: Immunofluorescent localiza-
tion of 10-nm (100-A) filaments in muscle and nonmuscle cells.
E. WANG,* R. K. CROSS,* J. STARGER,t R. D. GOLDMAN,t and P. W. CHOPPIN,* *Rockefeller University, New
York, New York; +Carnegie-Mellon University, Pittsburgh, Pennsylvania: Microtubules, 100-A filaments,
and intracellular movements.
J. V. SMALL, and J. E. CELTS, Institute of Molecular Biology, Salzburg, Austria, and Institute of Chemistry,
University of Aarhus, Denmark: Ultrastructural studies of the cytoskeleton of cultured cells.
G. P. TUSZYNSKI, E. FRANK, and C. H. DAMSKY, Wistar Institute, Philadelphia, Pennsylvania: Two-dimensional
gel electrophoresis of cytoskeletal proteins.
Session 5: 10-nm Filaments and Microfilaments
Chairperson: R. D. GOLDMAN, Carnegie-Mellon University, Pittsburgh, Pennsylvania
P. EAGLES, C. BELL, A. MAGGS, C. WAIS, and D. GILBERT, MRC Cell Biophysics Unit, Kings College, London:
Neurofilament structure and its enzymatic modification.
G. SHECKET and R. LASEK, Department of Anatomy, Case Western Reserve University School of Medicine,
Cleveland, Ohio: Phosphorylation of 10-nm neurofilaments.
P. F. DAVISON and B.-S. HONG, Fine Structure Department, Boston Biomedical Research Institute, Boston,
Massachusetts: Classes of cytoplasmic filaments.
G. SALOMON, R. LIEM, and M. SHELANSKI, Department of Neuroscience, Children's Hospital Medical Center,
Boston, Massachusetts: Isolation of intermediate filaments from central and peripheral nerve.
J. M. STARGER and R. D. GOLDMAN, Department of Biological Sciences, Carnegie-Mellon University,
Pittsburgh, Pennsylvania: Properties of 10-nm filaments from various cell types.
R. G. WHALEN, G. S. BUTLER-BROWNE, and F. GROS, Institut Pasteur, Paris, France: Multiplicity of the protein
subunits of intermediate filaments.
P. STEINERT and W. IDLER, NCI, National Institutes of Health, Bethesda, Maryland: Structural features of the
mammalian epidermal keratin filament.
I. K. BUCKLEY,* T. R. RAJU,* and M. STEWART,*t *Department of Experimental Pathology, John Curtin School
of Medical Research, the Australian National University; +Division of Computing Research, CSIRO,
Canberra, Australia: A reassessment of the distribution of F-actin in cultured fibroblasts.
R. RUBIN and J. HOWARD, Department of Anatomy, University of Miami School of Medicine, Miami, Florida:
A biochemical and ultrastructural comparison of Triton cytoskeletal models of normal and transformed
cells.
J. M. OLIVER and R. D. BERLIN, Department of Physiology, University of Connecticut Health Center,
Farmington: Analogous ultrastructure and surface properties during Con-A capping and phagocytosis in
leukocytes. I. Properties of the cytoskeleton.
J. CONDEELIS, Department of Anatomy, Albert Einstein College of Medicine, Bronx, New York: The actin
cytoskeleton and the mobility of cell-surface receptors for Con-A.
R.W. MERRIAM, M. NOWINSKI, and K. HAAS, Department of Biology, State University of New York, Stony
Brook: The demonstration of localized contractile programs in living oocytes and eggs of Xenopus Iaevis.
Session 6: Microfilaments I
Chairperson: E. TAYLOR, University of Chicago, Illinois
S. S. BROWN, D. G. UYEMURA, and J. A. SPUDICH, Department of Structural Biology, Sherman Fairchild
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Center, Stanford University School of Medicine, California: Characterization of the polymerization
properties of actin from Dictyostelium discoideum.
T. CLARK and J. R. ROSENBAUM, Department of Biology, Yale University, New Haven, Connecticut: Charac-
terization of nuclear actin from Xenopus oocytes.
D. A. BEGG, R. C. MORELL, and L. I. REBHUN, Department of Biology, University of Virginia, Charlottesville:
Studies of actin in the sea urchin egg cortex.
K. T. EDDS, Marine Biological Laboratory, Woods Hole, Massachusetts: The ultrastructure and biochemical
components of actin-containing filament bundles.
J. A. SCHLOSS and R. D. GOLDMAN, Department of Biological Sciences, Carnegie-Mellon University,
Pittsburgh, Pennsylvania: Studies on the proteins and organization of cultured-cell native microfilaments.
V. NACHMIAS Department of Anatomy, University of Pennsylvania School of Medicine, Philadelphia: Effects
of sulfhydryl inhibitors on AMP-induced filament genesis in Physarum.
J. D'HAESE,* and H. HINSSEN,t *Institut fiir Zoologie, Dusseldorf; tInstitut fur Cytologie, Bonn, Germany:
Functional studies on the different organization forms of Physarum actomyosin.
B. S. JACOBSON, Biochemistry Department, University of Massachusetts, Amherst: Plasma membrane isola-
tion and inversion on cationic beads-Actin association with highly purified plasma membrane from
Dictyostelium discoideum.
C.-J. H. CHEN, D. J. LITMAN, and V. T. MARCHES!, Department of Pathology, Yale University School of
Medicine, New Haven, Connecticut: Interactions between the cytoplasmic surface of the human erythro-
cyte membrane and potential cytoskeletal proteins.
M. P. SHEETZ and D. SAWYER, Physiology Department, University of Connecticut Health Center, Farmington:
Composition of the erythrocyte cytoskeleton and preliminary evidence for spectrin filaments.
H. MARUTA, J. H. COLLINS, H. GADASI, and E. D. KORN, NHLBI, National Institutes of Health, Bethesda,
Maryland: Catalytic site of Acanthamoeba myosin. I.
J. H. COLLINS, H. GADASI, H. MARUTA, and E. D. KORN, NHLBI, National Institutes of Health, Bethesda,
Maryland: Myosin-I heavy-chain kinase from Acanthamoeba castellanii.
H. GADASI, J. H. COLLINS, H. MARUTA, and E. D. KORN, NHLBI, National Institutes of Health, Bethesda,
Maryland: Tryptic digestion of Acanthamoeba myosin. II.
Session 7: Microfilaments II
Chairperson: D. HARTSHORNE, Carnegie-Mellon University, Pittsburgh, Pennsylvania
C. MAHENDRAN and S. BERL, Mt. Sinai School of Medicine of City University of New York, New York:
Resolution of troponin complex from bovine brain.
D. M. WATTERSON, Department of Cell Biology, Rockefeller University, New York, New York: The role of
calcium-modulated proteins in cell function.
R. DABROWSKA* and D. J. HARTSHORNE,t *Nencki Institute of Experimental Biology, Warsaw, Poland;
t Departments of Biological Sciences and Chemistry, Carnegie-Mellon University, Pittsburgh, Pennsylva-
nia: Ca "-Dependent myosin light-chain kinase from nonmuscle tissues.
M.-J. YERNA,* R. DABROWSKA,t D. J. HARTSHORNE,* and R. D. GOLDMAN,* *Department of Biological
Sciences, Carnegie-Mellon University, Pittsburgh, Pennsylvania; tDepartment of Biochemistry of the
Nervous System and Muscle, Nencki Institute of Experimental Biology, Warsaw, Poland: The regulation
of BHK-21 myosin-Possible function of an endogenous modulator protein.
D. R. HATHAWAY,* C. B. KLEE,t C. R. EATON,* and R. S. ADELSTEIN,* *NHLBI, National Institutes of Health;
tNCI, National Institutes of Health, Bethesda, Maryland: Regulation of platelet and smooth-muscle
myosin light-chain kinases.
S. P. SCORDILIS and R. S. ADELSTEIN, NHLBI, National Institutes of Health Bethesda, Maryland: Devel-
opmental changes in myosin and myosin light-chain kinase during myogenesis.
J. A. TROTTER and R. S. ADELSTEIN, NHLBI, National Institutes of Health, Bethesda, Maryland: Phosphoryla-
fion of macrophage myosin regulates actin activation.
W. BLOOM, W. SCHOOK, C. ORES, and S. PUSZKIN, Department of Pathology, Mount Sinai School of Medicine
of City University of New York, New York: Brain clathrin purification, assembly into basketlike structures
and interaction with contractile proteins.
R. R. WEIHING, Worcester Foundation, Shrewsbury, Massachusetts: Time course of heavy meromyosin
(HMM) inhibition of actin-related gelation of HeLa cell extracts.
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E. A. BROTSCHI, J. H. HARTWIG, and T. P. STOSSEL, Medical Oncology Unit, Massachusetts General Hospital,
Boston: Quantitative analysis of actin gelation by actin-binding protein, filamin, and myosin.
P. DAVIES, D. WALLACH, M. WILLINGHAM, and I. PASTAN, Laboratory of Molecular Biology, NCI, National
Institutes of Health, Bethesda, Maryland: Studies on the phosphorylation and function of the actin-
binding protein, filamin.
R. C. LUCAS, S. ROSENBERG, and A. STRACHER, Department of Biochemistry, Downstate Medical Center, State
University of New York, Brooklyn, New York: Regulation of the cytoskeletal elements of platelets-
Interaction of actin-binding protein and actin.
U. LINDBERG, L. CARLSSON, and F. MARKEY, Cell Motility Group, Wallenberg Laboratory, University of
Uppsala, Uppsala, Sweden: Profil in: actin complex-Its role in cell motility.
Session 8: New Concepts and Methods for Studying Cytoskeletal and Contractile Systems I
Chairperson: K. PORTER, University of Colorado, Boulder
G. ALBRECHT-BUEHLER, Cold Spring Harbor Laboratory, New York: The angular distribution of directional
changes of guided 3T3 cells.
E. BELL, L. MAREK, S. SHER, C. MERRILL, D. LEVINSTONE, and I. YOUNG, Massachusetts Institute of Technology,
Cambridge: Relation of motility to cell states and previous history.
S. TAMM, Laboratory of Molecular Biology, University of Wisconsin, Madison: Relations between membrane
movements and cytoplasmic structures during rotational motility of a termite flagellate.
R. A. Moor) coop, Albert Einstein College of Medicine, Bronx, New York: Chlamydomonas flagellar surface
motility.
J. L. HOFFMAN and U. GOODENOUGH, Department of Biology, Harvard University, Cambridge, Mas-
sachusetts: Flagellar surface motility in Chlamydomonas.
K. R. STRAHS and M. W. BERNS, Department of Developmental and Cell Biology, University of California,
Irvine: Laser irradiation of stress fibers and bundles of intermediate filaments in cultured nonmuscle cells.
M. C. WILLINGHAM, S. S. YAMADA, and I. PASTAN, NCI, National Institutes of Health, Bethesda, Maryland:
Ultrastructural localization of intracellular antigens-A new procedure for cultured cells.
H. R. BYERS* and K. R. PORTER,t *Department of Anatomy, Harvard Medical School, Boston, Mas-
sachusetts; tDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado,
Boulder: A stereo high-voltage electron microscopic and cinematographic correlative study of pigment
motion and the structure of the cytoplasmic matrix in erythrophores treated with colchicine.
V. G. FONTE, K. L. ANDERSON, J. J. WOLOSEWICK, and K. R. PORTER, Department of Molecular, Cellular, and
Developmental Biology, University of Colorado, Boulder: High-voltage electron microscope observations
of the response of the cytoskeleton to dihydrocytochalasin-B treatment.
M. H. ELLISMAN,* and K. R. PORTER,t *Department of Neurosciences, University of California, San Diego;
tDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder: The
cytoskeleton of axoplasm examined by stereo high-voltage electron microscopy-A possible vehicle for
axoplasmic transport.
J. J. WOLOSEWICK and K. R. PORTER, Department of Molecular, Cellular, and Developmental Biology,
University of Colorado, Boulder: Response of the microtrabecular lattice (MTL) to low temperature and
colchicine.
C. ALLEN, Laboratory of Molecular Biology, University of Wisconsin, Madison: High-voltage electron
microscope analysis of lamellar substructure in tissue cells.
Session 9: New Concepts and Methods for Studying Cytoskeletal and Contractile Systems II
Chairperson: V. NACHMIAS, University of Pennsylvania School of Medicine, Philadelphia
M. CLARKE, Department of Molecular Biology, Albert Einstein College of Medicine, Bronx, New York:
Isolation of motility mutants of Dictyostelium discoideum.
J. M. ZENGEL, D. C. REIN, and H. F. EPSTEIN, Department of Pharmacology, Stanford University, Stanford,
California: Genetic dissection of muscle development.
D. N. JACOBSON, Department of Anatomy, Duke University, Durham, North Carolina: Physarum amoebal
behavioral mutants have multiple effects on both regulation of cell movement and change of cell state.
V. LING, A. CHASE, J. E. AUBIN, and F. SARANGI, Department of Medical Biophysics, University of Toronto,
and Ontario Cancer Institute, Toronto, Canada: Chinese hamster ovary (CHO) cells with altered
colcemid-binding activity.
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R. HYNES, I. ALI, and A. DESIREE, Department of Biology and Center for Cancer Research, Massachusetts
Institute of Technology, Cambridge: Are there relationships between extracellular LETS protein fibers and
intracellular filaments?
S. PENMAN, A. BEN-ZE'EV, B. BENECKE, S. FARMER, R. LENK, and L. WEYMOUTH, Department of Biology,
Massachusetts Institute of Technology, Cambridge: Skeletons and macromolecular function.
W. E. GORDON III, A. BUSHNELL, and K. BURRIDGE, Cold Spring Harbor Laboratory, New York: Immuno-
fluorescent and ultrastructural studies of actin, myosin, and a-actinin in the "sarcomeres" of stress fibers
and in polygonal microfilament networks.
D. L. GARD and E. LAZARIDES, Division of Biology, California Institute of Technology, Pasadena: Specific
fluorescent labeling of chicken myofibril Z-line proteins catalyzed by guinea pig liver transglutaminase.
J. W. SANGER and J. M. SANGER, Department of Anatomy, University of Pennsylvania School of Medicine,
Philadelphia: The role of filaments in cell spreading.
M. M. BLACK* and R. J. LASEK,t *Neuroscience Department, Children's Hospital, Boston, Massachusetts;
tAnatomy Department, Case Western Reserve University, Cleveland, Ohio: Axonal transport of structural
complexes within the axon-Possible identification of the polypeptides associated with the microtrabecu-
lar system.
W. S. LYNN and C. MUKHERJEE, Duke University Medical Center, Durham, North Carolina: Function of Na
and extracellular protein in leukocyte motility and membrane ruffling.
F. R. MAXFIELD* ). SCHLESSINGER,t M. C. WILLINGHAM,* Y. SHECHTER,* and I. PASTAN,* *NCI, National Institutes of
Health; tNCI, National Institutes of Health, Bethesda, Maryland, and Department of Applied Physics,
Cornell University, Ithaca, New York; *Burroughs Wellcome Company, Research Triangle Park, North
Carolina: A common mechanism for the internalization of a2-macroglobulin, epidermal growth factor, and
insulin by cultured fibroblasts.
RNA TUMOR VIRUSES, May 24-May 28
arranged by
J. Michael Bishop, University of California Medical School, San Francisco
Harold E. Varmus, University of California Medical School, San Francisco
387 participants
Session 1: The Genome-Structure and Genesis
Chairperson: P. VOGT, University of Southern California, Los Angeles
R. SWANSTROM,* L. HALLICK,t J. E. HEARST,t and J. M. BISHOP,* *Department of Microbiology, University of
California, San Francisco; *Department of Microbiology and Immunology, University of Oregon, Port-
land; *Department of Chemistry, University of California, Berkeley: Secondary structure in avian sarcoma
virus RNA-Cross-linking as a molecular probe.
M. M. C. LAI and S. S. F. Hu, Department of Microbiology, University of Southern California, School of
Medicine, Los Angeles: The presence of variable and constant sequences in the env gene of avian RNA
tumor viruses.
J. M. COFFIN and C. BARKER, Department of Molecular Biology and Microbiology and Cancer Research
Center, Tufts University School of Medicine, Boston, Massachusetts: In vitro "evolution" of Rous
sarcoma virus.
A. SHIELDS, 0. N. WITTE, E. ROTHENBERG,* and D. BALTIMORE, Department of Biology and Center for Cancer
Research, Massachusetts Institute of Technology, Cambridge: Clonal isolates of Moloney murine leuke-
mia virus aberrantly express viral genes at high frequency.
J. ROMMELAERE, H. DONIS-KELLER, D. V. FALLER, J. SCHINDLER, and N. HOPKINS, Department of Biology and
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge: The sequence of three T1
oligonucleotides associated with the N-, B-, or NB-tropism ofcertain murine leukemia viruses.
D. V. FALLER, J. ROMMELAERE, and N. HOPKINS, Department of Biology and Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge: T1 oligonucleotide analysis of Moloney and HIX
genomic RNAs and of an intracellular, 21S, spliced Moloney virus RNA, the putative Moloney gp70
mRNA.
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D. J. DONOGHUE,* E. ROTHENBERG,' N. HOPKINS,* D. BALTIMORE,* and P. A. SHARP,* *Department of Biology
and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge; tMemorial Sloan-
Kettering Cancer Center, New York, New York: Heteroduplex analysis of the nonhomology region
between Moloney murine leukemia virus and the dual-host-range derivative HIX virus.
P. ANDERSSON, M. GOLDFARB, and R. A. WEINBERG, Department of Biology and Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge: Assignment of the transforming function of Moloney
sarcoma virus (Mo-MSV) to restriction-endonuclease-generated fragments of Mo-MSV cDNA.
J. G. LEVIN and J. G. SEIDMAN, NICHHD, National Institutes of Health, Bethesda, Maryland: Assembly of host
tRNAs into murine leukemia virus particles does not require genomic RNA.
G. PETERS, C. GLOVER, and R. WEISS, Department of Viral Oncology, Imperial Cancer Research Fund
Laboratories, Lincoln's Inn Fields, London, England: Absence of tRNATrP primer in polymerase-defective
avian sarcoma viruses.
M. LINIAL,* E. MEDEIROS,* B. GALLIS,* and W. HAYWARD,' *Fred Hutchinson Cancer Research Center,
Seattle, Washington; tRockefeller University, New York, New York: A mutant of Rous sarcoma virus
which packages cellular rather than genomic RNA.
Session 2: Viral DNA Synthesis and Integration
Chairperson: R. ERIKSON, University of Colorado, Denver
J. M. TAYLOR,* T. W. Hsu,* G. E. MARK,* W. S. MASON,* J. L. SABRAN,t A. KAJI," M. M. C. LAI,t and R. R.
GUNTAKA,§ *Institute for Cancer Research, Philadelphia, Pennsylvania; tUniversity of Pennsylvania,
Philadelphia; *University of Southern California Medical School, Los Angeles; §Columbia University,
New York: Avian RNA tumor virus genome-Structure and replication.
H. J. KUNG, P. R. SHANK, J. M. BISHOP, and H. E. VARMUS, Department of Microbiology, University of
California, San Francisco: The structure of unintegrated viral DNA in cells infected with avian sarcoma
virus-The size of (+) strands in linear DNA and the identification of dimeric, closed, circular DNA.
S. HUGHES,* P. R. SHANK,* D. SPECTOR,* H. J. KUNG,* H. L. ROBINSON,' E. STUBBLEFIELD,5 P. K. Voc-r,§ J. M.
BISHOP,* and H. E. VARMUS,* *Department of Microbiology, University of California, San Francisco;
tWorcester Foundation, Shrewsbury, Massachusetts; *M.D. Anderson Medical Center, Houston, Texas;
§University of Southern California Medical School, Los Angeles: Mapping of virus-specific DNA in avian
sarcoma virus-infected and uninfected cells.
E. KESHET and H. M. TEMIN, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison:
Sites of integration of reticuloendotheliosis virus DNA in chicken cellular DNA.
D. STEFFEN and R. A. WEINBERG, Department of Biology and Center for Cancer Research, Massachusetts
Institute of Technology, Cambridge: Moloney murine leukemia virus integrates its DNA in multiple sites
upon infection of cell cultures and induction of leukemia.
P. NoBis and R. MENISCH, Heinrich-Pette-Institut, Hamburg, Germany: Virus-specific expression, integration
and gene amplification in mice carrying Moloney leukemia virus in their germ lines.
J. C. COHEN,* P. R. SHANK,* V. L. MORRIS,' R. CARDIFF,' and H. E. VARMUS,* *Department of Microbiology,
University of California, San Francisco; ±Department of Bacteriology, University of Western Ontario,
London, Canada: *Department of Pathology, University of California, Davis: The endogenous and
acquired proviruses of mouse mammary tumor virus.
R. S. LEMONS, W. G. NASH, S. J. O'BRIEN, R. E. BENVENISTE, and C. J. SHERR, NCI, National Institutes of Health,
Bethesda, Maryland: A gene (Bevi) on human chromosome six is a preferred integration site for baboon
type-C DNA provirus in human cells.
M. GOLDFARB and R. A. WEINBERG, Center for Cancer Research and Department of Biology, Massachusetts
Institute of Technology, Cambridge: Physical mapping and transfection experiments with Harvey sar-
coma virus DNA.
G. M. COOPER and S. OKENQUIST, Sidney Farber Cancer Institute and Department of Pathology, Harvard
Medical School, Boston, Massachusetts: Mechanism of transfection of chicken embryo fibroblasts by
Rous sarcoma virus DNA.
A. ISHIMOTO, J. W. HARTLEY, and W. P. RowE, NIAID, National Institutes of Health, Bethesda, Maryland:
Rapid appearance of phenotypically mixed particles following superinfection of chronically infected
cultures.
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Session 3: Viral Gene Expression
Chairperson: N. HOPKINS, Massachusetts Institute of Technology, Cambridge
M. GROUDINE,*" S. DAS,t P. NEIMAN," and H. WEINTRAUB,§
*Division of Radiation Oncology, University of
Washington Hospital, Seattle; +Fred Hutchinson Cancer Research Center, Seattle, Washington; +Division
of Oncology, University of Washington School of Medicine, Seattle; §Department of BiochemicalScience, Princeton University, New Jersey: Subunit conformation and tissue-specific expression of theRous associated virus-0 (RAV-0) genone.
D. W. STACEY and H. HANAFUSA, Rockefeller University, New York: Envelope-glycoprotein mRNA and its
nuclear precursor within Rous associated virus-2 (RAV-2) virus particles.
S. R. WEISS, B. CORDELL, H. E. VARMUS, and J. M. BISHOP, Department of Microbiology, University of
California, San Francisco: The 5' termini of avian sarcoma virus mRNAs contain transposed sequences.
M. PERDUE, R. KRZYZEK, A. LAU, D. NOREEN, D. ANDERSON, and A. FARAS, Department of Microbiology,
University of Minnesota Medical School, Minneapolis: Characterization of spliced nucleotide sequences
present on Rous sarcoma virus-specific subgenomic RNAs from infected cells.
M. GORECKI,* Y. ALONI,* S. BRATOSIN,* and A. PANET,"
*Department of Organic Chemistry and Genetics,
Weizmann Institute of Science, Rehovot, Israel; +Department of Virology, Hebrew University, Hadassah
Medical School, Jerusalem, Israel: Moloney murine leukemia mRNAs are spliced.
D. L. ROBERTSON and H. E. VARMUS, Department of Microbiology, University of California, San Francisco:
Characterization of the murine mammary tumor virus-specific intracellular RNAs.
R. D. PALMITER,* J. GAGNON,* V. M. VOGT,' S. RIPLEY,' and R. EISENMAN,' *Department of Biochemistry,
University of Washington, Seattle; +Section of Biochemistry, Molecular and Cell Biology, Cornell Uni-
versity, Ithaca, New York; ,Fred Hutchinson Cancer Research Center, Seattle, Washington: Determina-
tion of the NH,-terminal amino acid sequence of Pr76.g.
P. HACKETT, H. OPPERMANN, S. WEISS, A. ULLRICH, L. LEVINTOW, J. M. BISHOP, and R. GESTELAND,* Department
of Microbiology, University of California, San Francisco;
*Cold Spring Harbor Laboratory, New York:
Translation in vitro of the mRNAs specifying the gag and pol proteins of avian sarcoma virus.
H. OPPERMANN, L. S. CHEN, A. D. LEVINSON, H. E. VARMUS, J. M. BISHOP, and L. LEVINTOW, Department of
Microbiology, University of California, San Francisco: Expression of avian sarcoma virus-specific proteinsin permissive and nonpermissive cells.
A. LAU,* R. KRZYZEK,* M. COLLETT,' J. BRUGGE,' R. ERIKSON,' and A. FARAS,* *Department of Microbiology,
University of Minnesota Medical School, Minneapolis; +Department of Pathology, University of ColoradoMedical Center, Denver: Src gene product is present in revertants of avian retrovirus-transformed
mammalian cells.
J. WYKE, J. BEAMAND, and K. QUADE, Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields,
London, England: Phenotypic reversion of avian sarcoma virus-transformed rat cells-Variation in the
expression of the virus genome.
Session 4: Viral Proteins
Chairperson: R. ARLINGHAUS, M.D. Anderson Hospital, University of Texas, Houston
A. Hizi, M. A. MCCRAE, and W. K. JOKLIK, Duke University Medical Center, Durham, North Carolina: Studies
on the amino acid sequences of polypeptides specified by the gag and pol genes of avian sarcoma virusB77.
R. D. SCHIFF and D. P. GRANDGENETT, Institute for Molecular Virology, St. Louis University Medical Center,
Missouri: Virus-coded origin of the 32,000-dalton endonuclease from avian retrovirus cores-Structural
relatedness of p32 and the g polypeptide of avian retrovirus DNA polymerase.
J. R. STEPHENSON,* A. S. KHAN,' F. H. REYNOLDS,' and T. L. SACKS,*
*NCI, National Institutes of Health,
Bethesda, Maryland; +Frederick Cancer Research Center, Frederick, Maryland: Mammalian sarcoma virus
translational products--Identification and processing of precursors containing structural and nonstruc-
tural components.
J.-S. TUNG, P. V. O'DONNELL, E. FLEISSNER, and E. A. BOYSE, Memorial Sloan-Kettering Cancer Center, New
York, New York: Relationships of gp70 of murine leukemia virus envelopes to gp70 components of
mouse lymphocyte plasma membranes.
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S. OROSZLAN, A. M. SCHULTZ, L. E. HENDERSON, and J. L. OLPIN, Viral Oncology Program, Frederick Cancer
Research Center, Frederick, Maryland: Biochemical and primary structure studies of retrovirus gag
polyproteins.
P. TRAKTMAN, 0. N. WITTE, and D. BALTIMORE, Department of Biology and Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge: Bypass by protease of temperature-sensitive lesions in
the final morphogenetic event of retrovirion synthesis.
A. PINTER, J. LIEMAN-HURWITZ, and E. FLEISSNER, Memorial Sloan-Kettering Cancer Center, New York, New
York: Characterization of murine leukemia virus structural subunits.
J. HILKENS,* A. COLOMBATTI,* M. STRAND,t and J. HILGERS,* *Division of Genetics, The Netherlands Cancer
Institute, Amsterdam; +Department of Pharmacology and Experimental Therapeutics, Johns Hopkins
University, Baltimore, Maryland: Identification of a mouse chromosome for type-C envelope glycoprotein
membrane receptor by somatic cell genetics.
D. ZARLING, R. DUKE, I. KESHET, A. WATSON, and F. BACH, University Of Wisconsin, Madison: Physical
association of H-2 and murine leukemia virus (MuLV) gp70 antigens on Rauscher MuLV transformed
leukemia cells and their recognition by syngenic cytotoxic T lymphocytes.
G. ROLOSON, C. CHAMBERS, D. HAAGENSEN, Jr., R. MONTELARO, and D. BOLOGNESI, Department of Surgery and
Department of Microbiology and Immunology, Duke University Medical Center, Durham, North
Carolina: A single genetic locus determines the efficacy of serum therapy against murine adenocar-
cinoma 755a.
Session 5: Endogenous Viruses and Genetic Interactions
Chairperson: H. ROBINSON, Worchester Foundation for Experimental Biology, Shrewsbury, Massachusetts
L. M. SOUZA and M. A. BALUDA, Molecular Biology Institute, University of California, Los Angeles: The
topology of endogenous proviral sequences in some chicken strains.
E. HUMPHRIES, C. GLOVER, and J. ARRAND, Imperial Cancer Research Fund Laboratories, London, England:
Restriction endonuclease analysis of Rous associated virus-0 (RAV-0)-related sequences in DNA of
chicken embryo fibroblasts from different inbred and outbred chicken flocks.
E. HUNTER,* A. S. BHOWN,* M. BARBACID,t and S. AARONSON,t *University of Alabama, Birmingham; +NCI,
National Institutes of Health, Bethesda, Maryland: Evolutionary relationship of reticuloendotheliosis virus
to avian and mammalian oncoviruses.
R. CALLAHAN and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland: Four major
endogenous retrovirus classes of the genus Mus.
M. BARBACID and S. A. AARONSON, NCI, National Institutes of Health, Bethesda, Maryland: In vitro genera-
tion of recombinants between mouse type-C RNA tumor viruses.
J. W. GAUTSCH,* J. H. ELDER,* J. SCHINDLER,t F. C. JENSEN,* and R. A. LERNER,* *Department of Cellular and
Developmental Immunology, Scripps Clinic and Research Foundation, La Jolla, California; +Department
of Biology, Massachusetts Institute of Technology, Cambridge: Structural markers of murine leukemia
virus p30-Functional correlation with Fv-1 tropism.
L. BENADE,* J. IHLE,* and A. DEctEvE,+ *NCI, Frederick Cancer Research Center, Frederick, Maryland;
+Stanford University School of Medicine, California: C57BL B-tropic viruses-Evidence for origin by
recombination with endogenous xenotropic virus.
N. G. COPELAND and G. M. COOPER, Sidney Farber Cancer Institute and Department of Pathology, Harvard
Medical School, Boston, Massachusetts: Lack of infectivity of endogenous murine leukemia virus DNAs.
D. R. Lows, NCI, National Institutes of Health, Bethesda, Maryland: Infectious murine leukemia virus from
normal mouse embryo cell DNA.
H. L. NIMAN, M. B. GARDNER, J. W. PARKER, J. STEINER, and P. ROY- BURMAN, University of Southern California
School of Medicine, Los Angeles: Endogenous RD-114 virus genome expression in immunological cells
of the cat.
C. MORONI,* R. P. MONCKTON,* J. F. DELAMARTER,* J. STOVE,* P. ERB,t G. SCHUMANN,t *Friedrich Miescher-
Institut; +Institut fur Mikrobiologie; ,Research Department, Ciba-Geigy, Ltd., Basel, Switzerland: A
putative role for endogenous C-type virus in the immune response.
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Session 6: Poster Session
Host Restriction
R. SOEIRO, S. DATTAGUPTA, and N. BURNETTE, Albert Einstein College of Medicine, Bronx, New York: Host
restriction of Friend leukemia virus-Structural studies of p30 and genome of N-, B-, and NB-tropic
virions.
J. SCHINDLER,* and J. GAUTSCHt *Department of Biology and Center for Cancer Research, Massachusetts
Institute of Technology, Cambridge; tScripps Research Foundation, La Jolla, California: Further analysis
of p3Os of N-, B-, and BNB-tropic murine leukemia viruses of BALB/c and of XLP-N recombinants
between the N- and B-tropic viruses.
G. DURAN-TROISE,* P. 0. WEISLOGEL,t R. H. BASSIN,* and T. A. HURT,* *NCI, National Institutes of Health;
+Litton Bionetics, Inc., Bethesda, Maryland: Use of amphotropic and heat-inactivated murine leukemia
viruses in studies on the mechanism of Fv-1 restriction.
B. M. BENJERS, R. H. BASSIN, A. REIN, and B. I. GERWIN, NCI, National Institutes of Health, Bethesda,
Maryland: Abrogation of Fv-1 restriction in N-type cells.
E. MEDEIROS and M. LINIAL, Fred Hutchinson Cancer Research Center, Seattle, Washington: Growth restric-
tion of a Prague E avian sarcoma virus recombinant in chicken embryo fibroblasts.
P. E. NEIMAN,* C. MCMILLIN-HELSEL,* and G. M. COOPER,* *Division of Oncology, University of Washington,
and Fred Hutchinson Cancer Research Center, Seattle; +Sidney Farber Cancer Institute and Department of
Pathology, Harvard Medical School, Boston, Massachusetts: Specific restriction of avian sarcoma viruses
by a line of transformed lymphoid cells.
Viral Genetics
K. TOYOSHIMA, M. YUTSUDO, H. SUGIYAMA, S. TAHARA, and A. HAKURA, Research Institute for Microbial
Diseases, Osaka University, Japan: Replication-defective mutants of avian sarcoma virus.
A. REIN,* B. M. BENJERS,* R. H. BASSIN,* B. I. GERWIN,* and D. R. Sincum,t *NCI, National Institutes of
Health; +Litton Bionetics, Inc., Bethesda, Maryland: Rescue and transmission of replication-defective
variants of ecotropic murine leukemia virus.
A. HORWICH,* C. DICKSON,* and B. OZANNE,* *Imperial Cancer Research Fund Laboratories, London,
England, tUniversity of Texas Health Science Center, Dallas: Isolation of absolute defective mutants of
murine leukemia virus.
G. S. MARTIN,* K. RADKE,* S. HUGHES,t N. QUINTRELL,t J. M. BISHOP,t and H. VARMUS,t *Zoology Depart-
ment, University of California, Berkeley; tDepartment of Microbiology, University of California, San
Francisco: Properties of quail cells transformed by replication-defective mutants of Prague Rous sarcoma
virus.
J. C. CHERMANN, F. SINOUSSI, and R. LIDEREAU, Unite d'Oncologie Virale, Institut Pasteur, Paris, France:
Evidence for a non-defective murine sarcoma virus.
C. BERGHOLZ, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois: A hybrid of the simian sarcoma
virus-related component of HL-23V with altered envelope properties.
R. SHAIKH," M. LINIAL,* and R. EISENMAN,* *Fred Hutchinson Cancer Research Center, Seattle, Washington;
tCenter for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts: Altered
gag proteins of recombinants between PR-Rous sarcoma virus-C and Rous associated virus-0 (RAV-0).
P. BALDUZZI, and J. R. CHRISTENSEN, Department of Microbiology, University of Rochester, New York:
Marker-rescue experiments with temperature-sensitive mutants of Rous sarcoma virus.
W. J. M. VAN DE VEN, Department of Biochemistry, University of Nijmegen, The Netherlands: Biological
assay of in vitro synthesized subgenomic DNA fragments of murine leukemia virus by marker rescue.
R. R. FRIIS,* and D. BECKER,t *Institut fur Virologie, Giessen, Germany; tRockefeller University, New York:
Mapping transformation-defective temperature-sensitive mutants of Rous sarcoma virus into src.
Homo Sapiens
F. WONG-STAAL, S. JOSEPHS, and R. C. GALLO, NCI, National Institutes of Health, Bethesda, Maryland:
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Hybridization of simian sarcoma virus RNA to endonuclease-restricted human DNA-Detection of
endogenous and acquired viral-related fragments.
P. C. JACQUEMIN, W. C. SAXINGER, and R. C. GALLO, NCI, National Institutes of Health, Bethesda, Maryland:
Presence of IgG on the membrane of leukemic cells which specifically neutralizes reverse transcriptase
from some mammalian type-C viruses.
P. D. MARKHAM,* F. RUSCETTI," S. Z. SALAHUDDIN,* R. E. GALLAGHER,' and R. C. GALLO,' *Litton Bionetics,
Inc.; "-NCI, National Institutes of Health, Bethesda, Maryland: Enhanced transformation of B lymphocytes
from normal human blood by exposure to primate type-C retroviruses.
P. HERBRINK, G. N. P. VAN MUYEN, and S. 0. WARNAAR, Laboratory for Pathology, University of Leiden, The
Netherlands: Search for C-type viral p30-related antigens and antibodies directed against C-type viral
antigens in human tissues and sera.
R. C. MELLORS and J. W. MELLORS, Hospital for Special Surgery, New York Hospital-Cornell University
Medical College, New York: Evidence for type-C virus antibody in human systemic lupus
erythematosus-Elution from renal lesions and demonstration by enzymoimmunoassay.
R. KURTH, Friedrich-Miescher-Laboratory, Max-Planck-Institute, Tubingen, Germany: Antibodies reactive
with purified primate type-C viral antigens.
Session 7: Poster Session
Viral Genome
I. M. VERMA and M. A. MCKENNETT, Tumor Virology Laboratory, Salk Institute, San Diego, California: Physical
maps of the in vitro synthesized murine leukemia and sarcoma viral DNA by restriction endonucleases.
Y. H. CHIEN,* N. DAVIDSON,* I. VERMA," P. H. DUESBERG,t T. Y. SHR-1,§ and E. M. SCOLNICK,§ *Department of
Chemistry, California Institute of Technology, Pasadena; ,Salk Institute, San Diego, California; ,Department
of Molecular Biology, University of California, Berkeley; §NCI, National Institutes of Health, Bethesda,
Maryland: Heteroduplex studies of murine sarcoma and focus-forming viruses.
T. Y. SHIH, D. R. WILLIAMS, M. 0. WEEKS, J. M. MARYAK, W. C. VASS, H. A. YOUNG, and E. M. SCOLNICK, NCI,
National Institutes of Health, Bethesda, Maryland: Genomic organization of Kirsten and Harvey murine
sarcoma viruses.
D. SCHWARTZ and W. GILBERT, The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Sequence analysis of the nucleotide region adjacent to the 3'-terminal poly(A) of Rous sarcoma virus 35S
RNA.
J. N. M. MOL and T. J. STOOF, Department of Experimental Pathology, Erasmus University, Rotterdam, Holland:
The genomic complexity of the Rauscher leukemia virus.
W. K. YANG,* D. L.-R. HWANG,' F. C. HARTMAN,* D. J. PRICE,* J. 0. KIGGANS,* C. D. STRINGER,* and D. M.
YANG,* *Biology Division, Oak Ridge National Laboratory; tOak Ridge Graduate School of Biomedical
Sciences, University of Tennessee: Primer tRNA binding of cellular RNAs from retrovirus-infected, -trans-
formed, and noninfected cells.
G. G. LOVINGER, H. OKABE, and R. V. GILDEN, Viral Oncology Program, Frederick Cancer Research Center,
Frederick Maryland: Nucleotide sequences close to the 5' terminus of Rauscher leukemia and baboon
endogenous viruses.
F. S. PEDERSEN, D. BUCHHAGEN, J. KOZLOV, Z. ROSENBERG, B. SAHAGAN, and W. A. HASELTINE, Sidney Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts: Structural studies of the genomes of RNA tumor
viruses.
Reverse Transcriptase
E. GILBOA, E. ROTHENBERG, and D. BALTIMORE, Department of Biology and Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge: Infective murine leukemia virus DNA made in vitro is
mainly linear, entirely double-stranded molecules.
M. GOLOMB, A. VORA, and D. P. GRANDGENETT, Institute for Molecular Virology, St. Louis University School of
Medicine, Missouri: Endonuclease activity of avian myeloblastosis virus RNA-directed DNA polymerase.
J. C. OLSEN and K. F. WATSON, Department of Chemistry, University of Montana, Missoula: Priming properties of
DNA complementary to sequences at the 5' terminus of the avian myeloblastosis virus genome.
R. Soo, J. MATTERSBERGER, and P. H. HOFSCHNEIDER, Max-Planck-Institut fur Biochemie, Martinsried, Germany:
Particles containing reverse transcriptase are released from primary quail embryo cultures.
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B. J. WEIMANN, Basel Institute for Immunology, Switzerland: Studies on the DNA polymerase of the sub-human
primate simian sarcoma RNA tumor virus.
R. FRIEDRICH, U. NOVAK, and K. MOELLING, Max-Planck-Institut fur Molekulare Genetik, Berlin, Germany:
Elongation of initial DNA of avian retroviruses synthesized in vitro.
C. H. CLAYMAN and A. J. FARAS, Department of Microbiology, University of Minnesota, Minneapolis: In vitro
synthesis of infectious, transforming DNA by Rous sarcoma virus.
Pro virus
B. VOGELSTEIN, D. GILLESPIE, B. NELKIN, and D. STRAYER, NCI, National Institutes of Health, Bethesda, Maryland:
Preparative electrophoresis of integrated simian sarcoma associated virus sequences in human DNA.
A. BERNS and H. v. PUTTEN, Department of Biochemistry, University of Nijmegen, The Netherlands: Integration
site of endogenous Moloney murine leukemia virus.
R. KOSHY,* F. WONG-STAAL,* R. C. GALLO,* W. HARDY,T and M. ESSEX,' *NCI, National Institutes of Health,
Bethesda, Maryland; *Memorial Sloan-Kettering Cancer Center, New York, New York; *Harvard University,
Boston, Massachusetts: Distribution of feline leukemia virus DNA sequences in tissues of normal and
leukemic domestic cats.
J. G. ANDRE, D. R. Lows, and G. L. HAGER, NCI, National Institutes of Health, Bethesda, Maryland: Separation of
integrated mouse mammary tumor virus and murine leukemia virus DNA sequences from cell DNA.
L. T. BACHELOR and H. FAN, Tumor Virology Laboratory, Salk Institute, San Diego, California: Integration sites for
Moloney murine leukemia virus DNA in infected mouse cells.
M. COHEN,* N. DAVIDSON,* R. M. McAttisTEK,* M. O. NICOLSON,T N. RICE,' and R. V. GILDEN,' *Department of
Chemistry, California Institute of Technology, Pasadena; tChildrens Hospital of Los Angeles, California;
*Frederick Cancer Research Center, Frederick, Maryland: Sequence organization of BABE -K (BKD) provirus
in the baboon and RD(BKD) genomes.
W. MCCLEMENTS,* L. BOONE,* H. HANAFUSA,T and A. SKALKA,* *Roche Institute of Molecular Biology, Nutley,
New Jersey; *Rockefeller University, New York, New York: Analyses of endogenous and infecting avian
oncornavirus proviral DNAs.
E. CANAANI and S. A. AARONSON, NCI, National Institutes of Health, Bethesda, Maryland: Restriction enzyme
analysis of unintegrated and integrated mouse sarcoma virus.
F. WONG-STAAL,* M. S. REITZ, jR.,T and R. C. GALLO,* *NCI, National Institutes of Health; *Litton Bionetics, Inc.,
Bethesda, Maryland: Integrated viral sequences in tissues from a leukemic gibbon ape and its "normal"
contact-Evidence for partial provirus in the nonleukemic gibbon.
J. J. O'REAR, E. KESHET, and H. M. TEMIN, McArdle Laboratory for Cancer Research, University of Wisconsin,
Madison: Restriction enzyme maps of integrated and unintegrated spleen necrosis virus DNAs of differing
specific infectivities.
F. CATALA and P. VIGIER, Faculte des Sciences, Institut du Radium, Orsay, France: Transfection studies with DNA
from nonpermissive hamster cells transformed by Rous sarcoma virus.
Endogenous Viruses
R. KOMINAMI,* and M. HATANAKA,* *Viral Oncology Program, Frederick Cancer Research Center, Frederick,
Maryland; *NCI, National Institutes of Health, Bethesda, Maryland: A commonly shared genetic region of
mammalian retroviruses.
V. L. MORRIS,* C. KOZAK,T W. FLINTOFF,* P. EDLICOEUR*, F. RUDDLE,§ H. VARMUS,** *University of Western
Ontario, London, Canada; TNIAID, National Institutes of Health, Bethesda, Maryland; *Institut de Re-
cherches, Clinique de Montreal, Canada; §Yale University, New Haven, Connecticut; **Department of
Microbiology, University of California, San Francisco: The distribution of mouse mammary tumor virus DNA
among mouse chromosomes as determined by somatic cell hybrids.
D. STRAYER, D. GILLESPIE, R. C. GALLO, B. VOGELSTEIN, and D. WHEELER, NCI, National Institutes of Health,
Bethesda, Maryland: Organization of RD114 sequences in domestic cat DNA.
W. DROHAN and J. SCHLOM, NCI, National Institutes of Health, Bethesda, Maryland: Detection of novel mouse
mammary tumor virus-related DNA sequences and virions in rodents.
S. G. DEVARE and J. R. STEPHENSON, NCI, National Institutes of Health, Bethesda, Maryland: Endogenous type-C
viruses of the RD114/baboon group and type-D viruses of the MPMV/SMRV group share common in-
terspecies antigenic determinants in their envelope glycoproteins.
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A. TEREBA, St. Jude Children's Research Hospital, Memphis, Tennessee: Chemical activation and regulation of a
C-type virus from ringnecked pheasant cells.
M. L. BRYANT, A. SEN, C. J. SHERR, and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland:
Biochemical and immunological characterization of five different endogenous primate retroviruses.
T. I. BONNER and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland: Distantly related primate
and certain nonprimate species contain DNA sequences related to primate viruses.
M. E. FRAZIER,* M. J. HOOPER,* J. R. PRATT,t and R. N. USHIJIMA,' *Battelle, Pacific Northwest Laboratory,
Richland, Washington; tSchering Corporation, Kenilworth, New Jersey; *Department of Microbiology,
University of Montana, Missoula: Characterization of retrovirus isolated from miniature swine with
radiation-induced leukemia.
Y. IKAWA,* M. OBINATA,* Y. UCHIYAMA,* M. AIDA,* H. ICHIMURA,t and H. SATO,t *Department of Viral
Oncology, Cancer Institute; tDepartment of Pathology, Sasaki Institute, Tokyo, Japan: Increased endogenous
virus expression in morphologically undifferentiated forms of rat carcinoma lines.
S. S. YANG and N. A. WIVEL, NCI, National Institutes of Health, Bethesda, Maryland: Integrated intracisternal
A-particle-specific DNA sequences in mammary tumor cell hybrids and cybrids.
D. JOSEPH and J. N. IHLE, Cancer Biology Program, Frederick Cancer Research Center, Frederick, Maryland:
Genetic and restriction endonuclease analysis of integrated murine leukemia virus DNA genomes.
H. L. ROBINSON,* J. M. COFFIN,t and R. N. EISENMAN,5 *Worcester Foundation for Experimental Biology,
Shrewsbury, Massachusetts; tDepartment of Molecular Biology and Microbiology and Cancer Research
Center, Tufts University School of Medicine, Boston, Massachusetts; *Fred Hutchinson Cancer Research
Center, Seattle, Washington: V-E7 and V-EC, two cellular genes for the expression of inducible subgroup E
avian leukosis virus, code for distinct viral products.
E. KUFF, K. LUEDERS, and E. SCOLNICK, NCI, National Institutes of Health, Bethesda, Maryland: A relationship
between intracisternal type-A particles of Mus musculus and an endogenous retrovirus (M432) of Mus
cervicolor.
Session 8: Transforming Genes I
Chairperson: T. GRAF, Max-Planck-Institut, Tubingen, Germany
R. L. ERIKSON,* J. S. BRUGGE,* A. SIDDIQUI,* M. S. COLLETT,* F. DEINHARDT,t and B. MARCZYNSKA,t *Depart-
ment of Pathology, University of Colorado, Denver; tDepartment of Microbiology, Rush Medical School,
Chicago, Illinois: Antibody to virus-specific proteins in mammals bearing avian sarcoma virus-induced
tumors.
G. JAY, R. P. C. SHIU, F. T. JAY, B. M. PATERSON, A. S. LEVINE, and I. PASTAN, NCI AND NIAMDD, National
Institutes of Health, Bethesda, Maryland: Identification of a transformation-specific protein induced by a
Rous sarcoma virus.
K. BEEMON, T. HUNTER, and B. SEFTON, Tumor Virology Laboratory, Salk Institute, San Diego, California:
Cell-free translation of Rous sarcoma virus src RNA.
A. LEVINSON, H. OPPERMANN, L. LEVINTOW, H. VARMUS, and J. M. BISHOP, Department of Microbiology,
University of California, San Francisco: In vivo and in vitro phosphorylation of avian sarcoma
transformation-specific proteins.
C. C. HALPERN, W. S. HAYWARD, and H. HANAFUSA, Rockefeller University, New York, New York: Recovery
of sarcoma-specific sequences from host cells by transformation-defective mutants.
L.-H. WANG and H. HANAFUSA, Rockefeller University, New York, New York: Comparison of src sequences
of Rous sarcoma virus (RSV) and recovered avian sarcoma viruses (rASVs) (recovered sarcoma viruses
from chicken tumors induced by transformation-defective RSVs).
R. VIGNE,* M. BREITMAN,* C. MOSCOVICI,t and P. K. VOLT,* *Department of Microbiology, University of
Southern California, School of Medicine, Los Angeles; *Virus Research Laboratory, Veterans Administra-
tion Hospital, Gainesville, Florida: Isolation and characterization of culture-derived and animal-derived
transforming avian oncoviruses.
D. H. SPECTOR,* J. M. BISHOP,* H. E. VARMUS,* H. HANAFUSA,t P. K. VOGT,5 and C. Moscovici,§ *Depart..
ment of Microbiology, University of California, San Francisco; *Rockefeller University, New York, New
York; *University of Southern California, Los Angeles; §Veterans Administration Hospital, Gainesville,
Florida: Mapping of endogenous sarc sequences in uninfected avian cells.
U. R. RAPP, J. R. STEPHENSON, and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland:
Generation of new mouse sarcoma viruses in cell culture.
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S. RASHEED and M. B. GARDNER, Department of Pathology, University of Southern California, School of
Medicine, Los Angeles: Isolation of rat sarcoma viruses.
D. TROXLER, D. LINEMEYER, S. RUSCETTI, and E. M. SCOLNICK, NCI, National Institutes of Health, Bethesda,
Maryland: Potential relationship of helper-independent mink cell focus-inducing strains of Friend murine
type-C virus to the origin of spleen focus-forming virus.
J. H. ELDER,* F. C. JENSEN,* J. W. GAUTSCH,* M. POTTER,' J. HARTLEY,' and R. A. LERNER,* *Department of
Cellular and Developmental Immunology, Scripps Clinic and Research Foundation, La Jolla, California;
'NCI, National Institutes of Health; ,NIAID, National Institutes of Health, Bethesda, Maryland: Envelope
gene recombinants in murine tumor systems.
Session 9: Transforming Genes II
Chairperson: W. K. JOKLIK, Duke University, Durham, North Carolina
S. SAULE, M. ROUSSEL, and D. STEHELIN, INSERM Virology Unit, Lille, France and Institut Pasteur de Lille,
France: A cDNA probe specific for avian erythroblastosis virus.
D. SHEINESS and J. M. BISHOP, Department of Microbiology, University of California, San Francisco: Charac-
terization of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29.
T. GRAF, N. ADE, and H. BEUG, Max-Planck-Institut fur Virusforschung, Tubingen, Germany: A mutant of
avian erythroblastosis virus (AEV) temperature sensitive for hemoglobin expression.
P. MELLON and P. DUESBERG, Department of Molecular Biology, University of California, Berkeley: The
genome of MC-29, an avian acute leukemia virus.
S. Hu, M. M.-C. LAI, and P. K. VOGT, Department of Microbiology, University of Southern California, School
of Medicine, Los Angeles: Biochemical and genetic studies on a defective carcinoma-inducing avian
oncovirus-MH2.
0. WITTE,* N. ROSENBERG,' M. PASIND,* A. SHIELDS,* R. de BABA,' and D. BALTIMORE, *Department of
Biology and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge; tDepartment
of Pathology and Cancer Research Center, Tufts University School of Medicine, Boston, Massachusetts;
,The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Identification of an Abelson
murine leukemia virus-encoded protein correlated with maintenance of the transformed state.
A. E. FRANKEL, J. GILBERT, P. J. FISCHINGER, and E. M. SCOLNICK, NCI, National Institutes of Health, Bethesda,
Maryland: The nature and distribution of feline sarcoma virus-specific nucleotide sequences in cat DNA
and RNA.
C. J. SHERR,* A. SEN,* G. J. TODARO,* A. SusKi,t and M. ESSEX,' *NCI, National Institutes of Health, Bethesda,
Maryland; 'Harvard School of Public Health, Boston, Massachusetts: A feline sarcoma virus-specific
protein in rescued pseudo-type particles contains FOCMA, p15, and p12 antigens.
A. SEN, U. R. RAPP, C. J. SHERR, and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland:
Mammalian sarcoma virus-specific phosphoproteins in "rescued" virions.
B. K. PAL, S. RASHEED, and P. ROY-BURMAN, University of Southern California, School of Medicine, Los
Angeles: Phosphorylated polypeptides of mammalian sarcoma viruses.
Session 10: Poster Session
Viral Gene Expression
A. DOLEI,* M. R. CAPOBIANCHI,* L. CIOE,* P. MEO,* F. BELARDELLO E. AFFABRIS," and G. B. Rossi ,t *Istituto di
Virologia, University of Rome; 'Section of Virology, Istituto Superiore di Sanita, Rome, Italy: Biphasic
effect(s) of interferon on FLC erythroid differentiation.
G. VECCHIO,* G. COLLETTA,* M. L. SANDOMENICO,* A. DOLE,' M. CAPOBIANCHI," and G. B. Rossi, *Cattedra di
Virologia Oncologica and Centro di Endocrinologia e Oncologia Sperimentale del CNR, University of
Naples; tIstituto di Virologia, University of Rome; tIstituto Superiore di Sanita, Rome, Italy: Control of the
viral genome expression in Friend cells.
E. C. MURPHY, JR. and R. B. ARLINGHAUS, University of Texas System Cancer Center, M. D. Anderson
Hospital and Tumor Institute, Houston: Separate mRNA species for the Rauscher murine leukemia virus
gag (gag-pol) and env gene products.
J. J. KOPCHICK,* K. F. WATSON,' E. C. MURPHY, JR.,* and R. B. ARLINGHAUS,* *University of Texas System
Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston; tDepartment of Chemistry,
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University of Montana, Missoula: Biosynthesis of reverse transcriptase from Rauscher murine leukemia
virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein.
S. EDWARDS, and H. FAN, Tumor Virology Laboratory, Salk Institute, San Diego, California: Glycosylation of
gag polyprotein in Moloney murine leukemia virus-infected fibroblasts.
L. MONTAGNIER, F. SINOUSSI, R. LIDEREAU, and J. C. CHERMANN, Viral Oncology Unit, Institut Pasteur, Paris,
France: Enhancement of retrovirus production by anti-interferon serum.
J. LEIS* and R. SmrrH,t *Department of Surgery and tDepartment of Microbiology and Immunology, Duke
University Medical Center, Durham, North Carolina: A mechanism for control of processing of oncor-
navirus RNA.
J. S. LEE, N. QUINTRELL, H. E. VARMUS, and J. M. BISHOP, Department of Microbiology, University of
California, San Francisco: Identification of virus-specific messenger RNA in permissive and nonpermis-
sive cells infected with avian sarcoma virus.
M. BONDURANT,* R. RAMABHADRAN, M. GREEN, and W. S. M. WOLD, Institute for Molecular Virology, St.
Louis University School of Medicine, Missouri: Sarc sequence transcription in Moloney sarcoma virus-
transformed nonproducer cell lines.
C. J. M. SARIS, H. C. M. VAN EENBERGEN, and H. P. J. BLOEMERS, Department of Biochemistry, University of
Nijmegen, The Netherlands: Cell-free translation of RNA species included in virions of Moloney murineleukemia virus.
Viral Proteins
S. J. ANDERSON and R. B. NASO, University of Texas Systems Cancer Center, M. D. Anderson Hospital and
Tumor Institute, Houston: Characterization of mouse mammary tumor virus proteins and precursorproteins.
K. MOELLING and K. DITIMAR, Max-Planck-Institut far Molekulare Genetik, Berlin, Germany: Proteolytic
activity in RNA tumor viruses.
T. G. WOOD, D. LYONS, E. C. MURPHY, JR., and R. B. ARLINGHAUS, University of Texas System Cancer Center,
M. D. Anderson Hospital and Tumor Institute, Houston: Characterization of viral proteins synthesized in
murine sarcoma virus (MuSV)-transformed cells and in a mRNA-dependent cell-free protein synthesis
system programed with RNA from MuSV-excess preparations.
R. NUSSE,* F. ASSELBERGS,t M. SALDEN,t and R. MICHALIDES,* *Division of Virology, Antoni van
Leeuwenhoekhuis, Amsterdam; tDepartment of Biochemistry, University of Nijmegen, The Netherlands:
Processing of primary translation products of mouse mammary tumor virus RNA.
P. V. O'DONNELL, E. STOCKERT, Y. OBATA, A. B. DELEO, H. W. SNYDER, JR., and L. J. OLD, Memorial
Sloan-Kettering Cancer Center, New York, New York: Characterization of ecotropic, xenotropic, and
dual-tropic murine leukemia virus (MuLV) isolates by in vitro induction of MuLV gag andenv gene-coded
cell-surface antigens.
A. P. BELL, and V. M. VOGT, Department of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: Avian gag precursor-Processing in vitro and lack of cleavage in mammalian cells in
vivo.
M. OSKARSSON,* G. VANDE WOUDE,* J. ELDER,' J. GAUTSCH,t and R. LERNER,t *NCI, National Institutes of
Health, Bethesda, Maryland; 1-Department of Immunology, Scripps Clinic and Research Foundation, La
Jolla, California: Chemical determination of the ml Moloney sarcoma virus pP60 gag gene order-
Evidence for unique peptides in the C terminus of the polyprotein.
J. PAPAMATHEAKIS and D. MARCIANI, NCI, National Institutes of Health, Bethesda, Maryland: Isolation and
physicochemical characterization of the major avian myeloblastosis virus glycoprotein.
L. ROHRSCHNEIDER, C. LEITCH, and G. Cox, Fred Hutchinson Cancer Research Center, Seattle, Washington:
Analysis of the viral glycoproteins of an amphotropic avian sarcoma virus.
P. H. YUEN and P. K. Y. WONG, Department of Microbiology and School of Basic Medical Sciences,
University of Illinois, Urbana: The ribonucleoprotein component of the Moloney strain of murine
leukemia virus.
A. H. Lu, M. M. SOONG, and P. K. Y. WONG, Department of Mitrobiology, University of Illinois, Urbana:
Maturation of Moloney murine leukemia virus.
R. NOwINSKI, J. LEDBETTER, and R. EISENMAN, Fred Hutchinson Cancer Research Center, Seattle, Washington:
Metabolism and biosynthesis of murine leukemia virus-coded cell-surface antigens.
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S. L. MARCUS, S. W. SMITH, J. RACEVSKIS, and N. H. SARKAR, Memorial Sloan-Kettering Cancer Center, New
York, New York: Purification and characterization of the low-molecular-weight polypeptides of the
murine mammary tumor virus-pp23 and p16 bind to oncornaviral RNA.
Y. YOSHINAKA and R. B. LUFTIG, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts:
Leucine aminopeptidase activity associated with purified murine leukemia viruses.
R. B. LUFTIG,* Y. YOSHINAKA,* and S. OROSZLAN,t *Worcester Foundation for Experimental Biology,
Shrewsbury, Massachusetts; +Frederick Cancer Center, Frederick, Maryland: TUFTSIN can stimulate
murine leukemia virus production.
R. KLEMENZ and H. DIGGELMANN, ISREC-Epalinges, Switzerland: A new intermediate in the processing of
the glycoprotein precursor of Rous sarcoma virus.
M. C. KEMP and R. W. COMPANS, University of Alabama, Birmingham: Glycopeptides of Rauscher murine
leukemia virus.
P. DEZELEE and F. CATALA, Fondation Curie, Institut du Radium, Orsay, France: Differences in the phospho-
proteins of avian sarcoma viruses related to their oncogenic capacity.
G. SCHOCHETMAN, R. GILDEN, D. FINE and R. MASSEY, Frederick Cancer Research Center, Frederick, Mary-
land: Analysis of mouse mammary tumor virus and murine leukemia virus cell-surface antigens on
mammary tumor cells and in vitro infected cells.
Session 11: Poster Session
Transformation
R. R. FRIIS,* and M. J. WEBER,t *Institut fur Virologie, Giessen, Germany; +Department of Microbiology,
University of Illinois, Urbana: Indications for multiple functions encoded in the src genetic element.
Y. C. CHEN,* F. J. JENKINS,* and L. B. ALLEN,t *Department of Biological Sciences and Genetics Center,
North Texas State University, Denton; +Department of Microbiology, Texas College of Osteopathic
Medicine, Fort Worth: Suppression of transformation by ribavirin (1 D ribofuranosy1-1,2,4-triazole-3-
carboxamide) in rat kidney cells infected with temperature-sensitive mutants of Rous sarcoma virus.
J. H. CHEN,* M. G. MOSCOVICI,t and C. Moscovio,+ *Life Sciences Biomedical Research Institute, St.
Petersburg; +Tumor Virology Laboratory, Veterans Administration Hospital, Gainesville, and Department
of Pathology, University of Florida, College of Medicine, Gainesville, Florida: Defectiveness of avian
myeloblastosis virus (AMV)-Analysis of viral gene products in AMV transformed myeloblasts.
C. GURGO,* M. B. BONDURANT,* and S. H. BRIDGES,* *Institute for Molecular Virology, St. Louis University
Medical Center; +Department of Pathology, Washington University School of Medicine, St. Louis,
Missouri: Cytoplasmic particles and expression of leukemia-related RNA sequences in the thymus of AKR
mice.
P. R. ANDERSEN,. D. BOETTIGER,t and P. D. LUNGER,t *NCI, National Institutes of Health, Bethesda, Maryland;
+Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia; *Depart-
ment of Life and Health Sciences, University of Delaware, Newark: Transformation of reptilian cells in
vitro by avian sarcoma viruses.
G. R. ANDERSON, K. R. MAROTTI, and P. WHITAKER-DOWLING, Department of Microbiology, School of
Medicine, University of Pittsburgh, Pennsylvania: Rat src genes induced in uninfected cells.
K. F. MANLY, Roswell Park Memorial Institute, Buffalo, New York: Xenotropic viruses in thymuses of
preleukemic mice.
D. DINA, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York: The "sarcoma-
specific" region of Moloney murine sarcoma virus 124.
M. YOSHIDA,* Y. HIRAYAmA,* A. NOMOTO,i and Y. IKAWA,* *Department of Viral Oncology, Cancer
Institute; +Department of Public Health, School of Pharmaceutical Sciences, Kitasato University, Tokyo,
Japan: Partial sarc-gene sequence in transformation-defective mutants of Rous sarcoma virus and their
transforming capacity.
T. PAWSON,* P. DuEsBERG,+ and G. S. MARTIN,* *Department of Zoology and +Virus Laboratory, University
of California, Berkeley: Cell-free translation of virion RNA from Rous sarcoma virus and MC29.
T. HUNTER, K. BEEMON, and J. PAPKOFF, Tumor Virology Laboratory, Salk Institute, San Diego, California:
Cell-free translation of Moloney murine sarcoma virus clone 124 RNA.
J. KAMINE and J. M. BUCHANAN, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Processing of the 60,000-dalton sarc gene protein synthesized in vitro.
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G. CALOTHY, F. POIRIER, and B. PESSAC, Fondation Curie, Institut du Radium, Orsay, France: Phenotypic
properties of transformation-defective mutants of Rous sarcoma virus and of avian erythroblastosis virus
inducing chick embryo neuroretinal cell proliferation.
C. MoscovIci, L. GAZZOLO, and M. G. Moscovici, Tumor Virus Laboratory, Veterans Administration
Hospital, and Department of Pathology, University of Florida Medical School, Gainesville: Oncogenic
and transforming expressions of avian acute leukemia viruses.
T. W. MAK, M. E. MACDONALD, and A. BERNSTEIN, Ontario Cancer Institute and Department of Medical
Biophysics, University of Toronto, Canada: Cellular and molecular mechanisms in Friend virus car-
cinogenesis.
H. W. SNYDER, JR., E. E. ZUCKERMAN, W. D. HARDY, JR., K. J. PHILLIPS, M. Fox, and E. FLEISSNER, Memorial
Sloan-Kettering Cancer Center, New York, New York: Characterization of molecular species carrying
feline leukemia virus-induced cell-surface antigens and FOCMA.
A. H. SLISKI and M. ESSEX, Department of Microbiology, Harvard University School of Public Health, Boston,
Massachusetts: Cross-species induction of the feline oncornavirus-associated cell membrane antigen by
feline sarcoma virus.
L. J. VAN GRIENSVEN, Tumor Virology Laboratory, Salk Institute, San Diego, California: Properties of the RNA
of a "mink cell focus-inducing" (MCF) virus derived from spontaneous thymomas of BALB/c mice
carrying Moloney murine leukemia virus as an endogenous virus.
S. GISSELBRECHT, P. DEBRE, C. BLAINEAU, M. A. HUROT, 0. MULLER, and J. P. LEVY, Laboratoire d'Immunologie
et Virologie des Tumeurs, INSERM, Hopital Cochin, Paris, France: Genetic control of sensitivity to
Moloney virus-induced leukemias in mice.
L. P. TUREK and P. K. Vour, Department of Microbiology, University of Southern California, School of
Medicine, Los Angeles: Randomly derived avian sarcoma virus-infected normal rat kidney cell clones:
Parameters of transformation and virus recovery.
K. D. SOMERS, Eastern Virginia Medical School, Norfolk: A novel morphological revertant of mouse sarcoma
virus-transformed rat cells.
J. S. RHIM,* C. CHANG,t and R. J. HUEBNER,' *Microbiological Associates, Inc.; ,NCI, National Institutes of
Health, Bethesda, Maryland: Solubilization and characterization of cross-reacting rat tumor antigens.
N. KOBAYASHI and A. KAJI, Department of Microbiology, School of Medicine, University of Pennsylvania,
Philadelphia: Differentiation and cellular transformation-expression of src gene in terminally differ-
entiated myotubes.
P. DEZELEE, F. CATALO, and J. M. BIQUARD, Fondation Curie, Institut du Radium, Orsay, France: Differences in
total proteins of normal and avian oncornavirus-infected chick embryo fibroblasts analyzed by high-
resolution polyacrylamide gel electrophoresis and computerized quantification of protein bands.
E. M. DURBAN and D. BOETTIGER, Department of Microbiology, School of Medicine, University of Pennsyl-
vania, Philadelphia: Effect of transformation by avian myeloblastosis virus on the progressive differentia-
tion of avian yolk-sac cells in vitro.
A. SCHINCARIOL and J. RIP, Cancer Research Laboratory, University of Western Ontario, London, Canada:
Sequence complexity of polysomal RNA in murine sarcoma virus-transformed mouse cells.
A. SCHINCARIOL, P. MAHER and J. RIP, Cancer Research Laboratory, University of Western Ontario, London,
Canada: Alteration in chromatin of cells infected with RNA tumor viruses.
M. S. MCGRATH and I. WEISSMAN, Department of Pathology, Stanford University Medical Center, California:
Identification and characterization of murine leukemia virus receptors on thymic lymphoma cells.
W. D. HARDY, JR. and E. E. ZUCKERMAN, Memorial Sloan-Kettering Cancer Center, New York, New York:
Immune response of healthy cats to feline leukemia virus exposure.
P. RICCIARDI-CASTAGNOLI,* M. LIEBERMAN,t 0. FINN,' and H. S. KAPLAN,' *Istituto di Farmacologia, University
Statale di Milano, Italy; tDepartment of Radiology, Stanford University Medical Center, California:
Lymphoma induction by radiation leukemia virus in athymic nude mice.
K. ULRICH* and B. A. NExo,t *The Fibiger Laboratory, Copenhagen, Denmark; tDepartment of Pharmacol-
ogy and Experimental Therapeutics, Johns Hopkins University School of Medicine, Baltimore, Maryland:
C-type virus activated during chemical leukemogenesis in mice.
S. K. RUSCETTI, D. L. LINEMEYER, D. H. TRoxLER, and E. M. SCOLNICK, NCI, National Institutes of Health,
Bethesda, Maryland: Type-specific immunoassays for the gp7Os of MCF murine leukemia viruses and the
expression of cross-reacting antigens in spleen focus-forming virus-infected rat cells as well as certain
normal mouse cell lines.
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Session 12: Transformation
Chairperson: N. ROSENBERG, Tufts University, Boston, Massachusetts
H. BEUG and T. GRAF, Max-Planck-Institut fur Virusforschung, Tubingen, Germany: Role of the cell nucleus
in the expression of Rous sarcoma virus-induced cell transformation.
K. RADKE and G. S. MARTIN, Department of Zoology, University of California, Berkeley: Polypeptides of cells
infected by Rous sarcoma virus.
D. BOETTIGER, M. PACIFIC! and H. HOLTZER, Departments of Microbiology and Anatomy, University of
Pennsylvania, Philadelphia: The transition of mesenchymal cells to mature chondroblasts is irreversibly
blocked by infection with Rous sarcoma virus.
L. GAzzoLo,*+ C. Moscovici,+ and M. G. Moscovici,+ *Unite de Virologie, INSERM, Lyon, France;
+Veterans Administration Hospital and Department of Pathology, University of Florida School of Medi-
cine, Gainesville: Expression of functional markers by leukemic cells.
F. RUSCETTI, S. COLLINS, R. GALLAGHER, and R. GALLO, NCI, National Institutes of Health, Bethesda, Maryland:
Inhibition of human myeloid differentiation in vitro by primate type-C retroviruses.
I. WEISSMAN and M. S. MCGRATH, Department of Pathology, Stanford University Medical Center, California:
The receptor-mediated model of leukemogenesis-Thymic maturation and AKR leukemogenesis.
R. RISSER,* D. J. GRUNWALD,* E. STOCKERT,t P. JELEN,* C. SINAIKO,* and L. J. OLD,t *McArdle Laboratory for
Cancer Research, University of Wisconsin, Madison; +Memorial Sloan-Kettering Cancer Center, New
York, New York: The Abelson antigen-A viral tumor antigen that is related to a differentiation alloanti-
gen.
A. DECLEVE,* M. LIEBERMAN,* J. N. IHLE,t and H. S. KAPLAN,* *Department of Radiology, Stanford University
Medical Center, California; +NCI, Frederick Cancer Research Center, Frederick, Maryland: Characteriza-
tion of the thymotropic and leukemogenic viruses isolated from the C57BL/Ka strain of mice.
A. J. MAYER, M. L. DuRAN-REYNALs, F. LILLY, and F. DURAN-STRUUCK, Department of Genetics, Albert Einstein
College of Medicine, Bronx, New York: Association between suppression of endogenous ecotropic and
xenotropic murine leukemia virus expression and suppression of spontaneous leukemia in crosses
between AKR/J and RF/J mice.
J. E. DE LARGO and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland: Growth factors
(SGFs) produced by murine sarcoma virus-transformed cells.
SV40, POLYOMA, AND ADENOVIRUSES, July 26-July 30
arranged by
Terri Grodzicker, Cold Spring Harbor Laboratory
Michael Botchan, Cold Spring Harbor Laboratory
295 participants
Session 1: SV40 and Polyoma-Genetics and Genome Structure
Chairperson: D. NATHANS, Johns Hopkins University, School of Medicine, Baltimore, Maryland
D. SHORTLE, S. LAZAROWITZ, and D. NATHANS, Johns Hopkins University School of Medicine, Baltimore,
Maryland: SV40 mutants with base substitutions around the origin of viral DNA replication.
J. R. ARRAND, B. E. GRIFFIN, N. SMOLAR, and E. SOEDA, Imperial Cancer Research Fund Laboratories, London,
England: The primary sequences of the late region of polyoma virus DNA.
G. G. CARMICHAEL, J. HATIORI, and T. L. BENJAMIN, Department of Pathology, Harvard Medical School,
Boston Massachusetts: Structural organization of the DNAs of nontransforming host-range mutants of
polyoma virus.
M. M. BENDIG and W. R. FOLK, Department of Biological Chemistry, University of Michigan, Ann Arbor:
Polyoma mutants with alterations at the HindIII, Hindll, and Haell cleavage sites.
J. E. MERTZ and S.-D. Yu, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison: A
new complementation group of SV40.
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D. HAMER and P. LEDER, NICHD, National Institutes of Health, Bethesda, Maryland: SV40 recombinants
carrying rabbit globin-gene sequences.
W. SCHAFFNER, W. TOPP, and M. BOTCHAN, Cold Spring Harbor Laboratory, New York: SV40-sea urchin
histone DNA recombinant integrated into mammalian chromosomes can be recovered in its original
form.
Y. GLUZMAN, Cold Spring Harbor Laboratory, New York: A new Ad5-SV40 hybrid which contains the entire
SV40 genome.
R. C. A. YANG and R. Wu, Department of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: BK virus DNA-Physical maps and coding sequences for T-antigens.
Session 2: SV40 and Polyoma-Early Proteins
Chairperson: T. L. BENJAMIN, Harvard Medical School, Boston, Massachusetts
T. HUNTER, M. A. HUTCHINSON, and W. ECKHART, Tumor Virology Laboratory, Salk Institute, San Diego,
California: Characterization of three polyoma T antigens.
B. SCHAFFHAUSEN, J. SILVER, and T. L. BENJAMIN, Department of Pathology, Harvard Medical School, Boston,
Massachusetts: T antigens of wild type arid nontransforming mutants of polyoma virus.
Y. ITO and J. E. SMART, Imperial Cancer Research Fund Laboratories, London, England: Three forms of
polyoma virus early proteins share common tryptic peptides probably near the N termini of the proteins.
E. PAUCHA, R. HARVEY, and A. E. SMITH, Imperial Cancer Research Fund Laboratories, London, England:
Cell-free synthesis of SV40 T antigens.
E. MAY, M. KRESS, and P. MAY, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France:
Characterization of the two SV40 early mRNAs coding for small-t and large-T antigens--Evidence that
nuclear RNA from infected mouse cells is translated very efficiently into small-t antigen.
D. T. SIMMONS,* G. JAY,t P. T. MORA,t and M. A. MARTIN,* *NIAID and +NCI, National Institutes of Health,
Bethesda, Maryland: Characterization of new species of tumor antigens from SV40- and polyoma-
transformed cells.
K. RUNDELL, Department of Microbiology-Immunology, Northwestern University, Chicago, Illinois: Addi-
tional early proteins induced by SV40.
J. A. MELERO, R. CARROLL, D. STIT,* and W. MANGEL,* Department of Pathology, New York University
Medical Center, New York; *Department of Biochemistry, University of Illinois, Urbana: Multiple
48-55K antigenic species immuno-precipitable by antiserum raised to purified large-T antigen of SV40.
A. GRAESSMANN, M. GRAESSMANN, and C. MUELLER, Institut fur Molekularebiologie and Biochemie der Freien
Universitat Berlin, Germany: The biological activity of different early SV40 DNA fragments.
Session 3: Poster Session SV40 and Polyoma
C. BLACKBURN and J. D. HARE, Department of Microbiology, University of Rochester School of Medicine and
Dentistry, New York: Quantification of DNA synthesis and template activity in 5E3049 polyoma virus.
J. N. BRADY, V. D. WINSTON, and R. A. CONSIGLI, Kansas State University, Manhattan: Characterization of a
DNA-protein complex and capsomere subunits derived from polyoma virus by treatment with
ethyleneglycol-bis-N,N'-tetraacetic acid (EGTA) and dithiothreitol (DTT).
H. CHAN, M. ISRAEL, W. ROWE,* and M. MARTIN, Laboratory of Biology of Viruses and *NIAID, National
Institutes of Health, Bethesda, Maryland: Construction of bacteriophage lambda-containing polyoma
virus DNA.
C. CHANG,* D. T. SimmoNs,f W. TOPP,t M. A. MARTIN,* and P. T. MORA,* *NCI and ,NIAID, National
Institutes of Health, Bethesda, Maryland; ,Cold Spring Harbor Laboratory, New York: Identification of a
new species of SV40-specific antigens.
L. V. CRAWFORD,* D. C. Pim,* P. Z. OTARRELL,t C. N. COLE,, H. VAN HEUVERSVVYN,§ and W. FiERs,§
*Department of Molecular Virology, Imperial Cancer Research Fund Laboratories, London, England;
,Department of Biochemistry and Biophysics, University of California, San Francisco; ,Department of
Human Genetics, Yale University School of Medicine, New Haven, Connecticut; §Laboratory of Molecu-
lar Biology, University of Ghent, Belgium: The effect of alkylation on SV40 T antigens and related
polypeptides.
T. CREFELD and W. KELLER, Department of Microbiology, University of Heidelberg, Germany: Transcription of
SV40 in vivo and in vitro.
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W. DEPPERT, Max-Planck-Institut fur Biophysikalische Chemie, Gottingen, Germany: Distribution of SV40 T
and U antigens in different nuclear subfractions of SV40-transformed cells.
J. FAVALORO, B. KAMEN, J. PARKER, and R. TREISMAN, Imperial Cancer Research Fund Laboratories, London,
England: Topography of polyoma virus transcripts.
R. FEIGHNY and M. CENTER, Division of Biology, Kansas State University, Manhattan: Polyoma DNA synthesis
in isolated nucleoprotein complexes.
B. FOHRING, P. GRUSS, and G. SAUER, Institut fur Virusforschung, Deutsches Krebsforschungszentrum,
Heidelberg, Germany: SV40 virions contain linear F0111 DNA molecules whose ends map close to the
origin of DNA replication.
J. P. FORD and M. T. Hsu, Molecular Cell Biology Department, Rockefeller University, New York, New York:
Late SV40 mRNA biogenesis.
T. FRIEDMANN,* A. ESTY,* P. LAPORTE,* R. DOOLITTLE,' and G. WALTER,' Departments of *Pediatrics and
+Chemistry, University of California, San Diego; *Salk Institute, San Diego, California: Nucleotide
sequence studies of polyoma tumor antigens.
E. GARBER, M. SEIDMAN, and A. J. LEVINE, Department of Biochemical Sciences, Princeton University, New
Jersey: SV40 nucleoprotein complexes-Efficient virion formation in vivo and the lability of virions in
vitro.
S. GATTONI, D. ZOUZIAS, and C. BASILICO, Department of Pathology, New York University School of
Medicine, New York: Control of the state of the viral DNA in rat cells transformed by polyoma virus.
P. K. GHOSH,* V. B. REDDY,t J. SWINSCOE,t P. LEBOWITZ* and S. M. WEISSMAN,' Departments of *Internal
Medicine and +Human Genetics, Yale University, New Haven, Connecticut: Heterogeneity and 5'-
terminal structure of late mRNAs of SV40.
B. E. GRIFFIN, C. MADDOCK, N. SPURR, and Y. ITO, Imperial Cancer Research Fund Laboratories, London,
England: Viable deletion mutants of polyoma virus.
J. D. GRIFFIN and D. M. LIVINGSTON, Sidney Farber Cancer Institute and Harvard Medical School, Boston,
Massachusetts: Intermediate size and very low molecular weight of SV40 T antigens.
J. B. HISCOTT and V. DEFEND!, Department of Pathology, New York University Medical Center, New York:
Characteristics of human fibroblasts transformed by subgenomic fragments of SV40 DNA.
M. HOROWITZ, S. BRATOSIN, and Y. ALONI, Department of Genetics, Weizmann Institute of Science, Rehovot,
Israel: Electron microscope evidence for splicing of polyoma late mRNAs.
M.-T. Hsu, M. COCA-PRADOS, and R. FERNANDEZ-MUNOZ, Rockefeller University, New York, New York:
Characterization of intracellular SV40 nucleoprotein complexes.
E. KINNEY-THOMAS and J. D. HARE, Department of Microbiology, University of Rochester School of Medicine
and Dentistry, New York: Restriction analysis of a polyoma variant which produces an excess of
virion-associated proteins.
M. KRESS, E. MAY, and P. MAY, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France: Study of
anti-T immunoprecipitable proteins present in addition to large-T and small-t antigens in SV40-
transformed cell lines.
R. E. LANFORD and J. S. Buta, Department of Virology, Baylor College of Medicine, Houston, Texas:
Characteristics of a cytoplasmic form of SV40 tumor antigen.
S. LAVI and Z. GROSSMAN, Department of Virology, Weizmann Institute of Science, Rehovot, Israel: The
effect of chemical carcinogens on the expression of SV40 genes.
M. F. LAW, K. K. TAKEMOTO, and P. M. HOWLEY, NCI, National Institutes of Health, Bethesda, Maryland:
Characterization of the genome of K virus, a murine papovavirus.
J. MARTIN, R. FRISQUE, B. PADGETT, and D. WALKER, Department of Medical Microbiology, University of
Wisconsin Medical School, Madison: A physical map of the DNA of JC virus.
M. P. MOYER and R. C. MOYER, Trinity University, San Antonio, Texas: SV40 rescue from "nonrescuable"
cell lines.
N. NEWELL and T. J. KELLY, JR., Department of Microbiology, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Base-sequence homologies among the genomes of the primate papovaviruses.
M. PATER, A. PATER, and G. DI MAYORCA, Department of Microbiology, University of Illinois Medical Center,
Chicago: Isolation and characterization of BK virus DNA from a human cell line from transitional cell
carcinoma of the urethra.
B. J. POMERANTZ and J. D. HARE, Department of Microbiology, University of Rochester School of Medicine
and Dentistry, New York: A variant of polyoma virus that overproduces processed viral RNA.
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P. RIGBY,* J. COOK,* M. LOVETT,* P. GALLIMORE,t C. COLE,' and P. BERG,' *Department of Biochemistry,
Imperial College of Science and Technology, London, England; *Department of Cancer Studies, Univer-
sity of Birmingham Medical School, England: *Department of Biochemistry, Stanford University Medical
Center, California: Viral DNA integration patterns and the biological properties of SV40-transformed
mouse cells.
A. ROMAN, Department of Microbiology and Immunology, Indiana University School of Medicine, In-
dianapolis: The growth of papovaviruses in primary isolates from different organs.
A. SEN, C. M. PUCHALSKI, and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland: The
replication of SV40 and the expression of gene A in human cells-Interactions between viral and cellular
growth regulatory functions.
C.-K. J. SHEN and J. E. HEARST, Department of Chemistry, University of California, Berkeley: Specific loop
formation of denatured SV40 DNA-A possible mechanism for the splicing of early and late SV40
transcripts.
A. E. SMITH, A. MELLOR, R. SMITH, E. PAUCHA, R. M. HEWICK, and M. D. WATERFIELD, Imperial Cancer
Research Fund Laboratories, London, England: Sequence and fingerprint analysis of SV40 T antigens.
E. SOEDA, J. ARRAND, N. SMOLAR, and B. E. GRIFFIN, Imperial Cancer Research Fund Laboratories, London,
England: The early region of polyoma virus DNA.
K. N. SUBRAMANIAN, Department of Microbiology, University of Illinois Medical Center, Chicago: Isolation
and characterization of deletion mutants of SV40 mapping within the leader sequence of the major late
viral mRNA.
C. T. WAKE and J. H. WILSON, Department of Biochemistry, Baylor College of Medicine, Houston, Texas:
Development of SV40 as a genetic system for investigating mammalian recombination mechanisms.
F. 0. WETTSTEIN and J. G. STEVENS, Department of Microbiology and Immunology, University of California
School of Medicine, Los Angeles: Virus-specific DNA and RNA in Shope-papilloma virus-induced
tumors.
J. H. WILSON, Department of Biochemistry, Baylor College of Medicine, Houston, Texas: Interference in
SV40 DNA infections-A possible basis for cellular competence.
D. ZOUZIAS,* K. K. JHA,t C. MULDER,t C. BASILICO,* and H. L. OZER," *New York University School of
Medicine, New York; *Hunter College, New York, New York; *University of Massachusetts Medical
School, Worcester: Extrachromosomal SV40 DNA in transformed human fibroblasts.
Session 4: SV40 and PolyomaTransformed Cells
Chairperson: P. TEGTMEYER, State University of New York, Medical School, Stony Brook
G. JAY, F. T. JAY, C. CHANG, R. M. FRIEDMAN, and A. S. LEVINE, NCI and NIAMDD, National Institutes of
Health, Bethesda, Maryland: Use of the Ad2+ND1 hybrid virus to identify the protein responsible for
SV40 tumor rejection and its genetic origin.
D. P. LANE and L. V. CRAWFORD, Department of Molecular Virology, Imperial Cancer Research Fund
Laboratories, London, England: SV40 virus-coded proteins are displayed on the surface of SV40 trans-
formed cells.
A. M. LEWIS, JR, and J. L. COOK, NIAID, National Institutes of Health, Bethesda, Maryland: The association of
tumor induction by Ad2-SV40 recombinants with a specific segment of SV40 DNA.
D. G. ATTARDI, L. LANIA, M. GRIFFITHS, B. COOKE, and M. FRIED, Imperial Cancer Research Fund Laboratories,
London, England: Polyoma virus sequences in transformed and untransformed rat cells.
M. M. FLUCK and T. L. BENJAMIN, Department of Pathology, Harvard Medical School, Boston, Massachusetts:
Properties of cells transformed by ts-a/A mutants of polyoma virus and SV40.
M. RASSOULZADEGAN, P. GAUDRAY, B. PERBAL, N. CHENCINER, E. MOUGNEAU, and F. CUZIN, Centre de
Biochimie, University de Nice, France: Transformation of rat fibroblast cells by polyoma and SV40
viruses-Characterization of two classes of virus-induced transformants.
R. SEIF, M. PERSICO-DILAURO, V. P. SETLOW, C. A. F. EDWARDS, and R. G. MARTIN, NIAMDD, National
Institutes of Health, Bethesda, Maryland: Polyoma and SV40 early functions involved in transformation.
C. C. ROBINSON and J. M. LEHMAN, Department of Pathology, University of Colorado Medical Center,
Denver: DNA content changes in SV40 tsAtransformed Chinese hamster cells at the permissive and
nonpermissive temperature.
W. TOPP,* M. SLEIGH,' D. RIFKIN,B C. CHANG,§ and S. SHIN,** *Cold Spring Harbor Laboratory, New York;
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+Molecular Biology Unit, CSIRO, Epping, Australia; +New York University Medical School, New York;
§NCI, National Institutes of Health, Bethesda, Maryland; **Department of Genetics, Albert Einstein
College of Medicine, Bronx, New York: SV40 viral mutants defective in small t are unable to induce any
of the phenotypes associated with maximally transformed cells.
Session 5: Adenoviruses-Transformed Cells and Early Transcription
Chairperson: H. GINSBERG, Columbia University, College of Physicians and Surgeons, New York, New York
N. JONES, W. COLBY, and T. SHENK, Department of Microbiology, University of Connecticut Health Center,
Farmington: Isolation of Ad5 deletion mutants defective for transformation of rat embryo cells.
K. DORSCH-HASLER, P. B. FISHER, and H. S. GINSBERG, Department of Microbiology and Institute of Cancer
Research, Columbia University College of Physicians and Surgeons, New York: Integration patterns of
viral DNA in cells transformed by WT5 adenovirus and H5ts125.
J. GRONEBERG, D. SUTTER, H. IBELGAUFTS, H. SOBOLL,* and W. DOERFLER, Institute of Genetics, University of
Cologne; *Paul Ehrlich Institute, Frankfurt, Germany: Patterns of integration of Ad12 DNA in transformed
hamster cells, in revertants, and in rat brain tumor cells.
K. FUJINAGA, Y. SAWADA, Y. UEMIZU, S. OJIMA, K. SHIROKI,* and H. SHIMOJO,* Department of Molecular
Biology, Cancer Research Institute, Sapporo Medical College; "Institute of Medical Science, University of
Tokyo, Japan: Analysis of the viral genome present in cells transformed by the Ad12 DNA fragment.
H. JOCHEMSEN, J. H. LUPKER, A. DAVIES, and A. J. VAN DER EB, Sylvius Laboratories, University of Leiden, The
Netherlands: Location of the transforming region and identification of the early gene products of Ad12 in
vitro and in vivo.
A. J. BERK and P. A. SHARP, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge:
Sizing and mapping of pulse-labeled early Ad2 nuclear and cytoplasmic RNAs.
L. T. CHOW, T. R. BROKER, and J. B. LEWIS, Cold Spring Harbor Laboratory, New York: Temporal differentia-
tion in the splicing pattern of mRNA for Ad2 single-strand DNA-binding protein and characterization of
new spliced early RNAs.
T. H. CARTER and R. A. BLANTON, Pennsylvania State University College of Medicine, Hershey: Regulation of
Ad5 early transcription by the 72,000 dalton DNA-binding protein.
D. SPECTOR, D. HALBERT, M. MCGROGAN, and H. J. RASKAS, Department of Pathology, Washington
School of Medicine, St. Louis, Missouri: Gene products specified by early region 1 of the Ad2 genome.
Session 6: Poster SessionAdenoviruses
A. R. BHATTI and J. WEBER, Department de Microbiologie, Centre Hospitalier Universitaire, Sherbrooke,
Quebec, Canada: Core protein PVII-specific endoprotease of Ad2.
S. BLANCHARD, E. DAVID, and W. WINTERS, University of Texas Health Science Center, San Antonio: DNA
replication and capsid antigen synthesis in human cells infected with Ad5 and Ad31.
B. DRAGON and H. S. GINSBERG, Department of Microbiology, Columbia University College of Physicians
and Surgeons, New York, New York: Studies on the "100K" protein from Ad-5 infected cells.
H. ESCHE, R. SCHILLING, and W. DOERFLER, Institute of Genetics, University of Cologne, Germany: In vitro
translation of Ad12-specific mRNA prepared from infected and transformed cells.
M. FEDOR, G. KIT, T. MULLENBACH, and E. DANIELL, Department of Molecular Biology, University of
California, Berkeley: Adenovirus chromatin composition and production in infected cell nuclei.
C. J. GOLDENBERG and H. J. RASKAS, Department of Pathology, Washington University School of Medicine, St.
Louis, Missouri: Evidence for cleavage and ligation of a nuclear precursor during formation of mRNA
from early region 2 of the Ad2 genome.
S. HASHIMOTO and M. GREEN, Institute for Molecular Virology, St. Louis University School of Medicine,
Missouri: Evidence for at least six 5'-terminal structures for Ad2 early mRNA molecules.
B. A. KILPATRICK and R. E. GELINAS, Cold Spring Harbor Laboratory, New York: Comparison of leader
sequences and message locations among adenovirus serotypes.
J. MAAT, H. VAN ORMONDT, and P. I. SCHRIER, Sylvius Laboratories, University of Leiden, The Netherlands:
Nucleotide sequence studies in the transforming region of Ad5 DNA.
R. RICCIARDI,* B. ROBERTS,* B. PATERSON,, and M. MATHEWS,' *Department of Biology, Brandeis University,
Waltham, Massachusetts; iNCI, National Institutes of Health, Bethesda, Maryland; +Cold Spring Harbor
Laboratory, New York: The organization of the Ad2 genome.
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P. I. SCHRIER and A. J. VAN DER EB, Sylvius Laboratories, University of Leiden, The Netherlands: Characteriza-
tion of T antigens from cells transformed by fragments of Ad5 DNA.
P. B. SEHGAL, N. W. FRASER, M. C. WILSON, and J. E. DARNELL, Rockefeller University, New York, New York:
Mapping of early Ad2 promoters in HeLa cells using 5, 6- dichloro- f3- D- ribofuranosylbenzimidole (DRB)
and UV irradiation.
K. SHIROKI,* H. SHIMOJO,* Y. SAWADA,t and K. HUJINAGA,t *Institute of Medical Science, University of Tokyo,
Shirokanedai Minato-ku; tCancer Research Institute, Sapporo Medical College, Japan: The transforming
gene of Ad12 DNA.
S. E. STRAUS, A. SERGEANT, M. A. TIGGES, and H. J. RASKAS, Department of Pathology, Washington University
School of Medicine, St. Louis, Missouri: The infecting parental Ad2 genome is recovered from early or
late nuclei as "circular" DNA-protein complexes.
J. WEBER, D. PLAAT, and R. BHATTI, Department de Microbiologie, Centre Hospitalier Universitaire, Sher-
brooke, Quebec, Canada: The processing of adenovirus core protein 50K to core protein V is linked to
but not dependent on DNA packaging.
C. S. H. YOUNG, Department of Microbiology Columbia University, College of Physicians and Surgeons,
New York, New York: The biological characteristics of adenovirus recombination.
Session 7: Adenoyiruses-Late Transcription
Chairperson: J. FLINT, Princeton University, Princeton, New Jersey
A. R. DUNN, M. B. MATHEWS, L. T. CHOW, J. SAMBROOK, and W. KELLER,* Cold Spring Harbor Laboratory,
New York; *Universif at Heidelberg, Germany: Leader sequences associated with a hybrid mRNA which
includes the start of the Ad2 fiber gene-Preliminary characterization of a clone (E. coli strain 776)
containing a DNA copy of Ad2 fiber mRNA.
L. T. CHOW, J. B. LEWIS, T. GRODZICKER, J. SAMBROOK, and T. R. BROKER, Cold Spring Harbor Laboratory, New
York: Mapping of additional Ad2 late mRNAs and characterization of RNA processing intermediates for
the late Ad2 and Ad2-SV40 hybrid viruses.
K. K. KALGHATGI, B. A. ROLLER, and L. D. HODGE, Department of Human Genetics, Yale University School of
Medicine, New Haven, Connecticut: Studies on adenovirus anti-mRNA.
E. ZIFF and R. EVANS, Rockefeller University, New York, New York: The capped 5' terminus of Ad2 late
nuclear transcripts.
J. R. NEVINS and J. E. DARNELL, JR., Rockefeller University, New York, New York: Processing of late
adenovirus nuclear RNA.
S. BACHENHEIMER, Department of Bacteriology and Immunology, University of North Carolina, Chapel Hill:
Heterogeneity at the 5' end of adenovirus 35S nuclear RNA.
R. M. EVANS and J. E. DARNELL, Rockefeller University, New York, New York: A new class of adenovirus
small nuclear RNA.
J. WEBER and J. M. BLANCHARD, Rockefeller University, New York, New York: In vitro processing of early
adenovirus RNA in isolated nuclei.
J. L. MANLEY, P. A. SHARP, and M. L. GEFTER, Department of Biology, Massachusetts Institute of Technology,
Cambridge: Synthesis and processing of adenovirus RNA in isolated nuclei.
Session 8: SV40 and Polyoma-Replication
Chairperson: M. A. MARTIN, NIAID, National Institutes of Health, Bethesda, Maryland
P. CLERTANT and F. CUZIN, Centre de Biochimie, University de Nice, France: Induction of in vitro synthesis of
polyoma virus DNA by partially purified T antigen.
C. PRIVES, H. SHURE, Y. BECK, D. GIDONI, and M. OREN, Department of Virology, Weizmann Institute of
Science, Rehovot, Israel: DNA binding and sedimentation properties of the proteins specified by the early
region of SV40.
D. M. LIVINGSTON, M. P. KRIEGLER, J. D. GRIFFIN, and J. HUDSON, Sidney Farber Cancer Institute and Harvard
Medical School, Boston, Massachusetts: Complementation of the tsA mutant defect in viral DNA
replication following microinjection of highly purified SV40 T antigen.
E. FANNING, K.-H. KLEMPNAUER, B. OTTO, and I. BAUMGARTNER, Fachbereich Biologie, University of Konstanz,
Germany: Structure of replicating and nonreplicating SV40 chromatin.
T. M. HERMAN, M. L. DEPAMPHILIS, and P. M. WASSARMAN, Department of Biological Chemistry, Harvard
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Medical School, Boston, Massachusetts: The structure of chromatin at the replication fork of SV40
chromosomes.
W. A. SCOTT and D. J. WIGMORE, Department of Biochemistry, University of Miami School of Medicine,
Florida: Distribution of endonuclease-sensitive sites in SV40 chromatin.
B. I. MILAVETZ, J. A. BURKE, M. J. EVANS, J. PLUMMER, M. J. EDDY, M. A. WAGAR, Y. TSUBOTA, and J. A.
HUBERMAN, Roswell Park Memorial Institute, Buffalo, New York: Proteins associated with SV40 chromo-
somes.
K. MANN and T. HUNTER,* Biology Department, University of Alaska, Anchorage; *Tumor Virology Labora-
tory, Salk Institute, San Diego, California: Association of SV40 T antigen with SV40 nucleoprotein
complexes.
N. YAMAGUCHI and M. KUBOTA, Institute of Medical Science, University of Tokyo, Japan: Association of
SV40 T antigen with chromatin in SV40-transformed cells.
Session 9: SV40 and Polyoma-Transcription
Chairperson: B. GRIFFIN, Imperial Cancer Research Fund Laboratories, London, England
A. COWIE, A. FLAVELL, B. KAMEN, and S. LEGON, Imperial Cancer Research Fund Laboratories, London,
England: Heterogeneity at the 5' ends of polyoma virus late mRNAs.
Y. ALONI, S. BRATOSIN, M. HOROWITZ, and 0. LAUB, Department of Genetics, Weizmann Institute of Science,
Rehovot, Israel: Splicing of SV40 late mRNAs.
M. BINA-STEIN, M. THOREN, N. SALZMAN, and T. THOMPSON, NIAID, National Institutes of Health, Bethesda,
Maryland: A new method for studying spliced regions in mRNA.
V. B. REDDY,* P. K. GHOSH,t P. LEBOWITZ,t and S. M. WEISSMAN,* Departments of *Human Genetics and
±Internal Medicine, Yale University School of Medicine, New Haven, Connecticut: Primary structure of
SV40 early mRNA.
G. HAEGEMAN, H. VAN HEUVERSWYN, A. VAN DE VOORDE, and W. FIERS, Laboratory of Molecular Biology, State
University of Ghent, Belgium: Characterization of late SV40 mRNA.
H. MANOR, M. WU, and N. DAVIDSON, Department of Chemistry, California Institute of Technology,
Pasadena: Electron microscopic analysis of the polyoma virus "late" RNA species.
N. H. ACHESON, Department of Virology, Swiss Institute for Experimental Cancer Research, Epalinges:
Polyoma giant nuclear RNAs contain tandem repeats of the nucleotide sequence of the entire viral
genome.
S. SEGAL and G. KHOURY, NCI, National Institutes of Health, Bethesda, Maryland: Expression of early and
late SV40 genes in nonpermissive cells.
B. THIMMAPPAYA, M. FITZGERALD, and T. SHENK, Department of Microbiology, University of Connecticut
Health Center, Farmington: Novel viral transcripts are synthesized in cells infected with a viable variant
of SV40.
Session 10: Adenoviruses-Proteins
Chairperson: R. ROBERTS, Cold Spring Harbor Laboratory
0. BRISON, C. KEDINGER, and P. CHAMBON, Laboratoire de Genetique Moleculaire des Eucaryotes du CNRS et
Faculte de Medecine, Unite 44 de I'INSERM, Strasbourg, France: Ad2 replication and transcription
complexes.
T. YAMASHITA, M. ARENS, M. GREEN, K. BRACKMANN, and M. CARTAS, Institute for Molecular Virology, St. Louis
University School of Medicine, Missouri: Ad2 DNA synthesized in vitro and in vivo in the absence of late
protein synthesis contains a protein attached to both termini.
R. PADMANABHAN, M. SHINAGAWA, C. F. GARON, and J. A. ROSE, Department of Biological Chemistry,
University of Maryland School of Medicine, Baltimore, and NIAID, National Institutes of Health,
Bethesda, Maryland: Interaction of other virion proteins with a specific protein of 55,000 daltons at the
termini of Ad2 DNA.
S. Ross, S. J. FLINT, and A. J. LEVINE, Department of Biochemical Sciences, Princeton University, New Jersey:
Adenovirus early proteins detected in infected and transformed cells.
T. G. STORCH and J. V. MAIZEL, JR., NICHD, National Institutes of Health, Bethesda, Maryland: The effects of
glycosylation inhibitors on the synthesis of early Ad2 proteins.
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D. M. FOWLKES, S. T. LORD, T. LINNE, U. PETTERSSON, and L. PHILIPSON, Department of Microbiology, Uppsala
University Biomedical Center, Sweden: Interaction between the adenovirus DNA-binding protein and
double-stranded DNA.
D. KLESSIG and J. HASSELL, Cold Spring Harbor Laboratory, New York: Characterization of mutants of human
adenovirus which multiply efficiently in simian cells.
J. ARRAND, National Institute for Medical Research, London, England: Analysis of adenovirus gene function
using DNA infection techniques.
C. TIBBETTS, Department of Microbiology, University of Connecticut School of Medicine, Health Center,
Farmington: Prospects for in vitro packaging of adenovirus DNA.
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Session 1: Immunity-Repressor-Operator Interactions
A. JOHNSON, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Interactions of the
Acro protein and A repressor with operator DNA.
R. T. SAUER, C. 0. PASO, M. J. Ross, and B. J. MEYER, The Biological Laboratories, Harvard University, Cambridge,
Massachusetts: Lambda repressor-Domain structure and function.
N. L. CRAIG, E. M. PHIZICKY, C. W. ROBERTS, and J. W. ROBERTS, Department of Biochemistry, Cornell University,
Ithaca, New York: Inactivation and cleavage of A and P22 phage repressors by E. coli recA gene product.
A. R. POTEETE, Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Mas-
sachusetts: Structure of the immC operators
F. WINSTON and D. BOTSTEIN, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Phenotypic distinctions among phage P22 cly mutants.
B. MEYER, Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Massachusetts:
Lambda repressor regulation during lysogeny.
R. PASTRANA, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Direct stimulation of
repressor synthesis in Aimm434 lysogens by repressor.
E. RoSEN, K. Z. McCunouGH, and G. GUSSIN, Zoology Department, University of Iowa, Iowa City: Effects of
mutations on binding of RNA polymerase to DNA containing the Aprm promoter.
D. WULFF, M. BEHER, S. lzuml, M. LEWIS, J. BECK, M. MAHONEY, M. ROSENBERG,* and H. SHIMATAKE,* Department
of Molecular Biology and Biochemistry, University of California, Irvine; *NCI, National Institutes of Health,
Bethesda, Maryland: Genetic and sequence studies of Acy mutants.
B. KNOLL, Department of Microbiology, Arizona Health Sciences Center, University of Arizona, Tucson: Single
infection lysogenization by phage A with dominant mutations of the c III gene.
C. EPP, M. L. PEARSON, M. 0. JONES,* and I. HERSKOWITZ,* Department of Medical Genetics, University of
Toronto, Ontario, Canada; *Institute of Molecular Biology and Department of Biology, University of Oregon,
Eugene: Control of the stability of the Ac II protein by the products of the phage gene clIl and the host gene hfl.
R. FISCHER, M. JONES,* I. HERsKowrrz,* and H. ECHOLS, Department of Molecular Biology, University of
California, Berkeley; *Department of Biology and Institute of Molecular Biology, University of Oregon,
Eugene: Location of the promoter for establishment of repression by bacteriophage X.
Session 2: Regulation of Gene Expression I
H. J. VOLLENWEIDER, M. FIANDT, and W. SZYBALSKI, McArdle Laboratory, University of Wisconsin, Madison: E.
coli RNA-polymerase-binding sites lie preferentially within A+T-rich DNA regions.
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U. HANSEN and W. MCCLURE, Department of Biochemistry and Molecular Biology, Harvard University, Cam-
bridge, Massachusetts: A noncycling activity assay for the sigma subunit of E. coli RNA polymerase.
J. D. HARRIS, I. MARTINEZ, J. HEILIG, L. CSONKA, R. CALENDAR, and L. ISAKSSON,* Molecular Biology Department,
University of California, Berkeley; *Molecular Biology Department, University of Uppsala, Sweden: Genet-
ics of the sigma subunit of DNA-dependent RNA polymerase from E. coli.
C. G. GOFF, Biology Department, Haverford College, Pennsylvania: Mutants affecting a 15,000 m.w. T4 protein
tightly bound to E. coli RNA polymerase.
D. H. HALL and R. D. SNYDER, School of Biology, Georgia Institute of Technology, Atlanta: Sip mutations affect
the "modifier of transcription" (mot) gene of bacteriophage T4.
B. SAUER, D. Ow, and R. CALENDAR, Molecular Biology Department, University of California, Berkeley:
Suppression of transcriptional polarity is nonessential for growth of phage P4.
R. ZIVIN, W. ZEHRING, C. MALONE, L. HAYNES, and L. B. ROTHMAN-DENES, Department of Biophysics and
Theoretical Biology, University of Chicago, Illinois: In vivo and in vitro specificity of N4 transcription by
N4-virion-associated RNA polymerase.
G. LEE, A. KORMAN, N. HANNETT, and J. PERO, The Biological Laboratories, Harvard University, Cambridge,
Massachusetts: Cloned fragments of SPO1 DNA fail to support transcription by phage-modified RNA
polymerase.
G. SELZER,* A. BOLLE, D. BELIN, G. VAN HOWE, and T. MATTSON, *National Institutes of Health, Bethesda,
Maryland; Department of Molecular Biology, University of Geneva, Switzerland: Expression of a plasmid-
carried T4 rlIA gene.
S. STROME and E. T. YOUNG, Biochemistry Department, University of Washington, Seattle: Translational control
of the expression of bacteriophage T7 gene 0.3.
M. F. SHEMYAKIN, E. L. KAPITZA, L. I. PATRUSHEV, E. A. STUKACHEVA, and S. K. ZAVRIEV, M. M. Shemyakin Institute of
Bioorganic Chemistry, USSR Academy of Sciences, Moscow: The influence of E. coli rho factor and RNase III
on the expression of 0174 and T7 genomes in vitro.
Session 3: Regulation of Gene Expression II
A. DAS, C. MERRIL, and S. ADHYA, NCI, National Institutes of Health, Bethesda, Maryland: Interaction between
rho and RNA polymerase during transcription termination.
A. DAS, D. COURT, S. ADHYA, and M. GOTIESMAN, NCI, National Institutes of Health, Bethesda, Maryland:
Transcription antitermination by bacteriophage X N-gene product.
S.-L. Hu, J. S. SALSTROM,* and W. SZYBALSKI, McArdle Laboratory, University of Wisconsin, Madison; *The
Biological Laboratories, Harvard University, Cambridge, Massachusetts: Stimulation of Tof function and
PL-tu and PR-t51 transcription by the N product of coliphage X.
N. C. FRANKLIN, M. L. PEAR50N,* and G. N. BENNETT, Department of Biological Sciences, Stanford University,
California; *Department of Medical Genetics, University of Toronto, Ontario, Canada: The N gene of X
codes only the 5' half of the 12S transcript.
E. FLAMM, M. MOZOLA, and D. FRIEDMAN, Department of Microbiology, University of Michigan, Ann Arbor:
Mutations affecting rightward transcription in bacteriophage X.
C. GAWRON and J. R. CHRISTENSEN, Microbiology Department, University of Rochester, New York: Lambda-N-
mediated exclusion of Tl-The escape of Tlam23.
S. HILLIKER, NCI, National Institutes of Health, Bethesda, Maryland: Comparison ofSalmonella phages P22 and L
by means of X-P22 and X-L hybrid phages.
D. FORBES and I. HERSKOWITZ, Institute of Molecular Biology, University of Oregon, Eugene: The Q protein of
bacteriophage X-An antiterminator.
M. G. SCHECHTMAN, J. D. SNEDEKER, and J. W. ROBERTS, Department of Biochemistry, Molecular and Cell Biology,
Cornell University, Ithaca, New York: Activity of late gene regulators of X and 6;582.
K. R. LEASON, E. N. JACKSON, and T. F. WEIGHOUS, Department of Microbiology, University of Michigan, Ann
Arbor: Products of P22 genes 12 and 18 are required for late gene transcription.
Session 4: Bacteriophage Mu
M. M. HOWE, K. J. O'DAY, and D. W. SCHULTZ, Department of Bacteriology, University of Wisconsin, Madison:
Identification of five new cistrons essential for development of bacteriophage Mu.
C. J. THOMPSON and M. M. HOWE, Department of Bacteriology, University of Wisconsin, Madison: Tn5- induced
mutations in bacteriophage Mu.
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J. ENGLER, Cold Spring Harbor Laboratory, New York: Mapping of Mu-specific RNA transcripts by electron
microscopy.
M. S. Du Bow and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York: Characterization of Mu proteins.
C. CHASE and R. BENZINGER, Department of Biology, University of Virginia, Charlottesville: Transfection of rec+
E. coil spheroplasts with bacteriophage Mu DNA.
R. KAHMANN and D. KAMP, Cold Spring Harbor Laboratory, New York: Structural analysis of the ends of
bacteriophage Mu DNA.
H. KHATOON and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York: Excision of Mu DNA.
R. A. Frrrs and A. L. TAYLOR, Department of Microbiology and Immunology, University of Colorado Medical
Center, Denver: Replication of bacteriophage Mu in dnaA- cells.
M. L. PATO, N. TYLER, and B. T. WAGGONER, National Jewish Hospital and Research Center and University of
Colorado Medical Center, Denver: Cellular location of Mu DNA replicas.
L. AMBROSIO, A. I. BUKHARI, and E. LJUNGQUIST,* Cold Spring Harbor Laboratory, New York; *Karolinska
Institutet, Stockholm, Sweden: Behavior of bacteriophage Mu DNA upon infection of E. coli.
F. DE BRUIJN, R. KAHMANN, D. KAMP, H. KHATOON, and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York:
Manipulation of Mu ends.
J. W. SCHUMM and M. M. HOWE, Department of Bacteriology, University of Wisconsin, Madison: Construction
of A phages containing both ends of Mu.
N. SCHAUS, K. O'DAY, and A. WRIGHT, Department of Molecular Biology and Microbiology, Tufts University
School of Medicine, Boston, Massachusetts: Properties of bacteriophage Mu carrying an EcoRl-generated
internal deletion.
D. KAMP and R. KAHMANN, Cold Spring Harbor Laboratory, New York: Properties of defective phage particles
obtained from a Mu gin-G(-) lysogen.
Session 5: Recombination
H. ECHOES, Department of Molecular Biology, University of California, Berkeley: Some in vivo properties of
integrative and general recombination inferred from interference (int) exchanges.
M. KOTEWICZ, E. GRZESIUK, W. COURCHESNE, H. ECHOLS, R. W. DAVIES,* and P. H. SCHREIER,5 Department of
Molecular Biology, University of California, Berkeley; *Department of Biology, University of Essex, England;
+Medical Research Council, Cambridge, England: Properties of the int protein of phage X.
T. POLLOCK and H. NASH, NIMH, National Institutes of Health, Bethesda, Maryland: Lambda int-dependent
site-specific recombination in vitro.
H. I. MILLER and D. I. FRIEDMAN, University of Michigan, Ann Arbor: Bacteriophage A int gene mutants that
bypass the need for the bacterial attachment site and integration host proteins.
K. ABREMSKI and S. GOTTESMAN, NCI, National Institutes of Health, Bethesda, Maryland: Excisive recombination
of bacteriophage lambda.
G. GUARNEROS and J. M. GALINDO, Department of Genetics and Molecular Biology, Centro de Investigacion del
IPN, Mexico City: Regulation of integrative recombination by the cll product and the b2 region of bac-
teriophage A.
R. FISCHER, Y. TAKEDA, and H. ECHOLS, Department of Molecular Biology, University of California, Berkeley: A
new in vitro RNA-polymerase-binding site and transcription start generated by int-c point mutations.
L. HEFFERNAN, M. BENEDIK, and A. CAMPBELL, Department of Biological Sciences, Stanford University, California:
Regulation in the int-xis region of bacteriophage lambda.
D. Ross,* J. SWAN, and N. KLECKNER, *Department of Biology, Massachusetts Institute of Technology, Cam-
bridge; Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Mas-
sachusetts: "Nearly precise" excision of transposon Tn10 from bacteriophage X.
D. G. Ross,* J. SWAN, and N. KLECKNER, *Department of Biology, Massachusetts Institute of Technology,
Cambridge; Department of Molecular Biology, Harvard University, Cambridge, Massachusetts: Tn10-
associated DNA rearrangements in a X::Tn10 transducing phage.
R. ZAGURSKY, C. WYMAN, and J. HAYS, Department of Chemistry, University of Maryland Baltimore County,
Catonsville: Recombination of A tandem duplication and triplication phages.
B. KORBA* and J. HAYS,' Departments of *Biological Sciences and +Chemistry, University of Maryland Baltimore
County, Catonsville: The DNA of recombinogenic A phages grown on E. coli an mutants contains sites
susceptible to Si endonuclease.
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J. HAYS, R. GOUGH, and S. BOEHMER, Department of Chemistry, University of Maryland Baltimore County,
Catonsville: Repair-stimulated recombination of bacteriophage X.
N. HUTCHINSON and S. J. LEE, Department of Microbiology, University of Pennsylvania, Philadelphia: Frequen-
cies of recombinants between primary and secondary phage in delayed superinfection.
Session 6: Small DNA Phages; Replication
I. TESSMAN and B. B. STEFFEN, Department of Biological Sciences, Purdue University, West Lafayette, Indiana:
Overlapping genes and multiple gene products of phages 0174, S13, and G4.
E. BECK, E. A. AUERSWALD, R. SOMMER, and H. SCHALLER, Department of Microbiology, Universitat Heidel-
berg, Germany: Genome organization and DNA sequence of filamentous bacteriophages.
A. RAZIN, K. ITAKURA, T. HIROSE, and A. D. RIGGS, Division of Biology, City of Hope National Medical Center,
Duarte, California: Synthetic-DNA-directed change of a specific base in bacteriophage OX174 DNA.
J. Sims and D. DRESSLER, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: The
negative-strand initiation site used by phages G4, St-1, OK, and a3.
E. BENZ, R. VICUNA, and J. HuRwrtz, Albert Einstein College of Medicine, Bronx, New York: DnaC-protein-
mediated priming of bacteriophage DNA replication in vitro.
M. LUSKY, R. GROSSCHEDL, and G. HOBOM, Institut fur Biologie III, Freiburg, Germany: A dual system for
initiation of X replication.
G. MOSIG and S. BOCK, Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee: Is
gene 41 of phage T4 analogous to the dnaG gene (primase) of E. coli?
A. LUDER and G. MOSIG, Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee:
Specific interactions of mutations in gene 32 and DNA delay genes of phage T4D.
R. C. MILLER, JR.,* E. T. YOUNG IV R. H. EPSTEIN,t H. M. KRISCH,t T. MATTSON,t and A. BOLLE,t *Depart-
ment of Microbiology, University of British Columbia, Vancouver, Canada; *Department of Molecular
Biology, University of Geneva, Switzerland; *Department of Biochemistry, University of Washington,
Seattle: Regulation of the synthesis of the T4 DNA polymerase (gene 43).
L. L. SILVER and N. G. NOSSAL, Laboratory of Biochemical Pharmacology, NIAMDD, National Institutes of
Health, Bethesda, Maryland: The bacteriophage T4 DNA-delay gene 61 (58) product is required for a
DNA chain initiating activity found in T4-infected cell extracts.
L. S. RIPLEY, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina: In
vivo errors of replication in T4 DNA containing 2-aminopurine.
A. C. RICE, T. A. FICHT, and R. W. MOYER, Department of Microbiology, Vanderbilt University, Nashville,
Tennessee: Purification and properties of a bacteriophage-T5-encoded DNA-binding protein that exhibits
multifunctional properties.
H. R. WARNER, R. B. THOMPSON, and W. J. SWART, Department of Biochemistry, University of Minnesota, St.
Paul: Isolation and properties of T5 mutants unable to induce dUTPase and thymidylate synthetase
activities.
Session 7: Bacteriophage P1 -Phage-Host Interaction
N. STERNBERG, T. Som, and S. AUSTIN, Cancer Biology Program, Frederick Cancer Research Center, Frederick,
Maryland: Determinants for copy number, segregation fidelity, and incompatibility of the P1 plasmid
prophage.
N. STERNBERG, Cancer Biology Program, Frederick Cancer Research Center, Frederick, Maryland: Site-
specific recombination in bacteriophage Pl.
J. B. RAZZA, C. A. WATKINS, and J. R. Sam, Department of Microbiology, Emory University, Atlanta,
Georgia: Temperature-sensitive mutants of Pl.
J. A. GOWAN,* J. R. SCOTT,* A. TOUSSAINT,+ and N. LEFEBVRE,' *Department of Microbiology, Emory
University, Atlanta, Georgia; tLaboratoires de Genetique et Microbiologie, University Libre de Bruxelles,
Rhode-Saint-Genese, Belgium: Relationships of phages P1 and Mu.
C. A. WATKINS, B. R. BAUMSTARK, and J. R. Scurf-, Department of Microbiology, Emory University, Atlanta,
Georgia: Characterization of bacteriophage D6.
S. GOTESMAN, NCI, National Institutes of Health, Bethesda, Maryland: Rap-An E. coli mutation affecting X
growth.
J. WAY, R. YOUNG, S. WAY, J. YIN, and M. SYVANEN, Department of Microbiology and Molecular Genetics,
Harvard Medical School, Boston, Massachusetts: A new gene in X affecting cell lysis.
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E. J. GRAYHACK, M. G. SCHECHTMAN, and J. W. ROBERTS, Department of Biochemistry, Molecular and Cell
Biology, Cornell University, Ithaca, New York: Lambda genes P and Q under lactose operon control.
M. MCEWEN, K. NAT, and P. SILVERMAN, Department of Molecular Biology, Albert Einstein College of
Medicine, Bronx, New York: Chromosomal mutants of E. coli defective in bacteriophage Q/3 replication.
M. E. DRESSER, R. C. GREENE, and J. R. JOHNSON,* Duke University Medical Center, Durham, North Carolina;
*Department of Biology, Texas A & M University, College Station: Isolation and characterization of
specialized A transducing phages carrying the cytR gene of E. coli K12.
L. D. SIMON, K. TOMCZAK, and A. C. ST. JOHN,* Waksman Institute of Microbiology and *Department of
Microbiology, Rutgers University, Piscataway, New Jersey: Inhibition of the degradation of abnormal
proteins in E. coli by bacteriophages.
K. DHARMALINGAM and E. B. GOLDBERG, Department of Molecular Biology and Microbiology, Tufts Univer-
sity School of Medicine, Boston, Massachusetts: "SOS" prevents restriction of nonglucosylated phage T4
in E. coli.
Session 8: Morphogenesis
D. W. BOWDEN and R. CALENDAR, Molecular Biology Department, University of California, Berkeley: In vitro
P2 DNA maturation-A complex, site-specific system for cleavage.
C. DIANA, J. GEISSELSODER, and R. GOLDSTEIN, Department of Microbiology and Molecular Genetics, Harvard
Medical School, Boston, Massachusetts: Propagation and characterization of the diploid and triploid
plaque-forming units of the capsid size determination mutant of satellite bacteriophage P4.
J. GEISSELSODER, M. CHIDAMBARAM, and R. GOLDSTEIN, Department of Microbiology and Molecular Genetics,
Harvard Medical School, Boston, Massachusetts: Transcriptional control of capsid size in the P2-P4
bacteriophage system.
C. DIANA, G. DEHO, J. GEISSELSODER, and R. GOLDSTEIN, Department of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachusetts: Viral interference at the level of capsid size
determination by satellite phage P4.
D. Ow, M. KAHN,* B. SAUER, and R. CALENDAR, Molecular Biology Department, University of California,
Berkeley; *Biology Department, University of California, San Diego: Marker-rescue study of bac-
teriophage P4 using ColE1-P4 hybrids.
R. A. FISHER, M. FEISS, D. A. SIEGELE, D. A. NICHOLS, and J. DONELSON, Departments of Microbiology and
Biochemistry, University of Iowa, Iowa City: Packaging of the bacteriophage A chromosome-A role for
sequences outside of cos.
R. A FISHER, K. KRIZANOVITCH-WILLIAMS, C. RUDOLPH, D. A. SIEGELE, J. YOCHEM, and M. FEISS, Department of
Microbiology, University of Iowa, Iowa City: Studies of bacteriophage A. assembly.
P. YOUDERIAN, Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston,
Massachusetts: Genetic control of the length of lambdoid phage tails.
R. J. DEANS and E. N. JACKSON, Department of Microbiology, University of Michigan, Ann Arbor: Hindi!l
cleavage-site map of Salmonella typhimurium bacteriophage P22.
E. JACKSON and F. LASKI, Department of Microbiology, University of Michigan, Ann Arbor: Specific cleavage
of P22 DNA concatemers in absence of DNA packaging.
S.-H. KAO and W. H. MCCLAIN, Department of Bacteriology, University of Wisconsin, Madison: Involvement
of bacteriophage T4 gene-5 protein in cell lysis.
J. D. CHILDS, Biology and Health Physics Division, Atomic Energy of Canada Ltd., Chalk River, Ontario,
Canada: Electrophoretic mutants of bacteriophage T4.
N. L. INCARDONA, Microbiology Department, University of Tennessee Health Science Center, Memphis:
Comparison of complex models for virus adsorption and eclipse by computer simulation of kinetic data.
This meeting was supported in part by a grant from the National Institutes of Health.
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Session la: Primary Structure of tRNA
Chairperson: U.L. RAJBHANDARY, Massachusetts Institute of Technology, Cambridge
R.P. MARTIN,* J.M. SCHNELLER,t A.P. SIBLER,* A. STAHL,t and G. DIRHEIMER,* *Laboratoire de Biochimie,
Institut de Biologie Moleculaire et Cellulaire du CNRS, and tLaboratoire de Biochimie, Faculte de
Pharmacie, Strasbourg, France: Yeast mitochondrial tRNAs-lsoacceptors, coding origin, and primarystructure of tRNA"°.
S. NOGUCHI,* Z. YAMAIZUMI,* Y. NISHIMURA,t Y. HIROTA,t T. OHGI,5 T. GOTO,' and S. NISHIMURA,* *Biology
Division, National Cancer Center Research Institute, Tokyo; +National Institute of Genetics, Mishima;
,Department of Agricultural Chemistry, Nagoya University, Japan: Isolation and properties of E. coli
mutants that lack modified nucleoside Q in tRNA.
N. OKADA,* N. SHINDO-OKADA,* S. SAT0,1- Y.H. 1-roFi,, K. ODA,§ and S. NISHIMURA,* *Biology and
+Biochemistry Divisions, National Cancer Center Research Institute, Tokyo; sDepartment of Molecular
Biology, Keio University School of Medicine, Tokyo; §Institute of Medical Science, Tokyo University,
Japan: Detection of unique tRNA species in tumor tissues by E. coli guanine insertion enzyme.
Z. YAMAIZUMI," Y. KUCHINO,* F. HARADA,* S. NISHIMURA,* and J.A. MCCLOSKEY,t *Biology Division, National
Cancer Center Research Institute, Tokyo, Japan; +College of Pharmacy, University of Utah, Salt Lake City:
Primary structure of E. coli tRNAkeu -The presence of an unknown adenosine derivative in the anticodon
that recognizes UU series of codon.
R.C. GUPTA, B.A. ROE,* and K. RANI:KRA-il, Department of Pharmacology, Baylor College of Medicine,
Houston, Texas; *Department of Chemistry, Kent State University, Ohio: Sequences of glycine tRNAsfrom human placenta.
H.P. GHOSH,* K. GHOSH,* M. SIMSEK,t and U.L. RAJBHANDARY,t
*Department of Biochemistry, McMaster
University, Hamilton, Ontario, Canada; +Department of Biology, Massachusetts Institute of Technology,
Cambridge: Primary sequence of wheat germ initiator tRNAret
Session 1b: Recognition of tRNA
Chairperson: P. SCHIMMEL, Massachusetts Institute of Technology, Cambridge
L.H. SCHULMAN, H. PELKA, and R.M. SUNDARI, Department of Developmental Biology and Cancer, Albert
Einstein College of Medicine, Bronx, New York: Recognition of E. coli methioninetRNAs.
J.P. EBEL, M. RENAUD, A. DIETRICH, M. BALTZINGER, R. EHRLICH, F. FASIOLO, 0. FAVOROVA, S. VASSILENKO, R.
GIEGE, and P. REMY, Laboratoire de Biochimie, Institut de Biologie Moleculaire et Cellulaire du CNRS,
Strasbourg, France: Interaction between tRNA and aminoacyl-tRNA synthetase in the valine and
phenylalanine systems from yeast.
S.M. HECHT, B.L. ALFORD, Y. KURODA, and S. KITANO, Department of Chemistry, Massachusetts Institute of
Technology, Cambridge: "Chemical aminoacylation" of tRNAs.
Session 2: Poster Session
M. BALTZINGER, F. FASIOLO, P. REMY, and Y. BOULANGER, Institut de Biologie Moleculaire et Cellulaire du
CNRS, Strasbourg, France: Localization of the sites in the tetrameric yeast phenylalanyl-tRNA synthetase.
C.J. BRUTON and L.A.-M. Cox, Department of Biochemistry, Imperial College, London, England: Cysteinyl-
tRNA synthetase from B. stearothermophilus is both structurally and functionally monomeric.
P. CHANG, P.A. SAFILLE, J. OMNAAS, and K.H. MUENCH, University of Miami School of Medicine, Florida:
Location of the required cysteine residue in tryptophanyl-tRNA synthetase from a superproducing strain
of E. coli.
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A. FAVRE* and E. HOLLER,t *Institut de Recherches en Biologie Moleculaire, Paris, France; tlnstitut fur
Biophysik und Physikalische Biochemie, Regensburg, Germany: Formation of the phenylalanyl-tRNA
synthetase tRNAPhe complex induces a conformational change of the tRNA.
C. GUNTNER and E. HOLLER, Institut fur Biophysik und Physikalische Biochemie, Universif at Regensburg,
Germany: The mechanism of phenylalanyl-tRNA synthetase of E. coil K10-The binding sites for free and
aminoacylated tRNA are not identical.
J. HUGHES and G. MELLOWS, Department of Biochemistry, Imperial College, London: Inhibition of isoleucyl-
tRNA synthetase by the novel antibiotic pseudomonic acid A.
D. KERN,* L. DUPLAIN,* S. POTIER,t Y. BOULANGER,t and J. LAPoiNTE,* *Departement de Biochimie, University
Laval, Quebec, Canada; tInstitut de Biologie Moleculaire et Cellulaire du CNRS, Strasbourg, France: The
monomeric glutamyl-tRNA synthetases from E. coil and B. subtilis-Relations between their structural
and catalytic properties, and their evolution.
D. KERN, R. GIEGE, and J.P. EBEL, Institut de Biologie Moleculaire et Cellulaire du CNRS, Strasbourg, France:
Interaction of tRNAs with yeast valyl-tRNA synthetase and valylation mechanism in correct and incorrect
systems.
G. KRAUSS,* F. VON DER HAAR,t and G. MAASS,* *Medizinische Hochschule Hannover, Germany; tMax-
Planck-Institut fur Medizinische Chemie, Gottingen, Germany: Role of the CCA end of the tRNA in the
recognition mechanism between tRNAP". (yeast) and phenylalanyl-tRNA synthetase (yeast).
M. KROGER, H. STERNBACH, and F. CRAMER, Max-Planck-Institut fur Experimentelle Medizin, Gottingen,
Germany: Reversible inactivation of tRNA nucleotidyltransferase from baker's yeast by tRNA"e contain-
ing iodoacetamide alkylated 2-thiocytidine in common and unusual positions.
M.-R. KULA and H. TSAI, Gesellschaft fur Biotechnologische Forschung mbH., Braunschweig-Sf ockheim,
Germany: Structural studies on isoleucyl-tRNA synthetase.
V. NIKODEM, R.C. JOHNSON, and J.R. FRESCO, Department of Biochemical Sciences, Princeton University,
New Jersey: Purification, molecular weight, and asymmetry of leucyl-tRNA synthetase from baker's yeast.
L. NILSSON, U. PACHMANN,* and R. RIGLER, Department of Medical Biophysics, Karolinska Institutet, Stock-
holm, Sweden; *Institut fur Physiologische Chemie, Universif at Munchen, Germany: Conformational
dynamics of yeast tRNA"e in the presence of Mg-H- spermine and phenylalanyl-tRNA synthetase.
C. PLANTARD, B. LABOUESSE, P.V. GRAVES, and G. MERAULT, Departement de Biochimie, University de
Bordeaux, France: Anticooperative binding of tryptophan and tRNATrP by tryptophanyl-tRNA synthetase
from beef pancreas.
S. RoBBE-SAuL, S. POTIER, F. FASIOLO, D. KERN, R. GIEGE, J. GANGLOFF, J. LAPOINTE,t and Y. BOULANGER, Institut
de Biologie Moleculaire et Cellulaire du CNRS, Strasbourg, France; tFaculte des Sciences et de Genie,
University Laval, Quebec, Canada: Structural studies on aminoacyl-tRNA synthetases-A tentative corre-
lation between the subunit size and the occurrence of repeated sequences.
R.P. SINGHAL and P.A. FALLIS, Chemistry Department, Wichita State University, Kansas: Study of tRNA
structures for a primordial sequence-Modified base locations and synthetase recognition sites.
R. THIEBE, Institut fur Physiologische Chemie, Physikalische Biochemie und Zellbiologie, Universif at Mun-
chen, Germany: Comparison of the aminoacylation mechanisms of tRNAPhe and tRNAArg in the steady
state.
G. ZAccAl,* P. MORIN,* B. JACROT,* D. MORAS,t J.C. THIERRY,t R. GIEGE,t P. DESSEN,t and S. BLANQUET,t
*Institut Max Von Laue-Paul Langevin, Grenoble; fUniversite Louis Pasteur and Institut de Biochemie
Moleculaire et Cellulaire du CNRS, Strasbourg; ,Ecole Polytechnique, Palaiseau, France: tRNA interac-
tions with aminoacyl-tRNA synthetases studied by neutron scattering.
Session 3: Structure and Function of Aminoacyl-tRNA Synthetases
Chairperson: B.S. HARTLEY, Imperial College, London, England
J.R. RUBIN,* and D.M. BLow,+ *MRC Laboratory of Molecular Biology, Cambridge; tBlackett Laboratory,
Imperial College, London, England: Tyrosyl-tRNA synthetase from B. stearothermophilus - Tertiary struc-
ture and ligand-binding studies.
G.P. WINTER,* G.L.E. KocH,* A. DELL,t and B.S. HARTLEY,t *MRC Laboratory of Molecular Biology, Cam-
bridge; +Department of Biochemistry, Imperial College, London, England: The tryptophanyl- and tyrosyl-
tRNA synthetases from B. stearothermophilus.
A. FERSHT,* J. GANGLOFF,t and G. DIRHEIMER,t *Institut de Biologie Moleculaire et Cellulaire du CNRS,
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Strasbourg, France; +MRC Laboratory of Molecular Biology, Cambridge, England: Reaction pathway and
rate-determining step in the aminoacylation of tRNAArg catalyzed by the arginyl-tRNA synthetase from
yeast.
L. KISSELEV, G. KOVALEVA, and 0. FAVOROVA, Institute of Molecular Biology, Moscow, USSR: Isolation,
properties, and possible role of tryptophanyl-enzyme in the reaction of enzymatic aminoacylation of
tRNATre.
G.L. IGLoi, F. VON DER HAAR, and F. CRAMER, Abteilung Chemie, Max-Planck-Institut fur Experimentelle
Medizin, Gottingen, Germany: Experimental proof for the misactivation of tyrosine by phenylalanyl-tRNA
synthetase from yeast.
H.G. FAULHAMMER, M. SPRINZL, and F. CRAMER, Abteilung Chemie, Max-Planck-Institut fur Experimentelle
Medizin, Gottingen, Germany: Interaction of tyrosyl-tRNA synthetase with fluorescamine-labeled tRNA"'
from yeast and participation of fluorescamine-modified E. coli tRNA"e in in vitro protein biosynthesis.
Session 4A: Crystal Structure of tRNA
Chairperson: S.-H. KIM, Duke University School of Medicine, Durham, North Carolina
N.H. Woo,* B.A. ROET and A. RICH,* *Department of Biology, Massachusetts Institute of Technology,
Cambridge; +Department of Chemistry, Kent State University, Ohio: Three-dimensional structure of the E.
coli initiator tRNA.
G.J. QUIGLEY, M.M. TEETER, and A. RICH, Department of Biology, Massachusetts Institute of Technology,
Cambridge: Role of spermine, magnesium, and water in yeast tRNA"..
A. DUCRUIX and A. RICH, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Conformation of peptidyl-tRNAP".
R.W. SCHEVITZ, A.D. PODJARNY, N. KRISHNAMACHARI, J. HUGHES, and P.B. SIGLER, Department of Biophysics
and Theoretical Biology, University of Chicago, Illinois: A crystallographic analysis of yeast initiator
tRNA.
R. Borr, C.D. STOUT,* and M. SUNDARALINGAM, Department of Biochemistry, University of Wisconsin
College of Agricultural and Life Sciences, Madison; *Department of Crystallography, University of
Pittsburgh, Pennsylvania: The structure of E. coli tRNAArg at 4A resolution.
H.T. WRIGHT, P.C. MANOR, K. BEURLING, R. KARPEL, and J.R. FRESCO, Department of Biochemical Sciences,
Princeton University, New jersey: Crystal structure of yeast tRNAG'll-Molecular packing and comparison
of the polynucleotide backbone conformation with that of yeast tRNAP".
Session 48: Physical Studies on tRNA in Solution
Chairperson: D. CROTHERS, Yale University, New Haven, Connecticut
B.R. REID and R.E. HURD, Biochemistry Department, University of California, Riverside: High-resolution
nuclear magnetic resonance (NMR) studies on tRNA structure.
P.D. JOHNSTON and A.G. REDFIELD, Department of Biochemistry, Brandeis University, Waltham, Mas-
sachusetts: Pulsed FT-NMR double resonance studies of tRNA in H2O.
R. PO-FES, D. FRITZINGER, N.C. FORD, and M.J. FOURNIER, University of Massachusetts, Amherst: Effect of
aminoacylation and magesium on the solution structure of yeast phenylalanine tRNA.
Session 5: Poster Session
J. CANADAY, P. GUILLEMAUT, and J.H. WEIL, Institut de Biologie Moleculaire et Cellulaire du CNRS, Stras-
bourg, France: Purification and nucleoside composition of chloroplastic and cytoplasmic initiator tRNAs
from Phaseolus vulgaris-Preliminary sequence results.
K. CHAKRABURTTY, Department of Biochemistry, Medical College of Wisconsin, Milwaukee: Effect of tem-
perature and divalent cation on chemical modification of E. coli tRNA,1'r9.
S.H. CHANG,* F.K. LIN,* L.I. HECKER,T J.E. HECKMAN,' U.L. RAJBHANDARY,t and W.E. BARNETT,T *Department
of Biochemistry, Louisiana State University, Baton Rouge; Department of Biology, Massachusetts !Insti-
tute of Technology, Cambridge; +Oak Ridge National Laboratory, Tennessee: Nucleotide sequence of
blue-green algae phenylalanine tRNA.
B. DUDOCK, J. LESIEWICZ, M.-Y. WANG, and R. GREENBERG, State University of New York, Stony Brook: A new
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class of tRNA modification reactions in E. coil and mammalian mitochondria-tRNA methyl esters.
M. EHRENBERG, W. WINTERMEYER,* P. GRASSELLI, and R. RIGLER, Department of Medical Biophysics, Karolinska
Institutet, Stockholm, Sweden; *Institut Mr Physiologische Chemie, Universitat MOnchen, Germany: On
the structure and conformational dynamics of tRNAyeasPthe in solution.
R. EHRLICH, D. FRECHET, M. RENAUD, P. REMY, J.P. EBEL, C. REISS,* and J. GABAR,* Institut de Biologie
Moleculaire et Cellulaire du CNRS, Strasbourg; *Institut du Radium, Orsay, France: High-resolution
optical study of the thermal unfolding of RNAs-Evidence for fine transitions in tRNAs.
A. FAVRE and G. THOMAS, Institut de Recherches en Biologie Moleculaire, Paris, France: The role of
4-thiouridine in E. coli tRNAs.
R. GARBER* and S. ALTMAN' Roche Institute of Molecular Biology, Nutley, New Jersey; Department of
Biology, Yale University, New Haven, Connecticut: tRNA precursors and processing ribonucleases in
Bombyx mori.
I. GINZBURG, P. CORNELIS, and U.Z. Li-n-AuER, Department of Neurobiology, Weizmann Institute of Science,
Rehovot, Israel: Assay of functionally impaired tRNA in injected Xenopus oocytes.
J.P. GODDARD and M. LOWDON, Department of Biochemistry, University of Glasgow, Scotland: The thermal
melting of E. co/i tRNA"e studied by chemical reactivity.
H. GROSJEAN,* S. DE HENAU,t and D. CROTHERS,T *University of Brussels, Belgium; tMedizinische
Hochschule Hannover, Germany; ,Yale University, New Haven, Connecticut: Studies on the complex
between tRNAs with complementary anticodons-A direct approach to the "wobble" problem.
C.L. HARRIS and F. MARASHI, Department of Biochemistry, West Virginia University, Morgantown: Purifica-
tion and properties of tRNAHe from E. coil C6-A 4-thiouridine-containing species.
N.K. HOWES and W.R. FARKAS, Memorial Research Center, University of Tennessee, Knoxville: Purification
of and studies with homogeneous guanine insertase.
R.E. HURD and B.R. REID, Biochemistry Department, University of California, Riverside: The structure and
dynamics of regulatory and nonregulatory tRNAs in solution.
H. ISHIKURA, K. MURAO, and Y. YAMADA, Laboratory of Chemistry, Jichi Medical School, Tochigi-ken, Japan:
New uridine derivatives present in tRNAs from B. subtilis.
R.L. KARPEL and A.C. BURCHARD, Department of Chemistry, University of Maryland Baltimore County,
Catonsville: Physical studies of the interaction of a nucleic acid helix destablizing protein with tRNA and
synthetic polynucleotides.
J. KATZE, Department of Microbiology, University of Tennessee Center for Health Science, Memphis: Serum
factor required for nucleoside Q-containing tRNA in tissue culture.
G. KEITH,* B. MENICHT, T. HEYMAN,± H.H. ARNOLD,, R. RAETTIG,t H. KERSTEN,t and G. DIRHEIMER,* *Institut de
Biologie Moleculaire et Cellulaire du CNRS, Strasbourg, France; +Institut du Radium, Orsay, France;
,Institut fur Physiologische Chemie der Universitat Erlangen-Nurnberg, Germany: Comparison of the
primary structures of tRNA°" and tRNAPhe of the gram-positive bacteria B. subtilis and B. stearother-
mophilus.
T. LABONE and M. STEINMETZ JAYNE, Department of Biology, Trenton State College, New Jersey: A rapid
assay for E. coli 4-thiouridine tRNA sulfurtransferase.
J.L. LEROY and M. GUERON, Ecole Polytechnique, Palaiseau, France: Search for specific binding sites of
divalent cations in tRNA.
G.A. LUOMA and A.G. MARSHALL, Department of Chemistry, University of British Columbia, Vancouver,
Canada: Laser Raman evidence for new cloverleaf secondary structures for 5S RNA and 5.8S RNA.
T. NY, K. HJALMARSSON, and G.R. BIORK, Department of Microbiology, University of Umea, Sweden:
Noncoordinated regulation of tRNA biosynthetic enzymes.
N. OKADA,* S. NOGUCHI,* H. KASAI,* N. SHINDO-OKADA,* T. OHGI,t T. GOTO,t and S. NISHIMURA,* *Biology
Division, National Cancer Center Research Institute, Tokyo; +Department of Agricultural Chemistry,
Nagoya University, Japan: Novel mechanism of posttranscriptional modification of tRNA-Insertion of
base of Q precursor into tRNA by tRNA transglycosidase reaction.
P.O. DUNS and D.S. JONES, Department of Biochemistry, University of Liverpool, England: The sequence of
the major formylatable species of methionine tRNA from S. obliquus.
A. PATKOWSKI* and B. CHU,t *Institute of Physics, A. Mickiewicz University, Poznan, Poland; +Department
of Chemistry, State University of New York, Stony Brook: Intensity fluctuation spectroscopy and tRNA
conformation.
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R. G. PERGoLizzi,* D. L. ENGELHARDT,' and D. GRUNBERGER,* Institute of Cancer Research, and Departments
of *Biochemistry and +Microbiology, Columbia University, New York, New York: Methionine-dependent
modification of a phenylalanine tRNA species lacking the hypermodified wye (Y) base in a monkey
kidney cell line.
B. A. ROE, E. Y. CHEN, H. L. Rizi, A. F. STANKIEWICZ, C. C. WEISZ, D. P. MA, C. Y. CHEN, and P. W.
ARMSTRONG, Chemistry Department, Kent State University, Ohio: The role of modified nucleotides in
mammalian tRNA-The Q nucleoside is replaced by guanosine in a tumor tRNAA'".
J. C. THIERRY, R. GIEGE, J. FISCHER, R. WEISS, J. P. EBEL, and D. MORAS, Laboratoire de Cristallochimie de I'ULP,
and Laboratoire de Biochimie, Institut de Biologie Moleculaire et Cellulaire du CNRS, Strasbourg, France:
Crystallographic studies on yeast tRNA"P.
P. WREDE,* R. WURST," J. VOURNAKIS," and A. RICH,* *Biology Department, Massachusetts Institute of
Technology, Cambridge; +Biology Department, Syracuse University, New York: Localization of salt-
induced conformational changes in 5'- and 3'-"P-labeled tRNAs.
R. M. WURST and J. N. VOURNAKIS, Department of Biology, Syracuse University, New York: Structure
mapping of 5'-"P-end-labeled yeast tRNA". with S1 nuclease.
Session 6: tRNA Biosynthesis-RNA Processing
Chairperson: W. MCCLAIN, University of Wisconsin, Madison
B. STARK, E. J. BOWMAN, R. KOLE, R. GARBER, R. KOSKI, and S. ALTMAN, Department of Biology, Yale
University, New Haven, Connecticut: Ribonuclease P-An enzyme with an essential RNA component.
Y. SHIMURA, H. SAKANO,* and F. NAGAWA, Department of Biophysics, Faculty of Science, Kyoto University,
Japan; *Basel Institute for Immunology, Switzerland: Studies on precursors of E. coli tRNAs.
H. SAKANO, Y. SHIMURA, T. IKEMURA, and H. OZEKI, Faculty of Science, University of Kyoto, Japan: tRNA
precursors accumulated in RNase P mutants of E. coli.
H. D. ROBERTSON, E. G. PELLE, and W. H. MCCLAIN,* Rockefeller University, New York, New York;
*Department of Bacteriology, University of Wisconsin, Madison: RNA processing in an E. coli strain
deficient in both RNase P and RNase III.
V. DANIEL, M. ZEEVI, and A. GOLDFARB, Biochemistry Department, Weizmann Institute of Science, Rehovot,
Israel: In vitro tRNA synthesis.
J. A. STEITZ, R. YOUNG, R. MACKLIS, and R. BRAM, Department of Molecular Biophysics and Biochemistry,
Yale University, New Haven, Connecticut: Sequences surrounding tRNA and rRNA processing sites in
the rRNA operons of E. coli.
E. LUND, J. E. DAHLBERG, and C. GUTHRIE,* Department of Physiological Chemistry, University of Wisconsin,
Madison; *Department of Biochemistry and Biophysics, University of California School of Medicine, San
Francisco: Processing of spacer and distal tRNAs from rRNA transcripts of E. coli in vitro.
R. K. GHOSH and M. P. DEUTSCHER, Department of Biochemistry, University of Connecticut Health Center,
Farmington: Isolation of tRNA-processing nucleases using synthetic tRNA precursors.
N. R. PACE, B. MEYHACK, B. PACE, and D. STAHL, National Jewish Hospital and Research Center, and
Department of Biophysics and Genetics, University of Colorado Medical Center, Denver, Colorado: The
in vitro metabolism of a 5S rRNA precursor from B. subtilis.
A. K. HOPPER, University of Massachusetts Medical School, Worcester: The biosynthesis of yeast tRNAs.
G. KNAPP, S. FUHRMAN, J. S. BECKMANN, P. F. JOHNSON, R. C. OGDEN, and J. ABELSON, Department of
Chemistry, University of California, San Diego: Transcription and processing of intervening sequences in
the tRNA genes of yeast.
C. GUTHRIE, R. ATCHISON, D. COLBY, M. C. ETCHEVERRY, and M. SALVATO, University of California, San
Francisco: Processing of tRNA in E. coli and S. cerevisiae.
P. VALENZUELA, P. Z. O'FARRELL, B. CORDELL, T. MAYNARD, H. GOODMAN, and W. J. RUTTER, Department of
Biochemistry and Biophysics, University of California, San Francisco: Structure and in vitro processing of
yeast precursor tRNAs containing intervening sequences.
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Session 7a: Coding and Suppression
Chairperson: D. SOLL, Yale University, New Haven, Connecticut
F. YAMAO, H. INOKUCHI, and H. OZEKI, Department of Biophysics, Faculty of Science, Kyoto University,
Japan: Recognition mutants in E. coli.
J. KOHLI, F. ALTRUDA, T. KWONG, G. WAHL,* A. RAFALSKI, R. WETZEL, and D. SOLL, Department of Molecular
Biophysics and Biochemistry, Yale University, New Haven, Connecticut; *Department of Biology,
University of Utah, Salt Lake City: UGA-suppressor tRNAs in S. pombe.
J.F. ATKINS and R.F. GESTELAND, Cold Spring Harbor Laboratory, New York: Effect of tRNA balance on gene
expression.
R.H. BUCKINGHAM, J. VACHER, and C.G. KURLAND, Institut de Biologie Physico-Chimique, Paris, France, and
Wallenberg Laboratory, Uppsala, Sweden: Suppressor activity of tRNATMP
Session 7b: Involvement of tRNA in Regulation
Chairperson: H.E. UMBARGER, Purdue University, West Lafayette, Indiana
H.E. UMBARGER, Department of Biological Sciences, Purdue University, West Lafayette, Indiana: Some
observations on the involvement of aminoacyl tRNAs-The current status of tRNA involvement in
regulation of amino acid biosynthesis.
L. Boss! and J.R. ROTH, Biology Department, University of Utah, Salt Lake City: Importance of anticodon-
region pseudouridine for in vivo tRNA function.
S.C. QUAY* and D.L. OXENDER,t *Massachusetts General Hospital, Harvard Medical School, Boston; tDe-
partment of Biological Chemistry, University of Michigan Medical School, Ann Arbor: Role of tRNALe" in
branched-chain amino acid transport regulation.
Session 8: Poster Session
P.F. AGRIS and S.A.H. KOVACS, Division of Biological Sciences, University of Missouri, Columbia: A possible
regulatory role for tRNA in melanin synthesis.
M. ALBANI,* A. HOBURG,* H. KERSTEN,* P. WURMBACH,t and K.H. NIERHAUS,t *Institut fiir Physiologische
Chemie and Biochemie, Erlangen; *Max-Planck-Institut fur Molekulare Genetik, Berlin, Germany: In-
teraction of specific prokaryotic ribothymidine-containing and ribothymidine-lacking tRNAs with the
programed ribosome.
A. ARAYA, J. LABOUESSE, and S. LITVAK, Departement de Biochimie, University de Bordeaux II, France: Studies
on the specific interactions between reverse transcriptase and primer tRNA.
A. BHUTA, K. QUIGGLE, G. BUTKE, R. GOLDBERG,* and S. CHLADEK, Michigan Cancer Foundation, and
*Department of Biochemistry, Wayne State University School of Medicine, Detroit, Michigan: Interaction
of the AA-tRNA acceptor terminus with E. coli ribosomes -Stereochemical control of the peptidyl-
transferase reaction.
R.M. BOCK, H. LATEN, and J. GORMAN, Laboratory of Molecular Biology, University of Wisconsin, Madison:
Isopentenyladenosine-deficient tRNA from an antisuppressor mutant of S. cerevisiae.
M.M. COMER, Department of Biology, Clark University, Worcester, Massachusetts: Genes for threonine and
lysine tRNAs-Approximate map location in E. co/i.
M.R. CULBERTSON,* C. CUMMINS,* and G.R. FINK,' *University of Wisconsin, Madison; tCornell University,
Ithaca, New York: Frameshift suppressors in S. cerevisiae.
S.M. DESAI, C. HUNT, and S.B. WEISS, Franklin McLean Memorial Research Institute, and Department of
Biochemistry, University of Chicago, Illinois: Organization of tRNA genes in the T5 bacteriophage
chromosome.
H.J. DRABKIN and L.N. LUKENS, Department of Biology, Wesleyan University, Middletown, Connecticut:
Discovery of a new glycine isoaccepting tRNA in chick embryo tissues and its preferential utilization in
collagen synthesis.
M.Y. FELDMAN, Veterinary Institute, Beit Dagan, Israel: The "covalent cross-linkage" model for interactions
of tRNA, mRNA, and ribosome.
E. GRIFFITHS, National Institute for Medical Research, Mill Hill, London, England: Alterations in E. coli tRNAs
induced by iron-binding proteins-A possible role in pathogenicity.
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H. GROSJEAN,* D. SANKOFF,t W. MIN-JOU,, W. FIERS,* and R. CEDERGREN,t *University of Brussels, Belgium;
,University of Ghent, Belgium; tUniversity of Montreal, Quebec, Canada: MS, RNA-A correlation
between the stability of the codon-anticodon interaction and the choice of code words.
H. GUILLEY, Laboratoire de Virologie, Institut de Biologie Moleculaire et Cellulaire du CNRS, Strasbourg,
France: In vitro aminoacylation of viral RNA-A kinetic study of the reaction and structure of the amino
acid-accepting 3'-OH extremity of turnip-yellow mosaic virus and tobacco mosaic virus RNA.
H.A. HOSBACH, M. SILBERKLANG, and B.J. MCCARTHY, Department of Biochemistry and Biophysics, University
of California, San Francisco: Structure of D. melanogaster tRNA genes.
T. IKEMURA, Faculty of Science, Kyoto University, Japan: Relative amount of individual tRNAs and 5S RNA of
E. coli.
K.B. JACOBSON, Biology Division, Oak Ridge National Laboratory, Tennessee: Correlation between the
absence of a tRNATYr isoacceptor and the activity of a mutant form of tryptophan oxygenase in
Drosophila.
Session 9: Cloning of tRNA Genes
Chairperson: J. ABELSON, University of California, San Diego
K. FUKADA, J. VELTEN, and J. ABELSON, Department of Chemistry, University of California, San Diego: Cloning
and sequencing of the T4 tRNA gene cluster.
J. Rossi, J. EGAN, M. BERMAN, and A. LANDY, Division of Biology and Medicine, Brown University,
Providence, Rhode Island: Structure, organization, and regulation of the two tRNATYr gene clusters in E.
coli.
M.J. RYAN,* E.L. BROWN,* R. BELAGAJE,* H.-J. FRITZ,t and H.G. KHORANA,* *Departments of Biology and
Chemistry, Massachusetts Institute of Technology, Cambridge; ',Institut fur Genetik der Universitat Köln,
Germany: Cloning of two chemically synthesized genes for a precursor to the tyrosine suppressor tRNA.
P. PHILIPPSEN, J.R. CAMERON, and R.W. DAVIS, Department of Biochemistry, Stanford University School of
Medicine, California: Analysis of tyrosine tRNA genes in yeast.
G. PAGE, M. OLSON, and B.D. HALL, Department of Genetics, University of Washington, Seattle: Molecular
characterization of seryl- and tyrosyl-tRNA genes of S. cerevisiae.
R. CORTESE, D. MELTON, T. TRANQUILLA, and J.D. SMITH, MRC Laboratory of Molecular Biology, Cambridge,
England: Cloning of nematode tRNA genes and their expression in frog oocytes.
0. SCHMIDT, B. HOVEMANN, J. MAO, S. SILVERMAN, and D. SOLL, Department of Molecular Biophysics and
Biochemistry, Yale University, New Haven, Connecticut: Specific transcription of eukaryotic tRNA genes
in Xenopus germinal vesicle extracts.
Session 10a: tRNA Gene Arrangement
Chairperson: G. TENER, University of British Columbia, Vancouver, Canada
G.M. TENER,* S. HAYASHI,* R. DUNN,* A. DELANEY,* I.C. GILLAM,* T. GRIGLIATTI,t T. KAUFMAN,t and D.T.
SUZUKI,' Departments of *Biochemistry and ',Zoology, University of British Columbia, Vancouver,
Canada: tRNA genes of D. melanogaster.
N.D. HERSHEY, P. YEN, R. ROBINSON, and N. DAVIDSON, Department of Chemistry, California Institute of
Technology, Pasadena: Sequence organization of Drosophila tRNA genes.
R. ELDER, P. SZABO, and 0. UHLENBECK, Department of Biochemistry, University of Illinois, Urbana: tRNA
gene organization in D. melanogaster.
E. KUBLI, A.H. EGG, and T. SCHMIDT, Zoological Institute, University of Zurich, Switzerland: Localization of
tRNA,A52 genes from D. melanogaster by in situ hybridization.
E.A. MORGAN, T. IKEMURA, and M. NOMURA, Institute for Enzyme Research, University of Wisconsin,
Madison: Identification of tRNA genes in rRNA operons of E. coli.
A. STEINMETz,* A.J. DRIESEL,t M. MUBUMBILA,* E.J. CROUSE,t K. GORDON," H.J. BOHNERT,t M. KELLER,* G.
BURKARD,* R.G. HERRMANN,t and J.H. WEIL,* *Institut de Biologie Moleculaire et Cellulaire du CNRS,
Strasbourg, France; tBotanisches Institut der Universitat Dusseldorf, Germany: Mapping of the tRNA
genes on the circular DNA molecule of S. oleracea chloroplast.
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H. INOKUCHI, M. KODAIRA, F. YAMAO, and H. OZEKI, Faculty of Science, Kyoto University, Japan: tRNA gene
clusters including suppressors in E. coli.
F. MOLLER, V. KURER, and S.G. CLARKSON, Institut fur Molekularbiologie II, Universitat Zurich, Switzerland:
Structure and transcription of a cloned tRNA gene fragment of X. laevis.
J. HECKMAN, B. ALZNER-DEWEERD, and U.L. RAJBHANDARY, Department of Biology, Massachusetts Institute of
Technology, Cambridge: Mitochondrial tRNAs of Neurospora crassa-Sequence studies, gene mapping,
and cloning.
Session lob: Other Functions of tRNA
Chairperson: J.E. DAHLBERG, University of Wisconsin, Madison
A.L. HAENNI,* S. JOSHI,* E. HUBERT,' G. HUEZ," and G. MARBAIX," *Universite Paris VII, France; tUniversite
Bruxelles, Rhode-St.-Genese, Belgium: In vivo aminoacylation and "processing" of turnip-yellow mosaic
virus RNA injected into X. laevis oocytes.
W.K. YANG* and D.L. HwArsio,t *Biology Division, Oak Ridge National Laboratory; ',University of
Tennessee-Oak Ridge Graduate School of Biomedical Sciences: Binding activities of selective tRNA
species to cellular retrovirus-specific and rRNAs.
S.P. EISENBERG, L. Son, and M. YARUS, Department of Molecular, Cell, and Developmental Biology,
University of Colorado, Boulder: Undermodification of specific tRNAs affects regulation of the trp
operon.
J.R. MENNINGER, Zoology Department, University of Iowa, Iowa City: Macrolide antibiotics enhance the
dissociation of peptidyl-tRNA from ribosomes of E. coli.
R.L. SOFFER, Department of Biochemistry, Cornell University Medical College, New York, New York:
Aminoacyl-tRNA-protein transferases.
Session 11: Poster Session
H. KERSTEN, T. DINGERMANN, and M. MACH, Institut fur Physiologische Chemie and Biochemie, Erlangen,
Germany: Importance of ribothymidine-lacking tRNAs in developing Dictyostelium discoideum.
M. KRAUSKOPF and J. VILLANUEVA, Instituto de Bioquimica, Facultad de Ciencias, Universidad Austral de
Chile, Valdivia: On the nature of the N-acetyl-phenylalanyl-tRNA hydrolase recognition site.
T.A. KRUSE and B.F.C. CLARK, Institute of Chemistry, Aarhus University, Denmark: Possible influence of
elongation factor Tu on the tRNA anticodon loop conformation.
Y. KUCHINO, T. SEKIYA, and S. NISHIMURA, National Cancer Center Research Institute, Tokyo, Japan: Multiple
copies of mammalian DNA fragment that specifically hybridizes with tRNAAsP.
I. KUDO, J.D. SMITH,* and U.L. RAJBHANDARY, Department of Biology, Massachusetts Institute of Technology,
Cambridge: *MRC Laboratory of Molecular Biology, Cambridge, England: Cloning of E. coli tyrosine
suppressor tRNA gene and expression of the cloned tRNA gene in E. coli minicells.
J.A. LAKE, Molecular Biology Institute and Department of Biology, University of California, Los Angeles:
Ribosome structure and tRNA-binding sites.
M. Lirr and K. WEISER, Department of Biochemistry and Division of Medical Genetics, University of Oregon
School of Medicine, Portland: Studies in the control of specific tRNA levels in Friend leukemia cells.
N. MARTIN,* D. MILLER,' and J.E. DONELSONJ *University of Minnesota, Minneapolis; ',University of Iowa,
Iowa City: Cloning of yeast mitochondrial tRNA genes in E. coll.
E.J. MURGOLA, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute,
Houston: Novel missense suppressors in E. coli.
G. NASS and J. THOMALE, Abteilung Molekulare Biologie, Max-Planck-Institut fOr Experimentelle Medizin,
Gottingen, Germany: Change of concentration of isoaccepting tRNAs caused by amino acid deficiency
and not by uncharged tRNA.
M.P. OESCHGER, N.S. OESCHGER, S.L. WOODS, G.T. WIPRUD, and P.M. CUCCARO, Department of Microbiol-
ogy, Georgetown University, Washington, D.C.: Suppressor-enhancing mutations in E. coli K12.
E. OHTSUKA, S. NISHIKAWA, R. FUKUMOTE, H. UEMURA, A.F. MARKHAM, S. TANAKA, T. MIYAKE, T. TANAKA, E.
NAKAGAWA, and M. IKEHARA, Faculty of Pharmaceutical Sciences, Osaka University, Japan: Joining and
reconstitution of chemically synthesized formyl-methionine tRNA fragments.
B.J. ORTWERTH, C. CONLON-HOLLINGSHEAD, and O.M.Y. CHU-DER, University of Missouri, Columbia: Corre-
lation between tRNA4's and cell division in tissue-culture cells.
J.B. PRINCE,* S.S. HIXSON," and R.A. ZIMMERMANN,' Departments of *Biochemistry and tChemistry, Univer-
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sity of Massachusetts, Amherst: Photochemical cross-linking of tRNALY' and tRNA2G'' to 16S RNA at the
ribosomal P site.
D. RICHTER, Institut fur Physiologische Chemie, Universitat Hamburg, Germany: Discrimination between
purine and pyrimidine base at the 3' terminus of the tRNA molecule by the stringent factor system from E.
coli.
J.M. ROBERTSON, H. WEIDNER, and W. WINTERMEYER, Institut fur Physiologische Chemie, Physikalische
Biochemie und Zellbiologie, Universitat Munchen, Germany: Fluorescence studies on tRNA-ribosome
interactions.
R.J. ROTHSTEIN, Department of Biochemistry, Cornell University, Ithaca, New York: Spontaneous deletion of
the tyrosine tRNA locus SUP4 of S. cerevisiae.
S.J. SPENGLER, Space Sciences Laboratory, University of California, Berkeley: The biosynthesis of
pseudouridine in tRNA-Isolation and characterization of the hisT gene product.
R. WIRTH, D. ELHARDT, and A. BOCK, Lehrstuhl fur Mikrobiologie, Universitat Regensburg, Germany: In vitro
synthesis of ribosomal protein S20 and isoleucyl-, phenylalanyl-, and threonyl-tRNA synthetases.
Session 12: Interaction of tRNA with Ribosomes
Chairperson: C.R. CANTOR, Columbia University, New York, New York
E. KUECHLER, A. BARTA, and A.J.M. MATZKE, Institute of Biochemistry, University of Vienna, Austria: Translo-
cation of photo cross-linked complexes between phenylalanyl-tRNA from yeast and poly(U) on E. coli
ribosomes.
J. OFENGAND,* M. BOUBLIK,* S. GATES,± L. Hsu,* M. KEREN-ZUR,* F.-L. LIN,* R. Liou,* I. SCHWARTZ,t and R.
ZIMMERMANN,t *Roche Institute of Molecular Biology, Nutley, New Jersey; +University of Massachusetts,
Amherst: Topography of tRNA-binding sites on ribosomes.
W. WINTERMEYER, Institut fur Physiologische Chemie, Physikalische Biochemie und Zellbiology, Universitat
MOnchen, Germany: tRNA-tRNA interactions in solution.
W. HILLEN, E. EGERT, H.-J. LINDNER, and H.G. GASSEN, Institut fur Organische Chemie und Biochemie,
Darmstadt, Germany: Function of "wobble nucleosides" in tRNA-Possible helix terminators in the first
position of some anticodons.
A.E. JOHNSON,* D.L. MILLER,t and C.R. CANTOR,' *Department of Chemistry, University of Oklahoma,
Norman; +Department of Biochemistry, Roche Institute of Molecular Biology, Nutley, New Jersey;
*Department of Chemistry, Columbia University, New York, New York: Affinity labeling of elongation
factor Tu and of ribosomes using a functional analog of lysyl-tRNA.
M. SPRINZL and K. WATANABE, Abteilung Chemie, Max-Planck-Institut fur Experimentelle Medizin, Gottingen,
Germany: Interaction of the ITC region of tRNA with the ribosomal A site.
This meeting was supported in part by funds from the National Institutes of Health and the National
Science Foundation.
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Russell Ross, University of Washington
Gordon Sato, University of California, San Diego
139 participants
Welcoming Remarks: J. D. Watson, Cold Spring Harbor Laboratory
Session 1
Chairperson: G. TODARO, National Institutes of Health, Bethesda, Maryland
S. COHEN,* H. HAIGLER,* G. CARPENTER,*t L. KING,t', Departments of *Biochemistry and +Medicine, Vander-
bilt University, and *Veterans Administration Hospital, Nashville, Tennessee: Epidermal growth factor
(EGF). I. Visualization of the binding and internalization of EGF in cultured cells. II. Enhancement of
phosphorylation by EGF in membrane preparations in vitro.
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C. F. Fox, University of California, Los Angeles: Specific labeling and dynamics of the receptor for EGF.
I. PASTAN, F. MAXFIELD, I. KEEN, Y. SHECHTER,* I. SCHLESSINGER, and M. WILLINGHAM, National Institutes of
Health, Bethesda, Maryland; *Burroughs Wellcome Company, Research Triangle Park, North Carolina:
Direct visualization of hormone binding and internalization in living cells.
R. W. HOLLEY, Salk Institute, San Diego, California: Control of growth of kidney epithelial cells in culture.
M. L. SMITH and J. M. BUCHANAN, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Activation of de novo purine synthesis after mitogenic stimulation of resting fibroblasts.
Session 2
Chairperson: R. BRADSHAW, Washington University, St. Louis, Missouri
R. Ross, A. VOGEL, P. F. DAVIES, E. RAINES, B. KARIYA, M. J. RIVEST, C. GUSTAFSON , and J. GLOMSET,*
Departments of Pathology and *Medicine, University of Washington School of Medicine, Seattle: The
platelet-derived growth factor.
C.-H. HELDIN, B. WESTERMARK,* and A. WASTESON, Institute of Medical and Physiological Chemistry, and
*Wallenberg Laboratory, Uppsala, Sweden: Purification and characterization of human growth factors.
C. D. STILES, W. J. PLEDGER, J. J. VAN WYK, H. ANTONIADES, and C. D. SCHER, Sidney Farber Cancer Institute
and Center for Blood Research, Boston, Massachusetts, and University of North Carolina Medical School,
Chapel Hill: Serum components which regulate the commitment of BALB/c-3T3 cells to DNA synthesis.
D. GOSPODAROWICZ, I. VLODAVSKY, G. GREENBURG, and L. K. JOHNSON, Cancer Research Institute, University
of California Medical Center, San Francisco: Cellular shape is determined by the extracellular matrix and
is correlated with the control of cellular growth and physiological function.
S. SCHWARTZ, P. BOWMAN, and S. SELDEN, Department of Pathology, University of Washington, Seattle:
Growth control of aortic endothelium at wound edges.
W. H. BEERS, Rockefeller University, New York, New York: The transmission of hormonal stimulation by a
cell-contact-dependent mechanism-In vitro studies and implications for hormone active in vivo.
Session 3
Chairperson: M. STOKER, Imperial Cancer Research Fund Laboratories, London, England
E. ROZENGURT and J. B. SMITH, Imperial Cancer Research Fund Laboratories, London, England: Monovalent
ion fluxes in quiescent cultures of 3T3 cells-Mechanism and significance in the regulation of cell
growth.
I. S. EDELMAN, Department of Biochemistry, Columbia University, New York, New York: Thyroid ther-
mogenesis in hepatocytes in primary cultures.
A. H. RUBIN, Department of Molecular Biology and Virus Laboratory, University of California, Berkeley: The
coordinate response of cells to hormones and its mediation by the intracellular availability of magnesium.
L. JIMENEZ DE ASUA, K. M. V. RICHMOND, M. K. O'FARRELL,* A. M. Quo, A. M. KUBLER, and P. S. RUDLAND,*
Friedrich Miescher-Institut, Basel, Switzerland; *Imperial Cancer Research Fund Laboratories, London,
England: Growth factors and hormones interact in a series of temporal steps to regulate the rate of
initiation of DNA synthesis in mouse fibroblasts.
A. B. PARDEE and A. YEN, Sidney Farber Cancer Institute, and Department of Pharmacology, Harvard Medical
School, Boston, Massachusetts: Variability of the cell cycle.
R. BASERGA, M. ROSSINI, J. FLOROS, and R. WEINMANN,* Fels Research Institute, Temple University Medical
School, and *Wistar Institute, Philadelphia, Pennsylvania: Induction of cellular DNA synthesis in resting
cells by serum, polyoma, and Ad2.
Session 4
Chairperson: R. HOLLEY, Salk Institute, San Diego, California
H. A. ARMELIN, M. C. S. ARMELIN, S. E. FARIAS, A. G. GAMBARINI, and E. KIMURA, Institute de Quimica,
Universidade de Sao Paulo, Brazil: Effects of hydrocortisone on the growth control of a mutant derived
from Swiss mouse 3T3 fibroblasts.
V. J. CRISTOFALO, J. M. WALLACE, and B. A. ROSNER, Wistar Institute, Philadelphia, Pennsylvania: Glucocor-
ticoid enhancement of proliferative activity in WI-38 cells.
W. H. DAUGHADAY, Washington University, St. Louis, Missouri: Somatomedins as mediators of growth
hormone action in vitro.
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L. FRYKLUND, A. SKOTTNER, K. HALL,* A. FORSMAN, and S. CASTENSSON, Recip Polypeptide Laboratory,
Aktiebolaget KABI, and *Karolinska Hospital, Stockholm, Sweden: Somatomedins A and B-Chemical
nature and in vivo activity.
P. S. RUDLAND, M. J. WARBURTON, and D. C. BENNETT, Imperial Cancer Research Fund Laboratories, London,
England: Growth and differentiation of cultured rat mammary cells.
T. KANO-SUEOKA, J. E. ERRICK, and D. M. COHEN, Department of Molecular, Cellular, and Developmental
Biology, University of Colorado, Boulder: Effects of hormones and a novel mammary growth factor on a
rat mammary carcinoma MCCLX in culture.
Session 5
Chairperson: R. IGLESIAS, Estado 57, Department 706, Santiago, Chile
D. D. CUNNINGHAM, D. H. CARNEY, and K. C. GLENN, Department of Medical Microbiology, University of
California, Irvine: Role of the cell surface in initiation of cell division by thrombin.
J. P. QUIGLEY, B. M. MARTIN, R. H. GOLDFARB, C. J. SCHEINER, and W. D. MULLER, Downstate Medical Center,
State University of New York, Brooklyn: The involvement of serine proteases in growth control and
malignant transformation.
E. REICH, Rockefeller University, New York, New York: Plasminogen activator-Modulation of enzyme
production and application in studying hormonal regulation of tissue function.
M. LACROIX, F. SMITH, and I. B. FRITZ, Banting and Best Department of Medical Research, University of
Toronto, Canada: The control of plasminogen activator secretion by Sertoli cells in culture, and its
possible role in spermato-genesis.
T. D. GELEHRTER, S. A. CARLSON, and B. L. FREDIN, Departments of Internal Medicine and Human Genetics;
University of Michigan Medical School, Ann Arbor: Glucocorticoid regulation of plasminogen activator
in rat hepatoma cells.
L. OSSOWSKI, Rockefeller University, New York, New York: Mammary plasminogen activator-Hormonal
control and life-cycle correlations in normal and malignant tissue.
Session 6
San Diego
E. R. FROESCH, I. ZAPF, E. RINDERKNECHT,.and R. E. HUMBEL, Departments of Medicine and *Biochemistry,
University of Zurich, Switzerland: Insulinlike growth factors (NSILA)-Structural and functional similarities
with insulin.
J. LARNER, J. C. LAWRENCE, P. J. ROACH, A. A. DEPAOLI-ROACH, R. J. WALKENBACH, J. GUINOVART, and R. J.
HAZEN, Department of Pharmacology, University of Virginia School of Medicine, Charlottesville: About
insulin and glycogen.
J. ROTH, Diabetes Branch, National Institutes of Health, Bethesda, Maryland: Insulin receptors in vivo and in
vitro.
A. TIXIER-VIDAL, N. BRUNET, and D. GOURDJI, Groupe de Neuroendocrinologie Cellulaire, College de France,
Paris: Plasma membrane modifications related to the action of thyrotropin-releasing hormone (TRH) on rat
prolactin cell lines.
G. N. GILL, P. J. HORNSBY, and M. H. SIMONIAN, Department of Medicine, University of California, San
Diego: Regulation of growth and differentiated function of cultured bovine adrenocortical cells.
A. H. TASHJIAN, Jr., A. SCHONBRUNN, and T. F. J. MARTIN, Harvard Medical School and Harvard School of
Public Health, Boston, Massachusetts: Interactions of TRH and somatostatin with pituitary cells
in culture-Modulation of peptide receptors and hormone release and synthesis.
B. P. SCHIMMER, P. A. RAE, N. S. GUTMANN, and V. M. WATT, Banting and Best Department of Medical
Research, University of Toronto, Canada: Genetic dissection of ACTH action in adrenal tumor cells.
Session 7
Chairperson: H. EAGLE, Albert Einstein College of Medicine, Bronx, New York
S. P. NI55LEY, M. M. RECHLER, A. C. MOSES, H. J. EISEN, O. Z. HIGA, I. FENNOY, C. B. BRUNT, R. M. WHITE, E. E.
SCHILLING, J. PODSKALNY, and P. A. SHORT, National Institutes of Health, Bethesda, Maryland: Evidence
that multiplication-stimulating activity (MSA) purified from the BRL-3A rat-liver cell line is found in rat
serum and fetal liver organ culture.
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A. LIPTON, M. F. SCHULER, E. MUSSELMAN, R. C. FELDHOFF, and L. S. JEFFERSON, Milton S. Hershey Medical
Center, Pennsylvania State University, Hershey: Liver as a source of transformed-cell growth factor.
G. J. TODARO and J. E. DE LARCO, NCI, National Institutes of Health, Bethesda, Maryland: Growth factors
produced by sarcoma-virus-transformed cells.
W. TOPP,* D. RIFKIN,' A. GRAESSMAN,t and M. SLEIGH,§ *Cold Spring Harbor Laboratory, New York; *New
York University Medical School, New York; *Institut fur Molekularebiologie and Biochemie, Freie
Universitat Berlin, Germany; §CSIRO, Epping, Australia: The role of early SV40 gene products in the
maintenance of the transformed state.
L. LEVINE, Department of Biochemistry, Brandeis University, Waltham, Massachusetts: Deacylation of
cellular lipids and archidonic acid metabolism in cultured cells.
K. NISHIKAWA, C. OKITSU, and G. H. SATO,* Department of Chemistry, Kanazawa Medical University,
Ishikawa, Japan; *Department of Biology, University of California, San Diego: Control of BALB/3T3
growth by factors present in tumor extract.
R. IGLESIAS, Estado 57, Department 706, Santiago, Chile: Tumors produced by hormones, hormones pro-
duced by tumors, and tumors produced by tumors.
Session 8
Chairperson: J. ROTH, National Institutes of Health, Bethesda, Maryland
R. GOODMAN, C. CHANDLER, and H. R. HERSCHMAN, University of California School of Medicine, Los
Angeles: Pheochromocytoma cell lines as models of growth-factor and hormone-induced neuronal
differentiation.
S. OHNO, Department of Biology, City of Hope National Medical Center, Duarte, California: Testis-
organizing H-Y antigen as a short-range hormone in gonadal development.
H. ISHIKAWA, M. SHIINO, and E. G. RENNELS, Department of Anatomy, University of Texas Health Science
Center, San Antonio: Normal functional clones of pituitary cells derived from Rathke's pouch epithelium
of fetal rats.
A. G. GILMAN, P. C. STERNWEIS, A. C. HOWLETT, and E. M. Ross, Department of Pharmacology, University of
Virginia School of Medicine, Charlottesville: Resolution and reconstitution of some components of
catecholamine-stimulated adenyl ate cyclase.
P. COFFINO, Departments of Medicine and Microbiology, University of California, San Francisco: Regulation
of mouse lymphoma cell growth by AMP.
K. KRATOCHWIL, R. DURNBERGER, B. HEUBERGER, and G. WASNER, Institut fur Molekularbiologie, Oster-
reichische Akademie der Wissenschaften, Salzburg, Austria: Hormone-induced cell and tissue interaction
in the embryonic mammary gland.
F. T. KENNEY, Oak Ridge National Laboratory, Tennessee: Control of enzyme synthesis in hepatoma cells by
steroids and other hormones.
Session 9
Chairperson: A. B. PARDEE, Sidney Farber Cancer Institute, Boston, Massachusetts
M. R. STALLCUP, J. RING, and K. R. YAMAMOTO, Department of Biochemistry and Biophysics, University of
California, San Francisco: Glucocorticoids regulate mammary tumor virus gene expression at the level of
initiation of transcription.
J. D. BAXTER, P. H. SEEBURG, J. A. MARTIAL, J. SHINE, L. K. JOHNSON, R. D. IVARIE, B. SCHACTER, and H. M.
GOODMAN, Departments of Biochemistry and Medicine, University of California, San Francisco: Struc-
ture, expression in bacteria, and regulation in cultured cells of the growth hormone gene.
D. GRANNER, M. DIESTERHAFT, T. NOGUCHI, P. OLSON, J. HARGROVE, and G. VOLENTINE, Departments of
Medicine and Biochemistry, University of Iowa, and Veterans Administration Hospital, Iowa City:
Regulation of liver and HTC cell tyrosine aminotransferase mRNA by glucocorticoids and dibutyryl AMP.
H. H. SAMUELS, F. STANLEY, L. E. SHAPIRO, J. CASANOVA, Z. D. HOROWITZ, and D. KLEIN, Department of
Medicine, New York University Medical Center, New York: Multihormonal control of the growth
hormone genome in cultured GH, cells by thyroid and glucocorticoid hormones.
E. B. THOMPSON,* D. K. GRANNER," T. D. GELEHRTER,t S. S. SIMONS,§ and G. HAGER,* *NCI, National Institutes
of Health, Bethesda, Maryland; *Department of Medicine, University of Iowa Medical School, Iowa City;
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,Department of Human Genetics, University of Michigan Medical School, Ann Arbor; §NIAMDD,
National Institutes of Health, Bethesda, Maryland: Unlinked control of multiple glucocorticoid-sensitive
processes in spontaneous HTC cell variants.
J. L. ROBERTS,* M. BUDARF,t R. G. ALLEN, J. D. BAXTER,* and E. HERBERT:, *University of California Medical
School, San Francisco; ,Chemistry Department, University of Oregon, Eugene: Effect of glucocorticoids
on the synthesis and processing of the common precursor to adrenocorticotropin and endorphin in
mouse pituitary tumor cells.
S. L. SABOL, A. LING, and M. P. DANIELS, NHLBI, National Institutes of Health, Bethesda, Maryland:
Endorphin production and its regulation by glucocorticoids in clonal pituitary tumor cells.
Session 10
Chairperson: R. Ross, University of Washington, Seattle
A. B. LERNER, Department of Dermatology, Yale University, New Haven, Connecticut: Action of MSH on
pigment cells.
D. A. SIRBASKU and R. H. BENSON, Department of Biochemistry and Molecular Biology, University of Texas
Medical School, Houston: Estrogen-inducible growth factors which may act as mediators (estromedins) of
estrogen-promoted tumor cell growth.
M. E. LIPPMAN, J. C. ALLEGRA, J. S. STROBL, and L. W. ENGEL, NCI, National Institutes of Health, Bethesda,
Maryland: Growth requirements of a human breast cancer cell line in serum-free medium.
M. L. WALSH, B. DAMIANI, D. WONG, E. J. WOLINSKY, and L. B. CHEN, Sidney Farber Cancer Institute, Harvard
Medical School, Boston, Massachusetts: A possible endogenous growth factor-Src gene product.
J. HOCHSTADT,*I4 D. C. QUINLAN,* A. J. OWEN,t and K. 0. COOPER,t *Worcester Foundation for Experimental
Biology, Shrewsbury, Massachusetts; ,Department of Biochemistry and Biophysics, University of Rhode
Island, Kingston; tDepartment of Microbiology, New York Medical College, Valhalla: Regulation of
transport upon interaction of fibroblast growth factor (FGF) with plasma membrane vesicles isolated from
quiescent (Go) BALB/3T3 cells.
J. BOTTENSTEIN, J. MATHER,* and G. SATO, Department of Biology, University of California, San Diego;*The
Population Council, Rockefeller University, New York, New York: Growth of neuroepithelial derived cell
lines in serum-free hormone-supplemented media.
G. R. SERRERO, D. B. MCCLURE,* and G. H. SATO, Centre de Biochimie, Faculte SPCNI, Nice, France;
*Department of Biology, University of California, San Diego: Growth of mouse 3T3 fibroblasts in
serum-free, hormone-supplemented media.
S. STRICKLAND, Rockefeller University, New York, New York: Differentiation in teratocarcinoma stemcells by
retinoic acid.
This meeting was supported in part by funds received from the National Cancer Institute, National
Institute on Aging, National Institute of Child Health and Human Development, National Institute of General
Medical Science, Fogarty International Center, and the National Science Foundation.
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IN-HOUSE SEMINARS
Cold Spring Harbor in-house seminars were initiated to provide a
semiformal avenue for communication between the various research
groups at the laboratory. They are particularly useful for research
personnel who have joined the laboratory during the summer. The
seminars also afford a necessary opportunity for the graduate students
and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, semi-
nars were given by many others involved in research at this laboratory.
1977-1978
.1. Broach giving seminar in Blackford Hall
October
Olke Uhlenbeck, University of Illinois, Chicago: RNA ligase and its application.
Virginia Walbot, Washington University, St. Louis, Missouri: Clonal development in corn and cytoplasmic organelles.
November
Herbert Heyneker, University of California, San Francisco: Expression in E. coli of a cloned somatostatin gene.
Nicholas Cozzarelli, University of Chicago, Illinois: DNA gyrase-The enzymatic alteration of super helix density and the
inhibition of DNA replication by nalidixic acid.
Neil Wilkie, Glasgow University, Scotland: Genetic and physical maps of herpesvirus genomes.
Alexander J. Varshaysky, Massachusetts General Hospital, Boston: On the structure of eukaryotic, prokaryotic, and viral
chromatin.
December
Frederick Alt, Massachusetts Institute of Technology, Cambridge: Selective multiplication of dihydrofolate reductase
genes in methotrexate-resistant cell lines.
Robert Sauer, Harvard University, Cambridge, Massachusetts: The lambda repressor.
James Stringer, University of California, Irvine: Mapping HSV transcripts by electron microscopy.
February
Kurt Drickamer, Harvard University, Cambridge, Massachusetts: Structure of band 3 in red blood cell membrane.
Richard Axel, Columbia University, New York, New York: Isolation, transfer, and integration of eukaryotic genes into
mutant mouse cells.
Shirley Tilgman, National Institutes of Health, Bethesda, Maryland: Insertion in the mouse hemoglobin gene.
Gary Strobel, United States Department of Agriculture, Bethesda, Maryland: Biochemical basis of disease resistance in
plants.
March
Peter Lengyel, Yale University, New Haven, Connecticut: Studies on the interferon system.
S. S. Tevethia, Tufts University Medical Center, Boston, Massachusetts: Imrnunobiology of 5V40 TSTA.
Brooks Low, Yale University, New Haven, Connecticut: Different modes of recombination during conjugation and
transduction in E. coli.
Eugene Bell, Massachusetts Institute of Technology, Cambridge: Semiautomated analysis of cell lineages in vitro.
Jim Feramisco, University of Washington, Seattle: Synthetic peptides as model substrates and inhibitors for the cAMP-
dependent protein kinase.
Mark Furth, University of Wisconsin, Madison: Control of lambda DNA replication.
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April
Aaron Shatkin, Roche Institute of Molecular Biology, Nutley, New Jersey: S' cap of eukaryotic messenger RNA.
Pamela Stanley, Albert Einstein College of Medicine, Bronx, New York: Alterations at the cell surface in lectin-resistant
CHO cell mutants.
Lucia Rothman-Denes, University of Chicago, Illinois: Control of development in the bacteriophage N4.
Bruce Zetter, University of California, San Francisco: Effects of growth factors and carcinogens on vascular endothelial
cells.
Jerry Rubin, Sidney Farber Cancer Center, Boston, Massachusetts: Cloned drosophila genes.
Helen Donis-Keller, Harvard University, Cambridge, Massachusetts: RNA sequencing.
Stephen Blose, University of Pennsylvania, Philadelphia: 10 nm filaments in endothelial cells-Structure and possible
function.
Tom Schenk, University of Connecticut Medical Center, Storrs: Deletion mutants of SV40.
Demetrius Spandidos, University of Toronto, Canada: Transfer of genes which cause malignancy in mammalian cells.
May
John Fiddes, University of California School of Medicine, San Francisco: Bacteriophage G4-A comparison of its
sequence and overlapping genes with cp X 1 74.
Michael Wigler, Columbia University, New York, New York: Gene transfer in tissue culture.
Kevin Struhl, Stanford University, California: Transformation in yeast.
Anton Jetten, Roche Institute of Molecular Biology, Nutley, New Jersey: Action of retinoids on fibroblasts and embryonic
carcinoma cells.
John Smart, Imperial Cancer Research Fund Laboratories, London, England: The biological implications of a comparative
cryptic peptide map analysis of the tumor antigens of polyoma virus.
Richard Frisque, University of Wisconsin, Madison: Biological and biochemical properties of IC virus DNA.
Janice Pero, Harvard University, Cambridge, Massachusetts: RNA polymerase from SP01-infected B. subtilis.
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UNDERGRADUATE SUMMER
RESEARCH PROGRAM
Another aspect of the summer program at the Laboratory is the participation of college undergraduate students in
active research projects under the supervision of full-time laboratory staff members. The program was initiated
in 1959. Since that year, 195 students have completed the course, and many have gone on to creative careers in
biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental principles of
biology, (2) an increased awareness of major problem areas under investigation, (3) better understanding of the
physical and intellectual tools for modern research and the pertinence of this information to future training, and
(4) a personal acquaintance with research, research workers, and centers for study.
The following students, selected from a large number of applicants, took part in the program, which is now
mainly supported by Laboratory funds. They are listed below, with their laboratory sponsors and topics of
research. We gratefully acknowledge the generosity of Central General Hospital, Plainview, New York, which
provided additional support.
Ezekiel J. Emanuel, Amherst College Isolation of mutations in the mating type locus of S.
Supervisor: J.B. Hicks
Debra Sue Erdmann, University of Wisconsin
Supervisor: D.Y. Kwoh
Scott Finley, State University of New York, Stony
Brook
Supervisor: N. Harter
Judith R. Krieger, Harvard University
Supervisor: K. Burridge
James Lupski, New York University
Supervisor: A.I. Bukhari
Kenneth B. McElwain, Wesleyan University
Supervisor: T.R. Broker
Jeremy H. Nathans, Massachusetts Institute of
Technology
Supervisor: R.I. Roberts
cerevisiae
Genetic recombination and complementation be-
tween bacteriophage Mu and cloned fragments
of Mu DNA
Immunological identification of Ad2 early proteins
The use of monoclonal antibodies to study cell
surface antigens
Construction of plasmids containing ends of pro-
phage Mu DNA
Identification of recombinant plasmids with Tn5
(the Kanamycin transposon) inserted in cloned
phage Mu DNA
Modifications of Sanger's chain termination DNA
sequencing method as applied to adenovirus 2
DNA
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Susan Rolseth, University of Connecticut
Supervisor: Y.-S. E. Cheng
Adam Leon Schulman, University of Chicago
Supervisor: G. Albrecht-Buehler
Michael J. Stern, Stanford University
Supervisor: J.R. Broach
Olney Fellowship
Steven Robi now, University of California, Berkeley
Supervisor: R. Tjian
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Characterization of E. coli K12 mutants defective in
protease III
The effect of cold shocks on the mirror-symmetrical
migration of sister 3T3 cells
Cloning SUP61, a yeast serine-inserting,
recessive-lethal, nonsense-suppressor gene
Enzymatic and DNA binding properties of the
SV40 A-gene product
NATURE STUDY PROGRAM
The Nature Study Program is designed for elementary and high school students who wish to achieve a
greater understanding of their environment. During the summer and fall a total of 324 students participated
in these activities. When weather permitted, most of the courses were held outdoors on Laboratory grounds
or at Uplands Farm Nature Preserve of The Nature Conservancy, where the Laboratory has equipped and
maintains classroom/laboratories for the study of field specimens collected by the students.
This summer the series of one day "Marine Biology Workshops" was extended to two weeks, including
two cruises for adults. The studies, conducted on Long Island Sound, were performed aboard the R/V
Tradewind, chartered from Schooner Inc., New Haven, Connecticut. The vessel is equipped with a variety of
instrumentation and staffed by a Captain, mate, and Marine Biologist. Students participated in the biological
studies and in the actual sailing of the vessel.
This past summer "Adventure Education" was added, which included an 18-mile bicycle hike, a 12-mile
canoe trip, and sailing on Long Island Sound.
In the Fall, "Observational Astronomy" was again offered as an introduction to all facets of astronomy.
Photography as related to Astronomy was included, with students utilizing our fully equipped darkroom.
Telescopes for the observational sessions were provided by Ehrenreich Photo-Optical, and technical assis-
tance by The Astronomical Society of Long Island and the Long Island Observers Association.
Program director: Sanford Kaufman, M.S., M.P.A., biology teacher, Hewlett High School
INSTRUCTORS
Don Dunn, M.S., art and photography teacher, Hewlett High School
Phylis Hechtlenger, M.S., science teacher, East Rockaway High School
Carolyn Hess, M.A. candidate, SUNY at Stony Brook
Lois Joseph, M.A., biology teacher, Hewlett High School
Fred Maasch, M.Ed., biology teacher, Islip High School
James Romansky, M.S., biology teacher, Bay Shore High School
Edward Tronolone, M.S., science teacher, Lynbrook North Middle School
COURSES
General Nature Study
Advanced Nature Study
Elementary Geology
Geology
Bird Study
Seashore Life
Animals with Backbones
Reptiles and Amphibians
Aquatic Biology
Marine Biology
Nature Photography I and II
Fresh Water Life
Observational Astronomy
Adventure Education
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BANBURY CENTER
The Banbury program of small meetings on environmental health risks
began the hard way. It poured with rain on the Sunday in May when
most of the scientists attending our first meeting were to arrive. Thus,
there were few to eat the first of a series of excellent meals prepared by
our local caterer. The details of the meeting, including the contract for
it, were arranged in just a few weeks during which it seemed that a new
chemical carcinogen was cropping up almost daily. And the subject of
the first meeting was inherently difficult. Leading students of animal
and human genetics spent three days arguing about the risk to future
generations from mankind's rapidly increasing commitment to chemi-
cal technology. The conclusions seemed to be that there is a risk, albeit
hard to measure, and that geneticists should warn governments of the
urgent need to gather data rigorously on the occurrence of mutations
in newborns. This would provide a background against which the
effects of new pollutants could be measured.
We taped it all, deciphered almost all of it, let the authors see our
transcript, and participated in the difficult task of writing a summary of
the conference. In November, a final draft report was produced for the
meeting's sponsor, the Office of Toxic Substances of the Environmen-
tal Protection Agency, using the same IBM Office System 6 equipment
that is producing the proceedings volume that the Laboratory is pub-
lishing April 1.
While learning hard lessons about rapid production of proceedings
volumes from tape recordings, the Banbury staff was planning a series
of 1979 meetings on six topics: short-term mutagenicity tests using
mammalian cells, risk assessment with the Mormon data bank, the
consequences of finding that ethylene dichloride causes cancer in
animals, the possibilities of a safe cigarette, the quantification of
industrial cancer, and prolactin inducers.
The planning involved many steps. The Banbury Director, Victor
McElheny, attended several conferences on environmental health
problems, including the massive sessions in June arranged for the New
York Academy of Sciences by Dr. Irving Selikoff. There were visits to
the libraries of Dr. Selikoff at Mt. Sinai Hospital and Dr. Norton Nelson
at Sterling Forest, New York. A select library on biological risk assess-
ment was established at Banbury, and the Director's 20-year file of
news clipping and releases on toxic substances was reworked. Advice
was sought widely. We held a two-hour session with the participants
of the Laboratory's phorbol ester meeting last May, and a smaller
session with participants in the Symposium on DNA replication and
recombination.
There were frequent contacts with John Cairns, Bruce Ames, Bernard Weinstein, Richard Peto, Joyce
McCann, Fred de Serres of the National Institute of Environmental Health Sciences, Alexander Hollaender of
Associated Universities, Inc. and with such representatives of industry as John Burns of Hoffmann-La Roche, Inc.
As the conversations proceeded, the subject of biological risk assessment divided itself into such salient topics as
the technology of short-term testing, problems of human data collection, industrial carcinogens, consumer
health risks, and diet and human cancer. In developing the Banbury program, it became clear that our topics are
a logical extension of the territory pioneered by the Laboratory's 1976 Conference on the Origins of Human
Cancer. It also became clear that every department of the laboratory was ready to help the new center get under
way-and that this help was vital.
ASSESSING CHEMICAL MUTAGENS: The Risk to Humans
May 15-May 17
Session 1
R.N. Hill, Office of Toxic Substances, Environmental Protection Agency, Washington, D.C.: Introduction.
J.V. Neel, Department of Human Genetics, University of Michigan Medical School, Ann Arbor: Mutation
and disease in humans.
W.G. Flamm, Division of Toxicology, Bureau of Foods, Food and Drug Administration, Washington, D.C.:
Strengths and weaknesses of tests for mutagenesis.
Session 2
E. Eisenstadt, Departments of Microbiology and Physiology, Harvard University School of Public Health,
Boston, Massachusetts: Bacterial mutagenicity testing: Some practical considerations.
G. Biology Department, Massachusetts Institute of Technology, Cambridge: Theory and design of
short-term bacterial tests for mutagenesis.
R. Setlow, Biology Department, Brookhaven National Laboratory, Upton, New York: DNA repair.
J. G. Brewer?, Biology Division, Oak Ridge National Laboratory, Tennessee: Cytogenetic studies and risk
assessment for chemicals and ionizing radiation.
Session 3
L. R. Valcovic, Public Health Service, Bureau of Foods, Food and Drug Administration, Washington, D.C.:
General aspects of comparative mutagenesis.
Session 4
J.W. Baum, Safety and Environmental Protection Division, Brookhaven National Laboratory, Upton, New
York: Radiation-induced cancer.
D. Hoel, Biometry Branch, National Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina: Low-dose and species-to-species extrapolation for chemically induced carcinogenesis.
S. Abrahamson, Department of Zoology, University of Wisconsin, Madison: Estimating radiation-induced
genetic disease burdens.
L. Ehrenberg, Wallenberg Laboratory, Stockholm University, Sweden: Risk assessment of ethylene oxide and
other compounds.
W.B. Lee, Jr., Department of Zoology, Louisiana State University, Baton Rouge: Dosimetry of alkylating
agents.
V. Ray, Medical Research Laboratory, Pfizer, Inc., Groton, Connecticut: Are benzene effects limited to the
chromosomal level?
Sessions 5, 6, 7
Discussions
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FINANCIAL STATEMENT
BALANCE SHEET
year ended December 31, 1978
with comparative figures for 12 months ended October 31, 1977
ASSETS
CURRENT FUNDS
Unrestricted
1978 1977
LIABILITIES AND
CURRENT FUNDS
Unrestricted
FUND BALANCES
1978 1977
Cash $ 312,756 $ 269,437 Accounts payable $
149,608 $ 68,291
Accounts Receivable 174,199 89,366 Mortgage Payable
166,500
Prepaid expenses 23,742 68,704 Due to plant funds 377,531
417,178
Inventory of books 135,838 121,937 Fund balance 69,533
199,544
Due from restricted fund 101,653 135,569
Due from Banbury Center 14,984
Total unrestricted 763,172 685,013 Total unrestricted 763,172
685,013
Restricted
Grants and contracts receivable 2,063,598 2,396,218
Restricted
Due to unrestricted funds
Fund balance
101,653
1,961,945
135,569
2,260,649
Total restricted 2,063,598 2,396,218 Total restricted 2,063,598
2,396,218
Total current funds $ 2,826,770 $ 3,081,231 Total current funds $ 2,826,770 $ 3,081,231
ENDOWMENT FUNDS ENDOWMENT FUNDS
Robertson Research Fund
Cash 25,073 96,492
Accrued interest 45,400
Marketable securities
(quoted market 1978-$8,427,386;
1977-$8,122,321) 7,978,726 7,814,204
Total Robertson Research Fund 8,033,799 7,956,096
Olney Memorial Fund
Cash 412 550
Marketable Securities
(quoted market 1978-$22,496;
1977-$20,951) 24,123 21,510
Total Olney Memorial Fund 24,535 22,060
Total endowment funds $ 8,058,334 $ 7,978,156 Fund balance $ 8,058,334 $ 7,978,156
PLANT FUNDS PLANT FUNDS
Investments 219,358 84,508
Due from unrestricted fund 377,531 270,362
Land and improvements 935,530 719,545
Buildings 5,493,511 5,171,784
Furniture, fixtures and equipment 857,891 792,690
Books and periodicals 365,630 365,630
Construction in progress 65,012 '24,136
8,314,463 7,428,655
Less allowance for depreciation
and amortization 1,545,396 1,143,102
Total plant funds 6,769,067 6,285,553 Fund balance $ 6,769,067 $ 6,285,553
BANBURY CENTER BANBURY CENTER
Cash 9,304 4,178 Due to unrestricted fund 14,984
Accrued interest - 18,181 Fund balance 1,488,074 1,537,907
Marketable securities
(quoted market 1978-$1,539,539;
1977-$1,530,097) 1,493,754 1,515,548
Total operating funds 1,503,058 1,537,907 Total operating funds 1,503,058 1,537,907
Land 772,500 772,500
Buildings 412,672 384,234
Furniture, fixtures, and equipment 160,700 147,887
Construction in progress 8,856 -
1,354,728 1,304,621
Less allowance for depreciation 86,886 45,211
Total plant funds 1,267,842 1,259,410 Plant funds balance 1,267,842 1,259,410
Total Banbury Center $ 2,770,900 $ 2,797,317 Total Banbury Center $ 2,770,900 $ 2,797,317
Total-All funds $20,425,071 $20,142,257 Total-All funds $20,425,071 $20,142,257
CURRENT REVENUES, EXPENDITURES AND TRANSFERS
year ended December 31, 1978
with comparative figures for 12 months ended October 31, 1977
COLD SPRING HARBOR LABORATORY
1978 1977
BANBURY CENTER
1978 1977
REVENUES REVENUES
Grants and contracts $2,826,545 $2,133,568 Endowment income $ 83,424 $107,291
Indirect cost allowances on grants and Grants & contributions 100,000 15,000
contracts 1,299,409 957,464 Conference fees 970
Contributions Rooms and apartments 16,700 12,750
Unrestricted 100,660 37,529 Transfer from Cold
Restricted 10,000 25,000 Spring Harbor Laboratory 12,900 61,043
Long Island Biological Association 31,000 194,000
Robertson Research Fund Distribution 379,167 325,000 Total revenues 213,994 196,084
Summer programs 207,838 183,744
Laboratory rental 21,796 20,554 EXPENDITURES
Marina rental 39,900 38,000 Conferences 10,179Investment income 45,424 10,430 Operation and maintenance of plant 81,929 56,665Publications sales 649,041 383,196 Program administration 86,949 12,545Dining hall 272,845 238,300 Capital plant 49,826 169,825Rooms and apartments
Other sources
183,575
59,175
151,601
8,234 Total expenditures 228,883 239,035
Total revenues 6,126,375 4,706,620
Excess of expenditures
EXPENDITURES over revenues $ 14,889 $ 42,951
Research* 2,583,374 2,014,119
Summer programs* 518,570 342,544
Library 111,479 100,927
Operation and maintenance of plant 796,998 638,316
General and administrative 598,880 497,863
Publications sales* 530,834 303,829
Dining hall* 228,767 211,647
Total expenditures 5,368,902 4,109,245
TRANSFERS
Plant funds 759,855 515,483
Banbury Center 12,900 61,043
Total transfers 772,755 576,526
Total expenditures and transfers 6,141,657 4,685,771
Excess (deficit) of revenues
over expenditures and transfers $ (15,282) $ 20,849
*Reported exclusive of an allocation for operation and maintenance of plant,
general and administrative, and library expenditures.
Note: Copies of our complete, audited financial statements, certified by our independent auditors, Peat, Marwick, Mitchell & Co., are available
upon request from the Comptroller, Cold Spring Harbor Laboratory.
GRANTS
January 1, 1978-December 31, 1978
NEW GRANTS
Grantor
COLD SPRING HARBOR LABORATORY
Principal investigator
and program Total award
Duration of
grant
National Institutes of Health Dr. Watson-advanced bacterial
genetics course $ 40,000 6/30/78- 4/30/79
Dr. Watson-transfer RNA
meeting 5,000 7/1/78- 6/30/79
Dr. Watson-hormones and cell
culture meeting 25,000 8/1/78-12/31/78
Dr. Gingeras-fellowship 26,400 1/1/78-12/31/79
Dr. Hicks-research 263,400 7/1/78- 6/30/81
Dr. Klar-research 253,000 7/1/78- 6/30/81
Dr. D. Zipser-fellowship
training 618,000 7/1/78- 6/30/83
Dr. Albrecht-Buehler-research 73,612 9/1/78- 8/31/80
Dr. Blose-research 169,237 12/1/78-11/30/81
National Science Foundation Dr. Watson-neurobiology courses 45,000 6/15/78- 5/31/79
Dr. Watson-hormones and cell
culture meeting 2,000 8/1/78- 7/31/79
Dr. Watson-transfer RNA
meeting 5,000 7/1/78- 6/30/79
W. Udry-Symposium support 5,000 5/15/78-10/31/78
Dr. Burridge-equipment 120,440 7/1/78-12/31/79
Dr. Hicks-equipment 24,000 8/15/78- 1/31/80
Dr. B. Zipser-research 120,000 11/1/78- 4/30/82
Dr. D. Zipser-research 136,000 2/15/78- 7/31/81
American Cancer Society Dr. Lewis-research 53,250 7/1/78- 6/30/79
Dr. Garrels-fellowship 21,075 9/1/78- 8/31/80
Dr. Zain-research 67,908 1/1/78 -12/31/79
Canadian Medical Research
Council Dr. Chaconas-fellowship 12,000 10/1/78- 9/30/79
Department of Energy W. Udry-Symposium support 8,000 5/1/78- 4/30/79
The Camille and Henry Dreyfus
Foundation Dr. Watson-undergraduate
research participation 20,000 12/1/78- 9/30/79
International Union
Against Cancer Dr. Graessman-institutional
allowance 1,000 4/1/78-10/31/78
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NEW GRANTS
COLD SPRING HARBOR LABORATORY
Principal investigator
Grantor and program
Leukemia Society of America Dr. Engler-fellowship
Muscular Dystrophy Association Dr. Burridge-research
Dr. Gordon-fellowship
Dr. D. Zipser-neurobiology courses
Total award
Duration of
grant
25,000 11/1/78-10/31/80
25,142 7/1/78- 6/30/79
15,500 1/1/78 -12/31/78
15,000 6/1/78- 9/30/78
Alfred P. Sloan Foundation Dr. D. Zipser-Biological Information
Processing Workshop 17,800 5/1/78- 4/30/79
Damon Runyon-Walter Winchell
Cancer Fund Dr. Brooks-fellowship
Dr. Hu-fellowship
Dr. Kilpatrick-fellowship
Dr. Stow-fellowship
Dr. Strathern-fellowship
28,560 1/1/78 -12/31/79
25,800 7/1/78- 6/30/80
30,000 1/1/78 -12/31/79
30,000 10/1/78- 9/30/80
29,980 4/1/78- 3/31/80
BANBURY CENTER
Environmental Protection Agency conference on chemical mutagens 29,000 5/11/78-11/10/78
Esther A. and Joseph
Klingenstein Fund program support 100,000 3/1/78- 2/29/80
Alfred P. Sloan Foundation program support 100,000 8/1/78- 7/31/80
CONTINUING GRANTS
Grantor
National Institutes of Health
COLD SPRING HARBOR LABORATORY
Principal investigator Duration of
and program Total award grant
Dr. Watson-Cancer Research
Center $13,500,000 1/1/77-12/31/81
Dr. Watson-general research
support 114,761 4/1/76- 3/31/79
Dr. Watson-Symposium support 96,000 4/1/74- 3/31/79
149
CONTINUING GRANTS
Grantor
National Science Foundation
Rita Allen Foundation
American Cancer Society
American Heart Association
Jane Coffin Childs
Energy Research and
Development Administration
Eppley Foundation
Muscular Dystrophy Association
Alfred P. Sloan Foundation
COLD SPRING HARBOR LABORATORY
Principal investigator Duration of
and program Total award grant
Dr. Watson-summer workshops 400,620 4/1/77 3/31/82
W. Udry-cancer research
facility
W. Udry-advanced bacterial
genetics course
Dr. Broach-research
Dr. Bukhari-career development
Dr. Bukhari-research
Dr. Chow-research
Dr. Gal loway-fellowship
Dr. Zain-research
Dr. D. Zipser-research
W. Udry-Symposium support
Dr. Bukhari-research
Dr. Gesteland-research
Dr. McDougall-research
Dr. Roberts-research
Dr. Zain-research
Dr. D. Zipser-research
Dr. Lewis-research
Dr. Lewis-research
Dr. Chen-research
Dr. Gluzman-fellowship
W. Udry-Symposium support
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1,411,000 9/15/77indefi-
nite
35,500 6/29/77 6/30/78
144,320 8/1/77 7/31/79
148,961 5/1/75 4/30/80
121,351 9/9/77 8/31/80
238,186 4/1/77 3/31/80
28,000 12/1/76 11/30/78
34,572 9/30/77 7/31/79
355,657 5/1/74 4/30/79
$ 10,000 6/1/77 5/31/78
130,000 8/1/76 1/31/79
168,000 1/1/75 8/31/78
45,274 8/1/77-10/31/78
130,000 4/1/77-10/31/79
65,000 8/15/77 1/31/80
160,000 1/1/74 8/31/78
150,000 8/1/76 7/31/81
45,500 7/1/77 6/30/78
12,000 7/1/77 6/30/78
24,000 9/16/77 9/15/79
$ 8,000 5/1/77 4/30/78
30,000 1/1/76-12/31/78
18,900 7/1/77 6/30/78
20,000 7/1/77 6/30/78
165,000 1/1/75 12/31/78
28,980 3/1/77 2/28/79
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FINANCIAL SUPPORT
OF THE LABORATORY
The Cold Spring Harbor Laboratory is a publicly supported educational institution chartered by the University of
the State of New York and may receive contributions which are tax exempt under the provisions of the Internal
Revenue Code, particularly Section 501C. In addition, the Laboratory has been formally designated a "public
charity" by the Internal Revenue Service. Accordingly, it is an acceptable recipient of grants which would result
from the termination of "private" foundations.
The Laboratory depends upon the generous contributions of its sponsors, participating institutions, and friends
for central institutional needs and capital improvements. In addition, the development of any new programs, such
as year-round research in neurobiology and the marine sciences, can only be undertaken with substantial support
from private sources.
Methods of contributing to Cold Spring Harbor Laboratory
Cifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities
(1) Your broker or bank may sell the securities and remit the proceeds directly to the Laboratory.
(2) If you wish to send stock directly to the Laboratory, either (a) endorse the certificate(s) by sign ingyour name
on the back, leave the space for the transferee's name blank, have your signature guaranteed on the
certificate(s) by your bank or broker, and send the certificate(s) by registered mail to the Laboratory, or (b)
send unsigned certificate(s) with a covering letter and send under separate cover a stock power executed in
blank, with signature guarantee, for each certificate, and also a copy of the covering letter (use first-class
mail). Depreciated securities should be sold to establish a tax loss, then the contribution to the Laboratory
should be made by check.
Bequests
Probably most wills need to be updated. Designating Cold Spring Harbor Laboratory as a beneficiary ensures
that a bequest will be utilized as specified for continuing good.
Appreciated real estate or personal property
Sizable tax benefits can result from such donations; the Laboratory can use some in its program and can sell
others.
Life insurance and charitable remainder trusts can be structured to suit the donor's specific desires as to extent,
timing, and tax needs.
Conversion of private foundation to "public" status on termination
This may be done by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of the
private foundation could be accounted for as a separate fund and used for the purposes specified by the donor.
Alternatively, the private foundation can be established as a "supporting organization of Cold Spring Harbor
Laboratory."
For additional information, please contact the Administrative Director, Cold Spring Harbor Laboratory, P.O.
Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-692-6660.
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LONG ISLAND
BIOLOGICAL ASSOCIATION
Carnegie Dormitory
The Laboratory was founded in 1890 by several local philanthropists and the Brooklyn Institute of Arts and
Sciences. The first chairman of the Board of Managers of the Laboratory was Eugene G. Blackford, who served
from 1890 until his death in 1904. William J. Matheson succeeded him, serving until 1923.
In that year, when the Brooklyn Institute of Arts and Sciences withdrew from Cold Spring Harbor, the local
supporters of the research formalized their efforts by incorporating as the Long Island Biological Association.
Colonel T.S. Williams became the first Chairman of the new group. Jointly with the Carnegie Institution of
Washington, LIBA continued to support and direct the research at Cold Spring Harbor Laboratory.
In 1962 the Laboratory was reorganized as an operating organization and LIBA relinquished its management
responsibilities. During the past 16years, LIBA's chief function has been to widen the interest of the community in
the Laboratory and to help support it financially.
OFFICERS
Chairman Mr. Edward Pulling
President Mr. Walter H. Page
Treasurer Mr. James A. Eisenman
Secretary Mrs. James J. Pirtle, Jr.
Asst. Secretary-Treasurer Mr. William R. Udry
DIRECTORS
Class of 1978 Class of 1979 Class of 1980 Class of 1981
Mr. Ralph I. Maffei Mr. David C. Clark Mrs. Charles 0. Ames Mr. Samuel R. Callaway
Mr. James A. McCurdy Mr. Roderick H. Cushman Mr. Charles S. Gay Mr. James A. Eisenman
Mr. Walter H. Page Mr. Norris W. Darrell, Jr. Mr. George J. Hossfeld, Jr. Mrs. Robert H. P. Olney
Mr. Gerard Piel Mrs. William A. Flanigan, Jr. Mr. Samuel D. Parkinson Mr. Richard Olney III
Mrs. Edward Everett Post Mr. Walter N. Frank, Jr. Mr. William Parsons, Jr. Mrs. James J. Pirtle
Mrs. Richardson Pratt Mr. Clarence E. Galston Mr. Edward Pulling Mr. Stanley Trotman
Mr. Richard J. Weghorn Mr. Theodore Wickersham Dr. James D. Watson Mrs. Alex White
153
CONTRIBUTORS
to the Long Island Biological Association
Mr. & Mrs. Thomas Ackerman
Mr. & Mrs. Warren S. Adams II
Mr. & Mrs. Amy. Ames
Mrs. Charles E. Ames
Mr. & Mrs. Charles 0. Ames
Dr. & Mrs. Oakes Ames
Mr. & Mrs. Hoyt Ammidon
Mr. Robert W. Anthony
Mr. & Mrs. J. S. Armentrout
Mr. & Mrs. Donald Arthur
Dr. & Mrs. Joseph T. August
Dr. & Mrs. Alfred Azzoni
Mr. Henry D. Babcock, Jr.
Mr. & Mrs. Benjamin H. Balkind
Mrs. Gilbert Ball
Mr. & Mrs. George C. Barclay
Mr. & Mrs. D. R. Barr
Mr. & Mrs. Edmund Bartlett
Mrs. E. Farrar Bateson, Jr.
Mr. & Mrs. Robert E. Belknap, Jr.
Dr. & Mrs. Stephen Belman
Dr. & Mrs. Alan Bernheimer
Mr. & Mrs. Loren C. Berry
Mr. & Mrs. R. Beuerlein
Mr. & Mrs. Nicholas Biddle, Jr.
Mr. & Mrs. William Binnian
Mr. F. Roberts Blair
Mr. & Mrs. Bache Bleecker
Rev. & Mrs. Lyman C. Bleecker
Mrs. R. DeWitt Bleecker
Mr. & Mrs. A. L. Boorstein
Dr. & Mrs. George Bowen
Dr. & Mrs. Arik Brissenden
Mr. Horace Brock
Mr. F. Sedgwick Browne
Mr. & Mrs. James Bryan, Jr.
Mr. & Mrs. R. P. Burr
Mr. & Mrs. John Busby
Mr. & Mrs. Albert Bush-Brown
Mr. & Mrs. Sidney G. Butler
Mr. & Mrs. S. R. Callaway
Mr. & Mrs. John P. Campbell
Dr. & Mrs. Rolla Campbell
Mr. & Mrs. Ward C. Campbell
Mr. & Mrs. John Carr
Mr. & Mrs. T. C. Cattrall, Jr.
Mr. & Mrs. Lionel Chaikin
Mr. & Mrs. Harry Charlston
Miss Joan Chodkowski
Mr. & Mrs. Charles M. Clark
Mr. & Mrs. David C. Clark
Dr. & Mrs. Bayard Clarkson
Mrs. C. Payson Coleman
Mr. & Mrs. John H. Coleman
Mr. Bradley Collins
Mrs. Michael Collins
Mr. & Mrs. Patrick Collins
Mrs. Ralph C. Colyer
Dr. & Mrs. Crispin Cooke
Mr. & Mrs. Howard Coming, Jr.
154
Mr. & Mrs. Duncan B. Cox
Mr. E. V. Cox, Jr.
Mr. & Mrs. Charles L. Craig
Mr. & Mrs. Miner D. Crary, Jr.
Mr. & Mrs. Arthur M. Crocker
Mr. Robert L. Cummings
Dr. & Mrs. Paul Cushman, Jr.
Mr. & Mrs. Roderick H. Cushman
Mr. & Mrs. George W. Cutting, Jr.
Mr. Theodore H. Danforth
Mr. & Mrs. Norris Darrell, Jr.
Mr. & Mrs. Lawrence Davis
Mrs. F. Trubee Davison
Mr. & Mrs. Jay De Bow
Mr. & Mrs. Raymond deClairville
Mr. & Mrs. Donald L Deming
Mrs. William Denby
Mr. & Mrs. Douglas Despard, Jr.
Mr. & Mrs. Joseph C. Dey, Jr.
Mr. David Dowd
Mr. & Mrs. Clark M. Drasher, Jr.
Dr. & Mrs. Lester Dubnick
Mr. & Mrs. Hutchinson DuBosque
Mr. & Mrs. James C. Dudley
Dr. & Mrs. John L. Duffy
Mr. & Mrs. Edgar P. Dunlaevy
Mr. & Mrs. William T. Dunn, Jr.
Mr. & Mrs. James D. Ebert
Mr. & Mrs. Paul S. Eckhoff
Mrs. Joseph R. Eggert, Jr.
Mr. & Mrs. James A. Eisenman
Mr. & Mrs. Fred J. Eissler
Mr. & Mrs. Duncan Elder
Mr. Ashton G. Eldredge
Mr. & Mrs. Martin Elias
Mr. Henri Eyl
Mr. & Mrs. Raymond Z. Fahs
Mrs. B. Tappen Fairchild
Mr. & Mrs. H. L. Fates
Mrs. Allston Flagg
Mrs. William A. Flanigan, Jr.
Mr. & Mrs. Nevi! Ford
Mr. & Mrs. Henry L. Fox
Mr. & Mrs. Joseph C. Fox
Mr. Walter N. Frank, Jr.
Mr. & Mrs. George S. Franklin
Frasse & Co.
Mr. & Mrs. Jack B. Friedman
Mr. & Mrs. Frank Fuller
Mr. D. Kent Gale
Mr. & Mrs. Clarence E. Galston
Mr. & Mrs. Charles S. Gay
Mr. & Mrs. Robert A. Gay
Mr. & Mrs. Louis F. Geissler, Jr.
Mrs. Ruth Reed Gillespie
Dr. & Mrs. H. Bentley Glass
Dr. & Mrs. Dulaney Glen
Mr. & Mrs. Bernard Gloisten
Mr. & Mrs. E. Rawson Godfrey
Mr. & Mrs. Joseph Goeschl
Dr. E. Raymond Goodrich
Mr. & Mrs. Kilbourn Gordon, Jr.
Mrs. Charles V. Graham
Mr. & Mrs. William R. Grant
Green lawn Veterinary Clinic
Mr. & Mrs. Alfred T. Gregory
Dr. & Mrs. Donald Gromisch
Mrs. Joanna Hadden
Mr. & Mrs. Morris Hadley
Mr. & Mrs. Lawrence Hahn
Mr. & Mrs. Henry U. Harris
Dr. & Mrs. C. Hartenstein
Mr. & Mrs. R. D. Hartman
Mr. & Mrs. Horace Havemeyer, Jr.
Mr. Jerry 0. Havranek, Jr.
Mr. Huy ler C. Held
Mr. & Mrs. James E. Hellier
Dr. & Mrs. William W. Heroy
Mr. & Mrs. Charles L. Hewitt
Mr. Edward L. Hewitt
Mr. & Mrs. Herman A. Heydt
Miss Cynthia Hopkins
Mr. & Mrs. Frederick G. Hoppin
Mr. & Mrs. George J. Hossfeld
Mr. & Mrs. George). Hossfeld, Jr.
Mr. Chandler Hovey, Jr.
Mrs. J. Taylor Howell
Mrs. Everett W. Hoyt
Mr. & Mrs. Charles J. Hubbard
Mr. & Mrs. Philip G. Hull
Mr. & Mrs. John C. Ingersoll
Mrs. David Ingraham
Mr. & Mrs. Frederic B. Ingraham
Mr. & Mrs. Valdemar F. Jacobsen
Mr. Irving D. Jakobson
Walter B. James Fund
Dr. N. Mitchel Jason
Mr. & Mrs. Robert D. Jay
Mr. & Mrs. John J. Juda
Mr. & Mrs. Henry J. Katie'
Dr. & Mrs. Irving H. Kagan
Mr. & Mrs. Morris I. Karpen
Mr. & Mrs. Francis E. Kelly, Jr.
Mrs. Walter A. Kernan
Mr. Brian King
Mrs. Samantha King
Mr. & Mrs. John P. Kipp
Mr. & Mrs. Robert P. Koenig
Mr. & Mrs. Edward W. Kozlik
Mr. & Mrs. Paul Kramer
Mrs. Carol Lamb
Mr. & Mrs. Gordon Lamb
Mr. & Mrs. Edward M. Lamont
Mr. & Mrs. Orin T. Leach
Mrs. Randall J. LeBoeuf, fr.
Mrs. Burton J. Lee
Mr. & Mrs. Henry C. Lee
Rev. & Mrs. T. Carleton Lee
Dr. & Mrs. R. V. Lewis
Mrs. Elizabeth A. Lindsay
Mr. & Mrs. George Lindsay
Mr. & Mrs. Robert V. Lindsay
Mr. & Mrs. Bernard Lippman
Mr. & Mrs. V. S. Littauer
Mr. & Mrs. John H. Livingston
Dr. S. E. Luria
Mr. & Mrs. John F. MacKay
Mrs. Malcolm MacKay
Mr. & Mrs. Marshall MacLeod
Mrs. Henry R. Macy
Mr. & Mrs. J. A. McCurdy II
Miss Diana Mcllvaine
Mr. & Mrs. Angus P. McIntyre
Mr. & Mrs. Randall P. McIntyre
Mr. & Mrs. Ralph J. Maffei
Mr. & Mrs. J. R. Mahoney
Mr. & Mrs. John Mariani
Mrs. John B. Marsh
Mr. & Mrs. John M. Martin
Mr. & Mrs. William H. Mathers
Dr. Ernst Mayr
Dr. & Mrs. Walter Meier
Dr. & Mrs. Leo M. Meyer
Mr. & Mrs. Kennedy B. Middendorf
Mr. & Mrs. William H. Miller
Mr. Dudley H. Mills
Mr. & Mrs. George G. Montgomery, Jr.
Mr. & Mrs. F. Franklin Moon
Mrs. William G. Moore
Mr. & Mrs. Henry S. Morgan
Mrs. Grinnell Morris
Mr. & Mrs. Allan F. Munro
Mr. & Mrs. Francis W. Murray III
Mr. & Mrs. Quigg Newton
Mr. Acosta Nichols
Mrs. George Nichols
Mr. & Mrs. John W. Nields
Mr. & Mrs. William S. Niven
Mr. Lawrence W. Northam
Mr. & Mrs. Charles P. Noyes
Mr. & Mrs. David C. Noyes, Jr.
Mr. & Mrs. Richard Olney Ill
Mrs. Robert H. P. Olney
Mr. & Mrs. George D. O'Neill
Mr. & Mrs. Grover O'Neill, Jr.
Mr. & Mrs. Arthur W. Page, Jr.
Dr. & Mrs. David A. Page
Mr. & Mrs. John H. Page
Mr. & Mrs. Walter H. Page
Mr. & Mrs. Fred W. Pain
Mr. & Mrs. Samuel D. Parkinson
Mr. & Mrs. William Parsons
Mr. & Mrs. William Parsons, Jr.
Mr. & Mrs. Charles F. Paul
Mr. & Mrs. William H. Peck, Jr.
Mr. & Mrs. Ernest Penchuk
Mrs. Paul G. Pennoyer
Mr. & Mrs. Paul Pennoyer, Jr.
Mrs. Bernard Peyton
Miss Linda Peyton
Mr. & Mrs. Lewis G. Phillips
Mr. & Mrs. Howard Phipps, Jr.
Mr. John Pickett
Mrs. Richard N. Pierson
Mr. & Mrs. James J. Pirtle
Mr. & Mrs. Collier Platt
Mr. & Mrs. Francis T. P. Plimpton
Mr. & Mrs. Martin Pollak
Mr. & Mrs. Edward Everett Post
Mrs. Frank C. Powell
Mrs. H. Irving Pratt
Mr. & Mrs. Richardson Pratt
Mr. & Mrs. William Preston
Mr. & Mrs. Edward Pulling
Mr. & Mrs. Thomas Pulling
Mr. & Mrs. James T. Pyle
Mrs. William Rand
Mr. & Mrs. Roland 0. Rasch
Dr. John H. Ray III
Mrs. Joanne Reed
Mr. & Mrs. John R. Reese
Mr. & Mrs. Willis L M. Reese
Mr. & Mrs. Cornelius J. Reid
Mr. & Mrs. Jose L. Reissig
Mr. & Mrs. Bernard J. Reverdin
Mr. & Mrs. John T. Ricks
Mr. & Mrs. Samuel B. Rogers
Mrs. Philip J. Roosevelt
Mrs. Quentin Roosevelt
Mr. & Mrs. Charles W. Root
Mrs. Donald W. Rose
Mr. & Mrs. Arthur W. Rossiter, Jr.
Mr. & Mrs. Walter N. Rothschild, Jr.
Mr. & Mrs. Francis J. Rue, Jr.
Mr. & Mrs. Harold B. Salembier
Mr. & Mrs. Bernard Salzberg
Mr. & Mrs. John K. Sands
Mr. John M. Schiff
Dr. & Mrs. Carl J. Schmidlapp II
Mr. & Mrs. Frederick P. Schmitt
Mr. & Mrs. Franz Schneider
Dr. Irving M. Schneider
Mr. & Mrs. Hermann C. Schwab
Mr. & Mrs. David R. Schwarz
Mr. & Mrs. Frederick E. Seymour
Mr. & Mrs. Dale Sharp
Mr. & Mrs. Paul C. Sheeline
Mr. & Mrs. Douglas A. Shepardson, Jr.
Dr. & Mrs. Paul Siminoff
Mr. & Mrs. Richard Simmons
Mr. & Mrs. W. 0. Simpson
Mrs. James C. Skiff
Mr. & Mrs. William S. Smoot
Mr. W. 0. Stanton
Mr. & Mrs. James F. Stebbins
Mr. & Mrs. Theodore E. Stebbins
Mrs. J. Rich Steers
Mr. & Mrs. Norman W. Stewart
Mr. Dudley W. Stoddard
Mr. & Mrs. Richard S. Storrs
Mr. & Mrs. Joseph S. Stout
Mr. & Mrs. Joseph S. Stout, Jr.
Mr. Theodore C. Streibert
Mrs. Terry Sullivan
Mr. Robert Swiggett
Mrs. E. W. Taylor
Mr. & Mrs. Frederick Taylor
Mrs. Henry C. Taylor
Mr. & Mrs. John W. Taylor
Mr. & Mrs. D. B. Tenney
Mr. & Mrs. Fred Thielking
Mr. & Mrs. Barry E. Thors
Mr. & Mrs. Stanley Trotman
Mr. & Mrs. Godfrey G. Truslow
Mr. & Mrs. E. T. Turner
Mr. & Mrs. William R. Udry
Mr. & Mrs. Stephen Van R. Ulrpan
Dr. & Mrs. Thornton Vandersall
Mr. & Mrs. Oliver 0. Vietor
Mr. & Mrs. Eric Von Raits
Mr. & Mrs. Colton P. Wagner
Ms. Christine M. Walker
Mrs. George Walker
Dr. & Mrs. David E. Warden
Mrs. Ethelbert Warfield
Mr. & Mrs. Bradford A. Wamer
Mr. & Mrs. Harold L. Warner, Jr.
Dr. & Mrs. James D. Watson
Mr. & Mrs. Arthur D. Weekes, Jr.
Mr. & Mrs. B. G. Weekes
Mrs. F. Carrington Weems
Mr. John C. Weghorn
Mr. & Mrs. Richard J. Weghom
Mr. & Mrs. Taggart Whipple
Mrs. Alex M. White
Mrs. James R. White
Whitehall Foundation
Mr. & Mrs. Theodore S. Wickersham
Mr. & Mrs. Douglas Williams
Mr. & Mrs. Duane N. Williams
Mr. & Mrs. Thorndike Williams
Mrs. John C. Wilmerding
Mr. & Mrs. Henry S. Wingate
Mrs. Willis D. Wood
Mr. & Mrs. William A. Woodcock
Mrs. Ford Wright
Mr. & Mrs. Woodhull Young
155


